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ABSTRACT 
Human use of antibiotics in China accounts for a quarter of worldwide antibiotic 
consumption and mainly occurs in outpatient and community settings. Non-clinical 
factors for antibiotic use are main drivers of its excessive consumption. To date, almost 
every intervention has focused exclusively on antibiotic prescribing behaviours, with 
little attention being paid to antibiotic consumer’s usage behaviours in the community. 
This PhD study aimed to develop an evidence-based, theory-informed 
behavioural change intervention to reduce inappropriate use of antibiotics in the Chinese 
communities. To conduct this programme of research, I employed a mixed-methods 
approach throughout the study phases, which included: 1) systematic literature reviews 
on determinants of antibiotic use in China and on behavioural change interventions to 
reduce unnecessary or inappropriate use of medical interventions, 2) secondary data 
analyses of large-scale population data on antibiotic use-related knowledge and practice, 
3) formative interviews to ensure acceptability and feasibility of proposed interventions, 
and finally 4) a mixed-methods feasibility evaluation of the pilot intervention.  
The systematic reviews identified non-clinical factors and potential pathways 
influencing public’s antibiotic use, and the components of promising behavioural 
change interventions. Using the survey data, some of the pathways were quantitatively-
assessed to inform the development of a context-appropriate intervention - reducing 
access to non-prescription antibiotics in rural China was identified to be a priority. 
Additionally, (mis-)perceived antibiotic efficacy for upper respiratory tract infections 
(URTIs) was found to be associated with increased odds of antibiotic use in the 
community. The new knowledge contributed to the design of the proposed intervention. 
Working with local partners, I developed and conducted a feasibility assessment of a 
pilot antibiotic take-back programme aiming to reduce household antibiotic storage and 
unsafe disposal in rural China. The proposed intervention was deemed feasible and 
appropriate.    
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CHAPTER ONE: INTRODUCTION 
1.1 Background 
Since the discovery of the first antibiotic, penicillin, by Alexander Fleming in 
1928, antibiotics have revolutionised modern medicine by making previously incurable 
infections and conditions, including pneumonia and other life-threatening bacterial 
infections, treatable. Today, many routine medical procedures, including caesarean 
sections, appendix removal, and chemotherapy, rely on effective antibiotics to prevent 
common infections from becoming fatal. However, decades of antibiotic misuse and 
overuse by doctors and patients (to treat minor ailments) and farmers (to promote 
growth in agriculture and aquaculture) have given rise to antimicrobial/antibiotic 
resistance (AMR or ABR), seriously threatening the health of humans, animals and the 
environment. Antibiotic resistance is a natural occurrence: when exposed to drugs, 
bacteria respond and evolve in ways that reduce or eliminate the effectiveness of 
antibiotics. Evidence has shown that excessive and inappropriate antibiotic consumption 
has accelerated the emergence and spread of AMR.1,2 In 2014, the World Health 
Organization (WHO) issued a warning, stating the world is headed for a “post-antibiotic 
era” where minor infections, once considered defeated, could kill again.1 
This PhD study aimed to develop an evidence-based, theory-driven, context-
appropriate behavioural intervention that seeks to influence norms and cultural habits 
and encourage prudent use and disposal of antibiotics in the community. Through a set 
of inter-linked aims and research activities, I led the development of a community-based 
intervention that was implemented by local partners and conducted a feasibility 
evaluation to assess it. Specifically, I employed a mixed-methods approach throughout 
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the study phases, which included four aims: 1) evidence synthesis: systematic literature 
reviews on determinants of antibiotic use in China and on behavioural change 
interventions to reduce inappropriate use of medical interventions driven by non-clinical 
factors; 2) social epidemiological methods: quantitative data analyses of large-scale 
population data on antibiotic use-related knowledge and practice; 3) intervention 
development and adaptation: formative interviews to ensure acceptability and feasibility 
of proposed interventions, and finally; 4) evaluation: a mixed-methods feasibility 
evaluation of the pilot intervention. Findings from my study were used in 2018 to 
inform the development of a full grant proposal of a multi-level complex intervention in 
Zhejiang province to the Joint Global Health Trial. This study has contributed to the 
field of implementation science research by laying out an explicit roadmap of the 
development of community-based behavioural change interventions and to overall 
global action against AMR by providing empirically-derived, evidence-based 
interventions, examples of appropriate feasible evaluation designs, and solutions to the 
identified methodological challenges associated with feasibility studies for such 
interventions.  
This chapter provides an introduction to the thesis and its structure. It briefly 
outlines the basis for this research with respect to the fields of implementation research 
and AMR, the aims and objectives, and the research methods and activities chosen.  
1.2 The background to the research  
1.2.1 Global health challenge of antimicrobial resistance 
Antibiotic resistance is a natural process that happens when bacteria (or other 
microorganisms like fungi) develop the ability to reduce or eliminate the effectiveness 
of the drugs designed to kill them. The bacteria survive and continue to multiply, 
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thereby causing more harm. Therefore, infections caused by antibiotic-resistant bacteria 
pose a serious threat to infection control as they become difficult, and sometimes 
impossible, to treat and require extended hospital stays, additional follow-up doctor 
visits, and costly and toxic alternatives. According to the surveillance report released by 
the World Health Organization (WHO) in 2014, resistance to a wide range of anti-
infective agents has become a worldwide public health threat that continues to grow, 
and its prevalence is closely related to the overuse of antibiotics.1China has one of the 
highest drug resistance rates in the world due to its excessive use. Take methicillin-
resistant Staphylococcus aureus (MRSA), broad-spectrum antimicrobial resistance, for 
example. According to the CHINET AMR surveillance network, in the tertiary 
hospitals, the average MRSA isolation rate ranged from 29.1% to 74.2% in 2014, with 
an average of 44.6%, and as high as 76.9% in eastern China where the prevalence in 
large cities such as Beijing, Shanghai and Guangzhou is higher than those of smaller 
cities.2,3 Another study based on data collected at 12 teaching hospitals across China 
from 2005 to 2010 reported the prevalence of MRSA and methicillin-resistant 
coagulase-negative staphylococci (MRSCoN) to be 46.8% and 81.5%, respectively.4 
The challenge is worse among Chinese children – it has been reported that 32.7% of S. 
aureus isolated from paediatric patients is MRSA, about twice of what has been 
observed in adult patients.5  
1.2.2 Common cold and antibiotics 
Considered the most common infectious disease among humans, the common 
cold - formally referred to as acute upper respiratory tract infections (URTIs) and 
usually informally described as a cough, runny nose, cold, or flu – refers to a group of 
diseases caused by members of several families of viruses.6 These diseases are 
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diagnosed on symptomatology and treatments are mainly symptomatic, rather than 
focusing on changes in viral titres in the airway or viral shedding.6 The symptoms of 
“Common cold” are triggered in response to the viral infection of the upper respiratory 
tract (i.e. nose and throat) and the immune response to infection may be the main factor 
in generating the symptoms, rather than damage to the airway.6 Depending on the 
physiological and immunological experience of the person who contracts it, common 
cold could occur without symptoms, could cause death, or most commonly could be 
associated with an acute self-limiting illness.6 Despite the common cold being a self-
limiting viral infection for which antibiotics are both unnecessary and may result in 
adverse outcomes,7 data show that the common cold is the most prevalent reason for 
primary care seeking and antibiotic prescribing in many countries.8-11  
The common cold strikes frequently, affecting every age and race: adults 
experience colds two to five times per year while children may catch a cold seven to ten 
times per year.12-14 The syndrome of the common cold is defined by experimental colds 
including a short mild illness with early symptoms of sneezing and sore throat and later 
symptoms of nasal discharge, nasal obstruction, and cough.6 They are so well-
recognised by patients and caregivers that, before consulting a physician, a layperson 
often engages in self-diagnosis and decides on a course of action, including whether or 
not to treat, to seek care, and/or to use medications.15-18 Medical anthropologists have 
found that high familiarity with common cold symptoms has resulted in a high 
consistency in the diagnostic process and a response that is shared in the form of a 
“cultural concept and practice” within each community, across people, and between lay 
and physician groups.19,20 Therefore, individual’s decision-making process for treating 
the common cold can be viewed as a continuum of steps starting from identification of 
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symptoms and self-diagnosis to choice of care pathways (e.g. no care, self-care or 
formal care) and use of medications and/or antibiotics (Figure 1-1), where each step 
may be shaped more by individual and socio-contextual factors than by clinical 
diagnoses.  
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Figure 1-1. Decision-making for antibiotic use for upper respiratory tract infections (URTIs) 
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1.2.3 Health system in China 
China has a three-tiered system for healthcare delivery, based on urban and rural 
residences; in rural areas, health care providers operate at county, township, and village 
levels and in urban areas at municipal, district, and community levels.21 Hospitals in 
China can be public or private, non-profit or for-profit. Urban areas have both public 
and private secondary and tertiary hospitals whereas township hospitals and community 
hospitals are mostly public. In general, the capacity of and the quality of care given by 
primary care facilities are considered inadequate, especially in the rural areas.22 Private 
facilities take up smaller market share, mainly offering ambulance services or 
specialised care, and are considered of lower quality and utilised by rural migrants in 
urban areas.23,24 Additionally, every city and county have at least one independent 
traditional Chinese medicine (TCM) hospital, and most comprehensive medical 
institutions and grassroots health facilities have a TCM department that provide TCM 
services such as herbal medicines and acupuncture services.25 Many Chinese people use 
traditional Chinese medicine (TCM) as a supplement to western medicine or self-care. 
TCM is considered a natural treatment with  fewer side-effects and when a common 
cold is present, is often given by providers with a mixture of western medicine. The fee-
for-service payment mechanism in the health care system, introduced in the late 1980s 
as a part of the economic reform, has reduced the role of the government in financing 
healthcare service and shifted a traditionally community-level, preventive care system to 
a commercialized, sub-specialty-oriented healthcare system over time.26 To compensate 
for the reduced subsidy, health facilities are allowed to make profit from drug sales - a 
15% or more mark-up on medicines.26 Such a mechanism incentivises hospitals to 
attract and retain health care consumers who could have been cared for by primary care 
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facilities and to profit from excessive examinations, unnecessary treatment, and overuse 
of medicines by routine healthcare services.22 The problem of over-prescribing 
(including antibiotics) was later improved after the introduction of the zero mark-up for 
essential medicines at primary level facilities.27 Inequity in health and health care exists, 
with gaps between urban and rural areas, among regions of different economic 
development levels, and among different groups of people.28  
Since 2003, China has undergone a comprehensive health care insurance reform and in 
2011, achieved universal health insurance coverage (95.7%). The public are covered by 
three main basic health insurance schemes based on employment (urban only) and 
residence or Hukou, a household register system. The Urban Employee Basic Medical 
Insurance (UEBMI) covering urban employees and retired employees is a mandatory  
employee-based health insurance funded by employer and employee contributions.22,25 
People who are not covered by UEBMI can join the voluntary the Urban Residence 
Basic Medical Insurance (URBMI) or the New Rural Cooperative Medical Scheme 
(NRCMS), which are jointly financed by premiums and government (mainly by 
government subsidies, about 70% of the total funds).22,25 These basic insurance systems 
cover inpatient and outpatient diseases in compliance with regulations and have specific 
deductibles, co-payment percentage, and a reimbursement cap.22,25 An urban and rural 
medical assistance system, financed through various channels including government and 
public donations, provides subsidies that form a safety net in China to ensure that those 
in poverty who are unable to afford the basic medical insurance premium have access to 
basic health care.25 
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1.2.4 Antibiotic use and resistance in China 
According to the Chinese Academy of Sciences, in 2013 total antibiotic usage in 
China was approximately 162,000 tons, accounting for roughly half of antibiotic usage 
worldwide.29 With a per-capita use of antibiotics of 138 g – ten times higher than in the 
United States30,31 – the AMR burden in China is reportedly much more serious than in 
other countries.32 The majority of antibiotics for human use in China are consumed in 
the outpatient setting, often unnecessarily for viral URTIs.33 Though usually benign and 
self‐limiting, URTIs have been a critical driver of inappropriate and excessive use of 
antibiotics in China,34-37 where antibiotics have been perceived for decades as a panacea 
by the general public and medical workers, and misused at all levels of Chinese medical 
care.30,31,38-42 In his landmark 2016 global AMR Review,43 Lord Jim O’Neill highlighted 
the importance of engaging China, and that the first step towards combating AMR is 
reducing demand through behavioural change interventions. However, despite WHO's 
efforts championing appropriate antibiotic use for the common cold, curbing antibiotic 
overuse and misuse has gained only limited traction in China.44 The 2019 BMJ policy 
review44 of China’s 10-year effort in health reform concluded that, although its 
enhanced national antibiotic stewardship programmes may have had a positive effect on 
regulating antibiotic use in tertiary hospitals, there has been no improvement in primary 
care or rural settings, where most of the population resides and the majority of antibiotic 
use takes place. 
Reasons for antibiotic misuse and antibiotic resistance in China include: 
improper prescribing and dispensing by clinicians, inadequate government oversight – 
especially poor policy enforcement at the local level - and inappropriate use among 
patients. 30,31,38,40-42  This misuse is due to cultural norms, as well as patients and 
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caregivers’ misconceptions, demands, and unrealistic expectations.30,31,38,40-42  Regional 
inequalities and disparities between urban-rural income per capita may also play a 
role.45 (Figure 1-2)  
Rising levels of AMR in China in recent years have become a serious healthcare 
problem, with high resistance rates of most common bacteria to clinically important 
antimicrobial agents including methicillin-resistant Staphylococcus aureus (MRSA), 
erythromycin-resistant Streptococcus pneumonia, ciprofloxacin-resistant E. coli, 
extended-spectrum β-lactamase-producing E. coli, imipenem-resistant Pseudomonas 
aeruginosa, and imipenem-resistant Acinetobacter baumannii—the so-called 
“superbugs” in nosocomial infections – and other bacteria that are resistant to 
fluoroquinolones, macrolides and third-generation cephalosporins.46-48 In tackling AMR 
in recent years, the Chinese government has enacted a series of clinician-directed 
measures to control the consumption of antibiotics, including a comprehensive 
surveillance network involving tertiary hospitals in distinct regions nationwide that was 
first created in 2005.2  A series of regulations and clinical guidelines were also 
introduced to tackle the irrational use of antibiotics by enhancing antimicrobial 
stewardship along with health system reform, 44 including the essential medicines 
scheme and zero-mark-up policy on antibiotic prescriptions,49-51 systematic training and 
a stewardship program (e.g. guidelines, lectures, workshops),52,53 and audit and feedback 
on antibiotic prescribing and dispensing practices.54-56 Importantly, in 2011, the 
Ministry of Health set up a special task force on antibiotic stewardship, resulting in strict 
rulings that covered all aspects of antibiotic use in hospitals with clear indicators linked 
to hospital quality evaluation procedures. Chief among the rulings was that antibiotic 
prescriptions for hospitalized patients and outpatients was set at less than 60% and 20% 
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of all prescriptions, respectively, and antibiotic utilization in hospitalised patients should 
be less than 40 daily defined doses per 100 patient days.48 These indicators have a direct 
impact on the allocation of future medical resources as well as the appointment or 
dismissal of hospital presidents, which has led to rapid reduction of the use of 
antibiotics in many tertiary hospitals.44,48  
However, these measures have shown only minimal impact on curbing the 
misuse of antibiotics and the use of antibiotics in primary care and rural settings remains 
high. 44 A high percentage of URTI patients in China was prescribed antibiotics and 
overutilization of antibiotics is particularly problematic in rural areas and in lower-level 
hospitals and health clinics.33-38,44,57 Further, though the sale of antibiotics in retail 
pharmacies without prescription was banned as early as 2004 it suffered from 
insufficient enforcement and absence of supervision, and was not addressed in the 2011 
regulations. Both over-the-counter sales and self-medication of antibiotics have been 
prevalent.58 In 2016, China announced a comprehensive national action plan to contain 
AMR, which included a prominent goal of prescription-only antibiotics at pharmacies in 
all provinces by 2020; however, specific details to achieve the goal were largely 
absent.59 Most of these interventions to date have been designed to address structural 
issues that influence individual antibiotic use and focus on supply-side factors through 
the promotion of rational prescribing, dispensing, and enforcing prescription-only sales, 
leaving demand-side factors conspicuously unaddressed.  
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Figure 1-2. Map of Chinese provinces indicating GDP PPP per capita in USDi 
 
Inappropriate demand and use of antibiotics for the common cold among various 
Chinese populations can be generally categorised into five types of ill-practice:  
asking/pressuring doctors for antibiotics,45 self-medication with antibiotics,34,41,45,60-64 
taking antibiotics as prophylaxis,45,61 storing antibiotics at home,41,45,60,62 and deviation 
from medical instructions, including incomplete courses, using antibiotics intermittently 
rather than regularly, and increasing and decreasing doses.38,45,61,65 Scientists have been 
attempting to dissect the complexity of the issue and investigating the reasons why 
interventions have been less effective than intended; they conclude that doctors are not 
solely to blame for misuse.66 One study estimated that antibiotic misuse in China is 
more driven by the demand-side of the health system – patients and caregivers – than by 
 
i Babones, Salvatore. China Quietly Releases 2017 Provincial GDP Figures. Forbes. Feb 12, 2018.  
https://www.forbes.com/sites/salvatorebabones/2018/02/12/china-quietly-releases-2017-provincial-gdp-
figures/#64558dc820dc (Last accessed: July 1, 2018) 
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the supply side.45 In other words, targeting clinicians without addressing demand side 
issues addresses less than half of the problem. Evidence showed that putting pressure on 
hospitals and doctors alone will not adequately tackle the challenge of antibiotic 
overuse44; rather, patients who sought care and displayed knowledge of appropriate 
antibiotics use could effectively reduce antibiotic prescription rates.56 Furthermore, as 
discussed above, when encountering the symptoms of the common cold before seeking 
formal care at a clinic, a lay person or caregiver is likely to have already gone through a 
pre-existing self-diagnostic process (Figure 1-1.) and formulated a response that was 
heavily influenced by the culture and community in which they live. Not surprisingly, 
self-medication with antibiotics for the common cold by the Chinese general public has 
been consistently reported as prevalent and is heavily linked with inappropriate use of 
antibiotics66, including using left-over antibiotics on a second occasion,62,63  frequent 
change in dosage, or simultaneous use of the same antibiotic with different 
names.34,45,62,65,67 In particular, non-prescription antibiotics have been very easy to 
access across China; without professional supervision, many Chinese households self-
report to use antibiotics from their own household storage or over-the-counter 
purchases.45,60,65,68-74 Depending on the region, 40-50% of those surveyed reported 
treating themselves with antibiotics without seeing a doctor, 31,61,75 and 20-30% had used 
antibiotics to prevent the common cold. 31,61 Even among the better-educated population 
- university students - many had misconceptions about antibiotic efficacy for self-
limiting illnesses and inadequate knowledge, and similarly reported a high prevalence of 
antibiotic misuse.61,67,75,76 
Medical decisions such as antibiotic use and treatments for the common cold are 
not made in a vacuum. They are influenced by factors at multiple levels, including 
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intrapersonal factors (e.g., knowledge and attitudes), interpersonal factors (e.g., social 
networks, communication with doctors), and societal environments (e.g. social norms, 
access to care, and laws and policy).77,78 In spite of the magnitude of antibiotic misuse in 
China and its unique sociocultural context, there is a dearth of evidence examining how 
these different levels of influences affect people’s medical decisions for the common 
cold, especially through their AMR awareness, attitudes, and knowledge about antibiotic 
use.  
1.2.5 Implementation research 
Implementation research, which focuses on the linkage between research and 
practice for effective implementation of proven interventions to improve health 
outcomes, emerged in recent years in response to the need to address the challenges of 
the know–do gap in real-world settings during the development and delivery of public 
health approaches.79 Implementation research builds on several research traditions - 
each has its own research targets, research questions and sets of core disciplines - 
providing a set of methods, tools, and approaches for bridging research and practice to 
create and apply knowledge that improves the implementation of health policies, 
programmes and practices.79 Implementation research is a growing but still not fully-
understood field of health research; considerable confusion remains regarding its 
terminology, approach and scope.80 In defining the scope of this PhD project and 
guiding the selection of methodology, I adopted the definition and principles first 
published by Peters et al80 on BMJ in 2013 and later iterated on by Theobald et al79 in 
the Lancet in 2018, which stated “Implementation research is the scientific inquiry into 
questions concerning implementation—the act of carrying an intention into effect, 
which in health research can be policies, programmes, or individual practices 
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(collectively called interventions)”.80 As implementation research seeks to understand 
and work within real world conditions, rather than trying to control them, Peter et al 
emphasised the central role that context plays in implementation research, which 
recognises the influence social, cultural, institutional and physical environments exert 
on people’s health and health behaviours.80 Theobald et al further identified a set of 
eight defining characteristics of implementation research, which were pinpointed during 
a series of structured and consultative international meetings with researchers, donors 
and policy makers, including context specific, relevant and agenda-setting purpose, 
methods fits for purpose, demand driven, multi-stakeholder and multidisciplinary, real 
world, real time and focuses on processes and outcomes.79  
Implementation research is typically a multi-method inquiry that uses both quantitative 
and qualitative data to assess how the programmes and policies – i.e. “interventions”, 
which are usually “complex” - produce their impacts. Interventions that have multiple 
interacting components with several “dimensions of complexity” can be described as 
“complex interventions,” according to the Medical Research Council (MRC), with 
distinctive characteristics in their complexity, such as variations in number and 
difficulty of behaviours required by those delivering or receiving the intervention and 
degree of flexibility required for implementation.81 The MRC guidance on developing 
and evaluating complex interventions provides a framework (Figure 1-3) that serves as a 
structured roadmap for the design and evaluation of such interventions.81 The 
framework highlights the importance of the development, feasibility and piloting phases 
of intervention design before engaging in full scale evaluations for effectiveness and 
cost-effectiveness and the final phase of implementation and dissemination.81 These 
initial phases ensure there is an evidence base and theory to support intervention 
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development, allow modelling the intervention implementation process and outcomes, 
and enable testing procedures, recruitment and retention. MRC also recommends the 
adoption of the RE-AIM (reach, effectiveness, adoption, implementation, 
maintenance)82 and/or other formal frameworks for developing and testing complex 
interventions.  
Figure 1-3. MRC framework of complex interventions81 
 
 
 
 
[Research Decision: Study Aim] For this project, I aimed to apply implementation 
research  frameworks in the development of and assessment of the feasibility of the 
proposed community-based intervention, where feasibility is defined as “the extent to 
which an intervention can be carried out in a particular setting,”80 in this case, rural 
Zhejiang. 
1.2.6 Feasibility and pilot studies 
There has been an increasing emphasis by large public funding bodies, such as 
MRC, UK National Institute for Health Research (NIHR), and the US National Institute 
for Health (NIH), on the importance of engaging in sufficient preliminary work prior to 
Research Aims 1-3 
Research Aim 4 
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the main bids of large-scale trials of complex interventions, so as to determine whether 
comprehensive and multilevel evaluations are justified. Given resource constraints, 
feasibility and pilot studies are necessary to produce a set of evidence that can evaluate 
and prioritize interventions with the greatest likelihood of being efficacious.83 Some 
researchers compare the spectrum of implementation research for complex interventions 
to that of pharmaceutical drug trials, which have a tradition of clearly defined stages 
from pre-clinical studies to phase 4-post-marketing studies,80,84 and note that feasibility 
studies are conducted with both flexible methodology and a main goal of assessing the 
feasibility of a newly developed intervention, as opposed to a rigorous examination of 
outcomes.85,86 This emphasis on preliminary work fuelled the rise of implementation 
research and the publishing of the results of feasibility and pilot studies; however, to 
date, the published literature has not proposed standards to guide the design and 
evaluation of feasibility studies.83 In this project, I therefore followed the MRC 
guidance, which stated that feasibility and pilot studies should address the main 
uncertainties that could be anticipated in development work, including acceptability, 
compliance, delivery of the intervention (fidelity), recruitment and retention, and that a 
mixed-methods approach is likely needed.81 In fact, a series of feasibility and pilot 
studies may be required to progressively refine the design before embarking on a full-
scale evaluation; therefore, some have described feasibility studies as iterative, 
formative and adaptive, a so-called kinaesthetic developmental learning process.81,83,87  
For the bid of the Joint Global Health Trial (Call 9), Zhejiang University funded 
and conducted a series of pilot studies to develop and test the feasibility of the proposed 
community-based behavioural change intervention. I contributed to the development of 
the intervention, designed and supervised a formal feasibility study nested within a 
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series of pilot projects, and interpreted and reported the evaluation data. Implementation 
research for behavioural change is largely influenced by a set of core disciplines in 
psychology, education, sociology, anthropology, education, and epidemiology,79 which 
follows the traditions of programme evaluation, dissemination and implementation in 
evidence-based medicine and participatory action research, as presented in Table 1. Data 
reported in this study came from a pilot study conducted in June 2019, which had a 
controlled before and after design – a stricter study methodology than most non-trial 
feasibility and pilot studies – with the intention of laying the groundwork for further 
work.  
 
Table 1-2. Implementation research traditions for behaviour change and their 
typical research targets, research questions, adapted from Peters et al80 and 
Theobald et al79 
 
Traditions Primary audience for 
research 
Research Questions 
Programme 
evaluation 
Stakeholders of a programme 
(e.g., funders, implementers, 
or the intended beneficiary) 
How is the programme designed, 
implemented, used, fit to context 
and problems, and with what 
results and programme changes? 
Dissemination and 
implementation of 
evidence-based 
medicine 
Practitioners, health 
organisation managers, and 
policy makers who do not 
use evidence-based 
interventions 
What promotes the integration of 
research findings and evidence on 
interventions into health-care 
practice? 
Participatory action 
research 
Research participants and 
community 
members  
How can we (community members 
and research participants) learn and 
be empowered to act? 
 
The purpose of this pilot study was to assess important parameters that would be 
needed to design the main study, e.g., willingness of local partners to recruit 
participants, number of eligible participants, follow-up rates, response rates and 
adherence/compliance rates. Zhejiang University had a plan for further work after this 
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pilot study, and the aim was to identify any problems or areas of concern and amend the 
intervention before the implementation of a full-scale study. 
Further, the MRC guidance on the feasibility/piloting phase has been extended to 
provide more detail on process evaluation through the publication of the MRC PHSRN 
process evaluation summary guidance,88 which enhances the development phase of the 
original MRC guidance. Derived from the guidelines, Figures 1-488 present the key 
functions of process evaluation (in blue boxes) informed by the intervention 
descriptions, relationships amongst them, and how they inform interpretation of 
outcomes.  
Figure 1-4. MRC PHSRN Process evaluation88   
 
[Research Decision: Work Stream Plan, informed by implementation science 
frameworks] Table 1-1 presents a work stream plan that summarises how the MRC 
guidance was operationalised by this PhD project. To meet the objectives of a feasibility 
study and fulfil the kinaesthetic nature of the intervention developmental process, I 
created the work stream plan based on the core disciplines of implementation science-
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related frameworks to guide the development and feasibility assessment of a behavioural 
change intervention, including RE-AIM, evidence-based medicine (e.g. intervention 
mapping89,90), intervention development model (e.g. MRC PHSRN Process evaluation 
Summary guidance,88 Six Essential Steps for Quality Intervention Development 
(6SQuID)91), and participatory action research (e.g. community-based participatory 
research (CBPR) principles).  
1.3 Research objective 
The primary objective of this study was to employ implementation research methods in 
the development of a community-based behavioural change intervention that aims to 
reduce inappropriate use of antibiotics, especially non-prescription use and unsafe 
disposal of antibiotics, in rural China. 
1.4 Research questions 
On the basis of the research gaps and decisions mentioned above, the following research 
questions were investigated: 
1. Question 1: What are the evidence-proven non-clinical determinants of various 
antibiotic use behaviours among Chinese clinicians, patients and caregivers? 
(Aim 1, chapter two) 
2. Question 2: What are the “active ingredients” in behavioural change 
interventions that have been proven to be effective in reducing the inappropriate 
or non-essential demand/use of medications or medical services? (Aim 1, chapter 
three) 
3. Question 3: What is the prevalence of antibiotic misuse for self-limiting illnesses 
among Chinese children in the community, within and beyond clinical settings? 
(Aim 2, chapter four)  
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4. Question 4: What are the factors influencing treatment decisions for the upper 
respiratory tract infections (URTIs, aka the common cold) with respect to 
antibiotic use in the Chinese community? (Aim 2, chapters five and six) 
5. Question 5: What should be the components of a novel community-based 
behavioural change intervention aiming to reduce antibiotic misuse through a 
focus on reducing unnecessary demand and increasing safe disposal? (Aim 3, 
chapter seven) 
6. Question 6: How feasible is it to implement the newly-developed behavioural 
change intervention that aims to reduce non-prescription use and unsafe disposal 
of antibiotics in rural Zhejiang, China? How well are the methodological issues 
around a feasibility study addressed in the pilot? (Aim 4, chapter eight)  
1.5 Research aims and tasks 
The research questions are addressed through 4 interlinked aims (Figure 1-5), each with 
associated methods, tasks, outputs: 
1. Aim 1 - Knowledge synthesis: to conduct systematic literature reviews in 
identifying (1a) non-clinical factors influencing health care consumers’ demand 
and use of antibiotics, and (1b) behavioural change interventions (BCIs) and 
techniques (BCTs) that have been proven to be effective in reducing health care 
consumers’ demand and use of medications or medical services. (Chapters two 
and three) 
2. Aim 2 - Social epidemiological methods to assess problems: to conduct 
quantitative data analyses and employ social epidemiological methods in 
exploring determinants of Chinese consumers’ treatment decisions for the upper 
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respiratory tract infections (URTIs) with respect to of antibiotic use. (Chapters 
four, five, and six) 
3. Aim 3 - Intervention Development & Adaptation: to employ a mixed-methods 
approach to develop a new behavioural change intervention to reduce non-
prescription use and unsafe disposal in the context of China. (Chapter seven) 
4. Aim 4 - Feasibility Evaluation: to employ a mixed-methods approach to assess 
the feasibility of the newly developed behavioural change interventions. 
(Chapter eight) 
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Figure 1-5. Research aims and tasks  
 
 
Aim 1: 
Knowledge 
synthesis
Aim 2: Social 
epidemiological 
methods to assess 
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Intervention 
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adaptation
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intervention 
eevelopment 
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assessment 
(mixed-methods)
Aim 4: 
Feasibility 
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(mixed-methods)
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1.6 Research methods and approaches  
I briefly summarise below each of the methods used in this PhD project and present 
a short overview of the objectives and progress for each phase of research in their 
corresponding chapters.  
 
Conceptual framework for behavioural change 
Kok et al.89,90 developed the Intervention Mapping (IM) taxonomy of behaviour 
change methods with an emphasis on an ecological approach, which was closely 
followed during the selection of methodology. In addition, Wight et al. mapped out 
six essential Steps for Quality Intervention Development (6SQuID).91  For this thesis 
project, with an aim to reduce unnecessary and/or inappropriate use of antibiotics for 
URTIs in China, I set out to incorporate behavioural theories like the Health Belief 
Model (HBM),92,93 which has been widely used since it was developed in 1966 in 
understanding a variety of long- and short-term health behaviours by focusing on the 
attitudes and beliefs of individuals, particularly in disease prevention 
behaviours.92,94,95 However, individual’s health decisions are not entirely driven by 
their cognitive and rational characteristics, and contextual factors – including access 
to antibiotics and interpersonal connections – are equally critical to healthcare 
decision-making processes.96-99 HBM92,93 does not account for the impact of habitual 
behaviours that are relatively independent of conscious, health-related decision 
making processes (e.g., storing leftover prescriptions) or socio-ecological 
environment (e.g. doctor-patient relationships, family dynamics, or overprescribing) 
on individuals’ decisions.92 To understand the impact of individuals’ perception of 
illness and treatment on one’s decisions for antibiotic use while accounting for the 
complex interplay between factors at different levels of socio-ecological 
environment (i.e. individual, interpersonal, and societal), in addition to HBM92,93, the 
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conceptual framework of this thesis (presented in Figure 1-6) also consulted the 
constructs of the Social Ecological Model.100 The two behavioural models helped 
explain and predict individual’s uptake of antibiotics centred around one’s risk 
appraisal of impending health threat (e.g. URTIs) while recognising multifaceted and 
interactive effects of personal and environmental factors that determine antibiotic 
use.  
44 | P a g e  
 
Figure 1-6. Conceptual Framework: Decisions about antibiotic use for upper respiratory tract infections (URTIs)   
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 Key modifying factors at individual, interpersonal, and societal levels that 
influence an individual’s antibiotic use decision included their knowledge and 
attitudes around antibiotic use and the impending health threat (e.g. URTIs), 
perceived threat to sickness or disease (perceived susceptibility), belief of 
consequence of contracting the health threat (perceived severity), potential positive 
benefits of antibiotic use (perceived benefits), perceived barriers to antibiotic use, 
and exposure to factors that prompt antibiotic use (cues to action). The conceptual 
framework of this thesis underscores that behavioural change occurs in a social 
context with dynamic and reciprocal interactions between the person, community, 
and environment - both spatially and temporally – as an individual’s behaviour is 
influenced by their past experiences through expectations and reinforcements. The 
modifying factors can potentially inform intervention design to change individual’s 
antibiotic use behaviours whereas socio-contextual factors, also recognised in the 
multilevel model, are less amendable. The model was later employed to guide the 
literature review (reported in chapter two), quantitative data analyses (reported in 
chapters five and six) and to inform the theory of change for the development of a 
behavioural change intervention (presented in chapters seven and eight). 
Because published feasibility study typologies for behavioural change 
interventions at the community level are rare, and practically non-existent in low and 
middle-income countries (LMIC), it was necessary to landscape what behavioural 
change techniques (BCTs) have been tested to be effective in improving consumers’ 
use of medical interventions and the implementation strategies and associated 
conditions in order to develop a new behaviour change intervention for improving 
antibiotic use in rural China,. Therefore, I concurrently conducted a second 
systematic literature review on behavioural change interventions that have been 
proven effective in reducing inappropriate demand/use of medications and medical 
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procedures. [Chapter three] The BCTs identified from the review were used to 
inform the initial design and development of the proposed community-based 
behavioural change intervention. I concluded in the review that interventions 
consisting of both health education messages (e.g. 4.1 Instruction on how to perform 
the behaviour 4.2 Information about Antecedents, 5.1 Information about health 
consequences, or 5.2 Salience of consequences) and a supporting environment that 
encourages and incentivises the adoption of a new behaviour (e.g. 8.2 Behaviour 
substitution, 10.1 Material incentive, 10.2 Material reward, 12.1 Restructuring the 
physical environment, and 12.5. Adding objects to the environment) are more likely 
to be successful.  
Alongside the literature reviews, I conducted three quantitative data analyses 
on two large-scale survey datasets across various geographic regions and economic 
developmental stages in China collected by Zhejiang University on public antibiotic 
use. The main target populations of these surveys were young adults and young 
parents. [Chapter four] I conducted a descriptive analysis on the severity and 
prevalence of antibiotic misuse for self-limiting conditions among Chinese parents 
on their children aged 0-13 years. [Chapters five and six] Then, guided by HBM92,93 
and SEM100 (presented in Figure 1-6. Conceptual Framework), I explored factors 
influencing treatment decisions for the common cold among young adults and young 
parents with respect to antibiotic use. Results from these analyses were used to 
inform socio-demographic priorities of target population and components for the 
proposed intervention. For example, I found that knowledge as a determinant of 
antibiotic use was in fact a complex domain; correcting misconceptions around 
antibiotic efficacy for the symptoms of the common cold and inflammation should 
be included as a core element of education interventions, as improvements in 
awareness of the risks of antibiotic resistance or ability to identify antibiotics without 
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clarifying such misconceptions might lead to unintended adverse impacts. Also, 
access to antibiotics is highly associated with self-medication for treatment of self-
limiting conditions, especially the common cold. Sources of antibiotics included 
unnecessary prescriptions, inappropriate prescriptions resulting from patients’ 
demands, and non-prescriptions antibiotics, such as over-the-counter purchases and 
household storage of antibiotics. As such, a complex intervention to simultaneously 
address all of the factors on both the supply-and-demand sides would be needed to 
effectively reduce antibiotic misuse in a Chinese community. Interventions on 
supply-side factors would be addressed by other components of the bid to joint 
global health trial, mentioned above. In this project, I focused on the development of 
a new community-based intervention that aimed to improve the awareness of the 
danger of antimicrobial resistance (AMR) and reduce unsafe antibiotic disposal in 
rural China.  
[Chapter seven] Steps taken in the development of behavioural change 
interventions have been closely aligned with the 6SQuID model,91 a pragmatic 
evidence-based guide to maximise likely effectiveness. I largely followed the first 
five steps of the six-step process of designing an intervention: 1) defining and 
understanding the problem and its causes (chapter two); 2) identifying which causal 
or contextual factors are modifiable: which have the greatest scope for change and 
who would benefit most (chapter four to six); 3) deciding on the mechanisms of 
change (chapter three); 4) clarifying how these will be delivered (chapter three and 
chapter seven); and 5) testing and adapting the intervention (chapter eight).91 The 
final step of 6SQuID, collecting sufficient evidence of effectiveness to proceed to a 
rigorous evaluation91, shall be conducted in the immediate future as a small pilot 
trial or a larger randomised controlled trial to establish its effectiveness. These five 
steps are presented in a theory-based work stream plan for the development and 
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feasibility-testing of behavioural change interventions at the community level with 
the intention for future full-scale implementation. The work stream plan (Table 1-1) 
for this project integrated the principles of RE-AIM, intervention mapping and 
6SQuID model, and community-based participatory research (CBPR), which helped 
me to identify feasibility-related evidence addressing methodological questions set 
out by the MRC guidelines and for the future implementation of the full trial. 
Following these theoretical frameworks and principles carefully, I expected each 
step in the development process would be based on best available theory and 
evidence at the time and would allow me to better use scarce public resources.91 I 
laid out four main research aims and associated tasks, which eventually led to the 
development of a community-based intervention to improve awareness of the danger 
of AMR and unsafe disposal and to reduce household storage of antibiotics for the 
target population, rural Chinese residents. The proposed interventions benefited from 
a broad variety of implementation research strategies, using multiple data sources to 
inform implementation changes. Evidence and intervention ideas generated by this 
PhD project Aims 1 and 2 were immediately used/field-tested by researchers at 
Zhejiang University in real time and real context for the development and testing of 
the proposed intervention in rural Zhejiang. The targeted interventions started with 
needs assessments to better understand the community of rural residents, revealing 
that a “proper” way of using and disposing of antibiotics should be established early 
on in the development of health education messages and the evaluation tool. I 
selected the health message content based on findings from secondary data analyses. 
Regarding the action design of the health education materials, of which the process 
and rationale are rarely reported, Zhejiang University adopted the design from 
products produced in an AMR crowdsourcing campaign they conducted with the UK 
Embassy in Shanghai in 2016. The behaviour component - an antibiotic take-back 
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programme - was jointly decided upon by researchers at Zhejiang University and 
local stakeholders. See Appendices II and III for sample health education and 
training materials.  
[Chapter eight] The design and delivery process of this chapter have relied 
heavily on the MRC’s progress evaluation framework.  Developing education 
materials and implementing a feasibility study for rural residents was challenging, 
because many were illiterate or possessed low ability to recognise antibiotics levels. 
In 2018 and 2019, Zhejiang University conducted a series of feasibility studies on 
the proposed intervention starting with flexible methodology, as the newly 
developed intervention materials required considerable testing and refinement to be 
appropriate for the target audience. In June 2019, I designed and led a formal 
feasibility study with a control group, nested within the feasibility and pilot work 
Zhejiang University was conducting. Feasibility data from this particular pilot are 
reported here. I found that the regular involvement by the Women’s Federation in 
facilitated community-led interventions generated greater community participation 
and was cost-saving. Eventually my assessment of resources required for the full 
study, as suggested by Thabane et al,101 prompted the conceptualization of the 
implementation capital for evidence-based practice (Figure 1-7) that enabled and 
determined the success of the knowledge translation process. I found that 
implementation capital for evidence-based practice consists of five key dimensions, 
which are bonding social capital, bridging social capital, human capital, financial 
capital and contextual capital. More detailed discussions on implementation capital 
were included in chapter seven. 
All study participants were informed and consented. The study methods 
involving use of primary and secondary data were approved locally in China via 
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Zhejiang University Ethics Committee and the LSHTM Ethics Committee. The 
ethics approvals are attached in Appendix IV.  
 
Figure 1-7. Implementation Capital for Evidence-Based Practice  
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1.7 Collaborations and partnership  
Zhejiang University is a leading institution in Chinese AMR research and 
recently experienced a fatal outbreak of drug-resistant pneumonia in one of its 
affiliated hospitals.102 I have served as an external expert for technical support and 
established a strong partnership with Zhejiang University since 2016 prior to the 
beginning of this PhD programme. I collaborated with the Institute of Social 
Medicine and Family Medicine on the investigations of many contemporary pressing 
public health issues in China, such as maternal and child health, public health 
emergency preparedness and response, and AMR. In recent years, the Zhejiang 
University Research Team on Prudent Use of Antibiotics, led by Professor Xudong 
Zhou (PI), have been pioneers in conducting large-scale surveys of public’s 
antibiotic use and trials of AMR interventions to reduce antibiotic misuse in the 
Chinese context – most were facility-based. I identified an urgent need for an 
intervention to reduce antibiotic misuse in the community.  
The nature of the proposed PhD project requires strong local support to 
ensure context-appropriateness and impact beyond lab settings. This PhD project – 
though a self-funded study – therefore was set up to collaborate closely with 
Zhejiang University. Since March 2018, I participated in weekly phone conferences 
with the PI and/or the team and whenever possible, conducted in-person meetings 
when I was on site. A signed letter of support laying out terms and conditions is 
attached in Appendix 1. In brief, for Aim 2, Zhejiang University agreed to share 
population data on antibiotic use for self-limiting illnesses by young adults 
(university students) and young parents with children under 13 years old. Prior to 
this PhD study, I contributed to the development and implementation of the surveys 
and during this PhD, I applied social epidemiological methods for secondary data 
analyses. I then created a theory-based work stream plan for the proposed 
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intervention, developed by this PhD project - a pilot antibiotic take-back programme 
embedded in local bartering markets for recyclables. This framework, presented in 
Table 1-1, was a working document used to guide the collaboration with local 
partners during the development and feasibility assessment. 
Under Aim 3, I conceived the intervention idea and design, visited targeted 
communities to understand local needs and concerns, and participated in the 
introduction sessions with local government officials and shareholders organised by 
Zhejiang University. Zhejiang University provided the financial, social and human 
capital necessary to implement an evidence-based practice project. They obtained an 
Institutional Review Board approval in compliance with local ethics guidelines, 
facilitated stakeholder engagement, and supported the proposed pilot activities, 
including securing pilot sites, producing project materials, and facilitating the 
recruitment of project participants and collection of data according to the study 
design.  
In preparation for a large community-based trial, building on their previous 
work, from January to June 2019, Zhejiang University conducted a series of pilot 
and feasibility work testing and refining various elements of the proposed 
intervention in targeted communities (e.g. the design of promotional materials, 
selection of household items for exchange at the bartering market, and the 
appropriate conversion rate between returned antibiotics and preferred household 
items). Evidence and intervention ideas generated by this project Aims 1 and 2 were 
immediately used/field-tested by the Zhejiang University research team in real time 
and real context in rural Zhejiang. To achieve Aim 4, I developed a feasibility study 
and associated assessment instruments, led the collection of formative and feasibility 
data, conducted data analyses, and drafted manuscripts for publication. The primary 
data collected to achieve Aims 3 and 4 came from a formal feasibility study in June 
53 | P a g e  
 
2019 that aimed to assess various elements altogether as a community-based 
intervention with a controlled pre- and post-design, nested within a series of pilot 
projects conducted by Zhejiang University. Having a strong local partner who 
provided critical contextual information and local network resources ensured the 
intervention achieved cultural sensitivity and local ownership. It will also catalyse 
and enable the process of translating findings into policy recommendations beyond 
this PhD.  
Findings from this study have contributed to the development and submission 
of a grant application to the Joint Global Health Trials led by Zhejiang University for 
a multi-level, community-wide intervention which aimed to reduce inappropriate 
antibiotic use and antibiotic resistance in rural Zhejiang (See 1.2.4 for more details). 
The results of this study will be disseminated in the form of conference 
presentations, publications, and in a report or white paper to be released together 
with Zhejiang University. They will inform evidence-based policy recommendations 
that strengthen China’s national effort to curb inappropriate antibiotic use.   
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Table 1-1. Work stream plan and associated chapters 
 
 
Aims Alignment with  
6SQuID91 
Methods/Ta
sks 
Chapter Activities Products 
Aim 1: 
Synthesise 
existing 
evidence 
about the 
problem 
and 
explore 
possible 
solutions 
 
 
 
 
Step 1. defining and 
understanding the problem 
and its causes;  
 
Step 2. identifying which 
causal or contextual 
factors are modifiable: 
which have the greatest 
scope for change and who 
would benefit most;  
Systematic 
Reviews 
2 
3 
 
1) Systematic review (SR1) on determinants of 
antibiotic misuse in the community, 
including primary care and hospital 
outpatient clinics in the Chinese context.  
2) Systematic review (SR2) on public-targeted 
behavioural change interventions to reduce 
inappropriate, unnecessary, and non-essential 
use of medicines or medical procedures. 
3) SR1 and thematic synthesis of qualitative 
studies of views, attitudes and experiences of 
health care providers and users (i.e. health 
professionals, patients, and caregivers) about 
treatment choices and antibiotic use for self-
limiting illnesses in the Chinese context. 
4) Synthesis of SR1 and SR2 to identify 
knowledge gaps where determinants of 
antibiotic misuse in the community are 
insufficiently addressed.  
Key 
assumptions 
about the 
problem 
Aim 
2:Assess  
problems 
in the 
context 
and form 
assumptio
ns 
Step 2. identifying which 
causal or contextual 
factors are modifiable: 
which have the greatest 
scope for change and who 
would benefit most; 
 
Step 3. deciding on the 
mechanisms of change; 
 
Quantitativ
e Research 
4 
5 
6 
 
1) Large-scale surveys on knowledge, attitudes 
and practice of treatment choice and 
antibiotic use among young adults 
(university students) regarding self-limiting 
illnesses in the Chinese context. 
2) Large-scale surveys on knowledge, attitudes 
and practice of treatment choices and 
antibiotic use among young parents (with 
children under 13) with respect to self-
limiting illnesses in the Chinese context. 
Key 
assumptions 
about the 
problem 
Aim 3: 
Develop 
and adapt 
interventio
n 
 
 
Step 4. clarifying how 
these will be delivered;   
 
Mixed-
methods 
7 3a. Theoretical Model Development 
1) Development of a Theory of Change (ToC). 
2) Formation of key assumptions for 
intervention development. 
Theory of 
Change 
(Figure 1-5) 
 3b: Preparation for Knowledge Translation  
1) Scoping and stage-setting  Identify pilot sites  Introduce proposed project aims and 
explain rationale for an intervention  Confirm presence of problems identified 
and needs  Introduce intervention adaptation process  Establish partnership and collaboration 
2) Preparation for adaptation of knowledge to 
local context  Define desired aim and the behavioural 
target of this intervention  Explore and identify intervention 
components  Discuss how the intervention may or 
may not address the problems and needs  Discuss how the intervention may or 
may not address key planning and 
evaluation issues: reach, effectiveness, 
adoption, implementation, maintenance 
(RE-AIM).  Identify areas for intervention adaption  Map resources needed to implement a 
pilot intervention and assess available 
Implementation Capital for evidence-
based practice    Form logic model 
Logic model 
 Implementation (pilot) 
 
Step 5. testing and 
adapting the intervention 
3c: Realist assessment of problems and needs of 
local context and appropriateness of proposed 
intervention 
1) Conduct pre-intervention (baseline) 
evaluation, which consists of face-to-face 
surveys with quantitative and qualitative 
components, to assess problems and needs in 
local context. 
2) Interview stakeholders to assess 
appropriateness, acceptability and feasibility 
of the proposed intervention.  
3) Evidence synthesis of findings from Aims 1-
2 and realist assessments with target 
population and stakeholders:  Identify the objectives, content, and 
channels for delivery of key health 
messages for the proposed intervention.   Pilot-test health messages. 
4) Critically synthesise mixed-methods findings 
revising the logic model and finalising the 
adapted intervention 
Finalised logic 
model 
 
Finalised  
intervention 
design for 
feasibility 
study  
Aim 4: 
Evaluation
: Assess 
feasibility 
and 
acceptabili
ty of the 
interventio
n 
 
Step 5. testing and 
adapting the intervention 
 
(Note: For this project, I 
only conducted feasibility 
evaluation) 
Mixed-
methods 
8 1) Develop feasibility study design 
2) Conduct endpoint and follow-up evaluations 
3) Conduct process evaluation 
4) Analyse evaluation outcomes 
5) Address 14 methodological issues of 
feasibility research for full-scale intervention 
development  
6) Identify strengths, limitations and next steps  
Finalised 
intervention 
design for 
pilot study 
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1.8 Joint Global Health Trial (Call 9)  
– Implementation Science to Combat Antimicrobial Resistance: a community-
randomised trial to reduce inappropriate antibiotic use and disposal in China 
In 2016, China released the National Action Plan to Contain Antimicrobial 
Resistance (2016-2020) with the following objectives: 1) All retail pharmacies will only 
sell antibiotics when provided with prescriptions; 2) Hospitals at the secondary level and 
above will establish clinical practice management mechanisms for antimicrobial drugs, 
and the growth rate of major antimicrobial resistance in medical institutions will be 
effectively controlled; 3) Medical staff across China will undergo training on the 
rational use of antimicrobial drugs; 4) Efforts towards public awareness and education 
on prudent antibiotic misuse will be strengthened strengthened; and 5) Antimicrobial 
pollution will be prevented and controlled. All relevant authorities are actively seeking 
solutions to contain AMR, but they lack experience and academic evidence of effective 
measures. Since 2016, Zhejiang University has conducted a series of pilot studies and 
trials testing various elements of a complex intervention, with the aim of taking a realist, 
evidence-based approach to implementing the national action plan with a rigorous 
design for evaluation and further adoption. Community-based trials in AMR are very rare, 
due to their high level of investment in terms of capacity to acquire stakeholders’ buy-in, 
expertise in rigorous design, and evaluation expense. To date, most AMR trials are limited 
to clinical settings, leaving community use of antibiotics poorly addressed. To my 
knowledge, there have only been three trials103-105 that aimed to reduce antibiotic misuse at 
the community-level and addressed both supply-and-demand-side factors of antibiotic 
misuse: all took place in the US over 15 years ago, with none being in China or another 
LMIC.  
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During my PhD studies, I collaborated with Zhejiang University in response to 
the call of the Joint Global Health Trial (JGHT call 9) aiming to create a novel complex 
intervention in addressing a major knowledge gap, which was directly relevant to this 
PhD study: there is currently no community-wide intervention targeting the demand-
side of antibiotic misuse specifically in the Chinese context. Furthermore, there have 
been only a few behavioural intervention trials in the Chinese hospital setting that aim to 
improve prescribing practices.52,54,106 We therefore proposed a first trial in China that 
integrates social science in its intervention design to contain AMR from both the supply-
and-demand sides of the health systems. The proposed intervention had four 
components - 1) reduce pharmacy non-prescription sales, 2) improve hospital 
dispensing, 3) enforce doctor training and stewardship policies, and 4) institute 
community recycling and health education – which aim to remove the barriers at the 
structural, community and individual levels that lead to inappropriate antibiotic use in 
the community. Evidence generated from this trial (including behavioural and 
biomedical data) would provide a strong evidence base to advance the science of 
measuring AMR burdens of disease,107 empower policy advocacy, and prompt changes 
in antibiotic use within the hospital and beyond.  
In the last five years, Zhejiang University has conducted pilot studies and trials 
on the first three components and some elements of the fourth component (e.g. users 
testing the design of health education messages). In this PhD project, I report on the 
development process and formal feasibility assessment for component #4.  Completed in 
June 2019, this feasibility assessment consisted of a pilot community-based antibiotic 
take-back programme that included health education strategies. 
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The JGHT bid successfully made it through the first two phases of outlines and full 
applications reviews but did not pass the final panel review; nevertheless, the process of 
preparing for these three phases and our responses to reviewers’ comments were 
profoundly helpful to my professional development and the implementation of this 
project.  
[Research Decision: Study Scope]  
I aimed to develop a non-clinical behavioural change intervention at the community 
level beyond clinical settings, with objectives aligned with those of China’s National 
Action Plan to Contain Antimicrobial Resistance (2016-2020) and the local context. 
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1.9  Thesis structure  
Below I present the structure of this PhD thesis and the respective evidence generated to inform intervention design: 
Thesis structure Key findings to inform intervention design Implications for intervention 
design 
Chapter two identifies non-clinical 
factors influencing the general public's 
and healthcare providers’ antibiotic 
use in the Chinese community 
a) Identification of factors and their potential 
pathways influencing public’s antibiotic use, 
guided by the conceptual framework. 
 Intervention design to address 
some of these 
factors/pathways.  
 Theory of Change 
Chapter three identifies behavioural 
change techniques (BCTs) that may 
effectively reduce inappropriate use of 
medicines and medical procedures 
b) Interventions consisting of health education 
messages (BCTs 4.1, 4.2, 5.1, 5.2), incentives 
(BCTs 10.1, 10.2), and a supporting 
environment (BCT 12.1, 12.5) that encourages 
the adoption of a new behaviour (BCT 8.2)  
are more likely to be successful. 
 Intervention design to include 
health education messages, 
recommended alternative 
behaviour, incentives, and a 
supporting environment. 
Chapter four assesses the prevalence of 
antibiotic misuse in children in the 
Chinese context 
c) Almost half of the surveyed parents kept 
antibiotics at home for children  
d) Many Chinese parents self-medicated children 
with antibiotics (prophylactic or treatment) 
and before seeking formal care. 
e) Household antibiotics primarily came from 
leftover prescriptions and over-the-counter 
purchases (OTC). 
 Household storage of 
antibiotics is a critical gap in 
current efforts to contain 
AMR in China (and most 
LMIC). 
 Health education messages to 
include awareness of the 
danger of AMR and non-
prescription use of antibiotics. 
Note: Issues around OTC were 
going to be addressed by other 
intervention components of the 
JGHT bid. 
Chapter five assesses the factors 
influencing Chinese parents’ treatment 
decisions for paediatric URTIs. 
f) Perceived antibiotic efficacy for URTIs 
symptoms is associated with an increased 
odds of self-medication with antibiotics and 
demand of antibiotic prescriptions. 
g) Parents who kept antibiotics at home for 
children were associated with increased odds 
of self-medication with antibiotics for URTIs 
in children and over-the-counter purchases.  
h) Household antibiotics primarily came from 
leftover prescriptions and over-the-counter 
purchases (OTC). 
 Health education message 
content selection (BCTs 4.1, 
4.2, 5.1, 5.2) 
 Intervention design to reduce 
household storage of 
antibiotics. (BCTs 10.1, 10.2, 
8.2, 12.1, 12.5) 
Note: Issues around OTC were 
going to be addressed by other 
intervention components of the 
JGHT bid. 
Chapter six assesses the factors 
influencing Chinese young adults’ 
treatment decisions for URTIs. 
i) Not knowing URTIs are self-limiting and 
perceived antibiotic efficacy for URTIs 
symptoms are associated with increased odds 
of self-medication with antibiotics and 
demand of antibiotic prescriptions. 
j) Participants who kept antibiotics at home were 
associated with increased odds of self-
medication with antibiotics.  
k) Household antibiotics primarily came from 
leftover prescriptions and over-the-counter 
purchases (OTC). 
Chapter seven reports the process of 
developing the proposed community-
based intervention, the antibiotic take-
back program with health education 
messages, in rural Zhejiang, China 
l) There is a need for an operable, theory-based 
work stream plan, which integrated the 
principles of RE-AIM, intervention mapping 
and community-based participatory research 
(CBPR), for the synthesis of available 
evidence and the acquisition of feasibility-
related evidence addressing methodological 
questions for future work. 
m) Next step is to conduct a pilot study to assess 
the feasibility (rather than effectiveness) of the 
proposed intervention  
 Development of a work 
stream plan 
 Development of a logic model 
 Reflection on the 
Implementation capital for an 
evidence-based practice in a 
new context  
Chapter eight reports the results of the 
feasibility study to examine the 
proposed behavioural change 
intervention in rural Zhejiang, China 
n) The feasibility study established the 
acceptability and usability of the proposed 
intervention in which 14 implementation 
research methodological issues for future 
trials were carefully assessed. 
 Pilot project to test feasibility 
to implement the intervention. 
 
59 | P a g e  
 
CHAPTER TWO  
Non-clinical factors influencing the general public's and healthcare 
providers’ antibiotic use in the Chinese community: a mixed-
methods review 
In this chapter, I report on a review of the literature to (1) identify non-clinical 
factors affecting the health care users’ and providers’ antibiotic use in China and (2) 
existing interventions to reduce inappropriate antibiotic use in China.  
I conceived the project, developed the literature review design, methods, and 
conducted analysis independently. I conducted the review in close collaboration with 
two colleagues (native Chinese speakers) based in Zhejiang University. The findings 
and results have been prepared as a first draft of the manuscript, with comments on 
drafts from Tingting Yao, Ruyu Sun, Professors Stephan Harbarth, Mark Perricrew, 
and Xudong Zhou. This manuscript has been submitted to Social Science Medicine 
for the consideration of publication.  
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Non-biomedical factors influencing outpatient and community antibiotic use in 
China: a mixed-methods review 
SYNOPSIS 
BACKGROUND: This study aimed to identify and assess the factors of 
inappropriate use of antibiotics in the Chinese context to inform the development of 
future interventions to mitigate inappropriate consumption, namely antibiotics 
consumed in the absence of clinical indications. 
METHODS: We conducted a mixed-methods systematic review and included 
empirical studies with original data conducted in mainland China, Hong Kong, and 
Taiwan that investigated factors of antibiotic use in the community including 
outpatient care among patients, caregivers, and prescribers. We searched 
MEDLINE, PubMed, EMBASE, the Cochrane Library, PsycINFO, Google Scholar, 
and one Chinese database CNKI (China Knowledge Resource Integrated Database), 
using a combination of the key terms ‘antibiotic’, ‘antimicrobial’, ‘use’, 
‘consumption’, ‘behaviour’, ‘prescribe’, and related syntax for all peer-reviewed 
publications published before June 2019. Health Belief Model was employed for 
data synthesis. 
FINDINGS: Forty-six studies were included in the full-text review: 39 quantitative, 
four qualitative, and three mixed-methods studies. Despite a high antimicrobial 
resistance (AMR) awareness, public perception/misconception of antibiotic efficacy 
and easy access to antibiotics for self-limiting conditions drive inappropriate 
demand and use in the community including primary care setting. Providers’ 
prescribing behaviours are influenced by financial incentives, lack of diagnostic 
capacity, and concerns over complications.  
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CONCLUSIONS: Inappropriate outpatient and community antibiotic use is 
influenced by non-biomedical factors at the individual, community, health system, 
and societal levels in mainland China, contributing to a high antibiotic use rate. This 
study calls for multifaceted AMR interventions that simultaneously address drivers 
of inappropriate use from both the supply- and demand-sides within and beyond 
clinical settings.  
SYSTEMATIC REVIEW REGISTRY: PROSPERO CRD42019139591 
KEYWORDS: antibiotics, antimicrobial resistance, China, behaviour 
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Non-biomedical factors influencing outpatient and community antibiotic use in 
China: a mixed-methods review 
ABSTRACT 
BACKGROUND: This study aimed to identify and assess the factors of 
inappropriate use of antibiotics in the Chinese context to inform the development of 
future interventions to mitigate inappropriate consumption in the absence of clinical 
indications. 
METHODS: We conducted a mixed-methods systematic review and included 
empirical studies with original data conducted in mainland China, Hong Kong, and 
Taiwan that investigated factors of antibiotic use in the community including 
outpatient care among patients, caregivers, and prescribers. We searched 
MEDLINE, PubMed, EMBASE, the Cochrane Library, PsycINFO, Google Scholar, 
and one Chinese database CNKI (China Knowledge Resource Integrated Database), 
using a combination of the key terms ‘antibiotic’, ‘antimicrobial’, ‘use’, 
‘consumption’, ‘behaviour’, ‘prescribe’, and related syntax for all peer-reviewed 
publications published before June 2019. Health Belief Model was employed for 
data synthesis. 
FINDINGS: Forty-six studies were included in the full-text review: 39 quantitative, 
four qualitative, and three mixed-methods studies. Despite a high antimicrobial 
resistance (AMR) awareness, public perception/misconception of antibiotic efficacy 
and easy access to antibiotics for self-limiting conditions drive inappropriate 
demand and use in the community including primary care setting. Providers’ 
prescribing behaviours are influenced by financial incentives, lack of diagnostic 
capacity, and concerns over complications.  
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CONCLUSIONS: Inappropriate outpatient and community antibiotic use is 
influenced by non-biomedical factors at the individual, community, health system, 
and societal levels in mainland China, contributing to a high antibiotic use rate. This 
study calls for multifaceted AMR interventions that simultaneously address drivers 
of inappropriate use from both the supply- and demand-sides within and beyond 
clinical settings.  
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INTRODUCTION 
For decades, antibiotics have been excessively consumed around the world, 
contributing to increased antimicrobial resistance (AMR) and negatively impacting 
health outcomes and expenditures.9,108,109 Reducing inappropriate antibiotic use is a 
pressing global health priority. Human use of antibiotics in China accounts for a 
quarter of worldwide antibiotic consumption,31,37 which mainly takes place in 
outpatient and community settings, often unnecessarily for self-limiting community-
acquired infections - mostly viral and non-complicated, and untreatable by 
antibiotics.37,57 A thorough examination of the prevalence of and factors influencing 
community antibiotic use in China is vital to inform the development of relevant 
policy and intervention strategies aiming to mitigate inappropriate or unnecessary 
antibiotic use, namely antibiotics consumed in the absence of clinical indications. 
This study aimed to conduct a mixed-methods systematic review that identifies and 
assesses factors influencing healthcare users’ and providers’ antibiotic use in the 
Chinese context. 
METHODS 
This mixed-methods review aimed to identify determinants for inappropriate 
antibiotic use in the community, including primary care and hospital outpatient 
settings, in Mainland China, Hong Kong, and Taiwan. We systematically searched 
the following databases: MEDLINE, PubMed, EMBASE, the Cochrane Library, and 
PsycINFO, Google Scholar, and one Chinese database CNKI (China Knowledge 
Resource Integrated Database), using a combination of the key terms ‘antibiotic’, 
‘antimicrobial’, ‘use’, ‘consumption’, ‘behaviour’, ‘prescribe’, and related syntax for 
all peer-reviewed publications published before June 2019.  
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As a primary outcome of interest, ‘inappropriate antibiotic use’ included 
antibiotic use for viral infections (treatment or prophylaxis), self-medication with 
antibiotics by consumers, and antibiotic prescriptions for viral infections by 
providers. Relevant behavior outcomes, such as household storage of antibiotics, 
over-the-counter purchases, and demands for antibiotic prescriptions, were also 
identified. No restrictions were applied to language, populations or antibiotic use for 
specific medical conditions. The search strategy for each database is presented in 
Supplement 1. Studies that focused only on (1) knowledge, attitudes and beliefs with 
regard to antibiotic use or (2) antibiotic prescriptions analysis were excluded. For the 
quantitative component, data from cross-sectional and longitudinal studies, where 
relevant confounders were accounted for by the study design or analysis, were 
included. Qualitative studies where methods of data collection and analysis were 
explicitly reported were eligible for inclusion. Non-empirical studies or studies not 
reporting original data were excluded. A full list of inclusion/exclusion criteria is 
presented in Supplement 2. In addition, we conducted manual searches of the 
reference lists of included studies to identify additional relevant studies. All citations 
identified were imported to Endnote, and duplicates were deleted. Two reviewers 
(LL and TTY or RYS) independently screened titles and abstracts to select 
potentially relevant citations. Articles included in the full text review stage were 
retrieved and independently scrutinized. Any discrepancies in the process were 
resolved through discussion with a third reviewer until consensus was reached. (See 
Figure 1. Flowchart) 
A standardised form based on Cochrane Review and behavioural theories 
including the Health Belief Model93 and Social Ecological Framework77 was 
developed specifically for this review prior to data extraction. Data were double 
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extracted by two reviewers (TTY and RYS). Disagreements were discussed with a 
third reviewer (LL) and resolved through consensus. The information extracted 
included characteristics of the study, methods, target population, sample size, 
antibiotic use behaviours, and associated factors influencing behaviours. Numerical 
data (numbers or percentages) that reported prevalence and non-medical factors of 
antibiotic use were extracted from the quantitative component; themes relevant to 
factors influencing antibiotic use behaviours were extracted for the qualitative 
component.  
Quality assessment of included studies 
Three reviewers (LL, TTY, RYS) independently assessed the risk of bias in 
all included studies using pre-determined tools and reached consensus through 
discussion when discrepancies arose. The quantitative studies and quantitative 
components from mixed-methods studies that met inclusion criteria were assessed 
by adapted BMJ survey appraisal tools;110 qualitative studies and the qualitative 
components from mixed-methods studies were appraised by the Critical Appraisals 
Skills Programme (CASP) Appraisal Checklists.111 We followed the PRISMA 
statement guidelines for reporting systematic reviews in structuring the review 
findings.  
RESULTS 
We identified 46 studies: 35 focused on the consumers of health care, nine 
on providers, and two on both, involving a total of 97,263 participants (Table 1, 
Appendix 1). All studies employed cross-sectional designs and included adult 
participants, with some (n=11; 23.9%) specifically involving the parents of children. 
Almost half (n=22; 47.8%) of the included studies were published after 2016. There 
were 39 quantitative (including three experiments), four qualitative, and three 
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mixed-methods studies. Nine studies were conducted in Hong Kong, one in Taiwan, 
and the rest (n=36) in mainland China, mostly in rural areas. Little evidence about 
community antibiotic use was available from Taiwan. Figure 2 summarised the 
characteristics of the included studies. Identified non-biomedical factors of antibiotic 
use in the community were analysed and synthesised, presented in Table 2.  
Quantitative synthesis of factors influencing antibiotic use in the community 
In Supplements 3.1-3.7 and 4.1-4.21, we summarized the identified factors of 
antibiotic use, measures (e.g. denominator, numerator, and recall period), and 
geographic distributions of antibiotic use practices that have been studied across 
China. We found inconsistency in defining and measuring various types of antibiotic 
use behaviors, which raises issues of cross-study comparability and evaluation. A 
total of 42 studies quantitatively investigated factors influencing inappropriate 
antibiotic use either by patients, caregivers or providers within and beyond clinical 
settings. The synthesis of quantitative data on public antibiotic misuse behaviours in 
the community by study region is presented in Figure 3.  
Clinical settings 
Antibiotic prescriptions for presumed self-limiting illnesses were widely 
reported. Three studies45,65,112 reported that 31.7%45 to about 50%65 of participants 
prescribed with antibiotics were administered them through intravenous (IV) 
infusion. Five 45,63,113-115 studies investigated how patient-related factors influenced 
antibiotic prescribing and among them, three 45,63,113 identified knowledge as a 
determinant: those aware that unnecessary use of antibiotics makes them ineffective 
(i.e. antimicrobial resistance awareness) were more likely to accept physicians’ non-
antibiotic prescriptions.63 People with a medical background114 or a higher education 
level63 were less likely to receive antibiotic prescriptions and more likely to approve 
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of that decision, yet having more than one type of health insurance had the opposite 
effect.63 Regional differences were also noted: living in regions of lower economic 
development114 was associated with an increased risk of antibiotic prescriptions for 
self-limiting illnesses.  
Demand for antibiotic prescriptions was reported in 20 studies, ranging 
from 1.8%60 to 74.5%116 in mainland China, compared with around 8.7%115,117-120 
and 8.8%121 in Hong Kong and Taiwan, respectively. Out of the 20 studies, 
eight45,63,112,114,116,118,122,123 identified factors influencing demands for antibiotic 
prescriptions. Three found knowledge to be a factor associated with demands for 
antibiotics,45,63,122 yet this relationship was inconsistent. Perceived antibiotic efficacy 
for upper respiratory tract infections (URTI) was associated with an increased risk of 
antibiotic prescriptions by request63, whereas having some level of medical 
education was found to have mixed effects.114,124  Older age,112,114 lower education 
levels,116 having more than one type of health insurance,63 and living in rural areas116 
or regions with lower economic development114 were associated with an increased 
risk of inappropriate prescriptions by demand among adult patients. Three 
experiments56,125,126 were conducted in the past decade to investigate drivers of 
antibiotic misuse by providers and concluded that antibiotic dispensing practices in 
mainland China have been mainly influenced by financial incentives for prescribers 
and/or dispensing facilities,56,125 lack of diagnostic capacity,126 and concerns over 
complications.35,126,127 Two Hong Kong-based studies127,128 examined the reasons 
family doctors prescribed antibiotics for URTI, and found reasons for this included 
‘no energy to resist demand’127, ‘lack of time’127,128 and ‘as a way to terminate the 
consultation.’128 They also found male doctors in Hong Kong to be more likely to 
over-prescribe antibiotics than their female peers.127,128 
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Community settings  
Self-medication with antibiotics was reported in 31 studies, all in mainland 
China. The overall prevalence of antibiotic self-medication (for therapeutic 
purposes) ranged from 7.6%113 to 82.6%116 in mainland China, with high prevalence 
found in Gansu (82.6%),116 Guangdong (63.5% in Guangzhou City),75,129,130 Shaanxi 
(60.6% in Xi’an City),60,61,131 and Jiangxi (62%).65 Out of 31 studies, six 
45,60,63,122,132,133 assessed the impact of knowledge on antibiotic self-medication with 
mixed results. Ability to identify or name different antibiotics,63 having an accepting 
attitude towards antibiotic self-medication,60 perceived susceptibility and perceived 
severity of the infection,60,63,134 and perceived antibiotic efficacy against the 
infection63 were associated with increased odds of antibiotic self-medication. Older 
age,63,65,67,75,132 being female,60,63,67,135 and having more than one child in the house65 
were associated with higher rates of antibiotic self-medication. The associations 
between antibiotic self-medication and education and urbanicity were inconsistent: 
some studies identified having higher education63,65,116 or living in the urban 
areas61,131,135 to be risk factors, while others came to the opposite 
conclusion.60,65,68,116,130,132,135 Having some level of medical education was 
associated with a higher likelihood of antibiotic self-
medication,60,61,67,75,114,123,129,131,135 compared with peers. Patterns were similar for 
associations with self-medication with antibiotics as prophylaxis - often for URTI 
to prevent deterioration - measured in eight studies,45,61,65,68,112,114,122,136 all in 
mainland China, with a prevalence ranging from 10.3%112 to 30.6%.61 Notably, 
regional differences were observed for antibiotic self-medication, both for 
therapeutic purposes and prophylaxis: consistently, those living in highly 
economically developed regions were less likely to self-medicate with antibiotics, 
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compared with their counterparts.60,68,114 Having health insurance was also 
associated with higher rates of antibiotic self-medication.60,63  
Access to non-prescription antibiotics, either via over-the-counter purchases 
or household storage, was strongly associated with antibiotic self-medication for 
therapeutic purposes45,60,65,68,129,130,133 or prophylaxis.68,72 The prevalence of over-
the-counter (OTC) purchases of antibiotics ranged from 8.8%113 to 84.9%136 in 
mainland China, 7.3%119,137 to 7.8%115,117,118,120 in Hong Kong and was around 
10.0%121 in Taiwan. Depending on the region138 and whether or not a licensed 
pharmacist was on duty,138 antibiotics were easily obtainable with very limited 
barriers from almost 80.0% of local pharmacies across mainland China when a 
paediatric diarrhoea or adult acute URTI was present.138 The prevalence of 
household storage of antibiotics ranged from 25.3%60 to 80.2%130 in mainland 
China and was around 6% in Hong Kong,115,117,119,120 principally originating from 
over-the-counter purchases45,68,129 and leftover prescriptions.45,68,117,119,129 Being 
female,63,68,112,114 of older age,63,68 attaining higher education,63,68,112,114 having 
higher income,68,114 living in urban areas,68,112,114 and having more than one type of 
health insurance63 were associated with a higher likelihood of household storage of 
antibiotics. Unsurprisingly, over-the-counter purchases119 were a risk factor for 
storing antibiotics at home. 
Qualitative studies  
Factors of antibiotic use identified from seven qualitative and mixed methods 
studies35,67,117,119,120,139,140 generally supported the quantitative findings. Participants’ 
trust in their doctors119 made them not demand antibiotics; on the other hand, 
previous “successful” experiences with similar symptoms prompted them to ask for 
antibiotics.139 Rural residents viewed self-medication, over-the-counter purchases 
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for self-limiting conditions such as diarrhoea and colds, and storing antibiotics at 
home for future use, as norms.140 Inappropriate antibiotic dispensing was reported as 
a severe issue in less economically developed regions like Guizhou, where 
antibiotics became a routine prescription for patients suffering from any complaint 
other than fatigue, due to strong financial incentives for over-prescribing.140 From 
the prescribers’ perspective, lack of diagnostic capacity, such as inability to perform 
a routine blood test and a C-reactive test, and fears of complications, such as 
pneumonia, bronchitis and otitis media, were the most frequently reported reasons 
for antibiotic prescriptions.35 Pressure to maintain a good doctor-patient relationship 
to maintain business was also reported as a reason to fulfil patients’ requests for 
antibiotic prescriptions.35  
Antibiotic use practices specific to the Chinese context 
Among the 46 included studies, nine studies45,60,61,65,117,119,122,139,141 found a 
misconception existed confusing anti-inflammatory medications and antibiotics, 
ranging in prevalence from 17.9%45 to 71.6%.60 Eleven 
studies35,45,60,61,65,75,113,119,133,139,141 reported a preference for IV injection of 
antibiotics, where 21.3%45 to 84.7%133 of participants believed infusion is much 
more efficacious than oral administration. In a less economically-developed region 
like Guizhou, IV antibiotic treatment was common for mild diarrhoea, often in the 
absence of a proper diagnostic test.140 Mixing antibiotics with traditional Chinese 
medicine or preferences for traditional Chinese medicine over antibiotics for 
relieving cold symptoms were observed.115,140 One found users of traditional 
Chinese medicine were less likely to accept antibiotics when offered (OR = 0.38, 
95% CI: (0.25, 0.60)) and were less likely to be treated with antibiotics for their last 
URTI (OR = 0.49, 95% CI: (0.27, 0.81)).115 Others found doctors prescribed 
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antibiotics for URTI and combined antibiotic prescriptions with traditional Chinese 
medicine to relieve symptoms.115,140 Self-medication is common in the Chinese 
community; doctors reported their patients had self-medicated with antibiotics 
before reaching health facilities.35,142   
The results of quality appraisal of the 46 studies were reported in the 
Supplements 5-7. Adapted from Health Belief Model, Figure 4 presented a 
conceptual framework of non-biomedical factors that influence outpatient and 
community antibiotic use for common community-acquired infections.  
DISCUSSION 
Summary of findings 
In this systematic review, quantitative synthesis showed that inappropriate 
antibiotic use is pervasive throughout mainland China, given the relatively easy 
access to antibiotics, with or without a prescription. Access to non-prescription 
antibiotics, either via over-the-counter purchases or household storage, was strongly 
associated with antibiotic self-medication.45,60,65,68,129,130,133 Public AMR awareness 
levels were frequently measured to be high in mainland 
China;45,60,61,63,65,67,75,112,115,117-119,123,133,134,137,141,143,144 however, there is little 
evidence that high awareness in China could lead to better antibiotic use. Striking 
regional differences were observed for antibiotic self-medication; those living in less 
economically developed regions were more likely to use antibiotics 
inappropriately.60,68,114 Both quantitative and qualitative studies in this review 
revealed that doctor-patient relationships are critical in influencing unnecessary or 
inappropriate antibiotic prescriptions.119 Patients who trust their doctors, as well as 
people with some medical education or a higher education level would likely accept 
non-antibiotic prescriptions.63,114,116,119  Financial incentives for doctors led to 
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inappropriate over-prescription of antibiotics.56,125 Antibiotic use is influenced by 
the local context in mainland China, where a misconception confusing anti-
inflammatory medications and antibiotics,45,60,61,65,117,119,122,139,141 and a preference 
for IV injection of antibiotics35,45,60,61,65,75,113,119,133,139,141 are prevalent.  
Strengths and limitations of the review 
To the best of our knowledge, this is the first mixed-methods systematic 
review to assess quantitative and qualitative data on factors influencing antibiotic 
use in China and the interventions to address them. This review included studies 
across different regions of mainland China, Hong Kong, and Taiwan, published in 
English and Chinese. This study reported the prevalence, measures and factors of 
antibiotic misuse across China. It captured statistically assessed factors of actual 
antibiotic use behaviours by both healthcare providers and consumers, rather than 
only considering their knowledge, attitudes or intentions in isolation of these 
influencing factors. We further synthesised the findings using the Health Belief 
Model (see Table 2) to inform the development of future behavioural change 
interventions to reduce antibiotic use in the community. The data and study design 
presented in the Chinese language publications were lean in general and therefore, 
for our review, we limited the inclusion to studies that had demonstrated sufficient 
rigor and detail in their reporting for us to appraise their evidence.  
Interpretation 
Inappropriate use of antibiotics is influenced by non-biomedical factors 
within and beyond clinical settings that are unique to mainland China, yet common 
among low-and-middle income countries (LMIC), including public misconceptions, 
habitual use without professional guidance, incentivising the healthcare system 
towards prescribing,56,125 lack of diagnostic capacity,35,126 and the delicate 
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relationships between patients and prescribers.35 To date, there have been only a few 
interventions implemented in primary care settings to reduce inappropriate 
prescribing,52,54,55,106,145-147 largely targeting clinicians and ignoring demand-side 
factors.  
This study found an urgent need to take an evidence-based approach to 
identify determinants of antibiotic use practices within the target context, 
programme parameters for improvement, and intervention components to optimise 
the use of antibiotics by the prescribers and the general public. These insights will be 
critical to tailor contextualized, multifaceted interventions for reducing inappropriate 
antibiotic use. For example, despite the AMR awareness campaigns invested in by 
the Chinese government, the inappropriate use of antibiotics was found to be 
prevalent across the country. Moreover, a study reported that well-intentioned 
government publicity about antibiotic abuse may have had the unintended 
consequence of increasing antibiotic prescriptions and exacerbating resistance.140 
Such a phenomenon might be explained by the non-rational strategies people lean on 
while managing the type of risk and uncertainty associated with an acute infection: 
so-called tacit or experiential knowledge such as trust, intuition, emotion, and prior 
“successful” experiences with similar symptoms for healthcare decision 
making.139,148 Also, we found the national ban on over-the-counter purchases of 
antibiotics has been very limited in its impact - non-prescription purchases and use 
of antibiotics were reported across mainland China. Furthermore, few studies 
investigated the common practice – very much influenced by local context – in 
which physicians and pharmacists prepare cocktails of various medications, 
including traditional Chinese medicine and antibiotic agents for patients with 
URTI.115,140 Inappropriate antibiotic consumption is unlikely to decrease without 
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multifaceted, context-tailored strategies targeting patients, prescribers, and 
healthcare systems. 
 
CONCLUSION 
This review revealed the impact of non-biomedical factors at individual, 
community, health system, and societal levels on outpatient and community 
antibiotic use by healthcare users and providers in the Chinese context and 
demonstrated that they impact each other in an interactive manner. Given the large 
population size and consumption volume, the threat to human health from the 
adverse side effects of inappropriate use and drug resistance calls for immediate 
action. Future AMR strategies should incorporate a multifaceted, evidence-based, 
context-tailored design that simultaneously addresses drivers of antibiotic misuse 
from both the supply- and demand-sides.  
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Table 1. Summary of characteristics of included studies that investigated non-
biomedical factors influencing outpatient and community antibiotic use in 
China. 
  
Characteristic Number 
of studies 
Studies 
Total 46 35,45,56,60,61,63,65,67,68,75,112-123,125-144,149-152 
Language   
Chinese 11 116,121,129-131,133,135,141,143,144,152 
English 35 35,45,56,60,61,63,65,67,68,75,112-115,117-120,122,123,125-128,132,134,136-
140,142,149-151 
Year of study   
2001–2005 2 127,128 
2006-2010 3 121,137,140 
2011-2015 19 56,61,65,75,115-120,122,123,125,129-131,134,135,139,149 
2016-later 22 35,45,60,63,67,68,112-114,122,126,132,133,136,138,141-144,150-152 
Study design   
Quantitative study 39 45,60,61,63,65,67,68,75,112-116,118,121-123,127-138,141,143,144,149-152 
    Longitudinal 0  
    Cross-sectional 36 45,60,61,63,65,67,68,75,112-116,118,121-123,127-138,141,143,144,149-152 
    Experiment 3 56,125,126 
Qualitative study 4 35,139,140,142 
Mixed methods 3 117,119,120 
Study region   
Mainland China   
    East 15 35,56,67,123,125,129,130,133,135,136,139,141,143,144,151 
    Central 6 63,65,113,134,142,152 
    West 4 61,116,131,140 
    Across regions 11 45,60,68,75,112,114,122,126,132,138,150 
Hong Kong 9 115,117-120,127,128,137,149 
Taiwan 1 121 
Location   
Urban 10 60,121,123,129,130,138,142,143,149,152 
Rural 6 35,63,113,126,136,139 
Mixed 26 45,56,61,65,68,112,114-120,122,125,127,128,131-135,137,140,141,144 
Unknown 4 67,75,150,151 
Participants   
General public  
(adults >18 yrs.) 
29 45,61,63,67,68,75,112-123,131,133-137,139,141,143,144,149 
Parents or caregivers 6 60,65,129,130,132,152 
Healthcare 
professionals 
9 56,125-128,138,142,150,151 
Mixed: Patients and 
Healthcare 
professionals 
2 35,140 
Antibiotic misuse in the 
community  
  
Self-medication with 
antibiotics 
33 35,45,60,61,63,65,67,68,75,112-123,129-133,135-137,140,141,143,144 
Taking antibiotics as 
prophylaxis 
9 45,61,65,68,112,114,122,136,139 
Over-the-counter 
purchases 
18 60,63,65,67,68,115,117-121,129,131,136,137,139,140,152 
Household storage of 
antibiotics 
22 45,60,61,63,65,68,112-117,119,120,129,130,133,136,140,141,143,144 
Demand for antibiotic 
prescriptions 
22 35,45,60,63,65,112,114-123,134,139,141,143,144,152 
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Table 2. Non-biomedical factors influencing outpatient and community antibiotic use for common community-acquired 
infections 
NON-
BIOMEDICAL 
FACTORS  
APPLICATION/ EXAMPLES INAPPROPRIATE ANTIBIOTIC USE  
(INCLUDING PREVENTION USE) 
ANTIBIOTIC USE BEHAVIOUR OUTCOMES REFERENCES 
Knowledge  
 
  
General 
knowledge 
about 
antibiotics/ 
Antimicrobial 
resistance 
(AMR) 
Combined knowledge score Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchases 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
Health care seeking behaviour 
The likelihood to be prescribed with antibiotics by 
doctors 
Combined behaviour score 
45,63,113,133,144 
Literacy  Being able to recognise antibiotics 
Knowing when/how to use antibiotics 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchases 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
The likelihood to be prescribed with antibiotics by 
doctors 
63 
Knowledge 
about the 
infection 
The participant’s knowledge about the 
specific infection (e.g. URTI symptoms will 
dissipate naturally) 
- 
No evidence available to date 
- 
AMR 
Awareness 
The participant’s awareness of AMR as a 
health threat on individual or on the society 
as a whole 
Complying with the physician’s decision not to 
prescribe antibiotics   
63 
Attitudes     
Attitudes 
towards 
antibiotic 
misuse 
behaviours 
The participant’s accepting attitudes towards 
self-medication with antibiotics 
Self-medication with antibiotics 60 
Self-efficacy         The participant’s perception of his/her or 
others’ competence in engaging in caring for 
the infection or in antibiotic use 
No evidence available to date - 
Medical 
background 
The participants or their family members 
Having some level of medical education 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchases 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
The likelihood to be prescribed with antibiotics by 
doctors 
Combined behaviour score 
60,61,67,68,75,112,114,123,129,131,
134,135 
Prior experience Participants use of antibiotics on previous 
occasions 
Over-the-counter purchase 152 
Perceptions    
Perceived 
susceptibility 
Self-rated health status Self-medication with antibiotics 
Combined behaviour score 
60,133,144 
Perceived 
severity 
The participant’s assessment/perception of 
the severity of the situation regarding the 
infection (e.g. self-diagnosed symptoms 
experienced) 
The participant’s perception of potential harm 
of over-the-counter purchase 
Over-the-counter purchase 120 
Perceived 
benefits and 
disbenefits 
The participant’s assessment/perception of 
the benefits of engaging in antibiotic use 
(antibiotic efficacy) 
The participant’s knowledge of the 
disbenefits/side effects of engaging in 
antibiotic use (antibiotic efficacy) 
The participant’s mistaken understanding of 
antibiotics (e.g. considering antibiotics as 
Xiaoyanyao, anti-inflammatory drugs) 
(misconceptions) 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchase 
Storing antibiotics at home 
Taking antibiotics as prophylaxis  
63,122 
Perceived 
barriers 
The participant’s assessment/perception of 
barriers to engaging in antibiotic use (health 
insurance and knowledge of current policy) 
Self-medication with antibiotics 
Asking/pressuring doctors for antibiotics 
Storing antibiotics at home 
Health care seeking behaviour 
Complying with the physician’s decision not to 
prescribe antibiotics 
60,63,113 
Family 
dynamics 
Family members who might influence the 
healthcare decisions of caregiver or the 
patients 
 
Self-medication with antibiotics 
 
60,132 
Doctor-patient 
relationships 
Having a regular doctor 
Following all the advice from physicians  
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
65,118 
Cues to action External trigger mechanisms to prompt 
engagement in antibiotic use behaviour 
  
Symptoms Presence of fever  
No evidence available to date 
- 
Information 
Sources and 
seeking for 
therapeutic 
purposes 
decisions 
Expectation for antibiotic use knowledge Combined behaviour score  144 
Socio-
demographic 
factors 
   
Age The age of the participant or caregiver Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchase 
Storing antibiotics at home 
Health care seeking behaviour 
The likelihood to be prescribed with antibiotics by 
doctors (oral, IV or both) 
Combined behaviour score 
63,65,67,68,75,112-
114,120,129,132,134,152 
Gender The gender of the participant or caregiver Self-medication with antibiotics 
Over-the-counter purchase 
Storing antibiotics at home 
Health care seeking behaviour 
Combined behaviour score 
60,63,67,68,112-114,132,135,137,141 
Education The education level of the participant, his/her 
parent or the caregiver 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Storing antibiotics at home 
Over-the-counter purchases 
Health care seeking behaviour 
Complying with the physician’s decision not to 
prescribe antibiotics 
60,63,65,68,112-
114,116,130,132,135,144,152 
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Combined behaviour score 
Income The household income or monthly allowance 
of the participant or caregiver 
Self-medication with antibiotics 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
68,75,114,116,120,132 
Location The rural/urban of residence of the participant 
or caregiver 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchases 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
The likelihood to be prescribed with antibiotics by 
doctors 
Combined behaviour score 
56,61,65,68,112,114,116,131,132,134
,135 
Region Region of residence of the participant or 
caregiver – geographic area or economic 
development stage 
Asking/pressuring doctors for antibiotics 
Self-medication with antibiotics 
Over-the-counter purchases 
Storing antibiotics at home 
Taking antibiotics as prophylaxis 
The likelihood to be prescribed with antibiotics by 
doctors 
60,68,114 
Socio-
contextual 
factors 
   
Access to 
antibiotics 
Access to antibiotics, with or without 
prescription 
  
Access to non-
prescription 
antibiotics 
Over-the-counter purchase 
Antibiotics stored at home 
Leftover prescriptions 
 
Self-medication with antibiotics 
Taking antibiotics as prophylaxis 
 
45,60,65,68,119,129,130,133 
Access to 
antibiotic 
prescriptions 
Asking/pressuring doctors for antibiotics 
The education level, training, specialty or 
seniority of the doctors 
The likelihood to be prescribed with antibiotics by 
doctors 
56,125 
Policy Health policy or AMR programme that might 
affect prescribing or access to antibiotics (e.g. 
measures to de-incentivise over-prescription 
in public health facilities, including 
decoupling the link between facility income 
and the sale of medicines and policy that bans 
over-the-counter purchases) 
Financial incentives for antibiotic prescribing 
of doctors 
Self-medication with antibiotics 
Over-the-counter purchases* 
The likelihood to be prescribed with antibiotics by 
doctors 
56,60,125 
Norm Participants’ view of how others treat 
illnesses and/or use antibiotics (non-China 
and non-predictor) * 
Health care providers reviewing others' 
prescriptions (non-predictor) * 
The likelihood to be prescribed with antibiotics by 
doctors* 
151,153-155 
Point-of-care Prescribing habits/capacity might vary at 
different levels of health facilities: tertiary 
hospital, secondary/county hospital, 
community health centres/township hospital 
or private clinics/village clinics 
 
 
No evidence available to date 
- 
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Figure 1: Flowchart of study identification and selection   
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in in the design or 
analysis (n=6) 
 Low quality (e.g. lack of 
details in study design 
and/or conflicting 
data)(n=4) 
( )
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Figure 2. Summary of characteristics of included studies 
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Figure 3. Synthesis of quantitative data on public antibiotic misuse behaviours in the community by study region  
 
Median, IQR and range percentage of participants who self-reported to have performed the misuse behaviours 
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Figure 4. Non-biomedical factors influencing outpatient and community antibiotic use for common community-acquired infections  
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Supplement 1. Search Criteria 
 
Database Search Strategy 
MEDLINE (("antimicrobial resistance"[tiab] OR "antibiotic*"[tiab] OR "Anti-Bacterial 
Agents/therapeutic use*"[Mesh] OR "Drug Resistance, Bacterial*"[Mesh]) AND 
("behaviour*"[tiab] OR "use*"[tiab] OR "misuse"[tiab] OR "abuse"[tiab] OR 
"practice"[tiab] OR "consumption"[tiab] OR "supply"[tiab] OR "prescribing*"[tiab] 
OR "prescription*"[tiab] OR "prescribe*"[tiab] OR "utilization*"[tiab] OR “Practice 
Patterns, Physicians*”[Mesh] OR "Health Knowledge, Attitudes, Practice*"[mesh]) 
AND (“China”[tiab] OR “Hong Kong”[tiab] OR “Macau”[tiab] OR “Taiwan”[tiab]) 
AND ("1920/09/01"[EDAT] : "2019/05/31"[EDAT]) AND ("1920/09/01"[PDAT] : 
"2019/05/31"[PDAT])) 
EMBASE ('awareness'/exp OR 'attitude to health'/exp OR 'clinical practice'/exp OR 
‘prescribe*’:ab,ti OR ‘prescription*’:ab,ti OR ‘prescribing*’:ab,ti OR ‘misuse’:ab,ti 
OR ‘abuse’:ab,ti OR ‘utilization*’:ab,ti OR ‘consumption*’:ab,ti OR ‘practice*’:ab,ti) 
AND ('antibiotic agent'/exp OR 'antibiotic*':ab,ti) AND (‘China’:ab,ti OR ‘Hong 
Kong’:ab,ti OR ‘Macau’:ab,ti OR ‘Taiwan’:ab,ti) AND [1-1-1920]/sd NOT [31-05-
2019]/sd NOT [animals]/lim NOT [medline]/lim 
PsycINFO (MA behaviour and behaviour mechanisms OR MA choice behaviour OR MA health 
knowledge, attitudes, practice* OR MA Practice Patterns, Physicians’ OR AB usage 
OR AB use OR AB consum* OR AB behaviour* OR AB behaviour* OR AB 
"practice*") (AB AMR OR AB antimicrobial resistance OR AB antibiotic*) NOT 
((animal* OR AB surgery OR AB Surgical OR AB dental OR AB cancer* OR AB 
Chronic obstructive pulmonary disease OR AB COPD OR AB alcohol OR AB 
tobacco OR AB addiction OR AB depression OR AB disorder* OR AB adherence 
OR AB diabet* OR MA Inpatients* OR AB inpatient* OR MA Hospitals OR AB 
tertiary OR AB HIV OR AB tuberculosis OR emergency[ti] OR ED[tiab] OR MA 
Intensive Care Units OR MA Economics OR AB analgesic* OR MA Hospitalization 
OR MA Health Care Facilities OR MA Health Care Facilities OR MA Patient Care 
Management)) NOT PO animal )) AND (AB China OR AB Taiwan OR AB hong 
kong OR AB macau) 
CNKI (China 
National 
Knowledge 
Infrastructure) 
(( ( (题名=(抗生素+抗菌素+消炎药) ) OR (Title=(抗生素+抗菌素+消炎药) ) ) 
AND ( ( 题名=(行为+使用)) OR ( Title=(行为+使用)) ) ) AND (( ( (摘要=(抗生素+
抗生素滥用+抗生素使用+抗菌素+消炎药) ) OR (ABSTRACT=(抗生素+抗生素滥
用+抗生素使用+抗菌素+消炎药) ) ) OR ( ( 主题=(抗生素+抗生素滥用+抗生素使
用+抗菌素+消炎药)) OR ( 题名=(抗生素+抗生素滥用+抗生素使用+抗菌素+消炎
药)) OR ( v_subject=(抗生素+抗生素滥用+抗生素使用+抗菌素+消炎药)) ) ) AND 
( ( (摘要=(行为+自我治疗+自我药疗+无处方购买+处方) ) OR (ABSTRACT=(行
为+自我治疗+自我药疗+无处方购买+处方) ) ) OR ( ( 主题=(行为+自我治疗+自
我药疗+无处方购买+处方)) OR ( 题名=(行为+自我治疗+自我药疗+无处方购买+
处方)) OR ( v_subject=(行为+自我治疗+自我药疗+无处方购买+处方)) ) ))) 并且 
发表时间 between (1900-1-1,2019-05-31) (精确匹配),专辑导航：医药卫生科技,社
会科学Ⅱ辑; 数据库：文献 跨库检索 
Google Scholar “antibiotics” and “China” 
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Supplement 2. Inclusion/Exclusion Criteria 
 
 Inclusion Criteria Exclusion 
Language English and Chinese Other language 
Time period Inception of databases to June 2019 Everything else 
Population 
General public, caregivers of children (age < 18 years old), 
outpatients, adults; family doctors, physicians, clinicians, 
pharmacists, health care workers 
Inpatients, animal only 
Study setting Community (primary care or outpatient setting) Inpatient setting, Emergency Department 
Illness No restrictions None 
Outcome Determinants of human antibiotic use behaviours (including self-medication with antibiotics or antibiotic prescribing, etc.) 
Results of prescription analysis; 
antibiotic knowledge or attitudes; 
determinants of general self-medication, antibiotics not specifically 
mentioned; 
for quantitative studies, those not presenting significant association 
between determinants and antibiotic use behaviours by multiple logistic 
regression analysis. 
Study design Empirical studies with original data (quantitative, qualitative and mix-methods) 
Editorials, commentaries, reviews or literature reviews, descriptive 
studies, poster abstracts 
Others  
Low-quality studies with obvious data mistakes (e.g. data in figures or 
tables were different with it in context); 
full-text article cannot be downloaded; 
other non-relevant studies. 
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Supplement 3.1 Prevalence of self-medication for therapeutic purposes among adults 
First 
Author, 
Year 
Region Denominator Numerator Recall period Reported Prevalence (%) 
Cheng, J., 
2018 
Central (Anhui) All respondents (rural 
residents) (n=2221) 
Rural residents who used pills leftover 
from a previous illness or from relatives or 
friends (n=329) 
Lifetime (past experience) 14.8 (329/2221) 
Cheng, J., 
2018 
Central (Anhui) All respondents (rural 
residents) (n=2274) 
Rural residents with symptoms of common 
cold in the past year or gastrointestinal 
infection or UTIs over the past 3 months 
who reported use of over‐the‐counter or 
leftover medicines (n=1052) 
Over the past 3 months or 
in the past year prior to the 
survey 
46.3 (1052/2274) 
Hu, Y., 
2018 
Across regions Medical students who 
reported having self-
limiting illness and self-
treated (n=285) 
Medical students who self-treated with 
antibiotics (n=77) 
In the past month prior to 
the survey 
27.0 (77/285) 
Lv, B., 
2014 
Western 
(Shaanxi) 
All respondents 
(undergraduate students) 
(n=731) 
Students who had self-medicated with 
antibiotics (n=294) 
In the past 6 months prior 
to the survey 
40.2 (294/731) 
Pan, H., 
2012 
Eastern 
(Guangdong) 
All respondents (university 
students) (n=1300) 
Students who had self-treated with 
antibiotics (n=621) 
Lifetime (past experience) 47.8 (621/1300) 
Peng, D., 
2018 
Eastern (Zhejiang 
University) 
Students who reported self-
limiting illness and self-
treated (n=254) 
Students who self-treated with antibiotics 
(n=41) 
In the past month prior to 
the survey 
16.1 (41/254) 
Peng, D., 
2018 
Western (Guizhou 
University) 
Students who reported self-
limiting illness and self-
treated (n=279) 
Students who self-treated with antibiotics 
(n=92) 
In the past month prior to 
the survey 
33.0 (92/279) 
Wang, X., 
2018 
Across regions Students who reported self-
limiting illness and self-
treated (n=1711) 
Students who self-medicated with 
antibiotics (n=507) 
In the past month prior to 
the survey 
29.6 (507/1711) 
Wang, X., 
2017 
Across regions Students who reported self-
limiting illness and self-
treated (n=1711) 
Students who self-treated with antibiotics 
(n=507) 
In the past month prior to 
the survey 
29.6 (507/1711) 
Zhu, X., 
2016 
Eastern (Jiangsu) All respondents (university 
students) (n=660) 
Students who had a history of self-
medication with antibiotics (n=316) 
Lifetime (past experience) 47.9 (316/660) 
Jiang, H., 
2017 
Eastern 
(Hangzhou City) 
All respondents 
(residents/general public) 
(n=449) 
Residents who self-medicated with 
antibiotics when ill (n=449-252=197) 
Lifetime (past experience) 43.9* (197/449) 
Jiang, H., 
2017 
Eastern 
(Hangzhou City) 
All respondents 
(residents/general public) 
(n=449) 
Residents who self-medicated with leftover 
antibiotics when the same symptoms 
appeared (n=449-151=298) 
Lifetime (past experience) 66.4 (298/449) 
Jin, Y., 
2014 
Western (Gansu) All respondents (residents 
of 45 to 74 years old) 
(n=2556) 
Residents who purchased and used 
antibiotics over the counter when getting ill 
(often/sometimes) (n=1092+1019=2111) 
Lifetime (habits) 82.6 (2111/2556) (42.72+39.87) 
Jin, Y., 
2014 
Western (Gansu) All respondents (residents 
of 45 to 74 years old) 
(n=2556) 
Residents who self-medicated according to 
commercial advertisement with antibiotics 
purchased over the counter 
(often/sometimes) (n=412+471=883) 
Lifetime (habits) 34.5 (883/2556) (16.12+18.43) 
Li, Y., 
2016 
Eastern (Jiangsu) All respondents 
(residents/general public) 
(n=1589) 
Residents who self-medicated with 
antibiotics (n=498) 
In the past 12 months prior 
to the survey 
31.3 (498/1589) 
Lu, T., 
2016 
Eastern (Nanjing 
City) 
All respondents (university 
students) (n=600) 
Students who reported had purchased and 
used antibiotics without prescriptions 
(n=non-reported) 
In the past 3 months prior 
to the survey 
38.3 (100-61.7) (unknown/600) 
Lv, B., 
2013 
Western 
(Shaanxi) 
All respondents (university 
students) (n=731) 
Students who had self-medicated with 
antibiotics (n=294) 
In the past 6 months prior 
to the survey 
40.2 (294/731) 
Chai, J., 
2019 
Central (Anhui) Respondents (rural 
residents) who had ARTIs 
(n=290+1872=2162) 
Residents who reported use of 
antimicrobials leftover from previous 
illness or given by relatives for ARTI 
symptoms (n=290) 
In the past year prior to the 
survey 
13.4 (290/2162) 
Chai, J., 
2019 
Central (Anhui) Respondents (rural 
residents) who had GTIs 
(n=43+356=399) 
Residents who reported use of 
antimicrobials leftover from previous 
illness or given by relatives for GTI 
symptoms (n=43) 
In the past year prior to the 
survey 
10.8 (43/399) 
Chai, J., 
2019 
Central (Anhui) Respondents (rural 
residents) who had UTIs 
(n=122+10=132) 
Residents who reported use of 
antimicrobials leftover from previous 
illness or given by relatives for UTI 
symptoms (n=10) 
In the past year prior to the 
survey 
7.6 (10/132) 
Huang, Y., 
2013 
Eastern 
(Northeastern 
China) 
All medical student 
respondents (n=1236) 
Medical students who had frequently used 
antibiotics without the doctor’s 
prescription previous occasions (n=non-
reported) 
Lifetime (past experience) 75.3 (unknown/1236) 
Huang, Y., 
2013 
Eastern 
(Northeastern 
China) 
All non-medical student 
respondents (n=852) 
Non-medical students who had frequently 
used antibiotics without the doctor’s 
prescription previous occasions (n=non-
reported) 
Lifetime (past experience) 49.5 (unknown/852) 
* Correction of minor published errors due to miscalculation 
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Supplement 3.2 Prevalence of self-medication for therapeutic purposes among children 
First 
Author, 
Year 
Region Denominator Numerator Recall period Reported Prevalence (%) 
Chang, 
J., 2018 
Across 
regions 
All respondents (caregivers) (n=3358) Caregivers reported non-prescription use of 
antibiotics for children (n=1617) 
In the past 6 months prior to the survey 48.2 (1617/3358) 
Chang, 
J., 2018 
Western 
(Xi'an) 
All respondents (caregivers) (n=1388) Caregivers reported non-prescription use of 
antibiotics for children (n=841) 
In the past 6 months prior to the survey 60.6 (841/1388) 
Chang, 
J., 2018 
Central 
(Changsha) 
All respondents (caregivers) (n=1008) Caregivers reported non-prescription use of 
antibiotics for children (n=505) 
In the past 6 months prior to the survey 50.1 (505/1008) 
Chang, 
J., 2018 
Eastern 
(Shanghai) 
All respondents (caregivers) (n=962) Caregivers reported non-prescription use of 
antibiotics for children (n=271) 
In the past 6 months prior to the survey 28.2 (271/962) 
Li, R., 
2016 
Across 
regions 
All respondents (caregivers) (n=39224) Children who have taken antibiotics to treat 
diarrhoea without any prescription (n=13775) 
Lifetime (past experience) 35.1 (13775/39224) 
Li, R., 
2016 
Middle 
China 
All respondents (caregivers) 
(n=6479+4430=10909) 
Children who have taken antibiotics to treat 
diarrhoea without any prescription (n=4430) 
Lifetime (past experience) 40.6 (4430/10909) 
Li, R., 
2016 
Eastern 
China 
All respondents (caregivers) 
(n=9191+4523=13714) 
Children who have taken antibiotics to treat 
diarrhoea without any prescription (n=4523) 
Lifetime (past experience) 33.0 (4523/13714) 
Li, R., 
2016 
Western 
China 
All respondents (caregivers) 
(n=9779+4822=14601) 
Children who have taken antibiotics to treat 
diarrhoea without any prescription (n=4822) 
Lifetime (past experience) 33.0 (4822/14601) 
Yu, M., 
2014 
Central 
(Jiangxi) 
All respondents (caregivers) (n=non-
reported) 
Caregivers who had medicated their children with 
antibiotics without the advice of a physician 
(n=non-reported) 
In the past 12 months prior to the survey 62 (unknown) 
Liao, 
R., 
2012 
Eastern 
(Shenzhen 
City) 
All respondents (primary school student 
caregivers) (n=509) 
Caregivers who self-medicated their children 
with antibiotics (n=222) 
Lifetime (past experience) 43.6 (222/509) 
Yao, 
Z., 
2013 
Eastern 
(Guangzhou 
City) 
All respondents (caregivers) (n=1295) Caregivers had self-medicated their children with 
antibiotics (n=822) 
In the past 12 months prior to the survey 63.5 (822/1295) 
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Supplement 3.3 Prevalence of self-medication for prophylaxis 
First Author, 
Year 
Region Denominator Numerator Recall period Reported 
Prevalence (%) 
Hu, Y., 2018 Western (Lanzhou 
University) 
All respondents (university medical 
students) (n=292) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=58) 
In the past year prior to 
the survey 
19.9 (58/292) 
Hu, Y., 2018 Eastern (Nankai 
University) 
All respondents (university medical 
students) (n=281) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=29) 
In the past year prior to 
the survey 
10.3 (29/281) 
Hu, Y., 2018 Central (Jilin University) All respondents (university medical 
students) (n=341) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=53) 
In the past year prior to 
the survey 
15.5 (53/341) 
Hu, Y., 2018 Central (Wuhan 
University) 
All respondents (university medical 
students) (n=303) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=33) 
In the past year prior to 
the survey 
10.9 (33/303) 
Hu, Y., 2018 Eastern (Zhejiang 
University) 
All respondents (university medical 
students) (n=302) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=44) 
In the past year prior to 
the survey 
14.6 (44/302) 
Hu, Y., 2018 Western (Guizhou 
University) 
All respondents (university medical 
students) (n=300) 
Medical students who took antibiotics to 
prevent diseases (such as common cold) 
(n=62) 
In the past year prior to 
the survey 
20.7 (62/300) 
Lv, B., 2014 Western (Shaanxi) All respondents (undergraduate 
students) (n=731) 
Students who used antibiotics to prevent the 
common cold (n=244) 
Lifetime (habits) 33.4* (244/731) 
Peng, D., 2018 Western (Guizhou 
University) 
All respondents (university students) 
(n=2073) 
Students who took antibiotics prophylactically 
(n=620) 
In the past year prior to 
the survey 
29.9 (620/2073) 
Peng, D., 2018 Eastern (Zhejiang 
University) 
All respondents (university students) 
(n=1922) 
Students who took antibiotics prophylactically 
(n=302) 
In the past year prior to 
the survey 
15.7 (302/1922) 
Wang, X., 2018 Across regions All respondents (university students) 
(n=11192) 
Students who took antibiotics for prophylaxis 
(n=2572) 
In the past year prior to 
the survey 
23.0 (2572/11192) 
Wang, X., 2017 Across regions All respondents (university students) 
(n=11192) 
Students who had taken antibiotics for 
prophylaxis (n=2572) 
In the past year prior to 
the survey 
23.0 (2572/11192) 
Dyar, O. J., 
2018 
Eastern (Shandong) All backyard pig farmer respondents 
(n=271) 
Backyard pig farmers who always or often 
used antibiotics in feed to keep pigs healthy 
and prevent diseases (n=non-reported) 
Lifetime (habits) 18 (unknown/271) 
Dyar, O. J., 
2018 
Eastern (Shandong) All backyard pig farmer respondents 
(n=271) 
Backyard pig farmers who used antibiotic for 
all pigs in a pen when some were sick (n=non-
reported) 
Lifetime (habits) 28 (unknown/271) 
* Correction of minor published errors due to miscalculation 
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Supplement 3.4 Prevalence of over-the-counter purchases 
First Author, 
Year 
Region Denominator Numerator Recall period Reported Prevalence (%) 
Cheng, J., 
2018 
Central 
(Anhui) 
Rural residents who were able to clearly 
recall the names of the medicines 
(n=624) 
Rural residents who had bought at least 
one kind of antibiotic over the counter in 
a pharmacy (n=391) 
Lifetime (past 
experience) 
62.7 (391/624) 
Cheng, J., 
2018 
Central 
(Anhui) 
All respondents (rural residents) 
(n=2262) 
Rural residents who reported they had 
bought medicines over the counter 
without prescription for symptoms of 
“common cold” in the past year, “GTIs” 
(over the past 3 months), or “UTIs” (over 
the past 3 months) (n=723) 
Over the past 3 
months or in the 
past year prior 
to the survey 
32.0 (723/2262) 
Peng, D., 
2018 
Eastern 
(Zhejiang 
University) 
Students who went to pharmacies to 
purchase antibiotics (n=893) 
Students who bought antibiotics without 
prescriptions (n=578) 
In the past year 
prior to the 
survey 
64.7 (578/893) 
Peng, D., 
2018 
Western 
(Guizhou 
University) 
Students who went to pharmacies to 
purchase antibiotics (n=1248) 
Students who bought antibiotics without 
prescriptions (n=922) 
In the past year 
prior to the 
survey 
73.9 (922/1248) 
Wang, X., 
2017 
Across 
regions 
Students who bought antibiotics from a 
pharmacy (n=6269) 
Students who bought antibiotics without 
prescriptions (n=4133) 
In the past year 
prior to the 
survey 
65.9 (4133/6269) 
You, J. H., 
2008 
Hong Kong All respondents (general public) 
(n=1002) 
Residents who had acquired antibiotic 
without a prescription from a pharmacy 
(n=73) 
Lifetime (past 
experience) 
7.3 (73/1002) 
Yu, M., 2014 Central 
(Jiangxi) 
All respondents (caregivers) (n=non-
reported) 
Caregivers who had purchased antibiotics 
without a physician’s prescription on at 
least one occasion (n=non-reported) 
Lifetime (past 
experience) 
40 (unknown) 
Jin, Y., 2014 Western 
(Gansu) 
All respondents (middle-aged residents) 
(n=2556) 
Residents who purchased and used 
antibiotics over the counter when getting 
ill (often/sometimes) 
(n=1092+1019=2111) 
Lifetime 
(habits) 
82.6 (42.72+39.87) (2111/2556) 
Lu, T., 2016 Eastern 
(Nanjing 
City) 
All respondents (university students) 
(n=600) 
Students who reported had purchased and 
used antibiotics without prescriptions 
(n=non-reported) 
In the previous 
3 months prior 
to the survey 
38.3 (100-61.7) (unknown/600) 
Wang, J., 
2017 
Central 
(Changsha 
City) 
All respondents (child parents) (n=310) Parents who would or sometimes would 
purchase antibiotics over the counter for 
their children (n=116) 
Lifetime 
(habits) 
37.4 (116/310) 
Dyar, O. J., 
2018 
Eastern 
(Shandong) 
Rural residents who reported that they 
had bought antibiotics for human use 
from a pharmacy (n=238) 
Residents who reported they did not have 
a prescription for at least one antibiotic 
(n=202) 
During the 
previous year 
prior to the 
survey 
84.9 (202/238) 
Dyar, O. J., 
2018 
Eastern 
(Shandong) 
All backyard pig farmer respondents 
(n=271) 
Backyard pig farmers who reported that 
they had bought antibiotics for their pigs 
without first speaking with a vet (n=82) 
In the previous 
year prior to the 
survey 
30.3 (82/271) 
Lam, T. P., 
2015 (BMC 
Pharmacol 
Toxicol) 
Hong Kong All respondents (patients) 
(n=108+77+1336+861=2382) 
Patients who ever bought antibiotics over 
the counter (n=108+77=185) 
Lifetime (past 
experience) 
7.8 (185/2382) 
Liao, C. C., 
2006 
Taiwan Respondents who himself or children in 
the family had taken antibiotics before 
(n=548) 
People who himself or family member 
ever purchased antibiotics over the 
counter (n=55) 
Lifetime (past 
experience) 
10.0 (55/548) 
Wun, Y. T., 
2014 
Hong Kong All respondents (general public) 
(n=162+21+249+1920=2352) 
People who ever bought antibiotics over 
the counter (n=162+21=183) 
Lifetime (past 
experience) 
7.8 (183/2352) 
Chai, J., 2019 Central 
(Anhui) 
Respondents (rural residents) who had 
suspected ARTIs (n=354+1763=2117) 
Residents who bought antimicrobials for 
suspected infection without prescriptions 
(n=354) 
In the past year 
prior to the 
survey 
16.7 (354/2117) 
Chai, J., 2019 Central 
(Anhui) 
Respondents (rural residents) who had 
suspected GTIs (n=36+371=407) 
Residents who bought antimicrobials for 
suspected infection without prescriptions 
(n=36) 
In the past year 
prior to the 
survey 
8.8 (36/407) 
Chai, J., 2019 Central 
(Anhui) 
Respondents (rural residents) who had 
suspected UTIs (n=22+106=128) 
Residents who bought antimicrobials for 
suspected infection without prescriptions 
(n=22) 
In the past year 
prior to the 
survey 
17.2 (22/128) 
Lam, T. P., 
2015 (Hong 
Kong Med J) 
Hong Kong All respondents (general public) 
(n=190+2250=2440) 
People who ever bought antibiotics over 
the counter (n=190) 
Lifetime (past 
experience) 
7.8 (190/2440) 
Wun, Y. T., 
2013 
Hong Kong All respondents (general public) 
(n=2460) 
People who had ever acquired antibiotics 
without prescription (n=191) 
Lifetime (past 
experience) 
7.8 (191/2460) 
Wun, Y. T., 
2015 
Hong Kong Local-born and recent immigrants 
(n=112+16+1518+116=1762) 
People who ever bought antibiotics over 
the counter (n=112+16=128) 
Lifetime (past 
experience) 
7.3 (128/1762) 
92 | P a g e  
 
Supplement 3.5 Prevalence of antibiotic household storage 
First Author, 
Year 
Region Denominator Numerator Recall period Reported 
Prevalence (%) 
Chang, J., 2018 Across regions All respondents (caregivers) (n=3358) Caregivers who always or often keep 
antibiotics at home (n=849) 
Lifetime (habits) 25.3 (849/3358) 
Hu, Y., 2018 Western 
(Lanzhou 
University) 
All respondents (university medical 
students) (n=292) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=191) 
Lifetime (habits) 65.4 (191/292) 
Hu, Y., 2018 Eastern (Nankai 
University) 
All respondents (university medical 
students) (n=281) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=201) 
Lifetime (habits) 71.5 (201/281) 
Hu, Y., 2018 Central (Jilin 
University) 
All respondents (university medical 
students) (n=341) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=215) 
Lifetime (habits) 63.0* (215/341) 
Hu, Y., 2018 Central (Wuhan 
University) 
All respondents (university medical 
students) (n=303) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=171) 
Lifetime (habits) 56.4 (171/303) 
Hu, Y., 2018 Eastern 
(Zhejiang 
University) 
All respondents (university medical 
students) (n=302) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=192) 
Lifetime (habits) 63.6 (192/302) 
Hu, Y., 2018 Western 
(Guizhou 
University) 
All respondents (university medical 
students) (n=300) 
Medical students who keep left-over 
antibiotics at home/dormitory (not for 
current use) (n=196) 
Lifetime (habits) 65.3 (196/300) 
Lv, B., 2014 Western 
(Shaanxi) 
All respondents (undergraduate students) 
(n=731) 
Students who kept antibiotics frequently 
(n=413) 
Lifetime (habits) 56.5 (413/731) 
Peng, D., 2018 Western 
(Guizhou 
University) 
All respondents (university students) 
(n=2073) 
Students who kept antibiotics at dorm/home 
(n=1152) 
In the past year 
prior to the 
survey 
55.6 (1152/2073) 
Peng, D., 2018 Eastern 
(Zhejiang 
University) 
All respondents (university students) 
(n=1922) 
Students who kept antibiotics at dorm/home 
(n=1233) 
In the past year 
prior to the 
survey 
64.2 (1233/1922) 
Wang, X., 2018 Across regions All respondents (university students) 
(n=11192) 
Students who keep antibiotics at home 
(n=7057) 
Lifetime (habits) 63.1 (7057/11192) 
Wang, X., 2017 Across regions All respondents (university students) 
(n=11192) 
Students who kept a stock of antibiotics at 
home or in the dormitory (n=7057) 
Lifetime (habits) 63.1 (7057/11192) 
Yu, M., 2014 Central (Jiangxi) All respondents (caregivers) (n=non-
reported) 
Caregivers who had kept antibiotics at home 
in case of future need (n=non-reported) 
Lifetime (past 
experience) 
75 (unknown, “three 
quarters” in text) 
Jiang, H., 2017 Eastern 
(Hangzhou City) 
All respondents (residents/general public) 
(n=449) 
Residents who kept penicillin, amoxicillin, 
cephalosporin and other antibiotics at home 
(n=449-157=292) 
Lifetime (habits) 65.0 (292/449) 
Jin, Y., 2014 Western (Gansu) All respondents (middle-aged residents) 
(n=2556) 
Residents who kept antibiotics at home 
(often/sometimes) (n=1628+320=1948) 
Lifetime (habits) 76.2 (63.69+12.52) 
(1948/2556) 
Li, Y., 2016 Eastern (Jiangsu) All respondents (residents/general public) 
(n=1589) 
Residents who kept antibiotics at home 
(n=1167) 
Lifetime (habits) 73.4 (1167/1589) 
Liao, R., 2012 Eastern 
(Shenzhen City) 
All respondents (primary school student 
caregivers) (n=112+263+134=509) 
Caregivers who kept antibiotics at home 
(n=112+263=375) 
Lifetime (habits) 73.7 (375/509) 
Lu, T., 2016 Eastern (Nanjing 
City) 
All respondents (university students) 
(n=600) 
Students who reported keeping antibiotics at 
home in case presence of illness (n=non-
reported) 
Lifetime (habits) >70 (unknown/600) 
Yao, Z., 2013 Eastern 
(Guangzhou 
City) 
All respondents (caregivers) (n=1295) Caregivers had household antibiotic storage 
(n=1038) 
Lifetime (habits) 80.2 (1038/1295) 
Dyar, O. J., 
2018 
Eastern 
(Shandong) 
All respondents (rural residents) (n=769) Residents who were observed to be keeping 
antibiotics for human use (n=321) 
At the time of the 
survey 
41.7 (321/769) 
Dyar, O. J., 
2018 
Eastern 
(Shandong) 
All respondents (rural residents) (n=769) Residents who reported keeping antibiotics 
for human use (n=343) 
In the past year 
prior to the 
survey 
44.6 (343/769) 
Dyar, O. J., 
2018 
Eastern 
(Shandong) 
All backyard pig farmer respondents 
(n=271) 
Back yard pig farmers who were observed to 
be keeping at least one antibiotic for pig use 
(n=83) 
At the time of the 
interview 
30.6 (83/271) 
Wun, Y. T., 
2014 
Hong Kong All respondents (general public) 
(n=13+128+218+1815=2174) 
People who generally kept left-over 
antibiotics (n=13+128=141) 
Lifetime (habits) 6.5 (141/2174) 
Lam, T. P., 
2015 (Hong 
Kong Med J) 
Hong Kong All respondents (general public) 
(n=147+2100=2247) 
People who kept left-over antibiotics for 
future use (n=147) 
Lifetime (habits) 6.5 (147/2247) 
Wun, Y. T., 
2015 
Hong Kong Local-born and recent immigrants 
(n=93+17+1443+104=1657) 
People who had kept left-over antibiotics for 
future use (n=93+17=110) 
Lifetime (past 
experience) 
6.6 (110/1657) 
Wun, Y. T., 
2013 
Hong Kong All respondents (general public) (n=2266) People who ever kept leftover antibiotics 
(n=150) 
Lifetime (past 
experience) 
6.6 (150/2266) 
* Correction of minor published errors due to miscalculation 
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Supplement 3.6 Prevalence of demand for antibiotic prescriptions 
First Author, 
Year 
Region Denominator Numerator Recall period Reported 
Prevalence (%) 
Chang, J., 
2018 
Across regions All respondents (caregivers) (n=3358) Caregivers who always or often ask antibiotics for their sick 
child when visiting a physician (n=62) 
Lifetime (habits) 1.8 (62/3358) 
Cheng, J., 
2018 
Central (Anhui) All respondents (rural residents) (n=2575) Residents who reported that they asked their doctor to 
prescribe a specific drug (n=368) 
Lifetime (past 
experience) 
14.3 (368/2575) 
Cheng, J., 
2018 
Central (Anhui) All respondents (rural residents) (n=2583) Residents who reported that they had asked multiple 
prescriptions (n=117) 
Lifetime (past 
experience) 
4.5 (117/2583) 
Gu, J., 2015 Central (Heilongjiang) All respondents (general public) (n=3600) Participants who require a prescription for antibiotics for a 
common cold (n=1789) 
Lifetime (habits) 49.7 
(1789/3600) 
Hu, Y., 2018 Western (Lanzhou 
University) 
All respondents (university medical students) 
(n=292) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=55) 
Lifetime (past 
experience) 
18.8 (55/292) 
Hu, Y., 2018 Eastern (Nankai 
University) 
All respondents (university medical students) 
(n=281) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=29) 
Lifetime (past 
experience) 
10.3 (29/281) 
Hu, Y., 2018 Central (Jilin 
University) 
All respondents (university medical students) 
(n=341) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=61) 
Lifetime (past 
experience) 
17.9 (61/341) 
Hu, Y., 2018 Central (Wuhan 
University) 
All respondents (university medical students) 
(n=303) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=33) 
Lifetime (past 
experience) 
10.9 (33/303) 
Hu, Y., 2018 Eastern (Zhejiang 
University) 
All respondents (university medical students) 
(n=302) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=42) 
Lifetime (past 
experience) 
13.9 (42/302) 
Hu, Y., 2018 Western (Guizhou 
University) 
All respondents (university medical students) 
(n=300) 
Medical students who asked for an antibiotic if did not 
receive one from a clinician during the consultation (n=53) 
Lifetime (past 
experience) 
17.7 (53/300) 
Peng, D., 
2018 
Eastern (Zhejiang 
University) 
All respondents (university students) 
(n=1922) 
Students who asked for antibiotics when doctors did not 
initially prescribe them (n=300) 
Lifetime (past 
experience) 
15.6 (300/1922) 
Peng, D., 
2018 
Western (Guizhou 
University) 
All respondents (university students) 
(n=2073) 
Students who asked for antibiotics when doctors did not 
initially prescribe them (n=444) 
Lifetime (past 
experience) 
21.4 (444/2073) 
Wang, X., 
2017 
Across regions All respondents (university students) 
(n=11192) 
Students who had asked a doctor for antibiotics, including by 
infusion, even when the doctor had not initially been willing 
to prescribe (n=2230) 
In the past year 
prior to the survey 
19.9 
(2230/11192) 
Yu, M., 2014 Central (Jiangxi) All respondents (caregivers) (n=non-reported) Caregivers who had asked antibiotic treatment directly from 
physicians on at least one occasion (n=non-reported) 
Lifetime (past 
experience) 
53 (unknown) 
Jiang, H., 
2017 
Eastern (Hangzhou 
City) 
All respondents (residents/general public) 
(n=449) 
Residents who ever asked doctors for antibiotics (n=449-
332=117) 
Lifetime (past 
experience) 
26.1 (117/449) 
Jin, Y., 2014 Western (Gansu) All respondents (middle-aged residents) 
(n=2556) 
Residents who asked for antibiotics when visiting a doctor 
(often/sometimes) (n=609+1296=1905) 
Lifetime (habits) 74.5 
(23.83+50.70) 
(1905/2556) 
Lu, T., 2016 Eastern (Nanjing City) All respondents (university students) (n=600) Students who reported had asked for antibiotics when visiting 
a doctor (n=non-reported) 
Lifetime (past 
experience) 
36.2 (100-63.8) 
(unknown/600) 
Wang, J., 
2017 
Central (Changsha 
City) 
All respondents (parents) (n=310) Parents who would not ask for antibiotic prescriptions for 
their children (n=268) 
Lifetime (habits) 86.5 (268/310) 
Huang, Y., 
2013 
Eastern (Northeastern 
China) 
All respondents (university students) 
(n=2042) 
Students who asked doctors to prescribe antibiotics when 
catching a common cold (n=335) 
Lifetime (past 
experience) 
16.4 (335/2042) 
Huang, Y., 
2013 
Eastern (Northeastern 
China) 
All non-medical student respondents (n=836) Non-medical students who would actively ask doctors to 
prescribe antibiotics (n=104) 
Lifetime (past 
experience) 
12.4 (104/836) 
Huang, Y., 
2013 
Eastern (Northeastern 
China) 
All medical student respondents (n=1206) Medical students who would actively ask doctors to prescribe 
antibiotics (n=231) 
Lifetime (past 
experience) 
19.2 (231/1206) 
Lam, T. P., 
2015 (BMC 
Pharmacol 
Toxicol)  
Hong Kong All respondents (patients) 
(n=129+78+1317+862=2386) 
Patients who ever asked for antibiotics (n=129+78=207) Lifetime (past 
experience) 
8.7 (207/2386) 
Liao, C. C., 
2006 
Taiwan Respondents who himself or children in the 
family had taken antibiotics before (n=548) 
People who had asking doctors for antibiotics or anti-
inflammatory medications (n=48) 
Lifetime (past 
experience) 
8.8 (48/548) 
Wun, Y. T., 
2014 
Hong Kong All respondents (general public) 
(n=17+188+250+1896=2351) 
People who ever asked for antibiotics (n=17+188=205) Lifetime (past 
experience) 
8.7 (205/2351) 
Lam, T. P., 
2015 (Hong 
Kong Med J) 
Hong Kong All respondents (general public) 
(n=212+2228=2440) 
People who ever asked for antibiotics (n=212) Lifetime (past 
experience) 
8.7 (212/2440) 
Wun, Y. T., 
2015 
Hong Kong Local-born and recent immigrants 
(n=136+15+1493+118=1762) 
People who ever asked doctors for antibiotics 
(n=136+15=151) 
Lifetime (past 
experience) 
8.6 (151/1762) 
Wun, Y. T., 
2013 
Hong Kong All respondents (general public) (n=2460) People who ever asked doctors for antibiotics (n=216) Lifetime (past 
experience) 
8.8 (216/2460) 
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Supplement 3.7 The likelihood to be prescribed with antibiotics 
First Author, 
Year 
Region Denominator Numerator Recall period Target 
illnesses/conditions 
Reported Prevalence 
(%) 
Chan, Y. H., 
2012 
Hong Kong All respondents (general 
public) (n=369) 
People having been prescribed 
antibiotics (n=210) 
In the past 2 years prior 
to the survey 
General diseases 56.9* (210/369) 
Peng, D., 
2018 
Eastern 
(Zhejiang 
University) 
Medical students who reported 
self-limiting illness and went 
to see a doctor (n=162) 
Students who were prescribed 
with antibiotics (n=91) 
In the past month prior 
to the survey 
Self-limiting illness 56.2 (91/162) 
Peng, D., 
2018 
Western 
(Guizhou 
University) 
Medical students who reported 
self-limiting illness and went 
to see a doctor (n=213) 
Students who were prescribed 
with antibiotics (n=170) 
In the past month prior 
to the survey 
Self-limiting illness 79.8 (170/213) 
Wang, X., 
2017 
Across regions Medical students who reported 
self-limiting illness and went 
to see a doctor (n=913) 
Students who were prescribed 
with antibiotics (n=600) 
In the past month prior 
to the survey 
Self-limiting illness 65.7 (600/913) 
You, J. H., 
2008 
Hong Kong All respondents 
(residents/general public) 
(n=1002) 
Residents who received 
antibiotic treatment for the most 
recent episode of URTI (n=237) 
The most recent 
episode of URTI 
URTI symptoms 23.7 (237/1002) 
Wun, Y. T., 
2014 
Hong Kong All respondents (general 
public) 
(n=47+603+67+324=1041) 
People accepting antibiotics 
when offered (n=47+603=650) 
Lifetime (past 
experience) 
URTI symptoms 62.4 (650/1041) 
Lam, T. P., 
2015 (Hong 
Kong Med J) 
Hong Kong All respondents (general 
public) (n=658+411=1069) 
People accepting antibiotics 
when offered (n=658) 
Lifetime (past 
experience) 
URTI symptoms 61.6 (658/1069) 
Wun, Y. T., 
2015 
Hong Kong Local-born and recent-
immigrants 
(n=464+46+278+22=810) 
People accepting antibiotics 
when offered (n=464+46=510) 
Lifetime (past 
experience) 
URTI symptoms 63.0 (510/810) 
Chai, J., 2019 Central 
(Anhui) 
Residents who sought medical 
help for ARTIs and had clear 
memory of whether receiving 
antimicrobials 
(n=1051+61=1112) 
Residents who said that they 
had been prescribed oral, 
intravenous antimicrobials or 
both (n=1051) 
In the past year prior to 
the survey 
ARTI symptoms 94.5 (1051/1112) 
Chai, J., 2019 Central 
(Anhui) 
Residents who sought medical 
help for GTIs and had clear 
memory of whether receiving 
antimicrobials (n=67+15=82) 
Residents who said that they 
had been prescribed oral, 
intravenous antimicrobials or 
both (n=67) 
In the past year prior to 
the survey 
GTI symptoms 81.7 (67/82) 
Chai, J., 2019 Central 
(Anhui) 
Residents who sought medical 
help for UTIs and had clear 
Residents who said that they 
had been prescribed oral, 
In the past year prior to 
the survey 
UTI symptoms 70.4 (38/54) 
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memory of whether receiving 
antimicrobials (n=38+16=54) 
intravenous antimicrobials or 
both (n=38) 
* Correction of minor published errors due to miscalculation 
96 | P a g e  
 
Supplement 4.1. Factors associated with self-medication with antibiotics without a prescription (East) 
(Chronological order, the list starts with the most recently published studies)  
Reference Setting Region Last year of 
data 
collection 
Study design Non-biomedical 
factors 
Description of the 
factor influencing 
outpatient and/or 
community antibiotic 
use 
ORs Study objective 
Zhu X, et 
al. 2016 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Prior knowledge of 
antibiotics 
2.26 (1.59-3.22) To investigate SMA 
behaviors and risk 
factors among Chinese 
university students, 
and further explore the 
association between 
SMA practices and 
adverse drug events 
(ADEs). 
Socio-Contextual 
(demographic 
characteristics) 
Female gender 1.44 (1.01-2.05) 
Older age 1.25 (1.12-1.38) 
Li Y, et al. 
2016 Outpatient East N/A Quantitative 
Knowledge (combined 
knowledge score) 
Combined knowledge 
score 
Squared combined 
knowledge score 
1.257 (1.081-1.461) 
0.978 (0.963-0.992) 
To investigate the 
prevalence and 
determinants of self-
medication with 
antibiotics (SMA) in 
Nantong, which made 
references for the 
rational use of 
antibiotics. 
Perceived barrier (or 
access) to antibiotics 
Keeping antibiotics at 
home 
Never 
Often 
 
Reference 
3.759 (2.759-5.122) 
Perceived Susceptibility Self-rated health status 
Poor 
Good 
 
Reference 
0.779 (0.620-0.978) 
Socio-Contextual 
(demographic 
characteristics) 
Married 
Not married 
Reference 
0.600 (0.476-0.757) 
Tian L, et 
al. 2015 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Not majoring in 
medicine 
2.746 (1.377-5.474) 
To assess university 
students’ antibiotic 
knowledge level (and 
its association with use 
behaviors). 
Socio-Contextual 
(demographic 
characteristics) 
Female 2.542 (1.426-4.532) 
Socio-Contextual 
(socio-economic status) 
Education: 
Lower grade 
3.550 (1.571-8.023) 
Hometown: Urban 2.186 (1.129-4.231) 
Liao R et 
al, 2013 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Having caregivers 
working in the medical 
field 
1.744 (1.107-2.746) 
To investigate the 
influence of parents' 
cognitive level of 
antibiotics on 
independent use of 
antibiotics among 
pupils. 
Perceived barrier (or 
access) to antibiotics 
Keeping antibiotics at 
home 
1.529 (1.169-2.001) 
Socio-Contextual 
(demographic 
characteristics) 
Parents’ age 0.807 (0.680-0.957) 
Yao Z et 
al, 2013 Outpatient East N/A Quantitative 
Perceived barrier (or 
access) to antibiotics 
Keeping antibiotics at 
home 
4.792 (3.541-6.485) 
To assess the 
prevalence and 
determinants of self-
medication with 
antibiotics among 
children in Guangzhou 
city, Guangdong 
province. 
Socio-Contextual 
(socio-economic status) 
Education: 
Postgraduate and 
above 
Elementary school and 
below 
Junior high school 
High school or 
secondary school 
 
Reference 
5.042 (1.495-
17.002) 
2.358 (1.150-4.838) 
2.104 (1.106-4.003) 
Huang Y, 
et al. 2013 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Medical students vs 
Non-medical students 
OR not applicable To analyze the present 
status of Chinese 
medical (MS)- and 
non-medical (NS) 
students’ KAP on the 
use of antibiotics and 
examine the influence 
of Chinese medical 
curriculum on the 
appropriate usage of 
antibiotics among 
medical students. 
Pan H, et 
al. 2012 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Prior knowledge of 
antibiotics 
2.23 (1.74-2.87) 
To evaluate 
knowledge and 
behaviors of university 
students and risk 
factors concerning 
SMA. 
Socio-Contextual 
(demographic 
characteristics) 
Age 1.23 (1.16-1.30) 
Socio-Contextual 
(socio-economic status) 
Higher allowance: 
≤500 RMB 
500 to 1,000 RMB 
>1000 RMB 
 
Reference 
1.49 (1.17-1.91) 
2.18 (1.29-3.68) 
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Supplement 4.2. Factors associated with self-medication with antibiotics without a prescription (Central) 
Reference Setting Region Last year 
of data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Cheng J et al. 
2018 Outpatient Central N/A Quantitative 
Knowledge (ability to 
recognize antibiotics) 
Could name at least one 
kind of antibiotic 
1.88 (1.40‐2.53) 
To examine antibiotic-
related knowledge and 
behaviors in rural 
Anhui, identify factors 
associated with 
knowledge, and 
explore the relationship 
between knowledge 
and antibiotic use. 
Knowledge (combined 
knowledge score) 
Greater total KS (KS ≥ 5) 2.80 (1.55-5.06) 
Knowledge (when and 
how to use antibiotics) 
Able to name at least one 
disbenefit of antibiotic use 
1.56 (1.17‐2.07) for 
using pills leftover 
from 
relatives/friends 
Cues to action 
(antibiotic efficacy) 
Able to point out one 
symptom no need of 
antibiotics 
1.49 (1.15‐1.93) 
Socio-Contextual 
(demographic 
characteristics) 
Older age 
Females 
2.85 (1.47‐5.52) 
1.41 (1.07‐1.87) 
Socio-Contextual 
(socio-economic 
status) 
0 year’s education 
≥10 years’ education 
Reference 
1.86 (1.11‐3.11) 
Perceived barrier (or 
access) to 
antibiotics/care 
With more than one type of 
health insurance 
1.35 (1.01‐1.80) 
Yu M, et al. 2014 Outpatient Central N/A Quantitative 
Perceived barrier (or 
access) to antibiotics 
Once purchased antibiotics 
without physicians’ 
prescription 
6.264 (4.144-9.469) 
To investigate parents’ 
perceptions of 
antibiotic use for their 
children, interactions 
between parents and 
physicians regarding 
treatment with 
antibiotics, and factors 
associated with parents 
self-medicating 
children with 
antibiotics. 
Sometimes, often or always 
stores antibiotics at home 
2.792 (1.961-3.975) 
Antibiotic use 
behaviors 
Would follow all the advice 
from physicians 
0.639 (0.451-0.906) 
Socio-Contextual 
(demographic 
characteristics) 
Raising more than one child 2.174 (1.485-3.183) 
Age of children 1.146 (1.037-1.266) 
Socio-Contextual 
(socio-economic 
status) 
Education: 
College or above 
Primary school 
 
Reference 
0.191 (0.049-0.754) 
Living in villages 1.643 (1.108-2.436) 
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Supplement 4.3. Factors associated with self-medication with antibiotics without a prescription (West) 
Reference Setting Region Last 
year of 
data 
collectio
n 
Study design Non-biomedical factors Description of the factor 
influencing outpatient and/or 
community antibiotic use 
ORs Study objective 
Lv B, et al. 
2014. 
Outpatie
nt West N/A Quantitative 
Having some level of 
medical education 
Medical students 1.612 (1.193–
2.178) 
To evaluate the 
knowledge, attitude 
and behaviors of 
university students on 
the use of antibiotics. 
Socio-Contextual 
(region/location) 
From urban areas 1.495 (1.103–
2.026) 
Lv B, 2013 Outpatient West N/A Quantitative 
Having some level of 
medical education 
Majoring in medicine 1.697 (1.229-
2.341) 
To investigate 
university students’ 
antibiotic use 
behaviors and related 
determinants in order 
to help improve their 
antibiotic use 
behaviors. 
Socio-Contextual (socio-
economic status) 
Hometown: 
Urban 
1.527 (1.109-
2.203) 
Jin Y, et al. 
2014 
Outpatie
nt West N/A Quantitative 
Socio-Contextual (socio-
economic status) 
Behaviour: over-the-
counter purchase and use 
of antibiotics according to 
commercial advertisement 
Hometown: 
Rural 
Urban 
Reference 
0.71 (0.60-0.84) To examine the 
influence of social 
demographic 
characteristics on 
antibiotics use among 
middle aged and 
elderly people and to 
provide evidences for 
making health 
intervention strategies. 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
1.72 (1.45-2.03) 
Socio-Contextual (socio-
economic status) 
Behaviour: over-the-
counter purchase and use 
of antibiotics 
Hometown: 
Rural 
Urban 
Reference 
0.56 (0.49-0.66) 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
0.70 (0.60-0.81) 
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Supplement 4.4. Factors associated with self-medication with antibiotics without a prescription (across regions) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical factors Description of the 
factor influencing 
outpatient and/or 
community antibiotic 
use 
ORs Study objective 
Wang W, et 
al. 2019 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
(misconceptions) 
Having the 
misconception that 
antibiotic is a 
Xiaoyanyao 
1.51 (1.21-1.89) To examine whether 
university students hold the 
misconception that Antibiotic 
is a Xiaoyanyao (literally 
means anti-inflammatory drug 
in Chinese), and association 
between this misconception 
and antibiotic misuse 
behaviors. 
Chang J, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Perceived barrier (or 
access) to antibiotics 
Knowing prescription-
only regulation for 
sales of antibiotics at 
community pharmacies 
0.77 (0.66-0.91) 
To investigate primary 
caregivers’ knowledge, 
attitudes, and practices of 
antibiotics use among children 
in urban China 
Attitudes (accepting 
attitudes towards SMA) 
Caregivers’ supportive 
attitude 
2.66 (2.21-3.19) 
Having some level of 
medical education 
Having family member 
or relatives working in 
health sector 
1.38 (1.14-1.66) 
Perceived barrier (or 
access) to antibiotics 
Keeping antibiotics at 
home 
6.25 (4.73-8.26) 
Perceived Susceptibility Child’s rated health 
status rated as fair, 
poor, or very poor 
0.48 (0.40-0.57) 
Socio-Contextual 
(demographic 
characteristics) 
Caregiver’s 
relationship with 
children was 
grandparents 
0.68 (0.49-0.94) 
Caregiver’s gender: 
Female 
1.25 (1.06–
1.47) 
100 | P a g e  
 
Socio-Contextual 
(socio-economic status) 
Caregivers with senior 
high school or 
equivalent 
0.75 (0.57-0.98) 
Socio-Contextual 
(region/location) 
Xi’an 
Shanghai 
Changsha 
Reference 
0.34 (0.28-0.42) 
0.78 (0.65-0.94) 
Perceived barrier (or 
access) to 
antibiotics/healthcare 
Having children’s 
health insurance 
1.30 (1.05-1.61) 
Peng D, et al. 
2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Parent's having medical 
background 
3.01 (1.66-5.47) To explore the antibiotic 
misuse behaviors among 
university students in western 
and eastern China and find out 
the regional differences. 
Socio-Contextual 
(region/location) 
Zhejiang 
Guizhou 
Reference 
3.00 (1.84-4.90) 
Wang X, et 
al. 2019 Outpatient 
Across 
regions N/A Quantitative 
Perceived barrier (or 
access) to antibiotics 
(over-the-counter 
purchase, keeping 
antibiotics at home, 
leftover prescriptions) 
Keep Antibiotics at 
Home: 
No 
Yes (Previously bought 
from pharmacies) 
Yes (Previously 
prescribed by doctors) 
Yes (Other) 
Reference 
5.29 (3.72-7.53) 
4.03 (2.68-6.07) 
6.06 (3.06-
12.02) To determine the sources of antibiotics leftover at home, 
the risk factors of keeping 
antibiotics at home, and the 
associations between keeping 
antibiotics at home and SMA 
among Chinese university 
students. 
Socio-Contextual 
(socio-economic status) 
Urban 0.65 (0.49-0.88) 
Socio-Contextual 
(region/location) 
Zhejiang University 
Lanzhou University 
Jilin University 
Nankai University 
Guizhou University 
Reference 
2.38 (1.55-3.65) 
3.07 (1.99-4.71) 
2.37 (1.52-3.69) 
2.27 (1.44-3.58) 
Wang X, et 
al. 2017 Outpatient 
Across 
regions N/A Quantitative 
Knowledge (combined 
knowledge score) 
0-4 
5-9 
10-13 
Reference 
0.53 (0.39-0.72) 
0.36 (0.24-0.54) 
To explore behaviors related to 
antibiotic use in university 
students across China. Perceived barrier (or 
access) to antibiotics 
Keeping antibiotics at 
home 
5.05 (3.58-7.14) 
Li R, et al 
2016 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
Socio-Contextual 
(demographic 
Guardians having basic 
health knowledge 
0.82 (0.79-0.86) To investigate the antibiotics 
usage pattern among Chinese 
children and provide further Female children 0.92 (0.88-0.96) Being raised by parents 0.90 (0.85-0.94) 
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characteristics) Children’s age: 
1–3 years 
4–6 years 
 
1.62 (1.54-1.71) 
1.90 (1.77-2.03) 
insight in developing 
strategies for promoting public 
health education. 
Higher education of 
guardians 
0.60 (0.55-0.66) 
Western China: 
Low income 
Middle income 
Higher income 
Eastern China: 
Low income 
Higher income 
Middle China: 
Low income 
Middle income 
 
Reference 
1.63 (1.51-1.78) 
1.71 (1.50-1.94) 
 
Reference 
0.75 (0.65-0.86) 
 
Reference 
0.86 (0.77-0.96) 
Urban area 0.79 (0.76-0.83) 
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Supplement 4.5. Factors associated with taking antibiotics as prophylaxis (across regions) 
Reference Setting Region Last year 
of data 
collection 
Study 
design 
Non-biomedical factors Description of the 
factor influencing 
outpatient and/or 
community 
antibiotic use 
ORs Study objective 
Wang W, et 
al. 2019 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
(misconceptions) 
Having the 
misconception that 
antibiotic is a 
Xiaoyanyao 
1.36 (1.24-1.50) To examine whether university 
students hold the 
misconception that Antibiotic 
is a Xiaoyanyao (literally 
means anti-inflammatory drug 
in Chinese), and association 
between this misconception 
and antibiotic misuse 
behaviors. 
Hu Y, et al. 
2018 Outpatient 
Across 
regions N/A Quantitative 
Socio-Contextual (socio-
economic status) 
Hometowns were 
urban 
0.69 (0.50-0.94) To understand knowledge, 
attitude, and practice (KAP) 
with respect to antibiotic use 
for self-limiting illnesses 
among medical students in 
China. 
Peng D, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Majoring in medicine 0.69 (0.55-0.87) To explore the antibiotic misuse 
behaviors among university 
students in western and eastern 
China and find out the regional 
differences. 
Parent's having 
medical background 
1.45 (1.08-1.95) 
Socio-Contextual 
(region/location) 
Zhejiang 
Guizhou 
Reference 
2.28 (1.89-2.76) 
Wang X, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Majoring in medicine 0.52 (0.44-0.60) To determine the sources of 
antibiotics leftover at home, the 
risk factors of keeping 
Parent with Medical 
Background 
1.47 (1.26-1.72) 
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Perceived barrier (or 
access) to antibiotics (over-
the-counter purchase, 
keeping antibiotics at home, 
leftover prescriptions) 
Keep Antibiotics at 
Home: 
No 
Yes (Previously 
bought from 
pharmacies) 
Yes (Previously 
prescribed by 
doctors) 
Yes (Other) 
Reference 
2.55 (2.22-2.92) 
2.62 (2.34-2.93) 
2.72 (1.97-3.76) 
antibiotics at home, and the 
associations between keeping 
antibiotics at home and SMA 
among Chinese university 
students. 
Socio-Contextual (socio-
economic status) 
Household Income: 
<3000 ($461 USD) 
3000-10,000 ($462-
$1538 USD) 
Reference 
0.88 (0.79-0.99) 
Hometowns were 
urban 
0.80 (0.71-0.90) 
Socio-Contextual 
(region/location) 
Zhejiang University 
Lanzhou University 
Jilin University 
Guizhou University 
Reference 
1.87 (1.58-2.22) 
1.99 (1.69-2.35) 
2.18 (1.83-2.58) 
Wang X, et 
al. 2017 Outpatient 
Across 
regions N/A Quantitative 
Knowledge (combined 
knowledge score) 
0-4 
5-9 
10-13 
Reference 
0.64 (0.57-0.72) 
0.35 (0.30-0.41) 
To explore behaviors related to 
antibiotic use in university 
students across China. 
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Supplement 4.6. Factors associated with over-the-counter purchase of antibiotics (Central) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Cheng J, et al. 2018 Outpatient Central N/A Quantitative 
Knowledge (ability 
to recognize 
antibiotics) 
Could name at least one 
kind of antibiotic 
2.11 (1.38‐3.22) 
To examine antibiotic-
related knowledge and 
behaviors in rural Anhui, 
identify factors associated 
with knowledge, and 
explore the relationship 
between knowledge and 
antibiotic use. 
Knowledge 
(combined 
knowledge score) 
Greater total KS (KS=4) 2.23 (1.01‐4.96) 
Perception 
(Perceived antibiotic 
efficacy) 
Are antibiotic combinations 
more effective? 
1.53 (1.03‐2.25) 
Socio-Contextual 
(demographic 
characteristics) 
Females 1.45 (1.01‐2.10) 
Wang J, et al. 2017 Outpatient Central N/A Quantitative 
Prior experience Whether been prescribed 
antibiotics by doctors or not 
β=0.239 
To investigate the knowledge 
and behavior of antibiotic 
usage for URTI among parents 
of young children in Changsha 
City, Hunan Province. 
Socio-Contextual 
(demographic 
characteristics) 
Age of child β=-0.074 
Socio-Contextual 
(socio-economic 
status) 
Parents’ education level β=0.090 
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Supplement 4.7. Factors associated with over-the-counter purchase of antibiotics (West) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Jin Y, et al. 
2014 Outpatient West N/A Quantitative 
Socio-Contextual (socio-
economic status) 
Behaviour: over-the-counter 
purchase and use of 
antibiotics 
Hometown: 
Rural 
Urban 
Reference 
0.56 (0.49-0.66) To examine the 
influence of social 
demographic 
characteristics on 
antibiotics use 
among middle aged 
and elderly people 
and to provide 
evidences for 
making health 
intervention 
strategies. 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
0.70 (0.60-0.81) 
Socio-Contextual (socio-
economic status) 
Behaviour: over-the-counter 
purchase and use of 
antibiotics according to 
commercial advertisements 
Hometown: 
Rural 
Urban 
Reference 
0.71 (0.60-0.84) 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
1.72 (1.45-2.03) 
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Supplement 4.8. Factors associated with over-the-counter purchase of antibiotics (across regions) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Peng D, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Parent's having medical 
background 
0.62 (0.43-0.89) To explore the antibiotic 
misuse behaviors among 
university students in 
western and eastern China 
and find out the regional 
differences. 
Socio-Contextual 
(socio-economic 
status) 
Education: 
Undergraduate 
Graduate 
Reference 
1.94 (1.35,2.80) 
Socio-Contextual 
(region/location) 
Zhejiang 
Guizhou 
Reference 
1.71(1.36,2.15) 
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Supplement 4.9. Factors associated with over-the-counter purchase of antibiotics (Hong Kong and Taiwan) 
Reference Setting Region Last year 
of data 
collection 
Study design Non-biomedical 
factors 
Description of 
the factor 
influencing 
outpatient 
and/or 
community 
antibiotic use 
ORs Study objective 
Lam TP, et al. 2015 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative + 
quantitative) 
Socio-Contextual 
(socio-economic 
status) 
Local-born 
New 
immigrants 
All immigrants 
Reference 
2.205 (1.230- 3.953) 
0.601 (0.436-0.829) 
To investigate the differences in antibiotic 
use between patients with and without a 
regular doctor in a pluralistic health care 
system. 
Wun YT, et al. 2015 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative + 
quantitative) 
Socio-Contextual 
(socio-economic 
status) 
Local-born 
Recent-
immigrants 
Reference 
2.37 (1.28-4.15) 
To study the difference in KAP with 
antibiotics between the recent-immigrants 
from mainland China and the local-born of 
Hong Kong—places with significantly 
different healthcare and socio-economic 
systems. 
Wun YT, et al. 2013 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative + 
quantitative) 
Socio-Contextual 
(demographic 
characteristics) 
Age Not reported To examine the public’s perspectives on 
antibiotic resistance in our study of the 
public’s knowledge, attitude and practice 
with antibiotics. Risk 
perception/Perceived 
severity 
Those who 
agreed with the 
potential harm 
of such practice 
0.47, 0.341–
0.654 
0.47 (0.341-0.654) 
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Supplement 4.10. Factors associated with storing antibiotics at home (Central) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Cheng et. Al, 
2018.  Outpatient Central N/A Quantitative 
Knowledge (ability to 
recognize antibiotics) 
Could name at least one kind 
of antibiotic 
1.88 (1.40‐2.53) 
To examine antibiotic-related 
knowledge and behaviors in 
rural Anhui, identify factors 
associated with knowledge, 
and explore the relationship 
between knowledge and 
antibiotic use. 
Knowledge (combined 
knowledge score) 
Greater total KS (KS≥5) 2.80 (1.55-5.06) 
Perception (antibiotic 
efficacy) 
Being able to point out one 
symptom no need of 
antibiotics 
1.49 (1.15‐1.93) 
Socio-Contextual 
(demographic 
characteristics) 
Females 1.41 (1.07‐1.87) 
Older age 2.85 (1.47‐5.52) 
Socio-Contextual (socio-
economic status) 
0 year’s education 
≥10 years’ education 
Reference 
1.86 (1.11‐3.11) 
Perceived barrier (or access) 
to antibiotics/healthcare 
With more than one type of 
health insurance 
1.35 (1.01‐1.80) 
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Supplement 4.11. Factors associated with storing antibiotics at home (West) 
Reference Setting Region Last year of 
data collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient and/or 
community antibiotic use 
ORs Study objective 
Jin Y, et al. 
2014 Outpatient West N/A Quantitative 
Socio-Contextual 
(socio-economic status) 
Hometown: 
Rural 
Urban 
Reference 
1.30 (1.06-1.58) 
To examine the influence of 
social demographic 
characteristics on antibiotics use 
among middle aged and elderly 
people and to provide evidences 
for making health intervention 
strategies. 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
1.31 (1.11-1.55) 
Household income (per month): 
≥2000 RMB 
<1000 RMB 
1000-1999 RMB 
Reference 
0.46 (0.36-0.60) 
0.69 (0.55-0.88) 
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Supplement 4.12. Factors associated with storing antibiotics at home (across regions) 
Reference Setting Region Last year of 
data collection 
Study 
design 
Non-biomedical factors Description of the 
factor influencing 
outpatient and/or 
community antibiotic 
use 
ORs Study objective 
Hu Y et al, 
2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Mothers with medical 
backgrounds 
0.53 (0.32-0.88) 
To understand knowledge, 
attitude, and practice 
(KAP) with respect to 
antibiotic use for self-
limiting illnesses among 
medical students in China. 
Socio-Contextual 
(demographic 
characteristics) 
Female students 1.20 (1.04–1.56) 
Socio-Contextual (socio-
economic status) 
Fathers had a higher 
educational level 
1.60 (1.10-2.30) 
Hometowns were urban 1.60 (1.20-1.90) 
Peng D, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education 
Parent's having medical 
background 
1.68 (1.24-2.27) 
To explore the antibiotic 
misuse behaviors among 
university students in 
western and eastern China 
and find out the regional 
differences. 
Socio-Contextual 
(demographic 
characteristics) 
Males 0.70 (0.61-0.80) 
Socio-Contextual (socio-
economic status) 
Education level of 
parents: 
Illiteracy/primary 
school 
Junior high school 
Senior high school 
University/above 
Reference 
1.33 (1.07-1.66) 
1.70 (1.32-2.17) 
2.03 (1.53-2.69) 
Household income per 
month: 
< 3000 RMB 
3000-10,000 RMB 
Reference 
1.30 (1.10-1.53) 
Hometowns were rural 0.64 (0.54-0.76) 
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Wang X, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education  
Parent with Medical 
Background 
1.56 (1.33-1.84) 
To determine the sources 
of antibiotics leftover at 
home, the risk factors of 
keeping antibiotics at 
home, and the associations 
between keeping 
antibiotics at home and 
SMA among Chinese 
university students. 
Socio-Contextual 
(demographic 
characteristics) 
Females 1.47 (1.35-1.59) 
Age 1.02 (1.00-1.04) 
Socio-Contextual (socio-
economic status) 
Household Income: 
<3000 ($461 USD) 
3000-10,000 ($462-
$1538 USD) 
Reference 
1.15 (1.04-1.27) 
Education level of 
parents: 
Illiteracy/primary 
school 
Junior high school 
Senior high school 
University/above 
Reference 
1.27 (1.09-1.47) 
1.54 (1.32-1.81) 
1.79 (1.51-2.13) 
Hometowns were urban 1.50 (1.35-1.66) 
Socio-Contextual 
(region/location) 
Zhejiang University 
Wuhan University 
Reference 
0.83 (0.72-0.96) 
Wang X, et 
al. 2017 Outpatient 
Across 
regions N/A Quantitative 
Knowledge (combined 
knowledge score) 
0-4 
5-9 
Reference 
1.29 (1.15-1.45) 
To explore behaviors 
related to antibiotic use in 
university students across 
China. 
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Supplement 4.13. Factors associated with storing antibiotics at home (Hong Kong and Taiwan) 
Reference Setting Region Last year 
of data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of 
the factor 
influencing 
outpatient 
and/or 
community 
antibiotic use 
ORs Study objective 
Lam TP, et al. 2015 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative 
+ 
quantitative) 
Socio-Contextual 
(socio-economic 
status) 
Local-born 
New immigrants 
Reference 
2.490 (1.385-4.477) 
To investigate the differences in 
antibiotic use between patients 
with and without a regular doctor 
in a pluralistic health care system. 
Wun YT, et al. 2015 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative 
+ 
quantitative) 
Socio-Contextual 
(socio-economic 
status) 
Local-born 
Recent-
immigrants 
Reference 
2.37 (1.29-4.15) 
To study the difference in KAP 
with antibiotics between the 
recent-immigrants from mainland 
China and the local-born of Hong 
Kong—places with significantly 
different healthcare and socio-
economic systems. 
Wun YT et al. 2013 
Outpatient Hong Kong N/A 
Mixed-
methods 
(qualitative 
+ 
quantitative) 
Socio-Contextual 
(demographic 
characteristics) 
Age Not reported To examine the public’s 
perspectives on antibiotic 
resistance in our study of the 
public’s knowledge, attitude and 
practice with antibiotics. 
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Socio-Contextual 
(socio-economic 
status) 
Income Not reported 
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Supplement 4.14. Factors associated with asking/pressuring doctors for antibiotics (East) 
Reference Setting Region Last year of data 
collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient 
and/or community antibiotic 
use 
ORs Study objective 
Huang Y, et al, 
2013 Outpatient East N/A Quantitative 
Having some level of 
medical education 
Medical students vs 
Non-medical students 
OR not 
applicable 
To analyze the present status 
of Chinese medical (MS)- and 
non-medical (NS) students’ 
KAP on the use of antibiotics 
and examine the influence of 
Chinese medical curriculum on 
the appropriate usage of 
antibiotics among medical 
students. 
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Supplement 4.15. Factors associated with asking/pressuring doctors for antibiotics (Central) 
Reference Setting Region Last year of 
data collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient and/or 
community antibiotic use 
ORs Study objective 
Cheng, et al, 
2018 Outpatient Central N/A Quantitative 
Knowledge (ability to 
recognize antibiotics) 
Could name at least one kind of 
antibiotic 
1.41 (1.08‐1.84) 
for asking for 
specific drug 
To examine antibiotic-related 
knowledge and behaviors in 
rural Anhui, identify factors 
associated with knowledge, 
and explore the relationship 
between knowledge and 
antibiotic use. 
Knowledge (combined 
knowledge score) 
A greater total KS (KS≥5) 2.63 (1.49‐4.65) 
for asking for 
specific drug 
A higher KS (KS = 4) 2.83 (1.27‐6.32) 
for requesting 
multiple 
prescriptions 
Knowledge (when and how to 
use antibiotics) 
Being able to name at least one 
disbenefit of antibiotic use 
1.38 (1.05‐1.18) 
for asking for 
specific drug 
Cues to action Being able to point out one 
symptom no need of antibiotics 
1.61 (1.26‐2.04) 
for asking for 
specific drug 
Being able to point out one 
symptom no need of antibiotics 
1.80 (1.19‐2.71) 
for requesting 
multiple 
prescriptions 
Perceived barrier (or access) 
to antibiotics/healthcare 
With more than one type of 
health insurance 
1.36 (1.03‐
1.79) for asking 
for specific drug 
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Supplement 4.16. Factors associated with asking/pressuring doctors for antibiotics (West) 
Reference Setting Region Last year of data 
collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient 
and/or community antibiotic 
use 
ORs Study objective 
Jin Y, et al. 
2014 Outpatient West N/A Quantitative 
Socio-Contextual (socio-
economic status) 
Behaviour: asking doctors 
for antibiotics 
Hometown: 
Rural 
Urban 
Reference 
0.73 (0.63-0.85) 
To examine the influence of 
social demographic 
characteristics on antibiotics 
use among middle aged and 
elderly people and to provide 
evidences for making health 
intervention strategies. 
Education: 
Senior high school and above 
Junior high school and below 
Reference 
1.18 (1.01-1.37) 
Socio-Contextual (socio-
economic status) 
Behaviour: asking doctors 
for antibiotics via 
intravenous injection 
Hometown: 
Rural 
Urban 
Reference 
0.78 (0.67-0.91) 
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Supplement 4.17. Factors associated with asking/pressuring doctors for antibiotics (across regions) 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient 
and/or community antibiotic 
use 
ORs Study objective 
Wang W, et 
al. 2019 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
(misconceptions) 
Having the misconception 
that antibiotic is a 
Xiaoyanyao 
1.34 (1.21-1.48) To examine whether 
university students hold 
the misconception that 
Antibiotic is a 
Xiaoyanyao (literally 
means anti-inflammatory 
drug in Chinese), and 
association between this 
misconception and 
antibiotic misuse 
behaviors. 
Hu Y et al, 
2018 Outpatient 
Across 
regions N/A Quantitative 
Socio-Contextual 
(demographic 
characteristics) 
Aged between 16 and 20 
years old 
Aged between 21 and 30 
years old 
Reference 
1.50 (1.00-2.20) 
To understand 
knowledge, attitude, and 
practice (KAP) with 
respect to antibiotic use 
for self-limiting illnesses 
among medical students 
in China. 
Peng D, et 
al. 2018 Outpatient 
Across 
regions N/A Quantitative 
Having some 
level of medical 
education 
Majoring in medicine 0.71 (0.56-0.90) 
To explore the antibiotic 
misuse behaviors among 
university students in 
western and eastern 
China and find out the 
regional differences. 
Socio-Contextual 
(demographic 
characteristics) 
Age 1.05 (1.00-1.11) 
Socio-Contextual 
(socio-economic 
status) 
Education level of parents: 
Illiteracy/primary school 
Senior high school 
Reference 
1.39 (1.01-1.91) 
Socio-Contextual 
(region/location) 
Zhejiang 
Guizhou 
Reference 
1.48 (1.22-1.80) 
Wang X et 
al. 2017 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
(combined 
0-4 
5-9 
Reference 
0.71 (0.62-0.80) 
To explore behaviors 
related to antibiotic use 
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knowledge 
score) 
10-13 0.50 (0.42-0.59) in university students 
across China. 
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Supplement 4.18. Factors associated with antibiotic prescriptions (Central) 
Outcome: accepting physician's decision not to prescribe antibiotics 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical factors Description of the 
factor influencing 
outpatient and/or 
community antibiotic 
use 
ORs Study objective 
Cheng J, et al. 
2018 Outpatient Central N/A Quantitative 
Knowledge (AMR 
awareness) 
Knowing unnecessary 
use of antibiotics make 
them ineffective. 
1.19 (1.00‐
1.42) 
To examine antibiotic-related 
knowledge and behaviors in 
rural Anhui, identify factors 
associated with knowledge, 
and explore the relationship 
between knowledge and 
antibiotic use. 
Socio-Contextual (socio-
economic status) 
Education: 
7-9 years 
≥10 years 
Reference 
1.39 (1.08‐
1.79) 
1.46 (1.01‐
2.10) 
Perceived barrier (or 
access) to 
antibiotics/healthcare 
With more than one 
type of health insurance 
0.75 (0.61‐
0.92) 
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Supplement 4.19. Factors associated with antibiotic prescriptions (Central) 
Outcome: likelihood of being prescribed with antibiotics 
Reference Setting Region Last year of 
data collection 
Study 
design 
Non-biomedical factors Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Chai J et 
al. 2019 Outpatient Central N/A Quantitative 
Knowledge (combined 
knowledge score) 
 
Zero 
≥3 scores 
Outcome: being prescribed 
oral/intravenous 
antimicrobials 
reference 
0.32 (0.13-
0.78) 
To describe help seeking 
behavior from a medical 
doctor and antimicrobial use 
for common infections among 
rural residents of Anhui 
province, China. 
Socio-Contextual 
(demographic 
characteristics) 
Age 
Outcome: being prescribed 
oral antimicrobial use 
0.81 (0.71-
0.93) 
Age 
Outcome: being prescribed 
intravenous antimicrobial 
use 
1.21 (1.10-
1.33) 
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Supplement 4.20. Factors associated with antibiotic prescriptions (across regions) 
Outcome: likelihood of being prescribed with antibiotics 
Reference Setting Region Last year of 
data 
collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient 
and/or community 
antibiotic use 
ORs Study objective 
Peng D et al, 
2018 Outpatient 
Across 
regions N/A Quantitative 
Having some level of 
medical education  
Majoring in medicine 0.49 (0.26-0.93) To explore the antibiotic 
misuse behaviors among 
university students in 
western and eastern 
China and find out the 
regional differences. 
Socio-Contextual 
(socio-economic 
status) 
Hometown were rural 2.01 (1.05-3.84) 
Socio-Contextual 
(region/location) 
Zhejiang 
Guizhou 
Reference 
2.95 (1.68-5.18) 
Wang X, et 
al. 2017 Outpatient 
Across 
regions N/A Quantitative 
Knowledge 
(combined knowledge 
score) 
0-4 
5-9 
10-13 
Reference 
0.58 (0.39-0.87) 
0.46 (0.27-0.76) 
To explore behaviors 
related to antibiotic use 
in university students 
across China. 
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Supplement 4.21. Factors associated with antibiotic prescriptions (Hong Kong and Taiwan) 
Reference Setting Region Last year of 
data collection 
Study 
design 
Non-biomedical 
factors 
Description of the factor 
influencing outpatient and/or 
community antibiotic use 
ORs Study objective 
Wun YT et al. 
2014 Outpatient 
Hong 
Kong N/A Quantitative 
Health care 
seeking 
behaviors 
Outcome:  TCM (Traditional Chinese 
medicine)-attenders 
0.38 (0.25-0.60) 
for accepting 
antibiotics when 
offered 
This study compares TCM attenders 
with the WM-attenders in Hong 
Kong about their KAP with 
antibiotics. The comparison could 
help future campaigns/education on 
appropriate antibiotic use. 
Health care 
seeking 
behaviors 
Outcome:  
0.49 (0.27-0.81) 
for being treated 
with antibiotics in 
last URTI 
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Supplement 5. Appraisal – quantitative 
Author Region 
of 
China 
Study 
design 
Data 
collection 
method 
Target population Eligibility 
criteria 
(yes/no) 
Sample 
size 
Response 
rate (%) 
Clarity of 
the 
questions
/statemen
ts 
(yes/no) 
Ethical 
consideratio
ns (yes/no) 
Clarity of 
data 
(including 
numerators, 
denominator
s, and 
missing 
values) 
(yes/no) 
Consistenc
y between 
the 
research 
question 
and data 
reported 
(yes/no) 
Chan, 
Y. H., 
2012 
Hong 
Kong 
Cross-
sectional 
Survey General public Yes 369 Not reported Yes Yes Yes Yes 
Chang, 
J., 2018 
Across 
regions 
Cross-
sectional 
Survey Caregivers of children 
under 7 years 
Yes 3358 87.4 Yes Yes Yes Yes 
Cheng, 
J., 2018 
Central Cross-
sectional 
Survey Residents in rural 
villages 
Yes 2760 94.6 Yes Yes Yes Yes 
Gu, J., 
2015 
Central Cross-
sectional 
Survey Rural and urban 
residents 
Yes 3631 Not reported Yes No Yes Yes 
Hu, Y., 
2018 
Across 
regions 
Cross-
sectional 
Survey Medical students Yes 1819 Not reported Yes Yes Yes Yes 
Li, R., 
2016 
Across 
regions 
Cross-
sectional 
Survey Guardians of children 
aged 0–6 years 
Yes 53665 87.6 Yes Yes Yes Yes 
Lv, B., 
2014 
Western Cross-
sectional 
Survey Undergraduate students Yes 731 73.1 Yes Yes Yes Yes 
Pan, 
H., 
2012 
Eastern Cross-
sectional 
Survey Shantou University 
(STU) students 
Yes 1300 47.7 
(1300/2724) 
Yes Yes Yes Yes 
Peng, 
D., 
2018 
Across 
regions 
Cross-
sectional 
Survey University students in 
western and eastern 
China (Guizhou 
University and 
Zhejiang University) 
Yes 3995 Not reported Yes Yes No Yes 
Wang, 
X., 
2018 
Across 
regions 
Cross-
sectional 
Survey University students Yes 11192 Not reported Yes No Yes Yes 
Wang, 
X., 
2017 
Across 
regions 
Cross-
sectional 
Survey University students Yes 11192 Not reported Yes Yes Yes Yes 
You, J. 
H., 
2008 
Hong 
Kong 
Cross-
sectional 
Survey, 
interview 
People aged 18 or older 
who were 
uninstitutionalized 
Hong Kong residents 
Yes 1002 14 Yes Yes Yes Yes 
Yu, M., 
2014 
Central Cross-
sectional 
Survey Primary caregivers Yes 854 92 Yes Yes Yes Yes 
Zhu, 
X., 
2016 
Eastern Cross-
sectional 
Survey Jiangsu university 
students 
Yes 660 41.6 Yes Yes Yes Yes 
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Jiang, 
H., 
2017 
Eastern Cross-
sectional 
Survey Community residents 
in Hangzhou City 
No 449 92.84 Yes No Yes Yes 
Jin, Y., 
2014 
Western Cross-
sectional 
Survey Middle-aged 
community residents 
Yes 2556 98.69 Yes No Yes Yes 
Li, Y., 
2016 
Eastern Cross-
sectional 
Survey Community residents Yes 1589 93.47 No No No Yes 
Liao, 
R., 
2012 
Eastern Cross-
sectional 
Survey Primary school 
student’s parents 
Yes 509 94.43 Yes No Yes Yes 
Lu, T., 
2016 
Eastern Cross-
sectional 
Survey University students Yes 600 97.1 
(600/618) 
Yes No Yes Yes 
Lv, B., 
2013 
Western Cross-
sectional 
Survey University students Yes 731 73.1 Yes No Yes Yes 
Tian, 
L., 2015 
Eastern Cross-
sectional 
Survey University students Yes 377 94.25 No No No Yes 
Wang, 
J., 2017 
Central Cross-
sectional 
Survey 
 
Yes 310 88.57 No No No Yes 
Yao, Z., 
2013 
Eastern Cross-
sectional 
Survey Child parents Yes 1295 86.3 No No No Yes 
Zhong, 
M., 
2018 
Eastern Cross-
sectional 
Survey 
 
Yes 1096 90.01 No No No Yes 
Dyar, 
O. J., 
2018 
Eastern Cross-
sectional 
Survey Residents of villages Yes 769 Not reported Yes Yes Yes Yes 
Huang, 
Y., 
2013 
Eastern Cross-
sectional 
Survey University students Yes 2088 83.5 Yes No Yes Yes 
Lam, T. 
P., 2015 
(BMC 
Pharm
acol 
Toxicol
) 
Hong 
Kong 
Cross-
sectional 
Survey Adult residents Yes 2471 68.3 Yes Yes Yes Yes 
Liao, C. 
C., 
2006 
Taiwan Cross-
sectional 
Survey Adults over 20 years 
old all over Taiwan 
Yes 1507 86.7 
[1507/(1771-
32)] 
Yes No Yes Yes 
Wun, 
Y. T., 
2014 
Hong 
Kong 
Cross-
sectional 
Survey Adult residents Yes 2471 68.3 Yes Yes Yes Yes 
Chai, 
J., 2019 
Central Cross-
sectional 
Survey, 
interview 
Rural residents of 
Anhui province 
Yes 2611 95 Yes Yes Yes Yes 
Wang, 
W., 
2019 
Across 
regions 
Cross-
sectional 
Survey University students Yes 11192 Not reported Yes Yes Yes Yes 
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Chang, 
J., 2017 
Across 
regions 
Cross-
sectional 
Survey community pharmacies 
pharmacists 
Yes 256 
(pharmac
ies) 
Not reported Yes Yes Yes Yes 
Lam, T. 
P., 2003 
(J Clin 
Pharm 
Ther) 
Hong 
Kong 
Cross-
sectional 
Survey Family doctors 
(fellows, members and 
associate members 
normally residing in 
Hong Kong) 
Yes 801 65.0 Yes No Yes Yes 
Lam, T. 
P., 2003 
(Int J 
Clin 
Pract) 
Hong 
Kong 
Cross-
sectional 
Survey Family doctors 
(fellows, members and 
associate members 
normally residing in 
Hong Kong) 
Yes 801 65.0 Yes No Yes Yes 
Guan, 
X., 
2019 
Across 
regions 
Cross-
sectional 
Survey Physicians Yes 344 
question
naires 
58512 
valid 
medical 
records 
95.6 Yes Yes Yes Yes 
Liu, C., 
2019 
Central Cross-
sectional 
Survey Primary care 
physicians 
Yes 503 71 Yes Yes Yes Yes 
Lam, T. 
P., 2015 
(Hong 
Kong 
Med J) 
Hong 
Kong 
Cross-
sectional 
Survey, 
interview, 
focus 
group 
General public Yes 2471 68.3 Yes No Yes Yes 
Wun, 
Y. T., 
2015 
Hong 
Kong 
Cross-
sectional 
Survey, 
interview, 
focus 
group 
General public Yes 2471 68.3 Yes Yes Yes Yes 
Wun, 
Y. T., 
2013 
Hong 
Kong 
Cross-
sectional 
Survey, 
interview 
Adult residents Yes 2471 68.3 Yes Yes No Yes 
Currie, 
J., 2014 
Unknow
n 
Cross-
sectional 
Experimen
t 
Physicians No 80 Not reported Yes No Yes Yes 
Currie, 
J., 2011 
Unknow
n 
Cross-
sectional 
Experimen
t 
Physicians No 231 visits Not reported Yes No Yes Yes 
Xue, 
H., 
2019 
Unknow
n 
Cross-
sectional 
Experimen
t 
Providers No 526 
complete
d SP 
interactio
ns 
97.8 
(545/557) 
Yes Yes Yes Yes 
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Supplement 6. Appraisal – qualitative (CASP) 
 
Section A: Are the results of the trial valid?  (Yes/Can't Tell/No) Section B: What are the results?  (Yes/Can't 
Tell/No) 
Section C: 
Will the 
results help 
locally?  
(Yes/Can't 
Tell/No) 
Article 1. Was there 
a clear 
statement of 
the aims of 
the 
research? 
2. Is a 
qualitative 
methodology 
appropriate? 
3. Was the 
research 
design 
appropriate 
to address 
the aims of 
the 
research? 
4. Was the 
recruitment 
strategy 
appropriate 
to the aims 
of the 
research? 
5. Was the 
data 
collected in 
a way that 
addressed 
the research 
issue? 
6. Has the 
relationship 
between 
researcher 
and 
participants 
been 
adequately 
considered? 
7. Have 
ethical issues 
been taken 
into 
consideration? 
8. Was the 
data 
analysis 
sufficiently 
rigorous? 
9. Is there a 
clear 
statement of 
findings? 
10. How 
valuable is 
the 
research? 
Jin, C., 
2011 
Yes Yes Yes Yes Yes No No Yes Yes Yes 
Reynolds, 
L., 2009 
Yes Yes Yes Yes Yes No Yes No Yes Yes 
Zhang, 
Z., 2016 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Zhu, X., 
2018 
Yes Yes Yes Yes Yes No Yes Yes Yes Yes 
Lam, T. 
P., 2015 
(Hong 
Kong 
Med J) 
Yes Yes Yes Yes Yes No No Yes Yes Yes 
Wun, Y. 
T., 2015 
Yes Yes Yes Yes Yes No Yes No Yes Yes 
Wun, Y. 
T., 2013 
Yes Yes Yes Yes Yes No Yes No Yes Yes 
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Supplement 7. Appraisal – mixed-methods (MMAT)   
  Questions Lam, T. P., 
2015 (Hong 
Kong Med 
J) 
Wun, Y. T., 
2015 
Wun, Y. T., 
2013 
Screening 
Questions 
S1. Are there clear research questions? Yes Yes Yes 
S2. Do the collected data allow to address the research questions? Yes Yes Yes 
1. Qualitative 1.1. Is the qualitative approach appropriate to answer the research question? Yes Yes Yes 
1.2. Are the qualitative data collection methods adequate to address the research question? Yes Yes Yes 
1.3. Are the findings adequately derived from the data? Yes Yes Yes 
1.4. Is the interpretation of results sufficiently substantiated by data? Yes Yes Yes 
1.5. Is there coherence between qualitative data sources, collection, analysis and interpretation? Yes Yes Yes 
2. Quantitative 
randomized 
controlled 
trials 
2.1. Is randomization appropriately performed? N/A N/A N/A 
2.2. Are the groups comparable at baseline? 
2.3. Are there complete outcome data? 
2.4. Are outcome assessors blinded to the intervention provided? 
2.5 Did the participants adhere to the assigned intervention? 
3. Quantitative 
non-
randomized 
3.1. Are the participants representative of the target population? N/A N/A N/A 
3.2. Are measurements appropriate regarding both the outcome and intervention (or exposure)? 
3.3. Are there complete outcome data? 
3.4. Are the confounders accounted for in the design and analysis? 
3.5. During the study period, is the intervention administered (or exposure occurred) as intended? 
4. Quantitative 
descriptive 
4.1. Is the sampling strategy relevant to address the research question? Yes Yes Yes 
4.2. Is the sample representative of the target population? Yes Yes Yes 
4.3. Are the measurements appropriate? Yes Yes Yes 
4.4. Is the risk of nonresponse bias low? No No No 
4.5. Is the statistical analysis appropriate to answer the research question? Yes Yes Yes 
5. Mixed 
methods 
5.1. Is there an adequate rationale for using a mixed-methods design to address the research question? No No Yes 
5.2. Are the different components of the study effectively integrated to answer the research question? Yes Yes Yes 
5.3. Are the outputs of the integration of qualitative and quantitative components adequately interpreted? Yes Yes Yes 
5.4. Are divergences and inconsistencies between quantitative and qualitative results adequately 
addressed? 
Yes Yes Yes 
5.5. Do the different components of the study adhere to the quality criteria of each tradition of the 
methods involved? 
Yes Yes Yes 
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CHAPTER THREE 
Public-targeted behavioural change interventions to reduce inappropriate use 
of medicines and medical procedures: a systematic review 
In this chapter, I report on a systematic review of the literature to (1) landscape 
existing interventions aiming to reduce inappropriate or unnecessary use of 
medicines or medical services and (2) identify potential barriers, intervention 
designs, and critical methodological challenges in evaluating such interventions.  
I conducted the literature review design, methods, and analysis independently. I 
conducted the review in close collaboration with two LSHTM colleagues. The 
findings and results have been prepared as a first draft of the manuscript, with 
comments and feedback on drafts from Prima Alma, Professors James Hargreaves, 
Elizabeth Fearon, Mishal Khan, John Cairns, and Mark Petticrew. This manuscript 
has been accepted by Implementation Science. 
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Public-targeted behavioural change interventions to reduce inappropriate use 
of medicines and medical procedures: a systematic review 
SYNOPSIS 
BACKGROUND An epidemic of health disorders can be triggered by a collective 
manifestation of inappropriate behaviours, usually systematically fuelled by non-
medical factors at the individual and/or societal levels. This study aimed to (1) 
landscape and assess the evidence on interventions that reduce inappropriate demand 
of medical resources (medicines or procedures) by triggering behavioural change 
among healthcare consumers; (2) map out intervention components that have been 
tried and tested; and (3) identify the “active ingredients” of behaviour change 
interventions that were proven to be effective in containing epidemics of 
inappropriate use of medical resources. 
METHODS For this systematic review, we searched MEDLINE, EMBASE, the 
Cochrane Library, and PsychINFO from the databases’ inceptions to May 2019, 
without language restrictions, for behavioural intervention studies. Interventions had 
to be empirically-evaluated with a control group that demonstrated whether the 
effects of the campaign extended beyond trends occurring in the absence of the 
intervention. Outcomes of interest were reductions in inappropriate or non-essential 
use of medicines and/or medical procedures for clinical conditions that do not 
require them. Two reviewers independently screened titles, abstracts, and full-text 
for inclusion and extracted data on study characteristics (e.g. study design), 
intervention development, implementation strategies, and effect size. Data extraction 
sheets were based on the checklist from the Cochrane Handbook for Systematic 
Reviews.  
RESULTS Forty-three studies were included. The behaviour change technique 
taxonomy v1 (BCTTv1), which contains 93 behavioural change techniques (BCTs), 
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was used to characterize components of the interventions reported in the included 
studies. Of the 93 BCTs, 15 (16%) were identified within the descriptions of the 
selected studies targeting healthcare consumers. Interventions consisting of 
education messages, recommended behaviour alternatives, and a supporting 
environment that incentivizes or encourages the adoption of a new behaviour were 
more likely to be successful.   
CONCLUSIONS There is continued tendency in research reporting that mainly 
stresses the effectiveness of interventions rather than the process of identifying and 
developing key components and the parameters within which they operate. 
Reporting “negative results” is likely as critical as reporting “active ingredients” and 
positive findings for implementation science. This review calls for a standardised 
approach to report intervention studies.  
PROSPERO registration number : CRD42019139537 
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Contributions to the literature 
 This review identifies the types, components, and combinations of 
interventions more likely to successfully initiate and sustain public behaviour 
change in the context of complexity. 
 It can inform practitioners’ decisions about designing, implementing, and 
reporting interventions to reduce inappropriate use/demand of medical 
interventions while researchers and funders can use this review to determine 
where research is needed.  
 No community-based interventions were found in LMICs; interventions were 
limited to primary care settings or policy restrictions on the supply side (e.g. 
ban on over-the-counter purchases). 
 There is a need for standardised reporting of intervention development, 
adaptation, and implementation to maximize generalisability and 
replicability. 
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BACKGROUND 
Epidemics, which traditionally refer to a widespread occurrence of an infectious 
disease in a community at a particular time, have in recent years been used to 
describe large-scale public health issues caused by a shared pattern of human 
behaviours that impact public health and well-being. An epidemic of health disorders 
can not only be triggered by organisms that cause communicable diseases, such as 
bacteria, viruses, fungi or parasites, but also by a collective manifestation of 
inappropriate behaviours, usually systematically fuelled by non-clinical factors at the 
individual and/or societal levels. When medicines or medical procedures are used for 
conditions for which they should not be used, they are deemed as inappropriate use 
of medical interventions. For example, the World Health Organisation and 
governments have warned about the recent spike in use of prescription drugs156 and 
caesarean sections157 globally, which has formed an epidemic that has caused 
avoidable damage to individual health and introduced excessive burdens on health 
systems.158,159   
There have been experiments with programmes specifically designed to 
address factors driving the epidemics of inappropriate use of medical interventions. 
These countermeasures are often non-clinical behavioural change interventions 
targeting physicians and pharmacists as a point-of-entry for interventions, and are 
designed to improve clinical practices and policies that restrict unnecessary 
dispensing.160,161 These programmes usually employed educational materials (e.g. 
guidelines, lectures, workshops),162,163 auditing and feedback on prescribing 
practices,164-167 or computer-aided clinical decision support systems.168 A 2005 
Cochrane review concluded that, for interventions occurring on multiple levels to be 
effective, local barriers to change – including the role patients play in driving 
inappropriate demand – must be addressed.160,169 Current interventions to address the 
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pressure of inappropriate demands outside the clinical setting range from national 
mass media campaigns to local interventions targeted at smaller communities,170 
aiming to influence the knowledge, attitudes and practices towards medical use of 
the general public who have yet to become healthcare consumers: namely patients 
and caretakers of patients.170-172 However, recent reviews highlighted that critical 
knowledge gaps exist in the evidence for engaging healthcare consumers as active 
decision-makers for appropriate medical use (as opposed to passive receivers of 
education materials).173,174 Furthermore, the lack of evidence in the development of 
and evaluation of the impact of these interventions, especially in low- and middle-
income countries (LMICs), complicates replication efforts.171,172,175   
The Behavioural Change Wheel (BCW)176 and the Behaviour Change 
Techniques Taxonomy Volume 1 (BCTTv1),177 developed by Michie and 
colleagues, facilitates researchers in organizing the content and components of 
behavioural interventions into nine intervention functions: education, persuasion, 
incentivization, coercion, training, enablement, modelling, environmental 
restructuring, and restrictions and assists them in translating specific techniques that 
were employed in a given intervention into change behaviours. Scientists have 
supported the use of BCW and BCTTv1 as a reliable and validated methodology that 
offers a common language for describing intervention components that can be used 
for the standardization of intervention content analysis and the development of 
interventions.178-180 
In this study, we aimed to (1)  landscape and critically assess the evidence on 
non-clinical programmes that reduce inappropriate or unnecessary use of medical 
interventions (i.e. medicines or medical procedures) by triggering behavioural 
change among healthcare consumers; (2) map out intervention components that have 
been tried and tested; and (3) identify the “active ingredients” of behaviour change 
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intervention programmes that were proven to be effective in containing “epidemics 
of inappropriate use of medical interventions.”  
METHODS 
Searches: For this systematic review, we searched MEDLINE, EMBASE, 
the Cochrane Library, and PsychINFO from the databases’ inceptions to May 2019, 
without language restrictions, for behavioural intervention studies. A search strategy 
was first developed for MEDLINE and adapted to other databases. The full search 
strategy is detailed in Appendix 1. We searched for behavioural change interventions 
that aimed to reduce inappropriate or non-essential use of medical services or 
medicines that were driven by non-clinical factors and targeted health care 
consumers in the community, including primary care settings. For the purpose of this 
study, health care consumers included the public, patients, and caregivers (e.g. 
parents or guardians). 
Study inclusion and exclusion criteria: Inclusion and exclusion criteria 
used for all stages of the screening process are stated in Appendix 2. Studies had to 
be empirically-tested by either randomized controlled trial (RCT), cluster-RCT 
(CRT), nonrandomized controlled trial (NCT), or interrupted times series (ITS) 
where the intervention time was clearly defined and there were at least three data 
points both before and after the intervention, or quasi-experiments with a control 
group. To enable assessment of effectiveness in included interventions, this review 
excludes before/after evaluations of public campaigns or interventions that failed to 
employ a control group and therefore cannot show whether the effects of the 
campaign extended beyond trends occurring in the absence of the intervention. 
Outcomes of interest were reductions in inappropriate or non-essential use of 
medicines and/or medical procedures for clinical conditions that do not require them. 
Four major types of behaviours were identified, namely inappropriate antibiotic 
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consumption (e.g. for viral infections or self-limiting conditions), elective caesarean 
section, demand for brand-name drugs that are available as generics, and non-
medical use of prescription drugs, defined as “use without a prescription or use for 
reasons other than what the medication is intended for”.171,181,182 Studies that focused 
only on change of knowledge or attitudes, and did not report actual behavioural data 
were excluded. Studies mainly targeting clinicians, other healthcare staff, hospitals, 
inpatients, emergency care, or patients with mental health conditions were excluded. 
To create a distinction between interventions directed at health care consumers rather 
than providers, studies that aimed to modify clinical practices (e.g. prescribing) were 
excluded. Also, to differentiate behaviour change interventions from 
therapies/treatments addressing mental health conditions such as addiction or 
depression, we excluded interventions for substance abuse, where inappropriate use 
was an outcome of a clinical condition, not a cause. 
Data extraction strategy: All titles retrieved from the searches were 
imported into Endnote referencing software. Duplicates were removed. Titles and 
abstracts were independently screened for inclusion by two reviewers (L.L and P.A.) 
and removed if deemed irrelevant. Both authors independently screened the full-text 
(n=347) of the remaining studies to assess eligibility. Substantial agreement was 
found at all three stages (>90%). Disagreements were resolved through discussion 
among reviewers to achieve consensus; any further discrepancies about study 
inclusion were resolved through discussion with a third reviewer (E.F. or J.H). We 
also manually searched the bibliographies of all the included studies and reference 
lists of relevant systematic reviews to identify additional citations.  
We extracted the data on study characteristics: the country where the study 
was conducted, type of inappropriate use, target population, study design (e.g. RCT, 
controlled pre- and post-study [CPP]), data collection methods (e.g. survey, 
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interview, medical records) and, when focused on a population study, sampling 
methodology (e.g. cluster, convenience), primary or main outcome measure, and 
conclusions reported. We further examined reporting on intervention 
development/adaption, design, and implementation strategies. Additionally, we 
extracted underlying theoretical domains, effect size, and risk of bias by two 
independent review authors, who determined the domains within the Behavioural 
Change Wheel (BCW) and identified the “active ingredients” of the interventions 
according to BCTTv1. Data extraction sheets were based on the checklist from the 
Cochrane Handbook for Systematic Reviews.183 The forms were modified after 
piloting on a sample of studies. When coding, we adopted the coding assumptions 
reported by Presseau et al180 that BCTs worked through targeting the behaviour of 
health care consumers, or both the behaviour of health care consumers and 
providers. We also assumed policy interventions and national campaigns were driven 
by governments and therefore coded governments as implementers for respective 
interventions.  After the data extraction phase, we identified critical evidence gaps in 
evaluation data and processes of intervention development and implementation. We 
therefore conducted another round of targeted, investigative searches, involving 
citation and publication searches on first, last and corresponding authors of selected 
interventions, seeking formative, process, and impact evaluation data. 
Study quality assessment: We conducted and reported the review in line 
with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
statement (PRISMA). Risk of bias was assessed by two reviewers using the Effective 
Public Health Practice Project’s (EPHPP) Quality Assessment Tool for Quantitative 
Studies,184 which includes eight components (21 items): selection bias, study design, 
confounders, blinding, data collection methods, withdrawals or dropouts, 
intervention , and integrity. A rating of weak, moderate or strong was given to each 
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of the first six components and these scores contributed to a global rating for the 
study. Qualitative data was assessed by the Critical Appraisal Skills Programme 
(CASP) checklist. 
Data synthesis on active ingredients: Using BCW domains and BCT 
taxonomies, we analysed descriptions of all interventions and identified the 
commonly targeted aspects by looking at the frequency with which BCW domain 
and BCT of the interventions were incorporated in the studies. We also explored the 
nature and pattern of the use of these active ingredients across the different studies, , 
and the associated magnitude of effect size. We descriptively reported the active 
ingredients and primary outcomes’ effect sizes at the study-level, counting the 
number of times a BCW domain and a BCT had been identified across studies and in 
different types of use behaviours and presented a description of features of included 
interventions.  
RESULTS 
Review statistics: Our systematic search of the literature yielded 4045 
results through database searching and an additional 238 were identified through 
bibliography searches. After de-duplication and title and abstract screening, 347 
references were assessed in full text. A flow diagram of the study selection process is 
shown in Figure 1. Forty-three studies (representing 43 interventions, see Appendix 
3) – conducted between 1994 and May 2019 and meeting inclusion criteria - were 
included in the systematic review. Twenty-five studied interventions focused on the 
reduction of antibiotic use – eight on elective caesarean section, four on the 
conversion from brand name drugs to generic equivalents, and six on nonmedical use 
of prescription drugs. Table 1 provides an overview of the included intervention 
studies for full-text extraction including intervention aims and components.  
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Study characteristics: All included studies were published in English. 24 in 
North America (excluding Mexico; USA: n=21, Canada: n=3), four in Latin 
America (Chile, Colombia, Venezuela, Brazil, and Mexico), four in the Middle East 
(Iran), eight in Europe (France, UK, Italy, Spain, and Moldova),  three in East Asia 
and Pacific (Australia and Singapore), and none from Sub-Saharan Africa, South 
Asia, or the Caribbean.  
The imbalance between high-income countries (HICs) and low-and-middle-
income countries (LMICs) is apparent when characterising types of inappropriate 
use. Multifaceted interventions are scarce and limited to HICs while interventions in 
LMICs were limited to primary care settings or policy restrictions (on over-the-
counter purchases) with zero community-based programs identified. No studies from 
LMICs focused on demands for brand-name drugs or non-medical use of 
prescription drugs.  
Study design: The included studies consisted of 18 RCTs and five NCTs, 
eight ITS, and 12 quasi-experimental studies. These studies varied in their quality, 
methodological design, and implementation. Twenty-four studies reported 
longitudinal data; the rest employed cross-sectional study designs. All were outcome 
evaluation studies. In terms of data collection methods for evaluation, 23 studies 
employed surveys and 30 utilised medical record data – these were not mutually 
exclusive. Four studies reported cost data. One study employed interviews as part of 
the intervention procedure, but not for evaluation purposes.185 No qualitative data 
were reported in the initial included studies; we therefore conducted a targeted, 
investigative search on the selected interventions, but only located minimal 
formative data on some of the studies.186-190 One UK-based project that aimed to 
improve the decision-making around mode of delivery among pregnant women 
published comprehensive implementation research data from pilot results191 and 
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study protocol188 to outcome and economic evaluation.186,187,192-194 Table 2 presents a 
summary of the key characteristics of each study measuring behavioural outcomes 
and reported formative and relevant evaluation data of the included interventions.  
Study quality assessment: Study quality varied by domain assessed based 
on the primary behavioural outcomes (Appendix 4). There were 11 studies of overall 
strong quality, 12 of overall moderate quality, and 20 of overall low quality. In order 
to provide an overview of the entire literature, no studies were excluded based on 
their methodological quality. The majority of behaviour outcomes were derived from 
medical records, leaving minimal room for reporting errors with the exception that 
some only relied on self-reported data for evaluation.  
Active ingredients of the behaviour change interventions: All of the 
interventions utilised multiple behaviour change techniques (BCTs) with a primary 
aim to improve health care consumers’ behaviour. Table 3 presents the features of all 
the included interventions; the frequency distributions of BCTs employed are 
presented in Figure 2. Of all 93 BCTs in the taxonomy, 19 (19/93, 22.9%) were used 
as active ingredients in the included interventions: four BCTs were used exclusively 
for interventions targeting health care consumers (BCTs 3.3, 6.1, 9.2, 12.2); another 
four were used exclusively for multifaceted interventions that also targeted providers 
(BCTs 1.3, 2.2, 3.2, 14.2), with 11 BCTs used for both (BCTs 3.1, 4.1, 4.2, 5.1, 5.2, 
8.2, 9.1, 10.1, 10.2, 12.1, 12.5; see Tables 4 and 5 for details). When compared with 
the principles in the Behavioural Change Wheel, 39 interventions employed 
education as an active ingredient followed by enablement (n=12), environmental 
restructuring (n=8), and restriction (n=4). Of the 43 included studies, 22 were 
interventions delivered only at the community-level, 12 in primary care settings, six 
in both community and primary care settings, and three in schools. 19 interventions 
were delivered on an individual basis, which tended to be shorter in duration, 
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ranging from one to multiple short sessions. The majority of studies focused on 
evaluation design and outcomes and only provided high-level descriptions of the 
intervention, with or without details on the development or implementation 
processes. 20 studies provided clear descriptions on the intervention 
adaption/development process, all on implementation strategies (e.g. channels and 
timing of dissemination), and, to a certain level, 15 on intervention dose 
(intensity)195-197 and nine on designs (e.g. colour and format).196-199 Some studies 
provided links to intervention designs, but most of these links had expired. Only 
eight interventions explicitly reported having adopted a theory or model of 
behavioural change, which included: Social Marketing,104,197,200 Social Cognitive 
Theory,196 Precede/Proceed Model,201 Social Development Model,202,203 and the 
Health Belief Model.204 However, little was reported on how these underlying 
theories were used in the development and evaluation of the interventions.  
Interventions targeting health care consumers: Table 4 reports the 
individual BCTs identified within the descriptions as active ingredients of the 
selected interventions targeting health care consumers. Of the 93 BCTs, the most 
frequently used active ingredients in the selected interventions targeting health care 
consumers were: BCTs: 4.1-Instruction on how to perform the behaviour (n=34), 4.2 
Information about Antecedents (n=22), 5.1 Information about health consequences 
(n=22), followed by 12.5 Adding objects to the environment (n=12), 8.2 Behaviour 
substitution (n=11), and 12.1 Restructuring the physical environment (n=8). Most 
studies employed education interventions aiming to improve public knowledge 
(including awareness or correcting misconceptions). Mass media campaigns were 
widely used to reduce antibiotic misuse,105,195-197,200,205-209 and demand for brand-
name drugs,210 all in HIC. The effectiveness of such behavioural change 
interventions was mixed. Decision aids to assist pregnant women making decisions 
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about mode of delivery were tested in three different trials in Australia, UK and US; 
all reported to be ineffective.193,211,212 Taylor et al,213 Lee et al,214 and Vallès et al185 
trialed patient-based education interventions in primary care settings to reduce 
antibiotic use or to substitute generic for brand-name drugs; only Vallès et al’s185 
intervention found a positive impact on behaviour change. Mainous et al. and 
McNulty et al. assessed community-wide education interventions in U.S. and U.K. 
on their effectiveness in improving public antibiotic use and found the provision of 
educational messages itself was insufficient to overcome the influence of past 
attitudes and behaviours.198,207 Formal and informal social support networks can be 
leveraged to influence individuals’ behaviours through improving doctor-patient 
communication103-105,199,200,213 or by actively engaging family members in the 
process.202,203,215 Four interventions aimed to encourage disposal of leftover opioids 
among postoperative patients by employing a combination BCWs of education, 
enablement, and environment restructuring (BCTs: 4.1, 4.2, 5.1, 5.2, 8.2, 12.1, 12.5), 
which reported positive impact.216-219 Two longitudinal RCTs on school-based 
universal preventive interventions in the U.S. that aimed to strengthen families and 
build life skills were introduced to middle schoolers202,203 and reported a lasting 
impact on preventing non-medical use of prescription drugs into adulthood. 
Structural environmental conditions regarding access to healthcare services and 
medicines, and promotive and restrictive policies – or the lack thereof – can be 
pathways to shaping individual behaviours. Two trend analyses assessing the 
effectiveness of French public education campaigns205,209 reported a significant 
reduction in antibiotic consumption rates; however, trials on community-wide public 
campaigns with academic detailing for practitioners did not demonstrate comparable 
levels of improvement in public antibiotic use. Belongia et al. and Fiskelstein et al. 
found little or no evidence – attributable to multi-year interventions in Wisconsin 
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and Massachusetts – on reductions in antibiotic prescribing in the intervention areas, 
despite improved public knowledge.103,104,195 Gonzales et al. found that the state-
wide “Get Smart Colorado” campaign did not improve prescription rates, but might 
be associated with a reduction in antibiotic use in the community through decreases 
in office visit rates among children.105,197 Four studies evaluated the effectiveness of 
the restrictions on OCT purchases on antibiotic consumption in five Latin American 
countries with mixed results.220-223 
Interventions also targeting health care providers: Table 5 reports the 
individual BCTs identified within the descriptions as active ingredients of the 
selected interventions targeting health care providers. The most frequently used 
BCTs targeting health care providers were similar with those targeting consumers, 
with small differences in the ranking:  BCTs: 4.1 Instruction on how to perform the 
behaviour (n=15), 4.2 Information about Antecedents (n=13), 12.5 Adding objects to 
the environment (n=10), followed by 5.1 Information about health consequences 
(n=9), 8.2 Behaviour substitution (n=9), and 12.1 Restructuring the physical 
environment (n=4). We noticed that, except for programs aiming to contain 
inappropriate use of antibiotics, other interventions had limited engagement between 
consumers and providers.  
DISCUSSION  
Summary of findings  
Using the Behavioural Change Wheel (BCW) domains to identify the theoretical 
concepts underlying interventions and the behaviour change technique taxonomy v1 
(BCTTv1) to identify the active ingredients of interventions, we found that the 
domain of education was the most commonly targeted by a majority of interventions 
with primary focus on the provision of information on BCTs 4.1 how to perform the 
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behaviour and 4.2 about antecedents and 5.1 the associated health consequences. 
A plethora of evidence supports the view that human behaviours should be 
understood in their social ecological context, as products of intertwined influences at 
the personal, communal, societal, and structural levels.224-226 Studies show that 
improving knowledge and awareness does not equate with appropriate behaviour 
change, as lack of information is often not the only barrier to changing 
behaviour.105,207,227-229 The effects of education interventions have been mixed – 
most likely due to heterogeneity in context, population served, and intervention 
design and measures. Cabral et al. examined how communication affects 
prescription decisions for acute illnesses and demonstrated a clear 
miscommunication with cross-purposes between health care consumers and 
providers, as patients and/or caregivers focused on their concerns and information 
needs, which clinicians interpreted as an expectation for antibiotics.230 This review 
supports the use of multifaceted (complex) interventions that incorporate BCTs 
related to provision of information (BCTs 4.1, 4.2, or 5.1) and, as an alternative to 
antibiotics, prescription pads with clear explanations on symptoms and appropriate 
treatment options (BCT 8.2), as education alone is not sufficient to be effective.  
Interventions consisting of health education messages (e.g. BCTs 4.1, 4.2, 5.1), 
recommended behaviour alternatives (BCT 8.2), and a supporting environment that 
incentivizes or encourages the adoption of a new behaviour (e.g. BCTs 10.1, 10.2, 
12.1, 12.5) are more likely to be successful. Other types of utilised behaviour change 
techniques often aimed to encourage alternative behaviours and improve the physical 
environments via regulations or mass media.  
The continuing tendency in research reporting has been to stress the 
effectiveness of interventions rather than the process of identifying and developing 
key components and the parameters within which they operate. There is a lack of 
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detail on how the intervention components were selected, designed and the process 
of implementing them, with limited descriptions provided on the “contexts” and 
“mechanisms” that determine the effectiveness of interventions. Few studies 
provided sufficient details on intervention development, dose/intensity, and design; 
some provided links to project materials that had expired.195-197,200 The majority of 
the selected interventions did not describe the pilot or process data for 
implementation, nor did they discuss the dissemination of findings and pathways to 
impact. Even after identifying active ingredients of interventions using BCTTv1, 
without a complete “recipe” one cannot recreate successes in other contexts. Just like 
there are agreed-upon elements that constitute a rigorous and comprehensive 
reporting of evaluation studies, publications on behavioural change interventions 
should systematically cover a standardised list of intervention elements from the 
development, adaption and refinement, feasibility and pilot-testing, implementation, 
evaluation, and reporting of BCTs. The CONSORT-SPI team231 have developed 
guidance and checklists for the reporting of BCT trials; however, the required details 
on the reporting are still primarily focused on evaluation study designs (e.g. process 
of randomization) rather than BCTs development and implementation. From 
implementation research perspective and following the Medical Research Council 
(MRC) guidance on developing and evaluating complex interventions, reporting of 
BCTs development and implementation should include: descriptions on the context, 
target behaviour determinants, theories and rationale (theory of change), intervention 
design features, adaption/development process, implementation strategy (e.g. 
implementor, dose/intensity), modifications made between the feasibility and 
effective assessment phases,  and evaluation outcomes. The lack of detailed 
reporting among included intervention studies on evidence-based development and 
implementation processes undermines the generalisability of study findings, makes 
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cross-intervention comparisons difficult, and complicates future adaption and 
replication efforts. 
This systematic literature review is the first on the effectiveness of public-
targeted behavioural change interventions to reduce inappropriate use of medical 
interventions. It identified a serious lack of formative data, which means that 
interventions to change public use of medical interventions are often designed on the 
basis of “best guesses” of what needs to change, without an evidence base or explicit 
rationale for the selection of a specific intervention strategy. There is an urgent need 
to adopt a multidisciplinary, systematic approach to developing evidence-based 
behavioural change interventions to reduce inappropriate medical use and to develop 
an operational mechanism for knowledge translation and scale-up within and across 
different countries. We found limited evidence202,205 on evaluating the impact of 
previous or ongoing education interventions on inappropriate use in terms of long-
term impact, scalability, and replicability. The root causes of why certain 
interventions were unsuccessful are not systematically explored or reported, yet 
reporting “negative results” is likely as critical as reporting “active ingredients” and 
positive findings for the development and sustainability of implementation science. 
Relation to other studies 
Like most stewardship programmes, quaternary prevention - a relatively new 
category of medical prevention first raised in 1986 by Dr. Marc Jamoulle, a family 
physician, to addressing concerns around the protection of people and patients from 
being harmed by over-diagnosis or overtreatment - tends to focus mostly on health 
care providers while placing less attention on consumers.160,232-234 The definition of 
quaternary prevention was later expanded by Brodersen et al. in 2014 to include 
patients and medical interventions as an ‘action taken to protect individuals 
(persons/patients) from medical interventions that are likely to cause more harm than 
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good.235,236 The expanded definition recognises the contemporary reality in medicine 
in which people may suffer harm from medical interventions throughout their entire 
lifetime - from conception to adulthood, in times of good health, as well as when 
experiencing self-limited disease, chronic conditions, or terminal disease. Therefore, 
quaternary prevention should include preventing all types of harm associated with 
medical interventions.235,236 From this perspective, quaternary prevention is aligned 
with the aims of the behavioural change interventions and techniques identified in 
our review and should be considered alongside the other four classical levels of 
preventive activities, i.e. primordial (e.g. laws that restrict over-the-counter 
purchases of antibiotics), primary (e.g. prescription drugs disposal programs), and 
secondary and tertiary preventions (e.g. interventions that reduce fear of childbirth or 
convert demand of brand-name drugs to generic drugs).  
Use of medicine or medical procedures is a highly complex set of behaviours 
involving multiple actions, including the self-diagnostic process, assessing 
benefit/risk, decision-making around healthcare seeking and treatment choice, and 
review of treatment – each performed at different time points across the care 
continuum.19,20 It involves interactions with various stakeholders (i.e. family 
members and providers) and is often shaped more by individual and contextual 
factors than by a clinical diagnosis.19,20 Therefore, developers and implementers of 
behavioural change interventions should be clear as to whose and which behaviours 
are being targeted for change and how – namely, who needs to do what differently, 
how, to whom, where, when, and for how long. A set of precisely specified 
behaviours would allow for easier measurement and therefore would offer a baseline 
and metric for evaluating the success of an intervention.  
In order to develop effective behavioural change interventions, we first need 
to explain why people behave in certain ways, yet a more in-depth look at people’s 
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lifeworld is lacking from every reviewed article. As the dual processing theory 
(DPT) posits, human behaviour is guided by two types of processing mechanisms: 
the implicit, intuitive System 1 and the explicit, rational System 2.237 Behavioural 
economists elaborate that, due to limited self-control, rationality and social 
preferences, actual decisions are less rational and stable than traditional normative 
theory suggests.237 They are usually made with a range of biases resulting from the 
way people think and feel, rather than with rationality or full information. However, 
most of the included interventions - appealing to System 2 processing - attempted to 
influence behaviours via improved knowledge and attitudes; disappointingly, many 
trials indicated that this did not automatically lead to preferred 
behaviours.103,104,195,213 To complicate things further, Zinn argues that between 
rationality and irrationality, there is a third, “in-between” dimension that includes 
trust, intuition and emotion, which is an important aspect of decision-making when 
people deal with risk and uncertainty, especially in anticipation of the possible 
undesired outcomes of decisions.238 This may explain why three RCTs on decision 
aids (System 1) to address individual emotions (System 2) had no real impact on 
choice of vaginal birth.193,211 On the other hand, in addition to education programs, 
financial incentives (changes in co-payment), free medicine, advertisements (print 
media) and health policies have been experimented with as behavioural change 
interventions to influence healthcare consumers’ choice of medicine – in particular, 
to promote uptake of generic medicines - though they have demonstrated 
inconsistent results.239,240  
The most promising measure was an intervention delivered face-to-face, 
where consumers were told that they had the option of switching back to brand-name 
drugs anytime;185,241,242 hence, an intervention that leverages human behavioural 
mechanisms may be more effective and cost-effective in optimizing decision-making 
157 | P a g e  
 
than repeated, expensive education campaigns. In response to the recent opioid 
epidemic across the globe, promising prevention programmes aimed not only to 
improve the knowledge and awareness of the risk of nonmedical use of prescription 
drugs among at risk individuals, but also to empower healthcare consumers by 
providing skills or tools that enable them to take action prior to the occurrence of 
misuse and/or before the development of poor habits.202,203,216-219 These interventions 
further improved the socio-ecological surroundings of the target audience by 
involving family members and restructuring their social or physical 
environments.202,203,216-219  
Our review showed only 19% of BCTs have been utilized by included 
interventions (i.e. 81% of BCTs unexplored), with great variation between different 
types of misuse - most were limited to education. Future studies should explore other 
BCTs. A wide range of disciplines engaging in social and behavioural sciences, such 
as psychology, sociology, anthropology, communication and marketing, can provide 
theories, models and methods for a more comprehensive and coherent approach to 
understanding or even modifying contextual, organizational and interpersonal 
determinants of behaviour. In terms of sustainability of the interventions themselves, 
other than a few longitudinal studies,202,203 we do not know how long the reported 
effect of behavioural change will sustain. Few studies incorporated economic 
evaluations and therefore, it was not possible to determine the returns on investment 
(ROI) for these included interventions. Future intervention studies should consider 
the aspects of RE-AIM (Reach Effectiveness Adoption Implementation Maintenance) 
framework or follow the MRC Guidelines on Developing and Evaluating Complex 
Interventions during the planning stage to enhance the impact of interventions and 
the reporting of them.  
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Development of a behavioural change intervention has to start with a realist, 
comprehensive understanding of the complex environment that shapes individual 
and collective behaviours. The aetiology of inappropriate use of medical 
interventions should be studied and addressed within the context of its biological, 
psychosocial, behavioural and environmental factors and the interactions between 
them. In early 2000, Sallies et al developed a behavioural epidemiology framework, 
which specified a systematic sequence of studies on health-related behaviours 
leading to evidence-based interventions directed at populations in the following five 
phases: 1) establish links between behaviours and health; 2) develop measures of the 
behaviour; 3) identify influences on the behaviour; 4) evaluate interventions to 
change the behaviour; and 5) translate research into practice.226,243,244 In 2011, 
Michie and colleagues mapped out various pathways to influencing behavioural 
change and recommended that interventions seeking to change behaviour should be 
designed on the basis of a thorough ‘behavioural diagnosis’ of why behaviours are 
the way they are and what needs to change in order to bring about the desired 
behaviour.243 Conducting such diagnosis should be facilitated by the use of 
behavioural theory. Not until recent years did researchers systematically report 
efforts in the identification of the root causes of operational barriers and facilitators 
in designing, implementing, and evaluating interventions. For instance, in 2018 and 
2019, Langdridge et al have attempted to decipher the intervention elements and 
visual imagery used in public antimicrobial stewardship.178,245  
Consistent with the findings from recent reviews by Cochrane and the 
Department of Health and Social Care and Public Health in England,160,246,247 our 
review found that few interventions employed behaviour change theories or 
techniques. Behavioural determinants and social influences are often not given 
sufficient consideration in the design and evaluations of interventions. To inform the 
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design of effective, context-specific behaviour change interventions, one must first 
define the problem in both behavioural terms and in its current context and adopt a 
theory-driven, systematic approach to intervention design. This points to another 
critical knowledge gap identified by this review in implementation science, namely 
early studies that take place prior to the implementation of behavioural change 
interventions. Following the Medical Research Council (MRC) guidelines on 
developing and evaluating complex interventions,81 as presented in Table 1, we find 
there is little reporting on the feasibility, pilot or process data that generates the 
needed contextual information and evidence base for acceptance, adaption and 
uptake. Limited detail has been made available on the development of the included 
interventions regarding how key decisions were made, including feasibility and 
compliance. Future research on pilot and/or feasibility studies that aim to strengthen 
large-scale behavioural change intervention design can span the continuum of 
implementation science research from idea generation to intervention development, 
implementation, evaluation, and scale-up.  
LIMITATIONS 
The diversity in the design and outcome measures of the included interventions 
prevent us from performing a meta-analysis. We cannot make a conclusion that 
certain types of behavioural change intervention might be more effective than any 
other type of design due to the limitations of the literature relating to the lack of 
evidence-based development process and evaluation design. Behavioural data that 
were gathered via survey instruments were by nature self-reported from health care 
consumers who may have been reluctant to report practices that could be considered 
inappropriate or may have been subject to recall bias. Often there were more than 
one BCT identified for each included intervention, yet retrospective coding and the 
study design did not allow us to pinpoint which component was more effective. 
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Future work should focus on addressing the limitations and uncertainties 
surrounding existing behavioural change interventions.  
CONCLUSION 
Systematically assessing the evidence across behavioural change interventions 
allows for the identification of the “active ingredients” of effective interventions that 
improve healthcare consumers’ use of medical interventions, as well as the 
identification of those with ineffective or uncertain outcomes. Although 
opportunities for behavioural change interventions are becoming more commonly 
recognised, multifaceted (complex) interventions are still new, scarce, limited to 
high-income countries, and, as is evident from our findings, highly heterogeneous. 
Public-targeted behavioural change interventions in low-and-middle-income 
countries (LMICs) were exclusively limited to primary care settings. Interventions 
that consist of health education messages, recommended behaviour alternatives, and 
a supporting environment that incentivizes or encourages the adoption of a new 
behaviour are more likely to be successful.  Future research should also seek to 
unpack the distinctions between various audience segments, the influence of the 
social ecological context, and the utility of the unexplored 81% of behavioural 
change techniques (BCTs). It is critical to adhere to a rigorous framework that 
guides the development, implementation, evaluation, and reporting of evidence-
based interventions, so that generated evidence can be documented, disseminated, 
compared and utilized for further research. The lack of reporting on evidence-based 
development and implementation processes makes cross-intervention comparisons 
and replication difficult. Our review further identified a need for standardised 
reporting of intervention development, adaptation, and implementation to maximize 
generalisability and replicability.  
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Figure 1. Flow diagram of systematic review search 
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Figure 2. Frequency distribution of Behaviour Change Techniques (BCTs) coded for 43 interventions 
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Table 1. An overview of the included studies: intervention aims, components and reporting 
 Context Intervention Elements Implementation   
First 
Author, 
Year 
Target 
Illness/co
ndition 
Coun
try 
Last 
month 
of 
data 
collect
ed 
Setting 
Target 
Drivers/ 
Factors 
Name Slogan Target audience 
Healthcare 
providers 
Healthcar
e 
consumer
s 
BCT-
provider 
BCT-
consu
mer 
Behav
ioral 
Chang
e 
Wheel 
Theory
-based 
Interven
tion 
Adaptio
n/ 
Develop
ment 
Imple
menta
tion 
strate
gy 
Imple
mente
r(s) 
Unit of 
interve
ntion 
Dose/intensi
ty 
Desig
n Costs 
Duratio
n 
Data 
sources 
Formative 
or process 
evaluation 
studies 
Inappropriate use of 
antibiotics                    
Belongi
a, 2001 RTIs USA 
June 
1998 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
cultural, 
and doctor-
patient 
relationship 
- None 
Commun
ity and 
healthcar
e 
providers 
Physician 
education 
(parent 
education 
pamphlets, 
parent 
information 
sheets, 
a sample 
letter, 
“prescription 
pad”, CDC 
fact sheets 
Public 
education 
materials: 
programs, 
pamphlets 
and 
posters, 
presentatio
ns and 
“Cold 
kits” 
4.1 
4.2 
5.1 
8.2 
12.5 
4.1 
4.2 
5.1 
8.2 
12.5 
Educat
ion - Yes Yes Yes 
Commu
nity 
Partially 
reported NR NR 
4 
months 
Medical 
records + 
self reports, 
lab testing 
- 
Belongi
a, 2005 
not 
specified USA 
Decem
ber 
2003 
Commu
nity 
Knowledge 
(including 
awareness) 
Wisconsi
n 
Antibioti
c 
Resistanc
e 
Network 
“There’s 
no excuse 
for 
overuse!” 
and “Get 
smart 
about 
antibiotics
!” 
Commun
ity and 
healthcar
e 
providers 
Physician 
education 
(mailings, 
susceptibility 
reports, 
practice 
guidelines, 
satellite 
conferences, 
and 
presentations
) 
Mass 
media 
campaign 
(television
, radio, 
newspaper
s, press 
conference
; paid ad); 
Patient 
education 
materials 
4.1 
4.2 
5.1 
12.5 
 
4.1 
4.2 
5.1 
12.5 
 
Educat
ion - Yes Yes Yes 
Commu
nity Yes 
Acce
ss 
expir
ed 
NR 5 years Medical records - 
Bernier
, 2014 
Not 
specified 
Franc
e 
Decem
ber201
0 
Commu
nity 
Knowledge 
(including 
awareness) 
- 
“Antibioti
cs Are 
Not 
Automatic
!” and 
“Antibioti
cs, Used 
Unnecessa
rily, Lose 
Their 
Potency!” 
Commun
ity 
guidelines, 
seminars, 
academic 
detailing, 
letters 
Pamphlets 
and 
posters, 
print 
media, 
radio, 
television, 
website 
4.1 
4.2 
5.1 
12.5 
4.1 
4.2 
5.1 
12.5 
Educat
ion - NR NR Yes 
Commu
nity NR NR NR 
6 
months 
(ongoin
g) 
Medical 
records - 
Cebota
renco, 
2008 
RTIs Moldova 
March 
2004 
School 
setting 
Knowledge 
(including 
awareness) 
peer 
- None 
Commun
ity - 
Students 
and 
guardians 
- 
Peer-
education, 
parents' 
meetings, 
booklet, 
vignette 
video, 
newsletter, 
poster and 
poster 
contest 
- 
4.1 
4.2 
6.1 
12.2 
Educat
ion 
Social 
Cogniti
ve 
Theory 
Yes Yes Yes Community Yes Yes NR 1 year Self reports - 
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Finkels
tein, 
2001 
RTIs USA 
Decem
ber, 
1998 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
doctor-
patient 
relationship
, peer leader 
- - 
Commun
ity and 
healthcar
e 
providers 
Guideline 
disseminatio
n, small-
group 
education, 
educational 
materials, 
and 
prescribing 
feedback. 
Education
al 
materials 
for parents 
by mail 
and in 
primary 
care 
practices, 
pharmacie
s, and 
childcare 
settings 
2.2 
3.2 
4.1 
4.2 
5.1 
8.2 
9.1 
 
4.1 
4.2 
5.1 
8.2 
9.1 
 
Educat
ion - Yes Yes Yes 
Commu
nity NR NR NR 1 year 
Medical 
records 189 
Finkels
tein, 
2008 
RTIs USA August 2003 
Commu
nity 
Knowledge 
(including 
awareness), 
doctor-
patient 
relationship 
Reducing 
Antibioti
cs for 
Children 
in 
Massach
usetts 
(REACH 
Mass) 
None 
Commun
ity and 
healthcar
e 
providers 
Guideline 
disseminatio
n, small-
group 
education, 
educational 
materials, 
“prescription 
pad”, and 
prescribing 
feedback. 
Education
al 
materials 
for parents 
by mail 
and in 
primary 
care 
practices, 
pharmacie
s, and 
childcare 
settings 
2.2 
3.2 
4.1 
4.2 
5.1 
8.2 
 
4.1 
4.2 
5.1 
8.2 
 
Educat
ion 
Social 
marketi
ng 
Yes Yes Yes Community 
Partially 
reported NR NR 
3 
winters 
(Oct-
March) 
Medical 
records 189 
Formos
o, 2013 RTIs Italy 
March 
2012 
Commu
nity 
Knowledge 
(including 
awareness), 
cultural, 
and doctor-
patient 
relationship 
Antibioti
cs, 
solution 
or 
problem 
“Antibioti
cs, 
solution or 
problem?” 
Commun
ity and 
healthcar
e 
providers 
a newsletter 
on local 
AMR.  
Campaign 
materials 
(highlighting 
how to deal 
with 
patients’ 
expectations, 
occurrence 
of AMR 
and of side 
effects. ) 
mass 
media 
spaces 
(television
, radio, 
newspaper
s) 
written 
materials 
(brochures
, posters, 
newsletter
s) 
4.1 
4.2 
5.1 
5.2 
12.5 
4.1 
4.2 
5.1 
5.2 
12.5 
Educat
ion/per
suasio
n 
Social 
marketi
ng 
Yes Yes Yes Community 
Partially 
reported 
Acce
ss 
expir
ed 
$60,80
0 
4 
months 
Medical 
records + 
self reports 
- 
Fuertes
, 2010 
not 
specified 
Cana
da 
Decem
ber 
2008 
Commu
nity 
Knowledge 
(including 
awareness) 
Do Bugs 
Need 
Drugs? 
None 
Commun
ity and 
healthcar
e 
providers 
Television 
campaign 
Television 
campaign 
4.1 
4.2 
5.1 
5.2 
8.2 
4.1 
4.2 
5.1 
5.2 
8.2 
Educat
ion - NR Yes Yes 
Commu
nity NR NR NR 
5 
months 
Medical 
records - 
Gonzal
es, 2004 RTIs USA 
Februa
ry 
2002 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(including 
awareness) 
and doctor-
patient 
relationship 
Minimizi
ng 
Antibioti
c 
Resistanc
e in 
Colorado 
Be 
SMART 
about 
Antibiotic
s 
Commun
ity and 
healthcar
e 
providers 
antibiotic 
prescribing 
profiles and 
practices 
guidelines 
Waiting 
room 
materials, 
examinati
on room 
posters;  
Mailing 
campaign 
packets: 
Household
- and 
office-
based 
patient 
education 
materials 
1.3 
12.5 
4.1 
4.2 
5.1 
9.1 
12.5 
Educat
ion - Yes Yes Yes 
Commu
nity 
Access 
expired 
Acce
ss 
expir
ed 
NR 1 year Medical records 248 
Gonzal
es, 2005 RTIs USA 
Februa
ry 
2002 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(including 
awareness) 
and doctor-
Minimizi
ng 
Antibioti
c 
Resistanc
Be 
SMART 
about 
Antibiotic
s 
Commun
ity and 
healthcar
e 
providers 
antibiotic 
prescribing 
profiles and 
practices 
guidelines 
Waiting 
room 
materials, 
examinati
on room 
1.3 
12.5 
4.1 
4.2 
5.1 
9.1 
12.5 
Educat
ion - Yes Yes Yes 
Commu
nity 
Access 
expired 
Acce
ss 
expir
ed 
$63,74
5 1 year 
Medical 
records 
(See 
Gonzales, 
2004) 
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patient 
relationship 
e in 
Colorado 
posters;  
Mailing 
campaign 
packets: 
Household
- and 
office-
based 
patient 
education 
materials 
Gonzal
es, 2008 
not 
specified USA 
Decem
ber 
2003 
Commu
nity 
Knowledge 
(including 
awareness) 
Minimizi
ng 
Antibioti
c 
Resistanc
e in 
Colorado 
“Get 
Smart: 
Use 
Antibiotic
s Wisely.” 
And “Use 
antibio´ 
ticos solo 
si un 
doctor se 
lo receta” 
Commun
ity and 
healthcar
e 
providers 
Primary care 
physicians 
Mass 
media 
campaign, 
educationa
l events 
and 
written 
educationa
l materials 
4.1 
4.2 
5.1 
12.5 
4.1 
4.2 
5.1 
12.5 
Educat
ion 
Social 
marketi
ng 
Yes Yes Yes Community Yes Yes 
$196,7
10 
4 
months 
Medical 
records + 
self reports 
- 
Hennes
sy, 
2002 
RTIs USA 
Decem
ber 
2000 
Commu
nity 
Knowledge 
(including 
awareness) 
- - 
Commun
ity and 
healthcar
e 
providers 
Workshops 
and follow-
up visits 
Printed 
informatio
n and 
newsletter
s 
4.1 
4.2 
 
4.1 
4.2 
5.1 
Educat
ion - Yes Yes Yes 
Commu
nity 
Access 
expired 
Acce
ss 
expir
ed 
NR 6 months 
Medical 
records + 
lab testing 
+ self 
reports 
- 
Kliema
nn, 
2016 
not 
specified 
Brazi
l 
Decem
ber 
2012 
Commu
nity 
Socioecono
mic 
determinant
s; Access to 
non-
prescription 
antibiotics 
- - 
Commun
ity and 
healthcar
e 
providers 
Restriction 
on sale of 
antibiotics 
without 
prescription 
Restriction 
on sale of 
antibiotics 
without 
prescriptio
n 
12.1 12.1 
Restric
tion, 
enviro
nment
al 
restruc
turing 
- NA Yes Yes Community NA NA NA 
Ongoin
g 
Medical 
records - 
Lambe
rt, 2007 RTIs UK 
Februa
ry 
2005 
Commu
nity 
Knowledge 
(including 
awareness) 
- 
Antibiotic
s – 
tracking 
down the 
trust 
Commun
ity and 
healthcar
e 
providers 
professional 
education 
and 
prescribing 
support 
Mass 
media 
with 
printed 
materials 
4.1 
8.2 
12.5 
4.1 
8.2 
12.5 
Educat
ion - NR Yes Yes 
Commu
nity NA 
Partia
lly 
repor
ted 
£25,00
0 
2 
winters 
Medical 
records + 
self reports 
- 
Lee, 
2017 RTIs 
Singa
pore 
Not 
specifi
ed 
Primary 
care 
setting 
Knowledge 
(correcting 
misconcepti
ons) 
-- - 
Commun
ity - 
patients 
- 
Education
al 
pamphlets 
and verbal 
counsellin
g 
- 4.1 4.2 
Educat
ion - NR NR Yes 
Individu
al NR NR NR 2 weeks 
Medical 
records - 
Mainou
s, 2009 
not 
specified USA 
June 
2008 
Commu
nity 
Knowledge 
(including 
misconcepti
ons); 
cultural 
"Solo 
Con 
Receta” 
(only 
with a 
prescripti
on) 
- Community - 
Culturally-
sensitive 
communit
y 
interventio
n with 
multiple 
media 
sources 
- 4.1 5.1 
Educat
ion - NR Yes Yes 
Commu
nity 
Partially 
reported NR NR 
9 
months 
Medical 
records + 
self reports 
- 
McNult
y, 2010 RTIs UK 
Januar
y 2009 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(correcting 
misconcepti
ons) 
-- - 
Commun
ity - 
patients 
NICE 
guidance on 
the primary 
care 
management 
of common, 
acute, self-
limiting RTIs 
three 
posters 
displayed 
in 
magazines 
and 
newspaper
s 
4.1 
4.2 
8.2 
4.1 
4.2 
Educat
ion - NR NR Yes 
Individu
al NR Yes NR 
2 
months self reports 249 
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Perz, 
2002 RTIs USA 
April 
1999 
Commu
nity 
Knowledge 
(including 
awareness); 
peer 
- 
Antibiotic
s and Your 
Child 
Commun
ity and 
healthcar
e 
providers 
Educating 
peer leader 
presentations 
Public 
education 
via printed 
material 
4.1 
4.2 
4.1 
4.2 
8.2 
Educat
ion - Yes Yes Yes 
Commu
nity 
Partially 
reported 
Partia
lly 
repor
ted 
NR 1 year Medical records - 
Sabunc
u, 2009 RTIs 
Franc
e 
Decem
ber 
2007 
Commu
nity 
Knowledge 
(including 
awareness) 
Keep 
Antibioti
cs 
Working 
‘‘Les 
antibiotiqu
es c’est 
pas 
automatiq
ue’’ 
(‘‘Antibiot
ics are not 
automatic’
’) 
Commun
ity 
guidelines, 
seminars, 
academic 
detailing, 
letters 
Pamphlets 
and 
posters, 
print 
media, 
radio, 
television, 
website 
4.1 
4.2 
5.1 
12.5 
4.1 
4.2 
5.1 
12.5 
Educat
ion - NR NR Yes 
Commu
nity NR NR NR 5 years 
Medical 
records 
(see  Bernier, 
2014)   
Santa-
Ana-
Tellez, 
2013 
Not 
specified 
Brazi
l and 
Mexi
co 
June 
2012 
Commu
nity 
Access to 
non-
prescription 
antibiotics 
- - 
Commun
ity and 
healthcar
e 
providers 
Restriction 
on sale of 
antibiotics 
without 
prescription 
in 
pharmacies, 
and 
introduction 
of fine on 
owners of 
pharmacies 
for non-
compliance. 
Restriction 
on sale of 
antibiotics 
without 
prescriptio
n 
12.1 
14.2 (only 
Mexico) 
12.1 
 
Restric
tion, 
coerci
on, 
enviro
nment
al 
restruc
turing 
- NA Yes Yes Community NA NA NA 
Ongoin
g 
Medical 
records 220-222,250 
Santa-
Ana-
Tellez, 
2015 
Not 
specified 
Brazi
l and 
Mexi
co 
March 
2012 
Commu
nity 
Access to 
non-
prescription 
antibiotics 
- - 
Commun
ity and 
healthcar
e 
providers 
Restriction 
on sale of 
antibiotics 
without 
prescription 
in 
pharmacies, 
and 
introduction 
of fine on 
owners of 
pharmacies 
for non-
compliance. 
Restriction 
on sale of 
antibiotics 
without 
prescriptio
n 
12.1 
14.2 (only 
Mexico) 
12.1 
 
Restric
tion, 
coerci
on, 
enviro
nment
al 
restruc
turing 
- NA Yes Yes Community NA NA NA 
Ongoin
g 
Medical 
records 
(see Santa-
Ana-Tellez, 
2013) 
Taylor, 
2005 RTIs USA 
April 
2002 
Primary 
care 
setting 
Knowledge, 
Doctor-
patient 
relationship 
- 
Puget 
Sound 
Paediatric 
Research 
Network 
Commun
ity - 
parents 
and 
children 
- 
educationa
l 
pamphlets 
and a 
video 
- 4.1 9.1 
Educat
ion - Yes Yes Yes 
Commu
nity NR NR NR 1 year 
Medical 
records - 
Trepka
, 2001 RTIs USA 
Augus
t 1998 
Commu
nity & 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
cultural, 
and doctor-
patient 
relationship 
- 
Your 
Child and 
Antibiotic
s 
Commun
ity and 
healthcar
e 
providers 
“Grand 
rounds” 
presentations
, small-group 
academic 
detailing, and 
distribution 
of written 
materials 
(clinical 
practice 
guidelines, 
clinical fact 
sheets, and 
samples of 
patient 
education 
materials.) 
Public 
education 
materials: 
programs, 
pamphlets 
and 
posters, 
presentatio
ns and 
newspaper
s 
4.1 
4.2 
5.1 
8.2 
12.5 
4.1 
4.2 
5.1 
8.2 
12.5 
Educat
ion - Yes Yes Yes 
Commu
nity 
Partially 
reported NR NR 
4 
months self reports - 
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Wirtz, 
2013 
Not 
specified 
Chile
, 
Colo
mbia, 
Vene
zuela, 
Mexi
co 
Septe
mber 
2009 
Commu
nity 
Access to 
non-
prescription 
antibiotics 
- - 
Commun
ity and 
healthcar
e 
providers 
Restriction 
on sale of 
antibiotics 
without 
prescription 
Restriction 
on sale of 
antibiotics 
without 
prescriptio
n 
12.1 12.1 
Restric
tion, 
coerci
on, 
enviro
nment
al 
restruc
turing 
- NA Yes Yes Community NA NA NA 
Ongoin
g 
Medical 
records 220-222,250 
Wutzke
, 2007 RTIs 
Austr
alia 
Augus
t 2004 
Commu
nity & 
Primary 
care 
setting 
Knowledge, 
Doctor-
patient 
relationship
; peer 
The NPS 
common 
colds 
communi
ty 
campaign 
‘Common 
colds need 
common 
sense: they 
don’t need 
antibiotics
’. 
Commun
ity and 
healthcar
e 
providers 
Prescription 
pads, patient 
information 
leaflets, 
prescribing 
software. 
Newsletters,. 
Prescribing 
feedback, 
educational 
visiting, 
clinical audit 
with 
feedback and 
case studies 
(paper and 
peer group 
discussion). 
Mass 
media 
activity 
using 
billboards, 
television, 
radio and 
magazines 
and small 
grants to 
promote 
local 
communit
y 
education 
2.2 
3.1 
4.1 
4.2 
8.2 
12.5 
4.1 
4.2 
8.2 
12.5 
Educat
ion/ 
persua
sion 
- Yes Yes Yes Community 
Partially 
reported Yes NR 6 years 
Medical 
records + 
self reports 
- 
Demand of brand name 
drugs                     
Beshea
rs, 2013 
not 
specified USA 
Octob
er 
2014 
Commu
nity 
Knowledge 
(including 
awareness), 
Peer 
influence 
- - 
Commun
ity - 
Union 
members 
- 
Informatio
nal letters 
with or 
without a 
Testimoni
al from 
person 
with/witho
ut shared 
union 
affiliation 
- 
8.2 
9.1 
10.1 
10.2 
Educat
ion, 
persua
sion 
- NR Yes Yes Individual 
Partially 
reported NR NR 1 letter 
Medical 
records - 
O'Mall
ey, 
2006 
not 
specified USA 
Decem
ber 
2003 
Commu
nity 
Knowledge 
(including 
awareness), 
Incentives 
- - 
Commun
ity and 
healthcar
e 
providers 
Free generic 
drug 
samples,  
physician 
financial 
incentives 
Member 
mailings, 
advertisin
g 
campaigns 
3.2 
4.1 
8.2 
10.1 
10.2 
12.5 
4.1 
8.2 
10.1 
10.2 
12.5 
Educat
ion, 
incenti
vizatio
n 
- NR Yes Yes community NR NR NR 4 years 
Medical 
records - 
Sedjo, 
2009 
not 
specified USA 
Decem
ber 
2007 
Commu
nity 
Knowledge 
(including 
awareness), 
Incentives 
- - 
Commun
ity – 
health 
plan 
enrollees 
- 
Targeted 
messaging 
to raise 
awareness 
regarding 
lower-cost 
generic 
alternative
s (a phone 
call and 
quarterly 
letters) 
- 
4.1 
8.2 
10.1 
10.2 
 
Educat
ion, 
incenti
vizatio
n 
- NR Yes Yes Individual NR NR NR 
1 call 
and 
quarterl
y mails 
Medical 
records - 
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Vallès, 
2003 
not 
specified Spain 
Februa
ry 
2000 
Primary 
care 
setting 
Knowledge 
(including 
awareness) 
 
- - 
chronic 
disorders 
patients 
who 
attended 
general 
practices 
- 
Verbal 
informatio
n and 
handout 
materials 
on 
advantage
s and 
disadvanta
ges of 
generic 
equivalent
s and 
brand-
name 
drugs 
- 
4.1 
8.2 
9.2 
Educat
ion - NR Yes Yes 
Individu
al NR NR NR 
1 
session 
Medical 
records - 
Non-medical use of 
prescription drugs                     
Hasak 
2018 
Pain 
manage
ment 
(short-
term 
USA 
Septe
mber, 
2017 
Commu
nity 
Knowledge 
(including 
awareness) 
, 
enabling 
- - - - 
informatio
n 
brochure, 
website 
 
4.1 
4.2 
5.1 
5.2 
12.1 
Educat
ion; 
enable
ment 
- Yes Yes Yes Individual Yes Yes NR 2 times self reports 251 
Lawren
ce, 2019 
Pain 
manage
ment 
(short-
term 
USA January 2019 
Commu
nity 
Knowledge 
(including 
awareness) 
, 
enabling - - - - 
informatio
n 
brochure, 
video, 
Deterra 
bags 
 
4.1 
4.2 
5.1 
5.2 
12.1 
12.5 
Educat
ion; 
enable
ment; 
enviro
nment
al 
restruc
turing; 
- Yes Yes Yes Individual Yes Yes 
Partiall
y 
reporte
d ($5-
7 per 
bag) 
1 time 
Medical 
records, self 
reports 
252 
Maugh
an, 
2016 
Pain 
manage
ment 
(short-
term 
USA 
Octob
er 
2015 
Commu
nity 
Knowledge 
(including 
awareness) 
, 
enabling - - - - 
informatio
n 
brochure, 
study 
hotline 
 
4.1 
4.2 
5.1 
5.2 
12.1 
12.5 
Educat
ion; 
enable
ment; 
enviro
nment
al 
restruc
turing; 
- NR Yes Yes Individual Yes NR NR 1 time self reports  
Rose, 
2016 
Pain 
manage
ment 
(short-
term 
Cana
da 
April 
2015 
Commu
nity 
Knowledge 
(including 
awareness) 
, 
enabling 
- - - - information brochure  
4.1 
4.2 
5.1 
5.2 
12.1 
Educat
ion; 
enable
ment 
- Yes Yes Yes Individual Yes Yes NR 1 time self reports  
Spoth, 
2008 
not 
specified USA 
Decem
ber 
2002 
School 
setting 
Enhance 
protective 
factors 
Family 
dynamics 
Strengthe
ning 
Families 
Program 
(ISFP) 
and Life 
Skills 
Training 
(LST) 
- 
Commun
ity - 
Students 
- 
Universal 
preventive 
interventio
ns 
implement
ed during 
middle 
school 
(strengthe
ning 
families 
program 
and life 
skills 
training) 
- 
3.1 
12.2 
 
Educat
ion; 
enable
ment; 
enviro
nment
al 
restruc
turing; 
social 
develop
ment 
model 
NR Yes Yes Individual NR NR NR 
6 2-hr 
sessions 
+ 1 
family 
follow 
up + 
boosters 
(cohort) 
self reports 202,203,253-256 
Spoth, 
2013 
not 
specified USA 
Decem
ber 
2011 
School 
setting 
Enhance 
protective 
factors 
Family 
dynamics 
Strengthe
ning 
Families 
Program 
(ISFP) 
- 
Commun
ity - 
Students 
- 
Universal 
preventive 
interventio
ns 
implement
- 
3.1 
12.2 
 
Educat
ion; 
enable
ment; 
enviro
social 
develop
ment 
model 
NR Yes Yes Individual NR NR NR 
6 2-hr 
sessions 
+ 1 
family 
follow 
self reports (see  Spoth, 20080)  
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and Life 
Skills 
Training 
(LST) 
ed during 
middle 
school 
(strengthe
ning 
families 
program 
and life 
skills 
training) 
nment
al 
restruc
turing; 
up + 
boosters 
(cohort 
Study 
1:1993-
2008; 
study 2: 
1998-
2011) 
Elective Caesarean Section          -  -         
Eden, 
2014 
experienc
ed 
previous 
caesarean 
birth 
USA May 2007 
Commu
nity & 
Primary 
care 
settings 
Knowledge 
(including 
awareness), 
enabling 
- - 
Commun
ity -  
Pregnant 
women 
with one 
previous 
caesarean 
birth 
- 
Evidence-
base 
informatio
n brochure  
or 
facilitated 
decision 
analysis 
- 
4.1 
5.1 
9.2 
Educat
ion; 
enable
ment 
- Yes Yes Yes Individual NR NR NR 
1 
session 
Medical 
records + 
self reports 
- 
Fraser, 
1997 
experienc
ed 
previous 
caesarean 
birth 
Cana
da 
Nove
mber 
1994 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
Predisposin
g, enabling 
and 
reinforcing 
factors 
 
- - 
Commun
ity -  
Pregnant 
women 
with one 
previous 
caesarean 
birth 
- 
Education
al 
pamphlet, 
prenatal 
education 
and peer 
support 
program 
- 
3.3 
4.1 
5.1 
 
Educat
ion; 
enable
ment 
The 
PRECE
DE-
PROCE
ED 
model 
NR Yes Yes Individual NR NR NR 
2 
sessions 
Medical 
records + 
self reports 
- 
Hassan
i, 2016 
not 
specified 
Iran NR Primary 
care 
setting 
Knowledge 
(including 
awareness 
- - Commun
ity - 
Primipar
ous 
Pregnant 
women 
- Instruction
al sessions 
in the 
form of 
speech, 
group 
discussion
s, 
questions 
and 
answers, 
and 
presentatio
ns 
 4.1 Educat
ion 
Health 
belief 
model 
NR Yes Yes Individual NR NR NR 
6  
sessions 
- 50-60 
minutes
/session  
self reports - 
Montgo
mery, 
2007 
experienc
ed 
previous 
caesarean 
birth 
UK August 2006 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
enabling 
- - 
Commun
ity -  
Pregnant 
women 
with one 
previous 
caesarean 
birth 
- 
Informatio
n program 
and 
facilitated 
decision 
analysis 
- 
4.1 
5.1 
9.2 
9.2 
Educat
ion; 
enable
ment 
- Yes Yes Yes Individual NR NR NR 
10 
weeks 
Medical 
records + 
self reports 
186-
188,191,192 
Navaee, 
2015 
fear of 
childbirth Iran NR 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
Emotions 
- - 
Commun
ity - 
Primipar
ous 
Pregnant 
women 
- 
Education 
through 
role play 
about 
advantage
s and 
disadvanta
ges 
- 
4.1 
4.2 
6.1 
9.2 
Educat
ion; 
modell
ing 
- NR Yes Yes Individual NR NR NR 
1 
session 
- 90 
minutes 
self reports - 
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Sharifir
ad, 
2013 
Primipar
ous 
Pregnant 
women 
Iran NR 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
Family 
dynamics 
- - 
Commun
ity – 
spouses 
of 
primipar
ous 
Pregnant 
women 
- 
Education
al session 
about 
mechanis
m of 
natural 
vaginal 
and 
caesarean 
deliveries 
as well as 
their 
advantage
s and 
disadvanta
ges. 
- 
3.1 
4.1 
5.1 
9.2 
Educat
ion; 
enable
ment 
- NR Yes Yes Individual NR NR NR 
1 
session 
- 90 
minutes 
self reports - 
Shorte
n, 2005 
experienc
ed 
previous 
caesarean 
birth 
Austr
alia 
May 
2003 
Primary 
care 
setting 
Knowledge 
(including 
awareness), 
enabling 
- - 
Commun
ity -  
Pregnant 
women 
with one 
previous 
caesarean 
birth 
- 
Informatio
n materials 
and 
facilitated 
decision 
analysis 
- 
4.1 
5.1 
9.2 
Educat
ion; 
enable
ment 
- Yes  Yes Yes Individual NR NR NR 
1 
session  
Medical 
records + 
self reports 
190 
Valiani, 
2014 
Primipar
ous 
Pregnant 
women 
Iran NR 
Primary 
care 
setting 
Knowledge 
(including 
awareness) 
- - 
Commun
ity - 
Primipar
ous 
Pregnant 
women 
- childbirth workshops - 
4.1 
4.2 
5.1 
6.1 
9.2 
Educat
ion; 
enable
ment 
- NR Yes Yes Individual NR NR NR 
3 x 4hr/ 
week 
Medical 
records - 
Note: NR = not reported; RTIs=Respiratory tract infections; GP = General Practitioner; CS=Elective Caesarean Section.
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Table 2. Summary of findings of included studies measuring changes behavioural outcomes 
First 
Author, 
Year 
Study design Study population 
Study 
sample size 
Primary 
outcome(s) 
Change in 
interventio
n group 
Change 
in control 
group 
Effect size (95% 
CI) P value 
 
Effective 
in 
changin
g public 
behavio
rs 
Quality 
Appraisal 
Belongia, 
2001 NCT 
Longitudin
al 
Physicians 
and public 
111 facilities, 
664 children 
Paediatric 
antibiotic 
prescribing 
in child 
care 
facilities 
Baseline: 
57.6%; 
post-
interventio
n: 59.5% of 
initial visits 
Baseline: 
60.1%; 
post-
interventio
n 61.5% 
of initial 
visits 
NR 
Baseline: P = 
0.56.; Post-
intervention: 
P = 0.66 
 
No WEAK 
Belongia, 
2005 CPP 
Longitudin
al 
parents and 
primary 
care 
clinicians 
4,115 
primary care 
physicians 
Change in 
annual 
antimicrobi
al 
prescribing 
rate 
- 20.4% - 19.8% -0.6% NR No MODERATE 
Bernier, 
2014 ITS 
Longitudin
al 
French 
citizens 
covered by 
NHI 
 
Not reported 
change in 
antimicrobi
al 
prescribing 
rate 
NA NA -30% (-36.3% to -23.8%) P<0.001 Mixed STRONG 
Cebotarenc
o, 2008 CPP 
Cross-
sectional 
Students 
and parents ~6302 people 
No 
antibiotic 
use for cold 
and flu 
Students: a 
33.7% net 
increase in 
no 
antibiotic 
use; 
Adults:  a 
38.0% net 
increase in 
no use 
students -
0.4%; 
adults 
+0.1% 
Students 3.694 
(CI 2.516 to 
5.423); adults 
5.541 (CI 4.559 
to 6.733) 
P<0.0001  Yes WEAK 
Finkelstein, 
2001 RCT 
Longitudin
al 
Physicians 
and parents 8815 children 
Antibiotics 
dispensed 
per person-
year of 
observation 
among 
children 
3 to 
<36mon (-
18.6%), 36 
to <72 (-
15.0%) 
3 to 
<36mon (-
11.5%), 
36 to <72 
(-9.8%) 
3 to <36mon (-
16%), 36 to <72 
(-12%) 
3 to <36mon 
(P<0.001), 
36 to <72 
(P<0.001) 
Yes STRONG 
Finkelstein, 
2008 RCT 
Longitudin
al 
Physicians 
and parents 
223,135 
person/years 
Antibiotics 
dispensed 
per person-
year of 
observation 
among 
children 
3 to 
<24mon (-
20.7%), 24 
to <48 (-
10.3), 48 to 
<72 (-2.5) 
3 to 
<24mon (-
21.2), 24 
to <48 (-
14.5), 48 
to <72 (-
9.3) 
3 to <24mon (-
0.5), 24 to <48 (-
4.2), 48 to <72 (-
6.7) 
3 to <24mon 
(p=0.69), 24 
to <48 
(p<0.01), 48 
to <72 
(p<0.0001) 
Mixed STRONG 
Formoso, 
2013 NCT 
Longitudin
al 
Modena 
and Parma, 
Emilia-
Romagna 
region 
1,150,000 
residents 
Antibiotic 
prescription 
rate 
-11.9 -7.4 -4.3% (−7.1% to −1.5%) P=0.008 Yes STRONG 
Fuertes, 
2010 ITS 
Longitudin
al 
Population 
in British 
Columbia, 
Canada 
Not reported 
Antibiotic 
utilization 
rate 
-5.8% NA NR NR No STRONG 
Gonzales, 
2004 NCT 
Longitudin
al 
Medicare 
enrollees 
with acute 
respiratory 
tract 
infections 
(ARIs) 
4,270 patient 
visits 
Decreased 
antibiotic 
prescription 
rates 
-5% -2% NR p=0.79 No MODERATE 
Gonzales, 
2005 NCT 
Longitudin
al 
Children 
with 
pharyngitis 
and adults 
with acute 
bronchitis 
Baseline:101
28 patients 
Study:9586 
patients 
Decreased 
antibiotic 
prescription 
rates 
Children:-
4% 
Adults: -
24% 
Children:-
2% at 
local 
control; 
1% at 
distant 
control; 
Adults:-
10% at 
local 
control; -
6% at 
distant 
control 
NR 
Children: 
P=0.18,p=0.
48 compared 
with distant 
and local 
control; 
Adults: 
p<0.002 and 
p=0.006, for 
distant and 
local control 
Mixed MODERATE 
Gonzales, 
2008 NCT 
Longitudin
al 
mothers of 
young 
children 
and primary 
care 
physicians 
922 
households, 
1.38+ million 
antibiotic 
prescriptions 
Net change 
in antibiotic 
dispensed 
per 1000 
persons 
– – 
−3.8% in retail 
pharmacy 
antibiotic 
dispenses and  
-8.8% in 
managed care 
organization 
(MCO) 
associated 
dispenses 
P=0.30 for 
public, 
P=0.03 for 
MOC 
members 
Mixed STRONG 
Hennessy, 
2002 NCT 
Longitudin
al 
Medical 
providers 
and 
community 
10,809 Antibiotic utilization 
-31% 
(P≤0.01) 
-10% 
(p≥0.05) -21% NR Mixed 
MODERAT
E 
Kliemann, 
2016 ITS 
Longitudin
al 
Residents 
of Sao 
Paulo 
41,262,199 Antibiotic utilization -1.616 DID NA 
NR 
p = 0.002 Yes MODERATE 
Lambert, 
2007 CPP 
Longitudin
al 
Communiti
es in North 
East of 
England 
Not reported 
per person, 
per clinic 
visit 
Initial: -
31% 
Expanded: 
-35% 
NA 
NR 
p< 0.01 Mixed WEAK 
Lee, 2017 RCT Cross-sectional 
Adult 
patients 914 patients 
antibiotic 
prescription
s 
20.6% 17.7% 1.20 (0.83-1.73) P=0.313 No WEAK 
Mainous, 
2009 
QE 
(controlled post 
test) 
Cross-
sectional 
Latino 
adults 
500 adults Use of non-
prescription 
antibiotics 
1.3% 3.2% NR P=0.90 No 
WEAK 
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McNulty, 
2010 CPP 
Cross-
sectional Adult ≥15 
Pre= (1999); 
post (1830) 
Antibiotic 
use without 
professiona
l advice 
-0.5% 0% NR NR No WEAK 
Perz, 2002 CPP Longitudinal 
Children 
<15 
464200 
person-years 
Antibiotic 
prescription 
rates 
Year 
3:19% 
Year 1: 
8% 11% (8%- 14%) p<0.001 Yes 
MODERAT
E 
Sabuncu, 
2009 ITS 
Longitudin
al 
French 
citizens 
covered by 
NHI 
Not reported 
Change in 
winter 
antibiotic 
prescribing 
rate (Oct to 
Mar) 
NA NA −26.5% (−33.5% to −19.6%)  < 0.0001 Yes STRONG 
Santa-Ana-
Tellez, 2013 ITS 
Longitudin
al 
Populations 
in Mexico 
and Brazil 
Not reported 
OTC 
antibiotics 
consumptio
n 
Brazil = -
1.35; 
Mexico = -
1.17 
NA NR 
Brazil 
p<0.01; 
Mexico 
p<0.001 
Mixed STRONG 
Santa-Ana-
Tellez, 2015 ITS 
Longitudin
al 
Populations 
in Mexico 
and Brazil 
Not reported 
Seasonal 
variation in 
total 
Penicillin 
use 
Brazil = 
0.077; 
Mexico = -
0.359 
NA 
Brazil = 0.077 (-
1.142 to 1.297); 
Mexico = -0.359 
(-0.613 to -0.105) 
Brazil 
p>0.05; 
Mexico 
p<0.01 
Mixed STRONG 
Taylor, 
2005 RCT 
Cross-
sectional 
Parent/child 
dyads 499 children 
Total no. of 
prescription
s for 
antibiotics 
2.2 ±2.6 2.5 ± 2.9 NR P=0.23 No WEAK 
Trepka, 
2001 CPP 
Cross-
sectional 
Physicians 
and public 365 children 
expected an 
antibiotic 
for their 
child and 
did 
not receive 
one and 
brought 
their child 
to another 
physician 
because 
they did not 
receive an 
antibiotic 
expected 
an 
antibiotic 
for their 
child and 
did 
not receive 
one: -5.1% 
brought 
their child 
to another 
physician 
because 
they did 
not receive 
an 
antibiotic: -
2.9% 
expected 
an 
antibiotic 
for their 
child and 
did 
not 
receive 
one: 3.2% 
brought 
their child 
to another 
physician 
because 
they did 
not 
receive an 
antibiotic: 
1.6% 
expected an 
antibiotic for their 
child and did 
not receive one: -
8.4% (-13.9 to -
2.8); brought their 
child to another 
physician because 
they did not 
receive an 
antibiotic: -4.5% 
(-8.0 to –0.9) 
they did not 
receive an 
antibiotic: 1.6% 
expected an 
antibiotic for 
their child 
and did 
not receive 
one: p=0.003 
brought their 
child to 
another 
physician 
because 
they did not 
receive an 
antibiotic: 
p=0.02 
 
Yes WEAK 
Wirtz, 2013 ITS Longitudinal 
Chile, 
Colombia, 
Venezuela, 
Brazil 
Not reported 
OTC 
antibiotics 
consumptio
n 
Colombia: 
-2.4DID; 
Chile: -
3.8DID; 
Venezuela: 
+5.39DID 
and 
Mexico: -
2.4DID 
NA 
Colombia: --1.00; 
Chile: -5.56; 
Venezuela: 
opposite impact; 
Mexico: no 
difference 
Colombia: p 
= 0.001; 
Chile: p < 
0.05 
Mixed MODERATE 
Wutzke, 
2007 ITS 
Longitudin
al 
Australian 
community Not reported 
change in 
use of 
antibiotics 
-3.40% NA 1.3–5.5 <0.05 Yes MODERATE 
Beshears, 
2013 RCT 
Cross-
sectional 
union 
members 5,498 adults 
Conversion 
rate to 
lower-cost 
alternatives 
Unaffiliate
d 
Testimonia
l Group 
11.3%; 
Affiliated 
Testimonia
l Group 
11.7% 
12.20% NR 
NR 
(insignificant
) 
 
 
No 
MODERAT
E 
O'Malley, 
2006 
QE  
(matched 
controlled) 
Longitudin
al 
Adult 
patients 
9790064 
claims 
Generic 
dispensing 
rate 
Mailing: -
4.94; 
Advertisin
g: -0.13; 
Generic 
sampling:  
-0.02; 
physician 
incentive: -
0.33 
Doubling 
co-
payment 
for brand-
name 
drugs: 
8.60 
NR p>0.05 No MODERATE 
Sedjo, 2009 QE Longitudinal 
Consumer-
Directed 
Health Care 
Enrolees 
4026 people 
Conversion 
rate to 
lower-cost 
alternatives 
0.30% 9.30% 29.82 (4.41–201.93) p<0.05 Yes 
MODERAT
E 
Vallès, 2003 RCT Longitudinal 
Patients 
taking 
medications 
for chronic 
disorders 
4620 patients 
Evolution 
of the 
percentage 
of generic 
prescribing 
5.10% 
(1999-
2000) 
1.90% 
(1999-
2000) 
NR p<0.001 Yes STRONG 
Hasak 2018 QE Cross-
sectional 
postoperati
ve patients 
258 patients 
Self-
reported 
proper 
opioid 
disposal 
28 (22) 14 (11) NR P=0.02 Yes WEAK 
Lawrence, 
2019 
RCT Cross-
sectional 
Parents of 
postoperati
ve patients 202 caregivers 
Self-
reported 
proper 
opioid 
disposal 
66 (71.7) 50 (56.2) 15.5 (1.7 to 29.3) P = 0.03. Yes MODERATE 
Maughan, 
2016 
RCT Cross-
sectional 
postoperati
ve patients 
79 patients 
Self-
reported 
proper 
opioid 
disposal 
52% 
(16/31) 
30% 
(8/27) NR p = 0.11. No WEAK 
Rose, 2016 
QE 
Cross-
sectional 
postoperati
ve patients 
87 patients 
Self-
reported 
proper 
opioid 
disposal 
12 (27%) 2 (5%) 22% (5 to 38) P = 0.005 Yes WEAK 
Spoth, 2008 RCT Longitudinal 
Late 
adolescents 
2651 (study 2 
on 
Self-
reported 
lifetime 
11th 
graders: 
3.9%; 
11th 
graders: 
7.7%; 
NR 11
th graders: 
p<0.01; Yes WEAK 
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and young 
adults 
prescription  
drugs) 
prescription 
drug 
misuse 
overall 
12th 
graders: 
7.7% 
12th 
graders: 
10.5% 
12th graders: 
p<0.1 
Spoth, 2013 RCT Longitudinal 
Late 
adolescents 
and young 
adults 
Study 1: 667 
students; 
Study 2: 
2127 students 
Self-
reported 
lifetime 
prescription 
drug 
misuse 
overall 
Study1- 
5.4; 
Study2- 2.5 
in age 21, 
4.4 in age 
22, 6.3 in 
age25. 
Study1- 
15.5; 
Study2- 
6.5 in age 
21, 8.9 in 
age 22, 
9.4 in 
age25. 
Study 1:65%; 
Study 2: 62% in 
age 21, 51% in 
age 22, 33% in 
age  25. 
Study 1-
p<0.01; 
Study 2- age 
21 p=0.015, 
age 22, 
p=0.019, age 
25 p=0.064 
Yes WEAK 
Eden, 2014 RCT Cross-sectional 
Pregnant 
women 
with 
previous 
caesarean 
131 women MoD (vaginal) 41% 37% NR p =0.724 No WEAK 
Fraser, 
1997 RCT 
Cross-
sectional 
Pregnant 
women 
with 
previous 
caesarean 
section 
1,275 women MoD (vaginal) 53% 49% 1.1 (1.0 to 1.2) p>0.05 No WEAK 
Hassani, 
2016 
QE Cross-
sectional 
Primiparous 
women 
60 women MoD 
(vaginal) 
30% 10% NR NR Yes WEAK 
Montgomer
y, 2007 RCT 
Cross-
sectional 
Pregnant 
women 
with 
previous 
caesarean 
section 
742 women MoD (vaginal) 
Decision 
analysis 
group: 
37%; 
Info:29% 
Usual 
care:30% 
 
Info  v. usual 
care:0.93(0.61,1.4
1) 
Decision v. usual 
care:1.42(0.94,2.1
4) 
p>0.9 
p=0.22 No STRONG 
Navaee, 
2015 RCT 
Cross-
sectional 
Primiparous 
women 67 women 
MoD 
(vaginal) 62.9% 43.8% NR P=0.117 No WEAK 
Sharifirad, 
2013 RCT 
Cross-
sectional 
Pregnant 
women and 
partners 
88 women 
and partners 
MoD 
(vaginal) 71.5% 50.0% NR p<0.05 Yes WEAK 
Shorten, 
2005 RCT 
Cross-
sectional 
Pregnant 
women 
with 
previous 
caesarean 
section 
227 women MoD (vaginal) VD: 49.2% 
CS: 
50.8% NR NR No WEAK 
Valiani, 
2014 RCT 
Cross-
sectional 
Pregnant 
women and 
partners 
180 women 
and partners 
MoD 
(vaginal) 
Mothers 
alone 
interventio
n = 60%; 
Couples 
=56.7% 
26.7% NR P=0.017 Yes WEAK 
Notes: CS=Elective Caesarean Section; CPP= controlled pre- and post-study; NA = not applicable; NR=not reported;  PDMO = Prescription drug 
misuse overall;  NCT=Nonrandomised controlled trial; OTC= over-the-counter purchases; MoD= Mode of delivery; RCT=randomised controlled trial; 
VD= Normal vaginal delivery; 
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Table 3. Features of included interventions 
 
First Author, 
Year 
Gov’t 
suppor
t 
Policy 
PROFESSIONAL TARGET PUBLIC TARGET Multilingual 
Letters to 
doctors 
Educationa
l meetings 
(academic 
detailing) 
Written 
material
s 
clinical 
practice 
guideline
s 
prescribin
g feedback 
physician 
financial 
incentive
s 
T
V 
Vide
o 
Newsletters/mail
s 
Poste
r 
radi
o 
Press 
conference
s 
Newspapers or 
Advertisement
s (including 
Bill boards, 
bus signs) 
Website
s 
Informational 
written materials 
(including 
Pamphlets/brochure
s) 
Educatio
n 
meetings 
Mascots 
School 
program 
(including 
Peer-
education) 
Famil
y & 
friend
s 
Decision
-
aid/Ena
bling 
Tools 
Other 
MassMedi
a  
campaign 
activities 
 
Belongia, 
2001 Yes  X X X X      X     X X      NR 
Belongia, 
2005 Yes  X X X X   X  X X X X X X X X X    X Yes 
Bernier, 2014 Yes  X X X X   X  X X X X X X X X     X NR 
Cebotarenco, 
2008 No         X  X   X  X X  X X  X NR 
Finkelstein, 
2001 Yes   X X X X    X     X X       NR 
Finkelstein, 
2008 Yes   X X X X    X     X X X  X X  X NR 
Formoso, 
2013 Yes  X      X   X X  X X X       NR 
Fuertes, 2010 Yes        X       X        NR 
Gonzales, 
2004 Yes    X X     X X    X X    X   Yes 
Gonzales, 
2005 Yes    X X     X X    X X    X   Yes 
Gonzales, 
2008 Yes  X         X X  X X X      X Yes 
Hennessy, 
2002 Yes   X       X     X X X      NR 
Kliemann, 
2016 Yes X                      NA 
Lambert, 
2007 Yes        X   X X  X  X  X    X NR 
Lee, 2017 No                X X      Yes 
Mainous, 
2009 
No            X  X  X       Yes 
McNuty, 2010 Yes  X  X X      X   X  X       NR 
Perz, 2002 Yes   X X X   X  X X   X  X X     X NR 
Sabuncu, 
2009 Yes  X X X X   X  X X X X X X X X     X NR 
Santa-Ana-
Tellez, 2013 Yes X                      NA 
Santa-Ana-
Tellez, 2015 Yes X                      NA 
Taylor, 2005 Yes         X       X       NR 
Trepka, 2001 Yes  X X X X      X   X  X X      NR 
Wirtz, 2013 Yes X                      NA 
Wutzke, 2007 Yes  X X X  X  X   X X X X X X X     X NR 
Beshears, 
2013 Yes          X             NR 
O'Malley, 
2006 No   X    X   X  X X X X       X NR 
Sedjo, 2009 No   X       X      X       NR 
Vallès, 2003 No                X X      NR 
Hasak, 2018 No               X X       NR 
Lawrence, 
2019 
No         X       X     X  NR 
Maughan, 
2016 
No                X     X  NR 
Rose, 2016 No                X       NR 
Spoth, 2008 No               X    X X   NR 
Spoth, 2013 No               X    X X   NR 
Eden, 2014 No                X     X  Yes 
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Fraser, 1997 Yes                X X   X   Yes 
Hassani, 2016 No                 X      NR 
Montgomery, 
2007 No               X      X  NR 
Navaee, 2015 No                X X   X   NR 
Sharifirad, 
2013 No                X X   X   NR 
Shorten, 2005 No                X     X  NR 
Valiani, 2014 No                X X   X   NR 
NR=not reported  
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Table 4. Behaviour change techniques and number of interventions targeting health care consumers and included specific behaviour change techniques, Behaviour Change Techniques Taxonomy Volume 1 
(BCTTv1) hierarchical clusters, and intervention content examples  
BCT BCTTv1 hierarchical clusters Examples extracted from descriptions of the interventions Frequency 
3.1 Social support (unspecified) 3. Social support Educational programs for husbands of pregnant women that aimed to provide social support of husbands, which 
consequently reduces the rate of elective cesarean section. 
3 
3.3 Social support (emotional) 3. Social support A resource person will provide peer influence during decision making process about mode of delivery 1 
4.1 Instruction on how to perform the behavior 4. Shaping knowledge Information about when antibiotics are and are not needed (eg, rarely for bronchitis, not for colds). 
 
34 
4.2 Information about Antecedents 4. Shaping knowledge Information about bacterial and viral infections 22 
5.1 Information about health consequences 5. Natural consequences Information about bacterial resistance or side effects of antibiotic use 22 
5.2 Salience of consequences 5. Natural consequences Emphasis on the consequences inappropriate use of antibiotics (eg. Antimicrobial resistance or side effects of 
antibiotic use) 
6 
6.1 Demonstration of the behavior 6. Comparison of behavior Role play education to reduce the fear of childbirth 3 
8.2 Behavior substitution 8. Repetition and substitution Alternative remedies instead of antibiotics for colds 11 
9.1 Credible source 9. Comparison of outcomes Endorsement by CDC was designed to increase the credibility of key messages. 4 
9.2 Pros and cons 9. Comparison of outcomes Information about the differences between generic and brand-name drugs in terms of advantages (high-quality 
bioequivalent formulations, health professionals’ preferences, avoidance of confusions) and disadvantages 
(popularity, fidelity to branded products)  
8 
10.1 Material incentive (behavior) 10. Reward and threat Switching to a lower-cost generic medication is cost-saving 3 
10.2 Material reward (behavior) 10. Reward and threat associated cost savings to the recipient from switching to each of these alternatives 3 
12.1 Restructuring the physical environment 12. Antecedents Restriction on sale of antibiotics without prescription 8 
12.2 Restructuring the social environment 12. Antecedents Interventions focused on empirically supported family risk and protective factors, such as parental nurturing, child 
management skills, improved parent–adolescent communication skills and adolescent prosocial skill development 
(e.g. managing conflict and stress, handling peer pressure, developing positive friendships) 
3 
12.5 Adding objects to the environment 12. Antecedents Mass media strategies were undertaken including advertising using billboards, television, radio and magazines.  12 
    
15 8  143 
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Table 5. Behaviour change techniques and number of interventions targeting health care providers that included specific behaviour change techniques, Behaviour Change Techniques Taxonomy Volume 1 
(BCTTv1) hierarchical clusters, and intervention content examples  
BCT BCTTv1 hierarchical clusters Examples extracted from descriptions of the interventions Frequency 
1.3 Goal setting (outcome) 1. Goals and planning Provision of individual prescribing profiles depicting: (1) the proportion of adult bronchitis patients receiving 
antibiotic treatment (target 10 percent or less); (2) the proportion of these antibiotics belonging to a first-line group 
(erythromycin, doxycycline, tetracycline) (target 70 percent or more); and (3) the proportion of these antibiotics that 
are ineffective against proven bacterial causes of uncomplicated acute bronchitis (target 0 percent). 
1 
2.2 Feedback on behavior 2. Feedback and monitoring Prescribing feedback, Clinical audit with feedback 3 
3.1 Social support (unspecified) 3. Social support Interventions that inform best practice prescribing and that support health professionals manage patient expectations 1 
3.2 Social support (practical) 3. Social support This intervention will (1) provide a range of patient education materials to physician offices without charge, (2) 
provide ongoing information about antibiotic-use rates and resistance in the community, (3) provide feedback about 
prescribing by practice, and (4) serve as a general resource on issues of antibiotic prescribing and resistance 
3 
4.1 Instruction on how to perform the behavior 4. Shaping knowledge Academic detailing to promote appropriate antibiotic use; practice guidelines which included with the patient profiles 
for adults with bronchitis and children with pharyngitis were compatible with those produced by the Centers for 
Disease Control and Prevention (CDC) 
15 
4.2 Information about Antecedents 4. Shaping knowledge Clinical practice guidelines for common respiratory illnesses 13 
5.1 Information about health consequences 5. Natural consequences a reference card providing easy-to-read facts about symptoms and treatments for ARIs 9 
5.2 Salience of consequences 5. Natural consequences Emphasis on AMR 2 
8.2 Behavior substitution 8. Repetition and substitution Prescription pads with explanations on symptoms and appropriate treatment options (to be given to patients instead 
of antibiotic prescriptions)  
9 
9.1 Credible source 9. Comparison of outcomes Endorsement by CDC was designed to increase the credibility of key messages. 1 
10.1 Material incentive (behavior) 10. Reward and threat An intervention intends to reward physicians for reducing pharmacy costs for their patients, one component of which 
was to increase their prescribing of generic drugs 
1 
10.2 Material reward (behavior) 10. Reward and threat Reward given to physicians for reducing pharmacy costs for their patients, one component of which was to increase 
their prescribing of generic drugs 
1 
12.1 Restructuring the physical environment 12. Antecedents Waiting room materials (CDC posters and patient reference cards) 4 
12.5 Adding objects to the environment 12. Antecedents Mass media strategies were undertaken including advertising using billboards, television, radio and magazines.  10 
14.2 Punishment 14. Scheduled consequences Regulations that require prescriptions for antibiotics to be retained and registered in pharmacies, and imposes fines 
to the owners of the pharmacies for non-compliance. 
2 
    
15 10  75 
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Appendix 1. Search Strategy  
Database Search Strategy Results 
 
PubMed 
(((((((((AMR[tiab] OR antimicrobial resistance[tiab] OR antimicrobial[tiab] OR antibiotic*[tiab] OR caesarean Section*[mesh] OR C section[tiab] OR 
Caesarean[tiab] OR topical corticosteroid OR prescription drug* OR Drug Utilization[Mesh] OR generic drugs[Mesh] OR Anti-Bacterial Agents/therapeutic 
use*[Mesh] OR Opiate[tiab] OR opioid[tiab]))) AND ((behavior and behavior mechanisms[Mesh] OR choice behavior[Mesh] OR health knowledge, attitudes, 
practice*[Mesh] OR usage[tiab] OR use[tiab] OR consum*[tiab] OR behavior*[tiab] OR behavior*[tiab]))) AND ((education[tiab] OR campaign*[tiab] OR patient 
education as topic/methods[Mesh] OR health communication[Mesh] OR health education[Mesh] OR health promotion/utilization*[Mesh] OR social media[Mesh] 
OR communication[Mesh] OR communication[tiab] OR intervention*[tiab] OR strateg*[tiab] OR program*[tiab] OR media[tiab] OR mass media[Mesh] OR 
initiat*[tiab]))) AND ((((evidence-based Practice*[Mesh] OR Epidemiologic Methods[Mesh] OR evaluat*[tiab] OR assess*[tiab] OR effect*[tiab] OR 
empirical*[tiab] OR evidence[tiab] OR Evaluation Studies as Topic[Mesh] OR Program Evaluation*[Mesh] OR Evaluation Studies[pt] OR Randomized Controlled 
Trial[pt]) OR impact[tiab]))))) NOT (((((((((((animals[MeSH Terms]) OR depression[MeSH Terms]) OR economics[MeSH Terms]) OR intensive care units[MeSH 
Terms]) OR practice guidelines as topic[MeSH Terms]) OR inpatients[MeSH Terms]) OR mental disorders[MeSH Terms]) OR bacterial genome[MeSH Terms]) 
OR ((surge*[Title/Abstract] OR addiction[Title/Abstract] OR inject*[Title/Abstract]))))  
1378 
EMBASE ('evidence-based'/exp OR 'evidence-based' OR 'evidence'/exp OR 'evidence' OR 'empirical' OR 'evaluat*':ab,ti OR 'assess*':ab,ti OR 'effect*':ab,ti) AND ('health 
education'/exp OR 'interpersonal communication'/exp OR 'intervention study'/exp OR 'behavior'/exp OR 'awareness'/exp OR 'health promotion'/exp OR 'patient 
education'/exp OR 'social media'/exp OR 'attitude to health'/exp OR 'health communication'/exp OR 'campaign*':ab,ti OR 'strateg*':ab,ti) AND (('misuse':ab,ti OR 
'overuse':ab,ti OR 'drug abuse':ab,ti) AND ('antibiotic agent'/exp OR 'antibiotic*':ab,ti OR 'opioid':ab,ti OR 'caesarean section':ab,ti OR 'topical corticosteroid':ab,ti 
OR 'prescription drug'/exp OR 'drug utilization'/exp) OR 'generic drug':ab,ti) NOT [animals]/lim NOT [medline]/lim AND [1-1-1900]/sd NOT [1-6-2019]/sd 
1110 
PsycINFO ( ((((((MA evidence-based Practice* OR MA Epidemiologic Methods OR AB evaluat* OR AB assess* OR AB effect* OR AB empirical* OR AB evidence))) 
AND ((AB education OR AB campaign* OR MA patient education as topic/methods OR MA health communication OR MA health education OR health policy OR 
MA health promotion/ utilization* OR MA social media/ utilization OR MA  communication OR AB communication OR intervention* OR strateg* OR program* 
OR MA access to information OR AB media OR MA mass media OR AB initiat*))) AND ((MA behavior and behavior mechanisms OR MA choice behavior OR 
MA health knowledge, attitudes, practice* OR AB usage OR AB use OR AB consum* OR AB behavior* OR AB behavior* OR AB "practice*"))) AND ((misuse 
OR overuse) AND (AB AMR OR AB antimicrobial resistance OR AB antibiotic*) OR MA caesarean Section* OR AB C section OR AB Caesarean OR AB topical 
corticosteroid OR AB prescription drug* OR MA Drug Utilization OR MA generic drugs OR MA anti-bacterial agents/therapeutic use* OR AB Opiate OR AB 
opioid))) NOT ((animal* OR AB surgery OR AB  Surgical OR AB dental OR AB cancer* OR AB Chronic obstructive pulmonary disease OR AB COPD OR AB 
alcohol OR AB tobacco OR AB addiction OR AB depression OR AB disorder* OR AB adherence OR AB diabet* OR MA Inpatients* OR AB inpatient* OR MA 
Hospitals OR AB tertiary OR AB HIV OR AB tuberculosis  OR MA Practice Guidelines as Topic OR emergency[ti] OR ED[tiab] OR MA Intensive Care Units OR 
MA Practice Patterns, Physicians’ OR MA Economics OR AB steward* OR AB analgesic* OR MA Hospitalization OR MA Health Care Facilities OR MA Health 
Care Facilities OR MA Patient Care Management)) NOT PO animal )  NOT Direct-to-consumer NOT AB inject 
1557 
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Appendix 2. Inclusion and exclusion criteria  
  
 Inclusion criteria Exclusion criteria 
Type of 
inappropriate or 
unnecessary use 
of medical 
services or 
medicine 
antibiotic use 
elective caesarean section 
nonmedical use of 
prescription drugs 
demand for brand-named 
drugs 
other types of inappropriate or 
unnecessary use of medical 
services or medicine 
interventions based solely in clinical settings and relying on 
clinicians’ participation 
 
Language  All  none  
Time period  inception of databases to May 
2019  
none  
Population  general public  
children (age < 18 years) 
pregnant women 
 
clinicians and other healthcare staff  
animal 
Intervention  Non-clinical interventions that 
aim to change behaviors for 
the reduction of inappropriate 
medical services or medicine 
use on demand side, and were 
assessed with robust 
evaluation data   
interventions that pertain to: 
behaviors of clinician, pharmacists, or prescribers 
treatments for impatient 
treatments for emergency services 
clinical guidelines 
stewardship programs targeting clinicians or providers 
dental setting 
cancer treatment 
addiction 
mental health 
tuberculosis 
clinical treatment 
HIV treatment 
direct-to-consumer advertisement 
alcohol or tobacco use 
substance abuse 
Outcome  Reduction in: antibiotic use, 
the public’s antibiotic-related 
behavior, or other types of 
inappropriate/unnecessary 
medical services or medicine 
use 
outcomes that were not changes in consumption or behaviors  
outcomes that mainly focused on knowledge or attitudes, but not on 
behaviors. 
Study Design  Randomized controlled trial 
(RCT) 
Cluster randomized controlled 
trial (CRT) 
Nonrandomised controlled 
trial (NCT) 
quasi-experiments: interrupted 
time series (with at least three 
data points before and three 
after the intervention) and  
controlled before-and-after 
studies 
editorials or commentaries 
modelling 
study protocols 
reviews or literature reviews 
descriptive studies 
observational studies without evaluation data 
studies reported evaluation data but did not employ a control group 
and/or report baseline data  
Time series analysis that do not have a clearly defined point in time 
when the intervention occurred and at least three 
data points before and three after the intervention 
cost analysis or cost-effective analysis without behavioral data 
economy evaluation 
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Appendix 3. List of included studies 
1. Belongia EA, Knobloch MJ, Kieke BA, Davis JP, Janette C, Besser RE. 
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managed care 2013; 19(9): e314-31. 
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taught program. Health Educ Res 2008; 23(1): 146-57. 
6. Eden KB, Perrin NA, Vesco KK, Guise JM. A randomized comparative trial 
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7. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in 
children: a randomized trial in 12 practices. Pediatrics 2001; 108(1): 1-7. 
8. Finkelstein JA, Huang SS, Kleinman K, et al. Impact of a 16-community trial 
to promote judicious antibiotic use in Massachusetts. Pediatrics 2008; 121(1): e15-
23. 
183 | P a g e  
 
9. Formoso G, Paltrinieri B, Marata AM, et al. Feasibility and effectiveness of a 
low cost campaign on antibiotic prescribing in Italy: community level, controlled, 
non-randomised trial. Bmj 2013; 347: f5391. 
10. Fraser W, Maunsell E, Hodnett E, Moutquin JM. Randomized controlled trial 
of a prenatal vaginal birth after cesarean section education and support program. 
Childbirth Alternatives Post-Cesarean Study Group. American journal of obstetrics 
and gynecology 1997; 176(2): 419-25. 
11. Fuertes EI, Henry B, Marra F, Wong H, Patrick DM. Trends in antibiotic 
utilization in Vancouver associated with a community education program on 
antibiotic use. Canadian journal of public health = Revue canadienne de sante 
publique 2010; 101(4): 304-8. 
12. Gonzales R, Corbett KK, Leeman-Castillo BA, et al. The "minimizing 
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Appendix 4. Summary of quality assessment of included studies 
 Selection Bias Study Design Confounders Blinding Data Collection Methods 
Withdrawal and 
Drop-outs Overall Rating 
Belongia, 2001 Weak Moderate Moderate Weak Strong Weak WEAK 
Belongia, 2005 Weak Moderate Moderate Moderate Strong Strong MODERATE 
Bernier, 2014 Strong Moderate Moderate Moderate Moderate Moderate STRONG 
Cebotarenco, 2008 Moderate Weak Moderate Weak Weak Weak WEAK 
Finkelstein, 2001 Moderate Strong Strong Moderate Strong Strong STRONG 
Finkelstein, 2008 Moderate Strong Strong Moderate Strong Strong STRONG 
Formoso, 2013 Moderate Strong Moderate Moderate Strong Strong STRONG 
Fuertes, 2010 Strong Moderate Moderate Moderate Moderate Moderate STRONG 
Gonzales, 2004 Weak Moderate Moderate Moderate Strong Strong MODERATE 
Gonzales, 2005 Weak Moderate Moderate Moderate Strong Strong MODERATE 
Gonzales, 2008 Moderate Strong Strong Moderate Strong Strong STRONG 
Hennessy, 2002 Moderate Strong Weak Moderate Strong Strong MODERATE 
Kliemann, 2016 Strong Moderate Weak Moderate Strong Strong MODERATE 
Lambert, 2007 Moderate Weak Weak Moderate Moderate Weak WEAK 
Lee, 2017 Weak Strong Weak Weak Moderate Strong WEAK 
Mainous, 2009 Weak Weak Moderate Weak Weak Weak WEAK 
McNulty, 2010 Moderate Weak Weak Weak Weak Moderate WEAK 
Perz, 2002 Moderate Moderate Weak Moderate Strong Strong MODERATE 
Sabuncu, 2009 Strong Moderate Moderate Moderate Moderate Moderate STRONG 
Santa-Ana-Tellez, 
2013 Strong Moderate Moderate Moderate Moderate Moderate STRONG 
Santa-Ana-Tellez, 
2015 Strong Moderate Moderate Moderate Moderate Moderate STRONG 
Taylor, 2005 Weak Weak Weak Moderate Strong Strong WEAK 
Trepka, 2001 Weak Moderate Moderate Weak Weak Weak WEAK 
Wirtz, 2013 Strong Moderate Weak Moderate Strong Strong MODERATE 
Wutzke, 2007 Strong Moderate Weak Moderate Moderate Moderate MODERATE 
Beshears, 2013 Moderate  Moderate  Weak Moderate Strong Strong MODERATE 
O'Malley, 2006 Moderate  Weak Strong Moderate Strong Strong MODERATE 
Sedjo, 2009 Moderate  Moderate Weak Moderate Strong Strong MODERATE 
Vallès, 2003 Moderate  Moderate Strong Moderate Strong Strong STRONG 
Hasak 2018 Weak Weak Weak Weak Weak Moderate WEAK 
Lawrence, 2019 Moderate Strong Moderate Weak Moderate Strong MODERATE 
Maughan, 2016 Weak Moderate Weak Weak Weak Strong WEAK 
Rose, 2016 Weak Weak Weak Weak Weak Moderate WEAK 
Spoth, 2008 Moderate Moderate Moderate Weak Moderate Weak WEAK 
Spoth, 2013 Moderate Moderate Moderate Weak Moderate Weak WEAK 
Eden, 2014 Weak Moderate Weak Moderate Strong Moderate WEAK 
Fraser, 1997 Weak Moderate Weak Moderate Strong Strong WEAK 
Hassani, 2016 Weak Weak Weak Weak Moderate Strong WEAK 
Montgomery, 2007 Moderate Moderate Moderate Moderate Strong Strong STRONG 
Navaee, 2015 Weak Moderate Weak Moderate Weak Strong WEAK 
Sharifirad, 2013 Weak Moderate Weak Weak Weak Strong WEAK 
Shorten, 2005 Weak Moderate Weak Moderate Strong Moderate WEAK 
Valiani, 2014 Weak Moderate Weak Weak Weak Strong WEAK 
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CHAPTER FOUR 
Contextualizing prevalent antibiotic misuse in children across 
China: a large-scale cross-sectional survey on parents’ antibiotic use 
for common childhood illnesses in children 
In this chapter, I report on secondary data analysis of a large-scale survey on 
antibiotic use for self-limiting illnesses among children under 13 across three 
provinces of different geographic regions and economic development stages in 
China. Data were collected from June 2017 to April 2018 by Zhejiang University. 
Institute of Social Medicine and Family Medicine. 
I conducted the analysis plan design and analysis independently. The findings and 
results have been prepared as a draft of the manuscript, with comments on drafts 
from Professors James Hargreaves, Stephan Harbarth, Elizabeth Fearon, Xiaomin 
Wang, and Xudong Zhou. This manuscript has been submitted to the Journal of 
Emerging Infectious Diseases for publication consideration.  
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Contextualizing prevalent antibiotic misuse in children across China: a large-
scale cross-sectional survey on parents’ antibiotic use on children for common 
childhood illnesses 
SYNOPSIS 
This study investigates antibiotic misuse behaviours among Chinese parents for their 
children. 9,526 parents of children (aged 0-13) across three Chinese provinces 
representing different geographical areas and economic development stages were 
surveyed. Antibiotic misuse was prevalent despite high levels of  awareness of 
antimicrobial-resistance. 31.9% of children with self-limiting illnesses were self-
medicated with antibiotics, with 70% of these antibiotics obtained from community 
pharmacies. Among children seeking care, 25.1% were administered antibiotics at 
home and 53.4% received antibiotic prescriptions, including 11.2% from parental 
demands. Parents with misconceptions about antibiotic efficacy and grandparents’ 
input in child-care decisions were associated with antibiotic misuse in children. 
48.1% of parents stored antibiotics at home leading to a higher likelihood of self-
medication (aOR=4.98) while parental demands contributed to inappropriate 
prescriptions (aOR=3.43). The demand-side accounted for 40% of antibiotic use for 
childhood self-limiting illnesses. Context-appropriate multifaceted interventions are 
needed to improve antibiotic use for children.  
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INTRODUCTION  
 China, which accounts for half of global antibiotic consumption, has 
reportedly high rates of antibiotic misuse and antimicrobial resistance (AMR) 31,40, 
especially among Chinese children.257,258 Parental knowledge and attitudes about 
common – and mostly self-limiting – childhood illnesses, such as the common cold 
and diarrhea, often lead parents to incorrectly conclude that antibiotics are 
necessary.34,60,62,132,257,259-263 In a collective society like China that has experienced 
decades of one-child policy, childcare is the focus of not only parents, but extended 
family. Parents’ antibiotic use for their children is influenced by multifaceted and 
interactive effects of personal and socio-environmental factors. A socio-ecological 
perspective77,98 is needed to unpack this issue. To date, most interventions in China 
have been directed towards the supply-side of the healthcare system - prescribers and 
pharmacists - aimed at curbing over-prescribing, while demand-side factors such as 
inappropriate administration of antibiotics to children by parents or caregivers have 
barely been addressed. Few studies have been done to understand Chinese parental 
antibiotic use on children and available evidence is limited in scope to small-scale 
data in one geographic area, none of which considers the larger Chinese socio-
cultural environment.34,60,62,257,261-263  
This study aimed to (a) investigate antibiotic use for common childhood 
illnesses by parents across different geographical areas and economic development 
stages, (b) assess parental knowledge levels on antibiotic use and resistance for 
common childhood illnesses, (c) identify personal and socio-environmental factors 
of antibiotic misuse in children, and (d) estimate the impact of demand-side pressure 
for antibiotics on prescribing behaviours and the demand-side contribution to the 
overall use of antibiotics in Chinese children.  
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METHODS 
Sites and population: This study used a cross-sectional survey, recruiting 
parents with children aged 0-13 years across three purposefully-selected Chinese 
provinces, between June 2017 and April 2018. China has 34 provinces, cities, and 
autonomous regions with wide regional inequality. We purposefully selected 
Zhejiang (East, ranked 5th in the 2017 provincial GDP ranking of economic 
development), Shaanxi (Central-Northwest, ranked 12th), and Guangxi (Southwest, 
ranked 26th) provinces.264 The survey was administered to the parent identified as the 
primary person responsible for decision-making for the child.  
Sampling: Parents were identified and recruited through their children. We 
anticipated the prevalence of common childhood illnesses within the last month to be 
35% among young children. To ensure an adequate sample size for the planned 
subgroup analyses, the team aimed to achieve a valid sample size per province of ca. 
3000 parents (i.e. 1500 per urban and rural area). Sample selection is stratified by 
urbanicity of residence (i.e. urban and rural) and by children’s age groups (0-2, 3-5, 
and 6-13). Multistage stratified random cluster sampling was conducted in four 
stages, specifically provinces, prefecture-level cities, urban and rural areas, and 
lastly local sampling sites: primary schools (age 6-13), kindergartens (age 3-5), and 
community-based health centers (age 0-2, with a vaccination rate of 90% or 
higher265). Every prefecture-level city, its urban/rural areas, and the local sampling 
sites in the selected provinces had an equal chance of selection.  
Questionnaire: This study used a systematically developed structured 
questionnaire. Questions were tailored to the Chinese sociocultural context, as 
informed by review of existing literature 62,261,266,267 and formative, qualitative 
interviews with stakeholders and experts. The questionnaire was comprised of four 
sections: 1) parental socio-demographic information, 2) antibiotics-related 
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knowledge, 3) last episode of illnesses and symptoms experienced by the child, and 
4) treatment and care-seeking behaviours for their child’s illness, including the 
chemical or brand names of antibiotics obtained from clinics and retail pharmacies. 
Before the formal survey, we conducted a pilot study with 315 respondents to 
validate the questionnaire and to evaluate potential sources of response error and 
improve the instrument. The reliability and validity fit the requirements. 
Data collection: The survey was developed using Wen Juan Xing (Chinese 
equivalent of Survey Monkey) – a popular web-based platform for professional 
electronic questionnaire design and data collection – and delivered via WeChat, 
China's most-used communication application. With assistance from administrators 
at the schools and health centers, parents were recruited via paper or face-to-face 
invitations with informed consent. Participants could complete the questionnaire by 
scanning a QR code via a mobile device or accessing it directly online. Paper copies 
were provided if preferred. To avoid survey fatigue, the survey took no more than 
ten minutes. For data quality control, measures (e.g. trap questions and IP address 
control) were in place to detect random responses or duplications. A consent form 
was presented at the first section of the questionnaire that was signed by all 
participants. Participants were informed that participation was confidential, 
voluntary, and could be terminated at any time. 
2.4 Main outcomes and exposures:  
Behaviour outcomes: for the purpose of this study, unsupervised, non-
prescription use of antibiotics for self-limiting illnesses was considered as antibiotic 
misuse.268 Four types of antibiotic misuse were measured: keeping antibiotics at 
home for children, giving children antibiotics prophylactically, self-medication with 
non-prescription antibiotics, and asking/pressuring doctors for antibiotics if not 
initially prescribed. 
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Exposures: Four individual-level personal and socio-environmental factors 
were included: age of children, parents’ antibiotic-related knowledge, grandparents’ 
involvement in treatment decisions, and health facilities used for care.  
2.5 Statistical analysis  
We first presented the descriptive analysis on key exposures and antibiotic 
misuse in children for common childhood illnesses across three Chinese provinces. 
Levels of parents’ antibiotic-related knowledge were measured in three domains – 
AMR awareness, misconceptions around antibiotic efficacy, and the ability to 
identify antibiotics). Scores for AMR awareness and antibiotic ability to identify 
antibiotics were created by adding the number of correct answers whereas scores for 
misconceptions were calculated by adding incorrect answers. A score of 0-1 was 
categorized as a low level, 2-3 medium, and 4 or above high. The internal 
consistency of the instrument was measured using Cronbach’s alpha.  
Unadjusted, univariate analyses were conducted to examine the associations 
between exposures and antibiotic misuse behaviours. Multivariable logistic 
regression and likelihood ratio tests were employed for adjusted analyses, 
controlling for socio-demographic variables and perceived severity of the illness 
(measured by number of symptoms expressed). The total percentage of missing 
values was low (< 11%)—these values were missing completely at random and 
therefore participants with missing data were excluded from final analyses according 
to the diagnostic results. Analyses were performed with STATA v.13.0. 
 
RESULTS  
3.1 Sample characteristics (Figure 1 and Table 1) 
A total of 9,526 parents completed and returned a valid survey, with a 
response rate of 89%. The sex ratio of the children represented was 108:100, male vs 
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female; 44.7% were from a rural area, and 48.8% were only-children. The mean and 
standard deviation age was 5.8±3.6years. 69.7% of the parents surveyed reported 
that grandparents were involved in the care decisions for their children. Among the 
respondents, approximately 37.6% (n=3,579) self-reported that their children 
experienced a minor illness within a month, of whom 82.1% reported that it was a 
common cold, 47.7% sore throat, 31.0% fever, 12.5% diarrhea, and 3.3% otitis 
media with some overlap between symptoms. Profound regional differences were 
observed in parental socioeconomic composition, antibiotic use practices, and 
medical facilities used when children were ill.  
3.2 Antibiotics-related knowledge and misconceptions (Table 2) 
Respondents were assessed on their antibiotics-related knowledge. The 
overall Cronbach’s alpha including all items was 0.92, with subscales ranging from 
0.83-0.89. Three quarters of surveyed parents (72.5-78.5%) reported they were 
aware of the danger that overuse of antibiotics poses to the country. Yet, more than 
half (52.8%) had a high level of misconception. Less than 20% of parents correctly 
stated that antibiotics were not anti-inflammatory drugs and did not work for viruses. 
Although 62-64% knew that antibiotics are not appropriate for children with a cold, 
three out of five were unsure or wrongly stated that antibiotics might help expedite 
recovery or alleviate symptoms. Overall, a majority of parents had a high level of 
AMR awareness and ability to identify antibiotics (Table 1: n=5,832, 61.2% and 
n=5,137, 53.9%, respectively).  
3.3 Antibiotic misuse in Chinese children outside of clinical settings (Tables 3 
and 4) 
More than half of the participating parents who reported an illness in their 
child treated their children (54.3%, n=1,944); among them, 31.9% (n=621) self-
reported to have self-medicated with antibiotics (SMA). A majority of the antibiotics 
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for SMA came from a local pharmacy (57.0%) and one-third from a personal stock 
(33.3%), which mostly had come from leftover prescriptions (63.1%) and leftover 
purchases from a local pharmacy (35.3%) – in other words, community pharmacies 
accounted for roughly 70% of SMA for children. After adjusting for confounders, 
parents with higher scores in AMR awareness, ability to identify antibiotics and 
misconceptions about antibiotic efficacy were more likely to store antibiotics for 
their children’s use (aOR=1.48 95%CI 1.28-1.71, aOR=3.01, 95%CI 2.61-3.47 and 
aOR=1.86, 95%CI 1.62-2.12, respectively) and to administer antibiotics 
prophylactically (aOR=1.22 95%CI 1.02-1.44, aOR=1.48, 95%CI 1.26-1.75 and 
aOR=3.44 95%CI 2.82-4.18, respectively). Parents with high ability to identify 
antibiotics and misconceptions were also more likely to self-treat their children with 
antibiotics when children were ill (aOR=1.84, 95%CI 1.28-2.63 and aOR=4.55 
95%CI 3.21-6.46, respectively). When grandparents were involved in the childcare 
decisions, parents were more likely to keep antibiotics at home (aOR=1.21, 95%CI 
1.10-1.33) and give them to children prophylactically (aOR=1.24, 95%CI 1.10-
1.39). Those who kept antibiotics at home were more likely to give their children 
antibiotics for preventive use and when children were ill (aOR=3.28, 95%CI 2.69-
4.01 and aOR=4.98, 95%CI 3.85-6.43 - see Supplement Tables A and B).  
3.4 Determinants and results of healthcare-seeking (Table 5) 
In total, parents of 70% of children (n=2,478) who were ill in the past month 
sought care for their children. A majority of parents brought their child to the doctor 
when otitis media or fever was present (57.1% and 51.0%, respectively), and one in 
three were prompted by a runny/stuffed nose, a cough (30.8%), or a sore throat 
(34.9%). Before seeing a doctor, 16.5% (n=410) of children had already been 
medicated with antibiotics at home; moreover, among them, 15.4% of parents 
admitted to having then asked for more antibiotics at the facility. Among those who 
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sought care after SMA, 83.9% (n=344, p<0.0001) were prescribed with antibiotics 
and 17.2% (n= 59) were due to further parental demands with a success rate of 
93.7%. The majority of children whose parents pressured doctors for antibiotics 
were prescribed with infusion or a combination of infusion and oral antibiotics 
(51%, p<0.0001). Parents were found to be more likely to ask for antibiotics for their 
children in lower level hospitals than in tertiary hospitals. Parents with high levels of 
ability to identify antibiotics and misconceptions about antibiotic efficacy were more 
likely to receive antibiotic prescriptions (aOR=2.27, 95%CI 1.73-2.99 and 
aOR=2.03, 95%CI 1.56-2.66, respectively) and to ask doctors for antibiotics 
(aOR=2.38, 95%CI 1.38-4.10 and aOR=2.86, 95%CI 1.50-5.43, respectively), which 
led to a more than three-fold increase in being prescribed antibiotics (aOR=3.43, 
95%CI 2.34-5.03 – see Supplement Table C), all of which were deemed to be 
inappropriate prescriptions. 
Overall, 53.4% of children (n=1,323) for whom care was sought were 
prescribed antibiotics. The most commonly prescribed antibiotic classes were 
penicillins, macrolides, and cephalosporins – either alone or in combination. 
Differences emerge in antibiotic prescription rates by healthcare facilities used, 
ranging from 47.4% in tertiary hospitals to 56.0% in county hospitals. More than one 
in three children were administered intravenous antibiotics (injections/infusions) for 
self-limiting conditions, evenly across all developmental stages, and about half of 
those infusions were combined with oral antibiotics. As children grow older, parents 
became more likely to demand antibiotics. 
Our data showed that, out of the 3,579 Chinese children who had self-
limiting conditions in the prior month, 1639 (45.8%) had used antibiotics at least 
once; among them, 621 were self-administered nonprescription antibiotics while 
1323 obtained a prescription, with 148 of those deemed inappropriate due to patient 
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pressure. Therefore, we estimated the demand-side contributed 40% 
[(148+621)/(1323+621)] of antibiotic use on Chinese children for self-limiting 
illnesses, compared with 60% on the supply-side. Though some doctors’ 
prescriptions (supply-side) might be considered appropriate, all antibiotic demands 
and non-prescription uses from the demand-side were misuse. 
 
DISCUSSION  
Our findings demonstrate that the prevalence of antibiotic misuse in children 
is high across China. 31.9% of parents self-medicated their children with antibiotics 
when a common minor childhood ailment was presented. Of 2,478 children who 
sought care, 53.4% resulted in antibiotic prescriptions - a majority of which were for 
self-limiting illnesses and deemed inappropriate - and 25.1% had already received 
antibiotics at home before the visit. The high prevalence of antibiotic misuse in 
Chinese children is influenced by both parents’ misconception about antibiotic 
efficacy for minor ailments and their surrounding social (e.g. family dynamics), 
healthcare (e.g. prescribing practice and doctor-patient interactions) and political 
contexts (e.g. laws and enforcement). Contrary to a previous study stating antibiotics 
abuse in China is not driven by patients actively demanding antibiotics,56 here we 
quantified the impact of the demand-side pressure on pediatric outpatient antibiotic 
prescribing: parents who self-reported to have pressured for antibiotics were more 
likely to be prescribed with antibiotics than parents who did not. Chinese parents are 
responsible for the majority (40%) of antibiotic misuse on self-limiting childhood 
illnesses. Keeping antibiotics at home increases the odds of prevention use in 
children by three times and the odds of SMA when ill by five times. Consistent with 
other studies,45,60 non-prescription sales of antibiotics at Chinese community 
pharmacies were found to be prevalent in all sampled sites. We estimated retail 
201 | P a g e  
 
pharmacies accounted for 70% of SMA in children. Although the Chinese Ministry 
of Health (MOH) issued an antimicrobial stewardship policy in 2012 limiting 
outpatient prescriptions with antibiotics to 20% for county hospitals and above and 
30% for township hospitals, and the Chinese Food and Drug Administration (FDA) 
regulations have forbidden non-prescription sales at retail pharmacies since 
2004,269,270 the impact of these policies has evidently been limited.  
The strength of this study is that we focused on common childhood illnesses 
with access to prescriptions across all levels of the health system in China. This is 
the first large-scale study that shows Chinese parents’ knowledge, attitudes and 
practices of antibiotic use for children in their socio-cultural environmental context 
across different geographical areas and economic development stages, where 
antibiotic misuse was found in parents’ chronic drug use habits, pre-visit medication 
for children, and demand for antibiotic prescriptions during visits. We demonstrated 
how parental antibiotic use in children is influenced by a set of complex and 
interactive socio-ecological factors. We acknowledge several limitations in our 
study. First, this is a cross-sectional survey and therefore cannot establish causal 
conclusions and is subject to recall bias. However, we limited the healthcare-seeking 
behaviours to a month prior - though it required a larger sample size – which helped 
to reduce the potential for bias. Second, the antibiotic consumption was estimated by 
a snapshot survey and not by prescriptions or visits; therefore, the true magnitude of 
misuse in children may be well-underestimated because repeated visit and use data 
were not included. Given young children present up to ten times a year with acute 
respiratory infections,14,271 the situation of misuse is expected to be much more 
severe than presented here. Lastly, because the samples were clustered, the estimated 
standard errors used in significance tests may be biased. Specifically, the estimated 
standard errors might be under-estimated because the similarities between 
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individuals within clusters are greater than those among individuals in a random 
sample drawn from the population. As such, significance levels reported might have 
been over-reported or underreported. However, in our case, samples were drawn 
from three provinces of different development levels and then from the rural and 
urban areas within each province; the differences among these provinces and/or 
between rural and urban areas might be greater than those between individuals 
drawn from a random sample across the country. Variations at the provinces and/or 
urbanicity levels were accounted for in the analyses.  
Compared with the estimate regarding university students,45 parents appeared 
to be more cautious, but still drove 40% of antibiotic misuse in children. Overuse of 
medical care for self-limiting illnesses combined with a high prescription rate and 
the population size of the country drove the overall high antibiotic consumption in 
China. In our data, about 77.3% of children with common cold symptoms in the past 
month sought care, which was more than twice as many as those in UK (34-40%).272 
The possibility of receiving an antibacterial prescription for such symptoms was 
around 33% in UK,273,274 compared to 53% in our survey. As such, we estimated that 
an average Chinese child consumes more than three times the amount of antibiotics 
as their peers in UK or other European countries.273,275-277 The gap is even wider for 
Chinese children in infancy and early childhood, as they have higher usage of 
medical care than older children. This estimate is alarming considering it did not 
account for non-prescription use antibiotics in Chinese children. Our data indicates 
one in four Chinese children (n= 2,464, 25.9%) has self-medicated with antibiotics at 
least once in the past year - either for prevention use or treating minor ailments, 
which is 10 times higher than that of some European countries.275-277 The true 
magnitude of this problem is underestimated because repeated use was not included 
in the calculation. This estimate is consistent with a survey conducted in 1995 and 
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demonstrates that Chinese parental antibiotic misuse for their children has not 
improved over the past two decades.278 Such persistent, high levels of misuse should 
be understood through the lens of China’s socio-ecological context.279,280  
At the intrapersonal level, our data suggested the link between knowledge 
and behaviours is not straightforward, and may even at times appear counter-
intuitive. Previous studies also identified this predicament – despite having a high 
level of knowledge, a majority of people still expect to get antibiotic prescriptions 
for self-limiting illnesses.276,281 We found misconceptions about antibiotic efficacy 
played a more determining role in respect to actual antibiotic misuse behaviours than 
did other types of antibiotics-related knowledge, such as AMR awareness, which 
showed a limited impact on improving antibiotic use. Interventions which aim to 
correct these misconceptions might be more effective than a general AMR 
awareness campaign. This phenomenon might be explained by the “negative 
externality” associated with antibiotic use, where the parent focus is on the 
immediate alleviation of their own child’s illness with little regard for the burden 
this behaviour places on society in the long run.282 We also found that Chinese 
consumers often confused antibiotics for anti-inflammatory drugs, and were 
confused by their various types and efficacy, and by their chemical components, 
brand names and/or drug labels. Without adequate knowledge about care for 
illnesses and antibiotic efficacy, our data indicated that those with high ability to 
identify antibiotics might be more likely to seek out and misuse antibiotics. Studies 
have shown previous recommendations from a physician for similar symptoms and 
prior successful experiences with antibiotics could lead to higher use, including 
SMA.160,283,284 Therefore, reverse causality is also likely, where high usage of 
antibiotics led to higher  ability to identify antibiotics about the drugs. Operating in 
such a context, interventions that aim to increase AMR awareness and ability to 
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identify antibiotics alone but do not address local misconceptions might be 
counterproductive and may actually increase public demand for antibiotics. This 
paradox was also recently reported in the UK and Greece.276,285,286 To effectively 
reduce antibiotic misuse in China, interventions should aim to educate the public 
about antibiotic efficacy, care for childhood illnesses, and correct local 
misconceptions. 
Interpersonally, our data highlighted the importance of understanding how 
local culture influences healthcare decision making, including interactions with 
health care providers. Education interventions to improve children’s antibiotic use 
must also target families as a whole, especially grandparents. Contrary to a previous 
finding,56 we found that caregivers’ high expectations of antibiotics for symptom 
relief and recovery for their children, coupled with the peculiar doctor-patient 
relationship in China,287 may increase pressures (i.e. negative externality) on doctors 
to inappropriately overprescribe.35,160 This might be further fueled by a local belief 
shared among Chinese medical professionals and the public that antibiotics act as a 
panacea for most illnesses.31 Realigning such deep-rooted beliefs requires a 
multifaceted antibiotic stewardship program that both enhances prudent prescribing 
and improves doctor–patient communication. 
Finally, consistent with previous findings, Chinese county hospitals were 
found to have the highest antibiotic prescription rates36 and, similar to other 
countries, community pharmacies and leftovers are the most common sources of 
non-prescription antibiotics.60,288 This study identified an immediate need to 
strengthen policy interventions at a structural level to enforce the restrictions on non-
prescription sales and over-prescribing rates at lower level hospitals,270 to implement 
a dose-based antibiotic dispensing system, and to encourage safe disposal or take-
back of leftover antibiotics. Chinese parents were more careful with antibiotic use in 
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infants, but more likely to misuse antibiotics on older children. A preference for IV 
infusion for children is still prevalent among Chinese parents. This phenomenon is a 
product of Chinese hospitals' financial incentives, as well as the expectations of 
consumers for rapid recovery. It is also fueled by widespread accepting attitudes 
towards the use of needles in Chinese society,289 influenced by the concept of 
acupuncture - an ancient traditional Chinese medical treatment. Since 2012, many 
Chinese hospitals have made an effort to limit or stop outpatient infusion 
treatments,270 yet these regulations have not been adopted by most lower level 
hospitals and exclude pediatric patients. Furthermore, over-prescription in rural 
China may be due to deficits in diagnostic knowledge among providers;126 
improving their professional capacity is necessary.  
 
CONCLUSION 
This study has provided a comprehensive picture of overall antibiotic misuse 
in children and contextualized the underlying issues related to parents’ routine 
medication practices and attitudes towards childhood illnesses and antibiotic use, 
intertwined with inadequate government oversight on retail sales and clinicians' 
prescribing behaviours. Context-tailored interventions that aim to correct 
misconceptions about antibiotic efficacy should be taken as a priority; otherwise 
AMR awareness and ability to identify antibiotics will continue to be linked to 
antibiotic misuse. Demand-side factors played a critical role in children’s antibiotic 
misuse in China. Physicians’ prescribing behaviour was significantly influenced by 
parents’ expectations and demand of antibiotics. This study addressed a national 
priority in China and called for culturally grounded approaches to reducing AMR 
and antibiotic misuse, especially in children.   
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Table 1. Sample characteristics, by province (N=9526) 
 
Province Zhejiang   Shaanxi  Guangxi  Total 
Region, National GDP ranking East, 5th Central-Northwest, 12th Southwest, 26th  
n (%) 2,924 (30.69)  3,355 (35.22)  3,247 (34.09)  9526 (100%) 
 Urban Rural Urban Rural Urban Rural  
 1715 (58.65) 1209 (41.35) 1940 (57.82) 1415 (42.18) 1610 (49.58) 1637 (50.42)  
Sex of children        
Male 888 (51.78) 623 (51.53) 967 (49.85) 716 (50.60) 874 (54.29) 875 (53.45) 4,943 (51.89) 
Female 827 (48.22) 586 (48.47) 973 (50.15) 699 (49.40) 736 (45.71) 762 (46.55) 4,583 (48.11) 
Age of children        
0-2 Infancy  271 (15.80) 262 (21.67) 368 (18.97) 373 (26.36) 440 (27.33) 274 (16.74) 1,988 (20.87) 
3-8 early childhood  934 (54.46) 556 (45.99) 1056 (54.43) 724 (51.17) 847 (52.61) 830 (50.70) 4,947 (51.93) 
9-11 middle childhood  412 (24.02) 348 (28.78) 429 (22.11) 288 (20.35) 288 (17.89) 447 (27.31) 2,212 (23.22) 
12-13 adolescence  98 (5.71) 43 (3.56) 87 (4.48) 30 (2.12) 35 (2.17) 86 (5.25) 379 (3.98) 
Average household income 
(RMB, monthly) 
       
<=3,000 ($461) 28 (1.63) 95 (7.86) 296 (15.26) 457 (32.30) 283 (17.58) 943 (57.61) 2,102 (22.07) 
3,001-5,000 ($462-$769) 187 (10.90) 332 (27.46) 724 (37.32) 570 (40.28) 575 (35.71) 501 (30.60) 2,889 (30.33) 
5,001-10,000 ($770-$1538) 538 (31.37) 495 (40.94) 710 (36.60) 330 (23.32) 520 (32.30) 156 (9.53) 2,749 (28.86) 
>10,001 (>$1539) 962 (56.09) 287 (23.74) 210 (10.82) 58 (4.10) 232 (14.41) 37 (2.26) 1,786 (18.75) 
Parents’ education level        
Primary school or below 15 (0.87) 41 (3.39) 60 (3.09) 50 (3.53) 69 (4.29) 200 (12.22) 435 (4.57) 
Middle school 137 (7.99) 378 (31.27) 484 (24.95) 569 (40.21) 369 (22.92) 826 (50.46) 2,763 (29.00) 
High school 272 (15.86) 333 (27.54) 631 (32.53) 499 (35.27) 513 (31.86) 420 (25.66) 2,668 (28.01) 
College or above 1291 (75.28) 457 (37.80) 765 (39.43) 297 (20.99) 659 (40.93) 191 (11.67) 3,660 (38.42) 
Parents with medical 
background 
       
No 1484 (86.53) 1095 (90.57) 1651 (85.10) 1268 (89.61) 1394 (86.58) 1512 (92.36) 8,404 (88.22) 
Yes 231 (13.47) 114 (9.43) 289 (14.90) 147 (10.39) 216 (13.42) 125 (7.64) 1,122 (11.78) 
Severity        
Low (1 symptom) 190 (30.69) 122 (30.35) 282 (38.06) 229 (41.41) 244 (36.15) 210 (35.65) 1,277 (35.68) 
Medium (2 symptoms) 268 (43.30) 163 (40.55) 316 (42.65) 196 (35.44) 263 (38.96) 198 (33.62) 1,404 (39.23) 
High (3 or more symptoms) 161 (26.01) 117 (29.10) 143 (19.30) 128 (23.15) 168 (24.89) 181 (30.73) 898 (25.09) 
Type of primary caregiver        
Parents 1377 (80.29) 988 (81.72) 1640 (84.54) 1156 (81.70) 1327 (82.42) 1415 (86.44) 7,903 (82.96) 
Grandparents 332 (19.36) 216 (17.87) 284 (14.64) 244 (17.24) 269 (16.71) 200 (12.22) 1,545 (16.22) 
Other 6 (0.35) 5 (0.41) 16 (0.82) 15 (1.06) 14 (0.87) 22 (1.34) 78 (0.82) 
Antibiotics-related knowledge        
AMR Awareness         
Low  96 (5.60) 191 (15.80) 281 (14.48) 311 (21.98) 326 (20.25) 556 (33.96) 1,761 (18.49) 
Medium  225 (13.12) 252 (20.84) 411 (21.19) 360 (25.44) 343 (21.30) 342 (20.89) 1,933 (20.29) 
High  1394 (81.28) 766 (63.36) 1248 (64.33) 744 (52.58) 941 (58.45) 739 (45.14) 5,832 (61.22) 
Misconception        
Low  489 (28.51) 214 (17.70) 283 (14.59) 144 (10.18) 184 (11.43) 153 (9.35) 1,467 (15.40) 
Medium  645 (37.61) 404 (33.42) 573 (29.54) 403 (28.48) 571 (35.47) 429 (26.21) 3,025 (31.76) 
High  581 (33.88) 591 (48.88) 1084 (55.88) 868 (61.34) 855 (53.11) 1055 (44.45) 5,034 (52.84) 
Ability to identify antibiotics        
Low  138 (8.05) 217 (17.95) 320 (16.49) 371 (26.22) 324 (20.12) 506 (30.91) 1,876 (19.69) 
Medium  363 (21.17) 321 (26.55) 542 (27.94) 389 (27.49) 447 (27.76) 451 (27.55) 2,513 (26.38) 
High  1214 (70.79) 671 (55.50) 1078 (55.57) 655 (46.29) 839 (52.11) 680 (41.54) 5,137 (53.93) 
Grandparents’ involvement in 
treatment decisions 
       
No 513 (29.91) 338 (27.96) 649 (33.45) 438 (30.95) 491 (30.50) 453 (27.67) 2,882 (30.25) 
Yes 1202 (70.09) 871 (72.04) 1291 (66.55) 977 (69.05) 1119 (69.50) 1184 (72.33) 6,644 (69.75) 
Children who were reported 
to be ill in the past month 
       
No 1096 (63.91) 807 (66.75) 1199 (61.80) 862 (60.92) 935 (58.07) 1048 (64.02) 5947 (62.43) 
Yes 619 (36.09) 402 (33.25) 741 (38.20) 553 (39.08) 675 (41.93) 589 (35.98) 3579 (37.57) 
Healthcare delivery system 
used (Urban/Rural) 
       
Tertiary hospital 40 (9.59) 26 (8.70) 76 (15.26) 38 (9.48) 145 (30.98) 42 (10.63) 367 (14.81) 
Secondary/County hospital  327 (78.42) 151 (50.50) 162 (32.53) 159 (39.65) 114 (24.36) 144 (36.46) 1,057 (42.66) 
Community Health 
Centers/Township hospital  
47 (11.27) 120 (40.13) 157 (31.53) 111 (27.68) 131 (27.99) 153 (38.73) 719 (29.02) 
Private Clinics/Village 
clinics 
3 (0.72) 2 (0.67) 103 (20.68) 93 (23.19) 78 (16.67) 56 (14.18) 335 (13.52) 
Keep antibiotics at home for 
children 
       
No 867 (50.55) 724 (59.88) 772 (39.79) 633 (44.73) 958 (59.50) 992 (60.60) 4946 (51.92) 
Yes 848 (49.45) 485 (40.12) 1168 (60.21) 782 (55.27) 652 (40.50) 645 (39.40) 4580 (48.08) 
Giving children antibiotics 
prophylactically 
       
No 1447 (84.37) 988 (81.72) 1417 (73.04) 1014 (71.66) 1339 (83.17) 1338 (81.73) 7543 (79.18) 
Yes 268 (15.63) 221 (18.28) 523 (26.96) 401 (28.34) 271 (16.83) 299 (18.27) 1983 (20.82) 
Self-treated children with 
antibiotics when being ill 
       
No 282 (78.99) 172 (85.15) 240 (57.28) 159 (55.23) 270 (73.77) 200 (61.92) 1,323 (68.06) 
Yes 75 (21.01) 30 (14.85) 179 (42.72) 118 (44.77) 96 (26.23) 123 (38.08) 621 (31.94) 
Asked doctors for antibiotics        
No 385 (92.33) 275 (91.97) 457 (91.77) 381 (95.01) 443 (94.66) 351 (88.86) 2292 (92.49) 
Yes 32 (7.67) 24 (8.03) 41 (8.23) 20 (4.99) 25 (5.34) 44 (11.14) 186 (7.41) 
Prescribed with antibiotics        
No 177 (42.45) 188 (62.88) 207 (41.57) 183 (45.64) 217 (46.37) 183 (46.33) 1155 (46.61) 
Yes 240 (57.55) 111 (37.12) 291 (58.43) 218 (54.36) 251 (53.63) 212 (53.67) 1323 (53.39) 
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Table 2. Antibiotics-related knowledge among Chinese parents (N=9,526) 
 
 Yes No Don’t Know alpha Overall 
alpha 
AMR Awareness    0.89 0.92 
[Do you think the following statement is true (or not)?]      
The more frequently people use antibiotics, the harder it is to cure the bacteria infections 6,902 (72.45) 609 (6.39) 2,015 (21.15)   
Excessive use of antibiotics can lead to bacterial antibiotic resistance 7,475 (78.47) 267 (2.80) 1,784 (18.73)   
Excessive use of antibiotics is a serious problem in China 7,420 (77.89) 175 (1.84) 1,931 (20.27)   
Bacterial antibiotic resistance in China will become a serious problem 6,999 (73.47) 190 (1.99) 2,337 (24.53)   
Misconception    0.83  
[Do you think the following statement is true (or not)?]      
Antibiotics are anti-inflammatory drugs 5,764 (60.51) 1,824 (19.15) 1, 938 (20.34)   
Antibiotics are effective for children’s viral infections.  5,416 (56.85) 1,934 (20.30) 2,176 (22.84)   
Antibiotics is appropriate when your child has [Sore throat]   2,356 (24.73) 5,911 (62.05) 1,259 (13.22)   
Antibiotics is appropriate when your child has [Cold/Runny or stuffy nose]   2,210 (23.20) 6,186 (64.94) 1,130 (11.86)   
Using antibiotics can speed up your child’s cold recovery 3,547 (37.23) 4,062 (42.64) 1,917 (20.12)   
Using antibiotics can alleviate your child's cold symptoms 3,824 (40.14) 3,636 (38.17) 2,066 (21.69)   
Ability to recognise antibiotics    0.86  
[Do you think the following drug is an antibiotic (or not)?]      
Penicillin (amoxicillin) 7,103 (74.56) 897 (9.42) 1,526 (16.02)   
Cephalosporin (cefaclor, ceftriaxone sodium) 7,179 (75.36) 788 (8.27) 1,559 (16.37)   
Nonsteroidal anti-inflammatory drugs (ibuprofen, aspirin) 3,792 (39.81) 3,086 (32.40) 2,648 (27.80)   
Steroidal (Dexamethasone, Prednisone) 2,833 (29.74) 2,725 (28,61) 3,968 (41.65)   
Quinolones (norfloxacin, ofloxacin) 4,626 (48.56) 1,704 (17.89) 3,196 (33.55)   
Macrolides (azithromycin, roxithromycin) 6,234 (65.44) 831 (8.72) 2,461 (25.83)   
*Correct answers are in bold. 
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Table 3. Factors of habitual nonprescription antibiotic use on children among Chinese parents (N=9526) 
 
 N=9526 Keep antibiotics at home for children  (n=4,580, 48.08%) 
Giving children antibiotics prophylactically  
(n=1,983, 20.82%) 
 N (%) n (%) OR (95%CI) aOR (95%CI) p-valueb n (%) OR (95%CI) aOR (95%CI) p-valueb 
Individual Factors:          
Age of children     <0.0001    <0.001 
0-2 Infancy  1,988 (20.87) 717 (36.07) Reference Reference  349 (17.56) Reference Reference  
3-8 early childhood  4,947 (51.93) 2,669 (53.95) 2.08 (1.87-2.31) 1.86 (1.65-2.08)  1,075 (21.73) 1.30 (1.14-1.49) 1.31 (1.14-1.51)  
9-11 middle childhood  2,212 (23.22) 1,035 (46.79) 1.56 (1.38-1.76) 1.55 (1.36-1.78)  489 (22.11) 1.33 (1.14-1.55) 1.33 (1.13-1.56)  
12-13 adolescence  379 (3.98) 159 (41.95) 1.28 (1.02-1.60) 1.28 (1.01-1.63)  70 (18.47) 1.06 (0.80-1.41) 1.09 (0.81-1.46)  
Antibiotics-related 
Knowledge 
         
AMR Awareness      <0.0001    <0.0005 
Low  1,761 (18.49) 531 (30.15) Reference Reference  322 (18.29) Reference Reference  
Medium  1,933 (20.29) 912 (47.18) 2.07 (1.81-2.37) 1.30 (1.11-1.51)  476 (24.62) 1.46 (1.25-1.71) 1.36 (1.14-1.62)  
High  5,832 (61.22) 3,137 (53.79) 2.70 (2.41-3.02) 1.48 (1.28-1.71)  1,185 (20.32) 1.14 (0.99-1.31) 1.22 (1.02-1.44)  
Misconception     <0.0001    <0.0001 
Low  1,467 (15.40) 679 (46.28) Reference Reference  137 (9.34) Reference Reference  
Medium  3,025 (31.76) 1,446 (47.80) 1.06 (0.94-1.20) 1.32 (1.15-1.51)  546 (18.05) 2.14 (1.75-2.61) 2.08 (1.69-2.54)  
High  5,034 (52.84) 2,455 (48.77) 1.10 (0.98-1.24) 1.86 (1.62-2.12)  1,300 (25.82) 3.38 (2.80-4.07) 3.44 (2.82-4.18)  
Ability to identify antibiotics     <0.0001    <0.0001 
Low  1,876 (19.69) 487 (25.96) Reference Reference  325 (17.32) Reference Reference  
Medium  2,513 (26.38) 1,203 (47.87) 2.62 (2.30-2.98) 2.26 (1.95-2.61)  592 (23.56) 1.47 (1.26-1.71) 1.51 (1.28-1.79)  
High  5,137 (53.93) 2,890 (56.26) 3.67 (3.26-4.12) 3.01 (2.61-3.47)  1,066 (20.75) 1.25 (1.09-1.43) 1.48 (1.26-1.75)  
Interpersonal Factors          
Grandparents’ involvement 
in treatment decisions 
    0.0001    <0.0005 
No 2,882 (30.25) 1,305 (45.28) Reference Reference  525 (18.22) Reference Reference  
Yes 6,644 (69.75) 3,275 (49.29) 1.17 (1.08-1.28) 1.21 (1.10-1.33)  1,458 (21.94) 1.26 (1.13-1.41) 1.24 (1.10-1.39)  
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, parents’ education and medical background, primary carer, urban/rural residence, province, and household income. 
bLikelihood ratio test  
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Table 4. Factors of self-treated children with antibiotics who were ill in the past month (N=1944)  
 
 
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, perceived severity, parents’ education and medical background, primary carer, urban/rural residence, province, and household 
income. 
bLikelihood ratio test 
  
 N=1944 Self-treated children with antibiotics who were ill in the past month  (n= 621, 31.94%) 
 N (%) n (%) OR aOR (95%CI) p-valueb 
Individual Factors:      
Age of children     0.005 
0-2 Infancy  360 (18.52) 99 (27.50) Reference Reference  
3-8 early childhood  1,238 (63.68) 398 (32.15) 1.25 (0.96-1.62) 1.41 (1.06-1.87)  
9-11 middle childhood  310 (15.95) 119 (38.39) 1.64 (1.19-2.27) 1.51 (1.05-2.18)  
12-13 adolescence  36 (1.85) 5 (13.89) 0.43 (0.16-1.12) 0.42 (0.15-1.16)  
Antibiotics-related 
Knowledge 
     
AMR Awareness      0.15 
Low  223 (11.47) 72 (32.29) Reference Reference  
Medium  328 (16.87) 130 (39.63) 1.38 (0.96-1.97) 1.39 (0.93-2.08)  
High  1,393 (71.66) 419 (30.08) 0.90 (0.67-1.22) 1.09 (0.75-1.60)  
Misconception     <0.0001  
Low  344 (17.70) 52 (15.12) Reference Reference  
Medium  628 (32.30) 153 (24.36) 1.81 (1.28-2.56) 1.90 (1.32-2.74)  
High  972 (50.00) 416 (42.80) 4.20 (3.05-5.79) 4.25 (2.98-6.07)  
Ability to identify 
antibiotics 
    <0.005  
Low  249 (12.81) 70 (28.11) Reference Reference  
Medium  495 (25.46) 163 (32.93) 1.26 (0.90-1.75) 1.60 (1.10-2.32)  
High  1,200 (61.73) 388 (32.33) 1.22 (0.90-1.65) 1.91 (1.32-2.76)  
Interpersonal Factor:      
Grandparents’ involvement 
in treatment decisions 
    0.22 
No 524 (26.95) 181 (34.54) Reference Reference  
Yes 1420 (73.05) 440 (30.99) 0.85 (0.69-1.05) 0.86 (0.68-1.09)  
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Table 5. Factors of antibiotic prescriptions for children who were ill in the past month (N=2478) 
 N=2478 Prescribed with antibiotics (n= 1,323, 53.39%) 
Asked doctors for antibiotics 
(n=186, 12.19%) 
 N (%) n (%) OR aOR (95%CI) p-valueb n (%) OR aOR (95%CI) p-valueb 
Individual Factors:          
Age of children     <0.01     0.005 
0-2 Infancy  603 (24.33) 281 (46.60) Reference Reference  26 (4.31) Reference Reference  
3-8 early childhood  1,448 (58.43) 816 (56.35) 1.48 (1.22-1.79) 1.23 (0.99-1.52)  108 (7.46) 1.79 (1.15-2.77) 1.75 (1.10-2.79)  
9-11 middle childhood  371 (14.97) 206 (55.53) 1.43 (1.10-1.86) 1.16 (0.87-1.54)  46 (12.40) 3.14 (1.91-5.18) 2.53 (1.39-4.32)  
12-13 adolescence  56 (2.26) 20 (35.71) 0.64 (0.36-1.13) 0.49 (0.27-0.90)  6 (10.71) 2.66 (1.05-6.77) 2.53 (1.23-6.70)  
Antibiotics-related 
Knowledge 
         
AMR Awareness      0.01    0.01 
Low  402 (16.22) 161 (40.05) Reference Reference  34 (8.46) Reference Reference  
Medium  488 (19.69) 262 (53.69) 1.74 (1.33-2.27) 1.45 (1.08-1.95)  51 (10.45) 1.26 (0.80-1.99) 1.09 (0.66-1.81)  
High  1588 (64.08) 900 (56.68) 1.96 (1.57-2.45) 1.52 (1.15-2.03)  101 (6.36) 0.74 (0.49-1.10) 0.62 (0.37-1.02)  
Misconception     <0.0001    <0.0005 
Low  356 (14.37) 165 (46.35) Reference Reference  12 (3.37) Reference Reference  
Medium  783 (31.60) 401 (51.21) 1.22 (0.95-1.56) 1.39 (1.06-1.81)  44 (5.62) 1.71 (0.89-3.27) 1.64 (0.84-3.20)  
High  1339 (54.04) 757 (56.53) 1.51 (1.19-1.90) 2.03 (1.56-2.66)  130 (9.71) 3.08 (1.69-5.64) 2.86 (1.50-5.43)  
Ability to identify 
antibiotics 
    <0.0001    <0.005 
Low  447 (18.04) 170 (38.03) Reference Reference  24 (5.37) Reference Reference  
Medium  651 (26.27) 341 (52.38) 1.79 (1.40-2.29) 1.62 (1.24-2.13)  60 (9.22) 1.79 (1.10-2.92) 2.42 (1.42-4.13)  
High  1,380 (55.69) 812 (58.84) 2.33 (1.87-2.90) 2.27 (1.73-2.99)  102 (7.39) 1.41 (0.89-2.22) 2.38 (1.38-4.10)  
Interpersonal Factor:          
Grandparents’ 
involvement in treatment 
decisions 
    0.54    0.01 
No 690 (27.85) 375 (54.35) Reference Reference  40 (5.80) Reference Reference  
Yes 1788 (72.15) 948 (53.02) 0.95 (0.79-1.13) 0.94 (0.78-1.14)  146 (8.17) 1.44 (1.01-2.07) 1.61 (1.10-2.35)  
Structural Factor:         0.08 
Healthcare delivery 
system used 
(Urban/Rural) 
    <0.01     
Tertiary hospital 367 (14.81) 174 (47.41) Reference Reference  13 (3.54) Reference Reference  
Secondary/County 
hospital  
1,057 (42.66) 592 (56.01) 1.41 (1.11-1.79) 1.56 (1.20-2.03)  89 (8.42) 2.50 (1.38-4.54) 2.04 (1.09-3.80)  
Community Health 
Centers/Township 
hospital  
719 (29.02) 373 (51.88) 1.20 (0.93-1.54) 1.29 (0.98-1.70)  63 (8.76) 3.14 (1.42-4.82) 2.87 (0.99-3.54)  
Private Clinics/ Village 
clinics 
335 (13.52) 184 (54.93) 1.35 (1.00-1.82) 1.38 (1.00-1.92)  21 (6.27) 2.66 (0.90-3.70) 1.40 (0.67-2.95)  
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, perceived severity, parents’ education and medical background, primary carer, urban/rural residence, province, and household income. 
bLikelihood ratio test
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Figure 1. Antibiotic use on children by Chinese parents 
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Supplement Table A. Factors of prevention use of antibiotics on children among Chinese parents (N=9526) 
 N=9526 Giving children antibiotics prophylactically  (n=1,983, 20.82%) 
 N (%) n (%) OR (95%CI) aOR (95%CI) p-valueb 
Individual Factors:      
Age of children     0.49 
0-2 Infancy  1,988 (20.87) 349 (17.56) Reference Reference  
3-8 early childhood  4,947 (51.93) 1,075 (21.73) 1.30 (1.14-1.49) 0.93 (0.82-1.16)  
9-11 middle childhood  2,212 (23.22) 489 (22.11) 1.33 (1.14-1.55) 1.04 (2.69-4.01)  
12-13 adolescence  379 (3.98) 70 (18.47) 1.06 (0.80-1.41) 1.41 (0.78-2.54)  
Antibiotics-related Knowledge      
AMR Awareness      0.53 
Low  1,761 (18.49) 322 (18.29) Reference Reference  
Medium  1,933 (20.29) 476 (24.62) 1.46 (1.25-1.71) 1.20 (0.87-1.64)  
High  5,832 (61.22) 1,185 (20.32) 1.14 (0.99-1.31) 1.12 (0.83-1.51)  
Misconception     <0.0001 
Low  1,467 (15.40) 137 (9.34) Reference Reference  
Medium  3,025 (31.76) 546 (18.05) 2.14 (1.75-2.61) 1.91 (1.36-2.68)  
High  5,034 (52.84) 1,300 (25.82) 3.38 (2.80-4.07) 3.09 (2.22-4.30)  
Ability to identify antibiotics     0.78 
Low  1,876 (19.69) 325 (17.32) Reference Reference  
Medium  2,513 (26.38) 592 (23.56) 1.47 (1.26-1.71) 1.10 (0.82-1.47)  
High  5,137 (53.93) 1,066 (20.75) 1.25 (1.09-1.43) 1.03 (0.77-1.39)  
Interpersonal Factors      
Grandparents’ involvement in 
treatment decisions 
    <0.005 
No 2,882 (30.25) 525 (18.22) Reference Reference  
Yes 6,644 (69.75) 1,458 (21.94) 1.26 (1.13-1.41) 1.34 (1.09-1.66)  
Keeping antibiotics at home     <0.0001 
No 4946 (51.92) 595 (30.01) Reference Reference  
Yes 4580 (48.08) 1983 (20.82) 3.18 (2.86-3.54) 3.28 (2.69-4.01)  
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, perceived severity, parents’ education and medical background, primary carer, urban/rural residence, province, and household income. 
bLikelihood ratio test 
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Supplement Table B. Factors of self-treated children with antibiotics who were ill in the past month (N=1944)  
 
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, perceived severity, parents’ education and medical background, primary carer, urban/rural residence, province, and household income. 
bLikelihood ratio test 
 N=1944 Self-treated children with antibiotics who were ill in the past month  (n= 673, 34.60%) 
 N (%) n (%) OR aOR (95%CI) p-valueb 
Individual Factors:      
Age of children     0.06 
0-2 Infancy  360 (18.52) 99 (27.50) Reference Reference  
3-8 early childhood  1,238 (63.68) 398 (32.15) 1.25 (0.96-1.62) 1.25 (0.93-1.70)  
9-11 middle childhood  310 (15.95) 119 (38.39) 1.64 (1.19-2.27) 1.36 (0.92-2.00)  
12-13 adolescence  36 (1.85) 5 (13.89) 0.43 (0.16-1.12) 0.43 (0.15-1.24)  
Antibiotics-related 
Knowledge 
     
AMR Awareness      0.07 
Low  223 (11.47) 72 (32.29) Reference Reference  
Medium  328 (16.87) 130 (39.63) 1.38 (0.96-1.97) 1.44 (0.94-2.21)  
High  1,393 (71.66) 419 (30.08) 0.90 (0.67-1.22) 1.04 (0.69-1.55)  
Misconception     <0.0001  
Low  344 (17.70) 52 (15.12) Reference Reference  
Medium  628 (32.30) 153 (24.36) 1.81 (1.28-2.56) 1.83 (1.25-2.67)  
High  972 (50.00) 416 (42.80) 4.20 (3.05-5.79) 4.21 (2.90-6.09)  
Ability to identify 
antibiotics 
    0.11  
Low  249 (12.81) 70 (28.11) Reference Reference  
Medium  495 (25.46) 163 (32.93) 1.26 (0.90-1.75) 1.38 (0.93-2.05)  
High  1,200 (61.73) 388 (32.33) 1.22 (0.90-1.65) 1.51 (1.02-2.23)  
Interpersonal Factor:      
Grandparents’ involvement 
in treatment decisions 
    0.05 
No 524 (26.95) 181 (34.54) Reference Reference  
Yes 1420 (73.05) 440 (30.99) 0.85 (0.69-1.05) 0.78 (0.61-1.00)  
Keeping antibiotics at 
home 
    <0.0001 
No 769 (39.56) 108 (14.04) Reference Reference  
Yes 1175 (60.44 513 (82.61) 4.74 (3.75-5.99) 4.98 (3.85-6.43)  
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Supplement Table C. Factors of antibiotic prescriptions for children who were 
ill in the past month (N=2478) 
 N=2478 Prescribed with antibiotics (n= 1,323, 53.39%) 
 N (%) n (%) OR aOR (95%CI) p-valueb 
Individual Factors:      
Age of children     <0.01  
0-2 Infancy  603 (24.33) 281 (46.60) Reference Reference  
3-8 early childhood  1,448 (58.43) 816 (56.35) 1.48 (1.22-1.79) 1.23 (0.99-1.52)  
9-11 middle 
childhood  
371 (14.97) 206 (55.53) 1.43 (1.10-1.86) 1.16 (0.87-1.54)  
12-13 adolescence  56 (2.26) 20 (35.71) 0.64 (0.36-1.13) 0.49 (0.27-0.90)  
Antibiotics-related 
Knowledge 
     
AMR Awareness      <0.01 
Low  402 (16.22) 161 (40.05) Reference Reference  
Medium  488 (19.69) 262 (53.69) 1.74 (1.33-2.27) 1.36 (1.04-1.78)  
High  1588 (64.08) 900 (56.68) 1.96 (1.57-2.45) 1.92 (1.47-2.52)  
Misconception     <0.0001 
Low  356 (14.37) 165 (46.35) Reference Reference  
Medium  783 (31.60) 401 (51.21) 1.22 (0.95-1.56) 1.36 (1.04-1.78)  
High  1339 (54.04) 757 (56.53) 1.51 (1.19-1.90) 1.92 (1.47-2.52)  
Ability to identify 
antibiotics 
    <0.0001 
Low  447 (18.04) 170 (38.03) Reference Reference  
Medium  651 (26.27) 341 (52.38) 1.79 (1.40-2.29) 1.53 (1.16-2.02)  
High  1,380 (55.69) 812 (58.84) 2.33 (1.87-2.90) 2.15 (1.63-2.84)  
Interpersonal Factor:      
Grandparents’ 
involvement in 
treatment decisions 
    0.34 
No 690 (27.85) 375 (54.35) Reference Reference  
Yes 1788 (72.15) 948 (53.02) 0.95 (0.79-1.13) 0.91 (0.75-1.10)  
Structural Factor:      
Healthcare delivery 
system used 
(Urban/Rural) 
    0.02 
Tertiary hospital 367 (14.81) 174 (47.41) Reference Reference  
Secondary/County 
hospital  
1,057 (42.66) 592 (56.01) 1.41 (1.11-1.79) 1.51 (1.16-1.96)  
Community Health 
Centers/Township 
hospital  
719 (29.02) 373 (51.88) 1.20 (0.93-1.54) 1.25 (0.95-1.65)  
Private Clinics/ 
Village clinics 
335 (13.52) 184 (54.93) 1.35 (1.00-1.82) 1.37 (0.99-1.90)  
Pressure for antibiotic 
prescriptions 
    <0.0001 
No 2,292 (92.49) 1,175 (88.81) 3.70 (2.57-5.34) Reference  
Yes 186 (7.51) 148 (11.19) 1.05 (0.97-1.14)  3.43 (2.34-5.04)  
OR, odds ratio; CI, confidence interval.  
aAdjusted for children’s sex, perceived severity, parents’ education and medical background, primary 
carer, urban/rural residence, province, and household income. 
bLikelihood ratio test 
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CHAPTER FIVE 
Large-scale survey of parental antibiotic use for paediatric upper 
respiratory tract infections in China: implications for stewardship 
programmes and national policy  
In this chapter, I report on secondary data analysis of a large-scale survey on 
treatment decisions with respect to antibiotic use for upper respiratory tract 
infections among children across three provinces of different geographic regions and 
economic development stages in China. Data were collected from June 2017 to April 
2018 by Zhejiang University. Institute of Social Medicine and Family Medicine. 
(See Appendix I: Letter of Support.) 
I conducted the analysis plan design and analysis independently with close 
collaboration with Senior Lecturer, Leah Li at the University College London 
Institute of Child Health. The findings and results have been prepared as a draft of 
the manuscript, with comments on drafts from Professors Stephan Harbarth, James 
Hargreaves, Xudong Zhou, and Leah Li. This manuscript has been submitted to the 
International Journal of Antimicrobial Agents for publication consideration.  
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Large-scale survey of parental antibiotic use for paediatric upper respiratory tract 
infections in China: implications for stewardship programmes and national policy 
SYNOPSIS 
BACKGROUND Inappropriate use of antibiotics for upper respiratory tract infections 
among Chinese children is rampant. To identify key constructs for effective 
interventions targeting the public, we investigated parents’ decision-making processes 
with respect to treatment choices and antibiotic use for paediatric URTIs. 
METHODS Data were collected between June 2017-April 2018 from a cluster random 
sample of 3,188 parents of children aged 0-13 across three purposefully-selected 
Chinese provinces, representing different stages of economic development. Risk factors 
of parents’ treatment choices and antibiotic use for paediatric URTIs were assessed, 
using binary and multinomial logistic regressions, adjusting for socio-demographic 
characteristics.  
RESULTS Of the 3,188 parents who self-diagnosed their children with a URTI, 46.0% 
children were given antibiotics, with or without prescription (n=1465). Among these 
children, 40.5% were self-medicated with non-prescription antibiotics by parents and 
56.1% obtained further antibiotic prescriptions at healthcare facilities. About 70% of 
children with URTI symptoms sought healthcare (n=2197); of them, 54.8% obtained 
antibiotic prescriptions and 7.7% asked for antibiotic prescriptions with a 79.4% success 
rate to obtain them. Those perceiving antibiotics as effective for treating common cold 
and fever (aOR=1.82[1.51-2.19] and 1.77[1.47-2.13], respectively), who had access to 
non-prescription antibiotics (aOR=5.08[4.03-6.39]), and with greater perceived severity 
of infection (aOR=2.01[1.58-2.56]), were more likely to use antibiotics for paediatric 
URTIs.   
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CONCLUSIONS Context-appropriate multifaceted interventions are vital to untangle 
the perpetual problem of self-medication, over-prescription and ill-informed demands 
for antibiotics. Our findings emphasize the need to prioritise interventions enhancing 
clinical training, neutralising the pressure from patients for antibiotics, educating on 
appropriate home care, discouraging antibiotic self-medication, and improving antibiotic 
dispensing.  
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INTRODUCTION 
Acute, uncomplicated upper respiratory tract infections (URTIs) – often benign, 
self‐limiting, and untreatable by antibiotics - are diagnosed on symptomatology and 
treatments are mainly symptomatic rather than focusing on changes in viral titres in the 
airway or viral shedding.14  Considered the most common infectious disease among 
humans, URTIs are the most common cause of primary care visits and unnecessary use 
of antibiotics for children around the world, especially in China,31,37,257 which has 
contributed to the rise of antimicrobial resistance (AMR), an imminent global health 
threat. Antibiotic-resistant pathogens, such as streptococcus pneumonia, have been 
reported in children across China.259,290 Antibiotic treatment changes gut microbiota and 
adversely impacts the development of the immune system, making it difficult for 
children to recover from repeated antibiotic exposure.291,292 Given the long-term 
consequences on human development and that children may experience URTIs seven to 
ten times on average annually,14 misuse of antibiotics in children is particular harmful. 
Nevertheless, 48.2% of urban parents60 and 62% of rural parents65 in China reported to 
have self-medicated children with antibiotics outside of clinical settings within the last 
six months.  
Understanding the underlying reasons that drive the parental decision to use 
antibiotics for paediatric URTIs without professional guidance is important for 
developing strategies to reduce antibiotic misuse. To date, most public-targeted health 
behaviour research and interventions on antibiotic use have centred on knowledge-
attitudes-practice (KAP), with the underlying assumption that individuals would make 
more risk-conscious choices if informed of the risks of AMR – an approach has long 
been criticised for its overemphasis on personal responsibility.293 When faced with an 
221 | P a g e  
acute infection in themselves or a loved one, individuals may disproportionately focus 
on the immediate outcome of curing the illness (i.e. perceived antibiotic efficacy), and 
discount long term risks such as AMR.148 As such, parents’ decision-making for treating 
URTIs might not be as rational or informed as a KAP approach would assume. To 
develop effective interventions to reduce unnecessary or inappropriate use of antibiotics 
for paediatric URTIs in the Chinese community, evidence is needed on parents’ 
decision-making for care and how these decisions influence antibiotic use within or 
outside of clinical settings. Here, for children with self-diagnosed URTI symptoms, we 
investigated the extent and risk factors associated with the likelihood of (1) self-
medication with non-prescription antibiotics by parents; (2) healthcare seeking; (3) 
parental requesting for antibiotics and unnecessary prescriptions by healthcare 
providers.  
 
METHODS 
Study population We used data from a survey of parents with children aged 0-13 years 
between June 2017 and April 2018. Three Chinese provinces, which represent different 
geographical areas and stages of economic development, 264 were chosen. These 
included Zhejiang (East, ranked 5th out of 31 in the 2017 provincial GDP ranking of 
economic development), Shaanxi (Central-Northwest, ranked 12th), and Guangxi 
(Southwest, ranked 26th) provinces. A multistage stage random clustering sampling 
design was applied. The four-stage sampling units are provinces, prefecture-level cities, 
urban and rural areas, and local sites: primary schools (age 6-13), kindergartens (age 3-
5) and community health centres (age 0-2), where most children received vaccination.265 
Parents were identified and recruited through their children from all selected sites. They 
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were asked to complete a structured questionnaire, which was tailored to the Chinese 
sociocultural context informed by literature review45,62,65 and formative/qualitative 
interviews with stakeholders and experts. The questionnaire was comprised of four 
sections: 1) parental socio-demographic information, 2) healthcare- and antibiotic-
related knowledge and perceptions, 3) last episode of URTI symptoms experienced by 
the child within the past month, and 4) treatment and parental care-seeking process and 
behaviours for the child’s illness (i.e. the chemical or brand names of antibiotics 
obtained from clinics and retail pharmacies). To minimise the burden for the parents and 
ensure high quality of the response data, the survey was designed to take no more than 
10 minutes and an IP address control was put in place to detect random responses or 
duplications. Parents could complete the questionnaire on a mobile device, online, or 
using a paper version and they were informed that participation was confidential, 
voluntary and could be terminated at any time. A consent form was presented in the first 
section of the questionnaire and was signed by the participants. To validate the 
questionnaire, we conducted a pilot study with 315 respondents to evaluate potential 
sources of response error and improve the instrument. The questionnaire was completed 
by 9,526 parents, with a response rate of 89%. Of those, 33.5% (n=3,188) reported that 
their children had experienced symptoms of a URTI within a month prior to the survey, 
including cold (cough, runny/stuffy nose), fever, sore throat, headache, and flu, either 
alone or in combination14. 
Outcome variables Participating parents reported whether they (1) self-treated children 
with antibiotics: did not use antibiotics, self-medication with antibiotics, and seeking 
formal care after self-medication with antibiotics at home; (2) sought care and/or 
requested antibiotics: did not seek care, sought care, and sought care and explicitly 
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requested antibiotics for their children. In addition, parents also reported whether 
clinicians’ prescribed antibiotics for their child: no antibiotic prescription, antibiotic 
prescriptions without being prompted, and inappropriate antibiotic prescriptions due to 
parental demands.  
Exposure variables Informed by the Health Belief Model92,93 and Social Ecological 
Model100, we included the following potential risk factors in our analyses: 
(1) Whether parents had a medical background (yes/no), as it is relevant to parents’ 
self-efficacy for making healthcare decisions for their children.  
(2) Parents’ ability to identify antibiotics, measured by number of commonly 
available drugs correctly identified by parents as antibiotics or non-antibiotics: low 
(0-1), medium (2-3), high (4 or higher); 
(3) Parents’ perceptions: (a) perceived benefits of antibiotic use, measured by two 
factual statements about antibiotics’ efficacy to treat the common cold or fever; and 
(b) perceived severity of the infection, measured by the number of self-diagnosed 
URTI symptoms the child experienced;  
(4) Cues to action: included (a) presence of fever and (b) information sources for 
treatment decisions: medical advice, family, and media including social media. 
(5) Parents’ access to antibiotics (with or without prescriptions), including: (a) non-
prescription antibiotics: parents’ habits of keeping antibiotics at homes for children 
in the past year; and (b) antibiotic prescriptions: when a child received formal care, 
point of care used for treatment was assessed, including hospitals above county 
level, county hospitals, township hospitals, and local clinics. 
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Covariates: Socio-demographic characteristics were included as potential confounders 
for the association between each exposure and treatment decisions, including sex and 
age of the child, household income, parental education, urbanicity and province. 
Statistical analysis We first developed a flow diagram (Figure 1) to illustrate parental 
decision-making process of treatment and antibiotic use in their children for URTIs, 
from (non-clinical) household to (clinical) facility. We summarised the distributions of 
socio-demographic characteristics and factors by treatment decision/behavioural 
outcomes. To examine the association between each factor and outcome, we applied 
logistic regressions to estimate the OR (95% CI) for (1) ‘self-medication with 
antibiotics’ (vs ‘no self-medication with antibiotics’) and (2) ‘seeking healthcare’ (vs 
‘without seeking healthcare’). Factors considered include parental medical background, 
ability to identify antibiotics, perceived antibiotic efficacy for cold or fever, self-
diagnosed severity, cues to action, and access to antibiotics. We explored the 
associations with subgroups of antibiotic and healthcare use, and applied multinomial 
logistic regressions to estimate the relative risk ratio, RRR (95% CI) for (1) ‘self-
medication with antibiotics without seeking healthcare’ and ‘self-medication with 
antibiotics then sought healthcare’ (vs ‘no self-medication with antibiotics’) and (2) 
‘sought healthcare without requesting antibiotic prescriptions’ and ‘sought healthcare 
and requested prescriptions’ (vs ‘no seeking healthcare’). For parents who sought 
healthcare for their children, we estimated RRR (95%CI) for "receiving prescriptions 
without patients’ request’ and ‘receiving prescriptions due to patients’ request’ (vs 
‘without an antibiotic prescription’). For each outcome and risk factor, we first fitted an 
unadjusted model, and then adjusted for the potential confounders to establish whether 
the association was independent of these socio-demographic characteristics. Because 
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different risk factors tend to co-occur, as sensitivity analyses, we mutually adjusted for 
all risk factors simultaneously.   
 
RESULTS  
Out of 3,188 parents whose children had URTI symptoms within the last month, 594 
(40.5%) were self-medicated by parents without medical prescription - 56% of these 
children further obtained antibiotic prescriptions at healthcare facilities. Approximately 
70% of children with URTI symptoms (n=2197) sought healthcare; of them, 1204 
(54.8%) obtained antibiotic prescriptions – a third of which (33.9%) contained 
intravenous antibiotics injected directly into the bloodstream, mostly combined with oral 
antibiotics. Patients or caregivers - the demand-side of the healthcare system – who are 
engaged in self-medication and who have demanded antibiotic prescriptions were 
estimated to have contributed to 41% of antibiotic use for paediatric URTIs 
[(594+135)/(594+1204)]. (See Table 2 and Figure 1.) 
Self-medication with antibiotics for paediatric URTIs (Table 2) 
Perceived antibiotic efficacy for common cold or fever (aOR=1.82[1.51-2.19] and 
aOR=1.77[1.47-2.13], respectively), presence of fever (aOR=1.46[1.20-1.77]), high 
perceived severity of infection (aOR=2.01[1.58-2.56]), obtaining health information 
from family for treatment decisions (aOR=1.80[1.49-2.16]), and keeping antibiotics at 
home (aOR=5.08[4.03-6.39]) were associated with increased odds of self-medication 
with antibiotics use by parents for URTIs in children, after adjusting for socio-
demographic characteristics. Parents who obtained health information from media were 
associated with a reduced risk (aRRR=0.46[0.24-0.89]). High levels of perceived 
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severity of the infection and presence of fever in children were associated with increased 
risk of self-medication with antibiotics then seeking healthcare.  
Healthcare seeking and parents request for antibiotic prescription (Table 3) 
Parents who perceived antibiotics as effective for the common cold and fever, who had 
high levels of perceived severity of infection, or presence of fever in children were more 
likely to seek healthcare and request antibiotic prescriptions, compared to their 
respective counterparts. Parents who had a medical background, obtained health 
information from family, or kept antibiotics at home were less likely to seek healthcare 
for their children (aOR=0.65, 0.81, and 0.84, respectively). Among parents who sought 
healthcare for their children, keeping antibiotics at home was associated with increased 
risk of requesting antibiotic prescriptions (aRRR=3.63[2.54-5.17]).   
Antibiotic prescriptions for the treatment of URTIs (Table 4) 
Children whose parents could identify most antibiotics perceived antibiotics as 
efficacious for common cold or fever, perceived higher severity in their children, and 
kept antibiotics at home were more likely to receive antibiotic prescriptions, with a 
greater risk of receiving prescriptions by request. Regarding point-of-care used, seeking 
healthcare from county hospitals was associated with an increased risk of antibiotic 
prescriptions for paediatric URTIs and inappropriate prescriptions by parents’ request 
(aRRR=1.48[1.11-1.96] and 2.52[1.23-5.18], respectively), compared with tertiary 
hospitals. Findings from sensitivity analyses showed that when all factors were mutually 
adjusted, most associations remained, though reduced slightly, with one exception that 
‘parental ability to identify antibiotics’ became non-significant for all outcomes. All 
other factors did not change substantially (data not shown). 
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DISCUSSION   
Main findings Of the 3,188 children experiencing URTIs, nearly half (46%) were given 
antibiotics either by parents or by clinicians, 69% sought care, and among them 55% 
were prescribed antibiotics (of these 28% had already self-treated with antibiotics at 
home). Caregivers account for at least 40% of outpatient antibiotic use. Antibiotic 
misuse for paediatric URTIs can be summarised into three forms: (1) self-medication 
among children by caregivers in the community; and in clinical settings from either (2) 
unnecessary prescriptions by doctors, or (3) inappropriate prescriptions due to parental 
demand. Parents’ perception of antibiotics as efficacious for treating URTIs and the 
nearly non-existent barriers to antibiotics are key risk factors in antibiotic misuse 
behaviours, including self-medication children with antibiotics and the demand and 
receipt of antibiotic prescriptions. Presence of fever leads to formal care seeking and 
the demand and receipt of antibiotics prescriptions. Those mainly taking advice from 
family members are more likely to self-medicate children with antibiotics and less likely 
to seek care; when they do seek care, they are more likely to receive antibiotic 
prescriptions. A majority of parents (n=1,728, 54.2%) reported having kept antibiotics at 
home for their children for the possibility of a future cold. Pressuring doctors for 
antibiotic prescriptions occurred at all levels of healthcare facilities with a high success 
rate (79.4%).  
Strengths and Limitations This study is based on a large survey conducted in  
geographical areas representing various stages of economic development in China. This 
is the first study to comprehensively examine parental treatment decisions with respect 
to antibiotic use in children in both rural and urban settings across China. Though the 
cross-sectional study design limited us from drawing causal relationships, it helped 
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generate causal hypotheses and offered several points for intervention. This study 
showed that the high childhood antibiotic consumption in China is largely driven by a 
combination of excessive use of formal care for URTIs, high prescription rates, and 
large population size. The actual antibiotic consumption in Chinese children is expected 
to be much more prevalent than what has been reported in this study, considering 
repeated infections throughout a year and non-prescription use at home.41 We found, 
before the parent sought formal care, 18% of children with URTIs had already received 
antibiotics, without prescription.  The samples were clustered and therefore the 
estimated standard errors used in significance tests may be biased. In our case, samples 
were drawn from three provinces of different development level and then from the rural 
and urban areas within each province; the differences between these provinces and/or 
between rural and urban areas might be greater than those among individuals drawn 
from a random sample across the country. We accounted for variations at the province 
and/or urbanicity levels in the analyses. 
Interpretation of our findings Evidence generated from this study can be used to 
inform intervention design to reduce inappropriate or unnecessary antibiotic use for 
paediatric URTIs in the context of China and in other low- and middle-income countries 
(LMICs) where antibiotic consumption is rising 294 and which also share similar 
challenges related to unsupervised or inappropriate use of antibiotics.295,296 First, this 
study highlighted the continued need to tackle the drivers of inappropriate prescribing 
behaviours, including poor diagnostic capacity and financial incentives,52,125 especially 
in primary care and rural settings44. 55% of paediatric patients with non-complicated 
URTI symptoms were prescribed with antibiotics while roughly 80% of those who 
demanded antibiotics were prescribed antibiotics, accounting for an estimate of 45% 
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outpatient paediatric antibiotic use in the country. Further, the influence of doctor-
patient encounters on antibiotic prescriptions might be more complex than verbal 
communication. Our data identified a surprisingly similar set of risk factors influencing 
antibiotic prescription outcomes for paediatrics URTIs between parents who explicitly 
demand antibiotics and those who did not. If Chinese doctors’ prescribing behaviours 
for paediatrics URTIs are mainly driven by poor diagnostic capacity or financial 
incentives, as suggested by previous literature,52,125 we would have expected no 
association between these risk factors of parents and doctors’ prescription decisions. 
This phenomenon might be explained by possible non-verbal cues (whether true or not) 
that prescribers pick up from their interactions with parents who showed certain 
character traits or profiles during consultation that signalled to the prescribers that an 
antibiotic prescription was desired. This explanation is supported by a study that 
identified a misalignment between parents' reported expectations, their communication 
messages, and physicians' perceptions of parents' expectations and their reaction to those 
perceptions.297 These data pointed to an urgent need to enhance clinician training 
focusing on 1) clinical guidelines and appropriate prescribing for paediatric URTIs and 
2) doctor-patient communication skills that aimed to help clinicians (a) neutralise the 
perceived expectation on/pressure from parents’ demand for antibiotics and (b) inquire 
about possible parental self-medication with antibiotics on children before reaching the 
facility to avoid multiple doses. 
Secondly, context-tailored patient/caregiver education interventions on 
appropriate home care for paediatric URTIs and prudent antibiotic use are needed. 
Content should prioritise correcting perceived antibiotic efficacy for relieving or 
eradicating URTI symptoms and appropriate care for self-diagnosed paediatric URTIs 
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symptoms and fever, and be delivered by medical professionals or mass media - both 
were identified as effective channels for health information. 
Lastly, we found antibiotic misuse in Chinese children was associated with 
parents’ access to antibiotics, within or outside of a clinical setting. Household 
antibiotic storage mainly came from leftover antibiotics from previous prescriptions 
(60.6%) and over-the-counter purchases (37.5%). Cephalosporines, Amoxicillins, and 
Azithromycins were the most commonly used antibiotics to treat paediatric URTIs, both 
with and without a prescription (data not shown). These antibiotics, Cephalosporines 
especially, are broad-spectrum antibiotics effective against a wide range of bacteria, 
which kill more normal microorganisms in children’s body compared with narrow-
spectrum antibiotics, and should only be used under professional supervision on patients 
who are sick on presentation. Furthermore, participants from all regions reported to have 
obtained antibiotics from retail pharmacies. Currently, antibiotic prescriptions are 
fulfilled and dispensed by packs, often more than the prescribed doses, leading to 
leftover antibiotics for unsupervised self-medication at home later on. Therefore, in 
addition to improving responsible prescribing practice, interventions should address the 
loopholes in current Chinese antibiotic dispensing system, including (1) strengthening 
the enforcement of Chinese government’s AMR policies298 that ban over-the-counter 
purchases and cap antibiotic prescriptions (e.g. at 20% for county hospitals), and (2) 
enabling responsible dispensing antibiotics according to prescribed doses.  
Policy implications Findings from this study suggest that context-appropriate 
multifaceted interventions are vital to untangle the perpetual problem of over-
prescription and ill-informed demands for antibiotics. Simultaneously enhancing both 
prescribing guidelines, doctor-patient communication skills, and patient education 
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targeting the family as a unit is critical. A blanket antibiotic awareness campaign in 
China and in other low- and middle-income countries (LMICs) will likely not be 
effective unless it is rigorously adapted to local context. Interventions enhancing 
parental self-efficacy of healthcare decision-making, especially regarding care 
management for paediatric URTIs, and correcting (mis-)perceptions around antibiotic 
efficacy for URTI symptoms, might reduce misuse. Education interventions should 
prioritise urban parents with low socio-economic status in less developed regions and be 
disseminated via medical professionals or media in order to effectively cue parents to a 
proper response. Enforcing regulations regarding the sale of antibiotics and pack-based 
antibiotic dispensing systems to reduce household antibiotic stockpiling could curb the 
main sources of non-prescription antibiotics for self-medication use in Chinese children.  
CONCLUSIONS 
Our data pointed to an urgent need for context-appropriate multifaceted interventions to 
untangle the perpetual problem of over-prescription and ill-informed demands for 
antibiotics. Having effective stewardship programmes that improve adherence to clinical 
practice guidelines for antibiotic prescribing and enhance doctor-patient communication 
over antibiotic use in China is vital. Risk  factors influencing caregivers’ antibiotic use 
identified in this study can inform much-needed interventions addressing the challenges 
posed by both the supply- and demand-side of healthcare system in China. Our findings 
emphasize the need to prioritise interventions enhancing clinical training, neutralising 
the pressure from patients for antibiotics, educating on appropriate home care, 
discouraging antibiotic self-medication, and improving antibiotic dispensing. 
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Figure 1. Antibiotic use for upper respiratory tract infections (URTIs) among Chinese children  
  
*Inappropriate antibiotic use for URTIs 
**170 parents pressured doctors for antibiotic prescriptions for their children, with a success rate of 79.4%.  
Parents of children who had 
experienced URTIs in past month 
3,188
Didn't treat
370 (11.6%)
Self-treated without 
antibiotics
423 (13.3%)
Self-treated with 
antibiotics*
198 (6.2%)
Self-treated with 
antibiotics first, then 
sought formal care* 
396 (12.4%)
Self-treated without 
antibiotics first, then 
sought formal care 
782 (24.5%)
Sought formal care 
immediately
1019 (32.0%)
Total sought care
2,197 (68.6%)
Prescriptions without 
antibiotics
958 (43.6%) 
Prescriptions without 
antibiotics, in spite of 
parental demands*
35 (1.6%)
Antibiotic 
prescriptions*
1,069 (48.7%)
Inappropriate 
antibiotic prescriptions 
due to pressure*
135 (6.1%)** 
Self-treated first, then 
sought formal care 
1,178 (37.0%)
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Table 1. Sample characteristics N (%) (N=3188) 
 
All 
children 
N (%) 
Treated 
with 
antibiotics 
Self-treated 
with 
antibiotics 
Children who 
sought care  
3188 1,465 (46.0) 594 (18.6%) 2,197(68.9%) 
Sex     
  Boys 1,623 (50.9) 746 (50.9) 310 (52.2) 1,125 (51.2) 
  Girls 1,565 (49.1) 719 (49.1) 284 (47.8) 1,072 (48.8) 
Age (years)      
0-3 1,025 (32.2) 441 (30.1) 163 (27.4) 735 (33.5) 
4-6 1,109 (34.8) 539 (36.8) 214 (36.0) 762 (34.7) 
7-9 673 (21.1) 331 (22.6) 147 (24.8) 462 (21.0) 
10-13 381 (12.0) 154 (10.5) 70 (11.8) 238 (10.8) 
Average household income (RMB, monthly)   
>5,000 1,520 (47.7) 655 (44.7) 232 (39.1) 1,023 (46.6) 
3,001-5,000 1,032 (32.4) 498 (34.0) 220 (37.9) 718 (32.7) 
<=3,000 636 (20.0) 312 (21.3) 142 (23.9) 456 (20.8) 
Parents’ education level     
College or above 1,365 (42.8) 603 (41.2) 228 (38.4) 889 (40.5) 
High school or below 1,823 (57.2) 862 (58.8) 366 (61.6) 1,308 (59.5) 
Province     
Zhejiang  885 (27.8) 346 (23.6) 94 (15.8) 612 (27.9) 
Guangxi 1,152 (36.1) 516 (35.2) 209 (35.2) 793 (36.1) 
Shaanxi 1,151 (36.1) 603 (41.2) 291 (49.0) 792 (36.1) 
Hometown     
Rural 1,384 (43.4) 612 (41.8) 258 (43.4) 978 (44.5) 
Urban 1,804 (56.6) 853 (58.2) 336 (56.6) 1,219 (55.5) 
Parents with medical background   
No 2,785 (87.4) 1,290 (88.1) 516 (86.9) 1,960 (89.2) 
Yes 403 (12.6) 175 (12.0) 78 (13.1) 237 (10.8) 
Parents ability to identify antibiotics    
Low  530 (16.6) 183 (12.5) 68 (11.5) 387 (17.6) 
Medium  829 (26.0) 384 (26.2) 154 (25.9) 579 (26.4) 
High  1829 (57.4) 898 (61.3) 372 (62.6) 1,231 (56.0) 
Parents perceptions     
Antibiotic efficacy     
Effective for common 
cold 
    
No/Don’t know 1,842 (57.8) 728 (49.7) 266 (44.8) 1,233 (56.1) 
Yes 1,346 (42.2) 737 (50.3) 328 (55.2) 964 (43.9) 
Effective for fever     
No/Don’t know 1,767 (55.4) 670 (45.7) 254 (42.8) 1,184 (53.9) 
Yes 1,421 (44.6) 795 (54.3) 340 (57.2) 1,013 (46.1) 
Self-diagnosed severity     
Low (1 symptom) 940 (29.5) 330 (22.5) 143 (24.1) 545 (24.8) 
Medium (2) 1354 (42.5) 604 (41.2) 236 (39.7) 918 (41.8) 
High (>=3) 894 (28.0) 531 (36.3) 215 (36.2) 734 (33.4) 
Cues to action     
Presence of Fever     
No 2189 (68.7) 886 (60.9) 384 (64.7) 1383 (63.0) 
Yes 999 (31.3) 579 (39.5) 210 (35.4) 814 (37.1) 
Information sources     
Medical advice     
No 451 (14.5) 209 (14.3) 99 (16.7) 280 (12.7) 
Yes 2,737 (85.9) 1,256 (85.7) 495 (83.3) 1,917 (87.3) 
Family     
No 1,672 (52.5) 737 (50.3) 254 (2.8) 1,194 (54.4) 
Yes 1,516 (47.6) 728 (49.7) 340 (57.2) 1,003 (45.6) 
Media     
No 2,846 (89.3) 1,313 (89.6) 545 (91.8) 1,961 (89.3) 
Yes 342 (10.7) 152 (10.4) 49 (8.3) 236 (10.7) 
Antibiotics access     
Keeping antibiotics at home   
No 1,460 (45.8) 471 (32.2) 105 (17.7) 1,042 (47.4) 
Yes 1,728 (54.2) 994 (67.9) 489 (82.3) 1,155 (52.6) 
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Table 2. Estimated odds ratio (OR, 95% CI) of ‘self-treated with antibiotic’ for URTIs among Chinese children and relative risk ratio 
(RRR, 95% CI) of ‘self-treated with antibiotics only’ and ‘self-treated then thought care’ (vs ‘non-self-treated’) for factors affecting 
parental treatment decisions (N=3188) 
 Self-treated with antibiotics* 
(594, 18.6%) 
Subgroup: Self-treated with antibiotics only 
(198, 6.2%) 
Subgroup: Self-treated with antibiotics, then 
sought care (396, 12.4%) 
 % OR (95%CI) aOR (95%CI) % RRR (95%CI) aRRR (95%CI) % RRR (95%CI) aRRR (95%CI) 
Parents with medical 
background 
         
No 18.5 - - 5.8 - - 12.7 - - 
Yes 19.4 1.06 (0.81-1.38) 1.04 (0.79-1.37) 8.9 1.55 (1.06-2.27) 1.47 (0.99-2.19) 10.4 0.83 (0.59-1.16`) 0.83 (0.59-1.18) 
Parents ability to identify 
antibiotics 
         
Low  12.8 - - 4.5 - - 8.3 - - 
Medium  18.6 1.55 (1.14-2.11) 1.67 (1.21-2.29) 6.3 1.48 (0.90-2.44) 1.51 (0.91-2.51) 12.3 1.59 (1.09-2.30) 1.75 (1.20-2.56) 
High  20.3 1.73 (1.31-2.29) 2.03 (1.51-2.72) 6.7 1.61 (1.03-2.53) 1.73 (1.08-2.77) 13.7 1.80 (1.29-2.52) 2.20 (1.55-3.13) 
Parents perceptions          
Antibiotic efficacy          
Effective for common cold          
No/Don’t know 14.4) - - 4.9 - - 9.6 - - 
Yes 24.4 1.91 (1.59-2.29) 1.82 (1.51-2.19) 8.0 1.86 (1.39-2.48) 1.81 (1.35-2.43) 16.3 1.94 (1.56-2.40) 1.88 (1.51-2.33) 
Effective for fever          
No/Don’t know 14.3 - - 4.8 - - 9.5 - - 
Yes 24.0 1.89 (1.58-2.26) 1.77 (1.47-2.13) 8.0 1.86 (1.39-2.50) 1.69 (1.26-2.28) 16.1 1.90 (1.54-2.36) 1.81 (1.45-2.25) 
Self-diagnosed severity          
Low (1 symptom) 15.2 - - 6.7 - - 8.5 - - 
Medium (2) 17.4 1.18 (0.94-1.48) 1.23 (0.97-1.55) 6.1 0.94 (0.67-1.32) 0.96 (0.68-1.35) 11.3 1.36 (1.03-1.81) 1.44 (1.07-1.92) 
High (>=3) 24.1 1.76 (1.40-2.23) 2.01 (1.58-2.56) 5.8 0.97 (0.66-1.42) 1.09 (0.74-1.61) 18.2 2.39 (1.80-3.18) 2.73 (2.04-3.66) 
Cues to action:          
Presence of Fever          
No 17.5 - - 6.6 - - 10.9 - - 
Yes 21.0 1.25 (1.04-1.51) 1.46 (1.20-1.77) 5.3 0.79 (0.58-1.09) 0.99 (0.71-1.38) 15.7 1.52 (1.23-1.88) 1.74 (1.39-2.17) 
Information sources          
Medical advice          
No 22.0 - - 8.2 - - 13.8 - - 
Yes 18.1 0.79 (0.62-1.00) 0.79 (0.62-1.01) 5.9 0.68 (0.47-0.99) 0.69 (0.47-1.01) 12.2 0.85 (0.63-1.13) 0.85 (0.63-1.14) 
Family          
No 16.9 - - 5.2 - - 10.0 - - 
Yes 23.6 1.61 (1.35-1.93) 1.80 (1.49-2.16) 7.3 1.54 (1.15-2.06) 1.72 (1.28-2.31) 15.1 1.65 (1.34-2.05) 1.84 (1.48-2.29) 
Media          
No 19.2 - - 6.6 - - 12.5 - - 
Yes 14.3 0.71 (0.51-0.97) 0.79 (0.57-1.10) 2.9 0.42 (0.22-0.80) 0.46 (0.24-0.89) 11.4 0.86 (0.60-1.22) 0.97 (0.68-1.39) 
Keeping antibiotics at home         - 
No 7.2 - - 2.5 - - 4.7 -  
Yes 28.3 5.09 (4.07-6.37) 5.08 (4.03-6.39) 9.4 4.92 (3.40-7.12) 4.63 (3.18-6.75) 18.9 5.18 (3.95-6.80) 5.31 (4.03-7.01) 
OR, odds ratio; RRR, relative risk ratio; CI, confidence interval.  
*Reference group: parents who did not self-medicated children with antibiotics (n=2,594, 81.4%) 
aAdjusted for sex, age, household income, parents’ education, urbanicity and province. 
236 | P a g e  
 
Table 3. Estimated odds ratio (OR, 95% CI) of ‘healthcare seeking’ for URTIs among Chinese children and relative risk ratio (RRR, 95% 
CI) of ‘seeking formal care without requesting for antibiotics’ and ‘Seeking antibiotic prescriptions’ (vs ‘no formal care’) for factors 
affecting parental treatment decisions (N=3188) 
 Healthcare seeking* 
(2,197, 68.9%) 
Subgroup: Seeking formal care without 
requesting for antibiotics 
(2027, 63.6%) 
Subgroup: Seeking antibiotic prescriptions 
(170, 5.3%) 
 % OR (95%CI) aOR (95%CI) % RRR (95%CI) aRRR (95%CI) % RRR (95%CI) aRRR (95%CI) 
Parents with medical background          
No 70.4 - - 64.9 - - 5.5 - - 
Yes 58.8 0.60 (0.48-0.74) 0.65 (0.52-0.81) 54.3 0.60 (0.48-0.75) 0.79 (0.67-0.93) 4.5 0.59 (0.35-0.99) 0.91 (0.55-1.51) 
Parents ability to identify antibiotics          
Low  73.0 - - 68.7 - - 4.3 - - 
Medium  69.8 0.86 (0.67-1.10) 0.92 (0.72-1.18) 63.6 0.83 (0.65-1.06) 1.12 (0.96-1.31) 6.3 1.29 (0.76-2.20) 1.86 (1.14-3.10) 
High  67.3 0.76 (0.61-0.94) 0.87 (0.69-1.09) 62.1 0.75 (0.60-0.93) 1.25 (1.08-1.44) 5.2 0.99 (0.60-1.61) 1.81 (1.12-2.91) 
Parents perceptions          
Antibiotic efficacy          
Effective for common cold          
No/Don’t know 66.9 - - 63.8 - - 3.2 - - 
Yes 71.6 1.25 (1.07-1.45) 1.27 (1.09-1.49) 63.3 1.16 (0.99-1.35) 1.22 (1.10-1.35) 8.3 3.08 (2.19-4.33) 3.10 (2.25-4.28) 
Effective for fever          
No/Don’t know 67.0 - - 63.4 - - 3.6 - - 
Yes 71.3 1.22 (1.05-1.42) 1.23 (1.06-1.44) 63.8 1.16 (0.99-1.35) 1.18 (1.07-1.31) 7.5 2.37 (1.69-3.31) 2.32 (1.69-3.18) 
Self-diagnosed severity          
Low (1symptom) 58.0 - - 54.9 - - 3.1 - - 
Medium (2 symptoms) 67.8 1.53 (1.28-1.81) 1.60 (1.35-1.91)  63.0 1.50 (1.26-1.78) 1.58 (1.32-1.89) 4.8 2.03 (1.28-3.21) 2.04 (1.29-3.25) 
High (>=3 symptoms) 82.1 3.32 (2.68-4.12) 3.43 (2.76-4.26) 73.6 3.15 (2.53-3.91) 3.25 (2.60-4.05) 8.5 6.47 (4.06-10.31) 6.63 (4.14-10.61) 
Cues to action:          
Presence of Fever          
No 63.2 - - 59.3 - - 3.9 - - 
Yes 81.5 2.56 (2.14-3.08) 2.55 (2.12-3.07) 73.1 2.45 (2.04-2.95) 2.43 (2.02-2.93) 8.4 4.26 (3.03-5.98) 4.44 (3.14-6.28) 
Information sources          
Medical advice          
No 62.1 - - 57.7 - - 4.4 - - 
Yes 70.0 1.43 (1.16-1.76) 1.43 (1.16-1.77) 64.6 1.42 (1.15-1.75) 0.82 (0.70-0.96) 5.5 1.56 (0.95-2.57) 0.88 (0.55-1.41) 
Family          
No 71.4 - - 65.7 - - 5.7 - - 
Yes 66.2 0.78 (0.67-0.91) 0.81 (0.70-0.94) 61.3 0.79 (0.68-0.92) 1.22 (1.10-1.35) 4.9 0.72 (0.52-1.00) 1.18 (0.86-1.61) 
Media          
No 68.9 - - 63.7 - -  - - 
Yes 69.0 1.00 (0.79-1.28) 1.05 (0.82-1.34) 62.9 0.99 (0.77-1.27) 1.10 (0.93-1.30) 6.1 1.18 (0.71-1.94) 1.45 (0.91-2.33) 
Keeping antibiotics at home          
No 71.4 - - 68.4 - - 3.0 - - 
Yes 66.8 0.81 (0.70-0.94) 0.84 (0.72-0.98) 59.5 0.75 (0.64-0.87) 1.18 (1.07-1.31) 7.4 2.15 (1.49-3.11) 3.63 (2.54-5.17) 
OR, odds ratio; RRR, relative risk ratio; CI, confidence interval.  
*Reference group: Parents who did not seek formal care for their children (n=991, 31.1%) 
aAdjusted for sex, age, household income, parents’ education, urbanicity and province. 
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Table 4. Clinicians’ antibiotic prescriptions for URTIs for among Chinese children (N= 2,197): estimated relative risk ratio (RRR, 95% CI) 
of ‘antibiotic prescriptions’ and ‘Inappropriate antibiotic prescriptions due to patients’ demand’ (vs ‘no antibiotic prescription’) for factors 
affecting parental treatment decisions 
 Antibiotic prescriptions 
(1,069, 48.7%) 
Inappropriate antibiotic prescriptions due to 
patients’ demand (135, 6.1%) 
 % RRR (95%CI) aRRR (95%CI) % RRR (95%CI) aRRR (95%CI) 
Parents with medical background       
No 48.7 - - 6.2 - - 
Yes 48.5 0.99 (0.75-1.30) 0.92 (0.69-1.22) 5.9 0.95 (0.53-1.71) 1.04 (0.57-1.91) 
Parents ability to identify 
antibiotics 
      
Low  37.0 - - 3.4 - - 
Medium  46.5 1.62 (1.24-2.12) 1.66 (1.26-2.18) 7.3 2.72 (1.45-5.09) 3.16 (1.64-6.09) 
High  53.4 2.15 (1.69-2.73) 2.25 (1.74-2.91) 6.5 2.82 (1.57-5.07) 3.37 (1.79-6.35) 
Parents perceptions:       
Antibiotic efficacy       
Effective for common cold       
No/Don’t know 46.4 - - 3.0 - - 
Yes 51.6 1.47 (1.23-1.75) 1.49 (1.24-1.78) 10.2 4.48 (3.00-6.68) 4.17 (2.78-6.25) 
Effective for fever       
No/Don’t know 43.1 - - 3.7 - - 
Yes 55.2 1.90 (1.59-2.27) 1.91 (1.60-2.29) 9.0 3.59 (2.45-5.26) 3.57 (2.43-5.26) 
Self-diagnosed severity       
Low (1 symptom) 42.8 - - 3.7 - - 
Medium (2) 47.5 1.29 (1.04-1.61) 1.34 (1.08-1.68) 6.4 2.78 (1.46-5.32) 1.99 (1.17-3.40) 
High (>=3) 54.5 1.80 (1.43-2.27) 2.00 (1.58-2.54) 7.6 2.88 (1.57-5.28) 3.12 (1.81-5.38) 
Cues to action:       
Presence of Fever       
No 46.0 - - 4.8 - - 
Yes 53.2 1.48 (1.23-1.77) 1.64 (1.36-1.98) 8.4 2.20 (1.53-3.17) 2.44 (1.68-3.53) 
Information sources       
Medical advice       
No 51.4 - - 5.4 - - 
Yes 48.3 0.89 (0.69-1.15) 0.88 (0.68-1.15) 6.3 1.11 (0.63-1.96) 1.07 (0.60-1.90) 
Family       
No 45.4 - - 6.5 - - 
Yes 52.5 1.34 (1.12-1.59) 1.36 (1.14-1.63) 5.8 1.04 (0.72-1.49) 1.11 (0.77-1.60) 
Media       
No 48.5 - - 6.0 - - 
Yes 50.0 1.10 (0.83-1.45) 1.12 (0.84-1.49) 7.2 1.27 (0.74-2.20) 1.44 (0.83-2.52) 
Access to antibiotics       
No 38.1 - - 2.1 - - 
Yes 58.2 2.85 (2.38-3.41) 2.84 (2.36-3.41) 9.8 8.65 (5.38-13.90) 9.81 (6.04-15.94) 
Healthcare system used       
Tertiary hospital 45.5 - - 3.3 - - 
Secondary/County hospital  50.5 1.34 (1.03-1.75) 1.48 (1.11-1.96) 7.0 2.55 (1.28-5.09) 2.52 (1.23-5.18) 
Community Health 
Centres/Township hospital  
45.9 1.08 (0.82-1.43) 1.16 (0.87-1.56) 6.6 2.15 (1.05-4.39) 1.89 (0.90-3.96) 
Private Clinics/ Village clinics 52.2 1.37 (0.99-1.91) 1.27 (0.90-1.80) 5.1 1.83 (0.80-4.22) 1.42 (0.60-3.37) 
ANTIBIOTIC USE       
No 38.6 - - 2.2 - - 
Yes 70.0 6.74 (4.95-9.19) 6.70 (4.89-9.23) 14.1 24.21 (13.24-44.25) 25.50 (13.62-47.74) 
OR, odds ratio; RRR, relative risk ratio; CI, confidence interval.  
* Reference group: No antibiotic prescription (n=993, 45.2%) 
aAdjusted for sex, age, household income, parents’ education, urbanicity, province, and point-of-care used.  
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CHAPTER SIX 
Decisions on antibiotic use for upper respiratory tract infections 
across China among university students: a large-scale cross-
sectional survey  
In this chapter, I report on secondary data analysis of a large-scale survey on 
treatment decisions with respect to antibiotic use for upper respiratory tract 
infections among young adults (university students) across six provinces of different 
geographic regions and economic development stages in China. Data were collected 
from September to November 2015 by the Zhejiang University Institute of Social 
Medicine and Family Medicine. (See Appendix I: Letter of Support.) 
I conducted the analysis plan design and analysis independently. I employed two 
behavioural models - Health Belief Model and Social Ecological Model - for 
antibiotic use in the analysis and interpretation of the results. The findings and 
results have been prepared as a draft of the manuscript, with comments on drafts 
from Professors James Hargreaves, Stephan Harbarth, Elizabeth Fearon, Chunling 
Lu, Xiaomin Wang, and Xudong Zhou. This manuscript has been accepted by BMJ 
Open.  
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Decisions to use antibiotics for upper respiratory tract infections across China: 
a large-scale cross-sectional survey among university students 
SYNOPSIS 
BACKGROUND: Antibiotic misuse for upper respiratory tract infections (URTIs) 
is a global health challenge to efforts to contain antimicrobial resistance (AMR). The 
misuse is especially severe in China.  
OBJECTIVES: We investigated the decision-making process of Chinese university 
students with respect to antibiotic use for URTIs. 
METHODS: Data were obtained from a cluster random sample of 2834 university 
students across six Chinese regions, collected from September to November 2015. 
Using regular and multinomial logistic regression and adapted Health Belief Model, 
we identified and measured a number of variables as potential risk factors for 
antibiotic misuse behaviours in order to explain and predict people’s treatment 
decisions and antibiotic use including knowledge, perceptions, access to antibiotics, 
and cues to action. 
RESULTS: Of the 2834 university students who self-diagnosed a URTI, 947 
(33.4%) self-reported having taken antibiotics; among them, 462 (48.8%) used non-
prescription antibiotics, which came principally from leftover prescriptions (29.0%) 
and over-the-counter purchases at retail pharmacies (67.3%). One in four who sought 
care pressured their doctors for antibiotics; all received them. Those who perceived 
greater severity of the disease, had access to antibiotics, perceived benefits of using 
antibiotics, and were cued to action (e.g. seeing presence of fever or self-diagnosing 
their current infection as severe) were more likely to misuse antibiotics.  
CONCLUSIONS: Misconceptions of antibiotic efficacy and easy access to 
antibiotics - with or without a prescription - were associated with antibiotic misuse 
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among Chinese university students, which calls for context-appropriate multifaceted 
interventions in order to effectively reduce antibiotic misuse.   
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INTRODUCTION 
Acute upper respiratory tract infections (URTIs), widely known as “the 
common cold” and caused by several families of viruses, are the most common 
infectious diseases.14 The use of antibiotics is unnecessary for treating URTIs, as 
most URTIs are viral whereas antibiotics neither expedite recovery from infections 
nor prevent complications.7,299,300 Nevertheless, URTIs remain the most common 
reason for primary care seeking of antibiotics and antibiotic prescriptions in many 
countries, including China, which has one of the highest reported per-capita rates of 
antibiotics use globally at 138g/person.32 Most Chinese antibiotic consumption 
occurs in outpatient settings, often unnecessarily for URTIs, which is a critical driver 
of inappropriate and excessive antibiotic use in China.36,37 Despite the magnitude of 
antibiotic misuse in China, there is little evidence towards understanding how people 
make URTI treatment decisions, and little effort has been made to apply health 
behaviour theories towards understanding such decision-making. 
An individual’s medical decisions, such as antibiotic use for URTIs, are 
influenced by their attitudes and perceptions of the illness and treatment options 
while these attitudes and perceptions themselves are heavily influenced by socio-
ecological context.45,61,65  Adults may experience a URTI two to five times 
annually,14 making it so well-recognised that, before consulting a physician, 
individuals commonly engage in self-diagnosis and decide a course of action – a 
majority of these self-recognized episodes were managed without seeking formal 
care.301 To date, a majority of  studies on antibiotic use behaviours examine the 
issues from a traditional, Knowledge-Attitudes-Practice (KAP) perspective, 
assuming people would make more ‘risk-conscious’ choices if informed of risks that 
could easily have been avoided (i.e. improved knowledge and awareness leads to 
changes in practice). However, decision scientists argue that, when people engage in 
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healthcare decision-making, they focus on attaining a goal – curing of an illness.148 
This thinking focuses on a positive rather than a negative outcome, where people 
accept the risks of drug resistance (for the immediate perceived benefits of antibiotic 
use) rather than intentionally taking risks.148 
AMR stewardship programmes in China focused mostly on healthcare 
providers, i.e. prescribers2,302, with very few targeting the public - the demand side of 
the healthcare system. In this study, we undertook a risk factor analysis for public’s 
antibiotic misuse behaviours for informing effective intervention development. Risk 
factors were identified using the Health Belief Model with an aim to explain and 
predict health behaviours with respect to antibiotic use for URTIs. Specifically, with 
self-diagnosed URTIs cases, we aimed to assess Chinese university students’ (1) 
antibiotic use, (2) treatment decisions regarding care-seeking and antibiotic use, and 
(3) prescription outcomes after seeking formal care, with a focus on antibiotic 
demands.  
METHODS 
Population Sample: We used a cluster random sampling method to recruit 
university students across six Chinese regions for a cross-sectional survey from 
September to November 2015. The single best comprehensive university303 in each 
of six sampled provinces in each region was identified. Students attending these 
universities were eligible for enrolment. With assistance from school officials, class 
schedules were obtained the day prior to the survey. Classes were randomly selected 
from the timetable; every class had an equal chance of selection. All university 
students attending these classes were included. Over 95% of students in the selected 
classes completed the questionnaire; some students did not participate due to lacking 
a phone or laptop at the time of survey. Pilot tests indicated the prevalence of URTIs 
among Chinese university students in the past month to be 25-30%. To ensure an 
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adequate sample size for the planned subgroup analyses, we aimed to achieve a 
sample size per university of ca.1800 students. A total of 11,192 students completed 
the survey, with a response rate of 96%.  Among participants, 25.32% (n=2834) self-
reported experiencing symptoms of URTIs within the past month and such 
respondents were evenly distributed across all demographic groups. Further details 
on the survey’s design and sampling methods have been previously described and 
published.45,304 
Data collection: This study used a systematically developed questionnaire. 
Questions were tailored to the Chinese sociocultural context, as informed by 
literature review,61,65,75,123 behavioural theories, and qualitative interviews with 
stakeholders and experts. A consent form was presented at the first section of the 
questionnaire and was signed by all participants, who were informed that 
participation was confidential, voluntary, could be terminated at any time, and that 
the questionnaire would take ~5 minutes to complete. The survey was developed 
using Wen Juan Xing – a popular web-based platform for professional electronic 
questionnaires and data collection – and delivered via WeChat, China's most used 
communication application. The survey was finalized after a pilot test with 254 
respondents to evaluate potential sources of response error and improve the 
instrument. The reliability and validity fit the requirements.  
Behavioural frameworks: We adapted the Health Belief Model92,93 in the 
conceptual framework for analysis, as presented in Figure 1. The study aims to 
understand the impact of individuals’ perception of illness and treatment on one’s 
decisions for antibiotic use while accounting for the complex interplay between 
factors at different levels of socio-ecological environment100 (i.e. individual, 
interpersonal, and societal). Knowledge relates to AMR awareness, ability to identify 
antibiotics, and misconceptions. Perceptions involve expectations about the 
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seriousness of the consequences of acquiring URTIs (i.e. perceived severity) or the 
benefits of antibiotic treatment for URTI symptoms (perceived antibiotic efficacy). 
Cues to action are external determinants of health behaviours (e.g. presence of 
symptoms). 
Outcome variables: When responding to the question: “During the most recent 
episode of sickness, what were the symptoms that you experienced?”, participants 
who self-reported having symptoms of a URTI14 - including cold (cough, 
runny/stuffy nose), fever, sore throat, headache, and flu, either alone or in 
combination - within a month prior to the survey were categorized into three 
subgroups with respect to their treatment decisions for using antibiotics: no 
treatment or self-treated without antibiotics (reference group), self-treated with 
antibiotics, and sought formal care. Diagnostic outcomes of care seeking were 
categorised into three subgroups with respect to doctors’ prescribing decisions for 
antibiotics: no antibiotic prescription (reference group), unnecessary antibiotic 
prescriptions for URTI symptoms, and inappropriate antibiotic prescriptions due to 
patients’ demands.  
Exposure variables: We included the following potential risk factors in our 
analyses:  
(1) Knowledge about antibiotics and resistance were measured by a series of 
factual statements related to AMR awareness (5 items), ability to identify 
antibiotics (7 items), and misconception about the antibiotics as “anti-
inflammatory drugs” (1 item).  
(2) Perceived severity of URTIs was measured by knowing that URTIs are 
self-limiting and will dissipate naturally. 
(3) Perceived antibiotic efficacy was measured by 5 factual statements about 
antibiotics’ efficacy to treat URTIs.  
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(4) Cues to action: (a) numbers of cold symptoms experienced and (b) 
presence of fever.  
(5) Access to antibiotics were measured by two yes/no questions:  (a) keeping 
antibiotics at home in the past year, and (b) over-the-counter purchase of 
non-prescription antibiotics in the past year.  
Additionally, considering the Chinese socioecological environment regarding 
healthcare decisions, data on (6) point of care used for care seeking was collected, 
ranging from hospitals above county level, county level hospitals, township 
hospitals, and private clinics. 
Covariates: Socio-demographic characteristics were included as potential 
confounders for the association between each exposure and treatment decisions, 
including age, sex, household income, urbanicity, university major in medicine, 
having at least one parent with medical background, and region/province. 
Statistical analysis: First, we described and summarised participants’ 
sociodemographic characteristics and modifying factors by treatment 
decision/behavioural outcomes. Second, we developed a flow diagram to show 
pathways of different medical decision outcomes with respect to antibiotic use for 
URTIs. Third, we described responses to different domains of knowledge about 
antibiotic use and resistance. Fourth, to examine the association between each risk 
factor and outcome, we applied logistic regressions to estimate the OR (95% CI) for 
‘treatment with antibiotic for URTIs’ (vs ‘no antibiotic use’). Last, we explored the 
associations with subgroups of antibiotic use for URTIs by self-medication and via 
formal care, and applied multinomial logistic regressions to estimate the relative risk 
ratio, RRR (95% CI) for (1) ‘self-treatment with antibiotics’ and ‘sought healthcare’ 
(vs ‘no treatment or self-medication without antibiotics’). For students who sought 
healthcare, we estimated RRR (95%CI) for (2) "receiving (unnecessary) 
248 | P a g e  
 
prescriptions without request’ and ‘receiving (inappropriate) prescriptions due to 
patients request’ (vs ‘without an antibiotic prescription’). For each outcome and 
exposure, we first fitted an unadjusted model, and then a full model adjusted for 
potential confounders. These confounders - identified via published studies61,65,75,123 
on public’s antibiotic use - include: age, sex, household income, urbanicity, being a 
medical student or having at least one parent with a medical background, and 
hometown region of residence (university/province). 
RESULTS  
Distributions of decisions for treatment and antibiotic use for URTIs (Figure 2) 
When the 2834 university students with self-diagnosed URTIs were asked 
about their choice of treatment, 20.4% decided against treatment (n=579), 54.5% 
decided to self-treat (with or without antibiotics, n=1545), and a quarter sought 
formal care (n= 710, 25.1%). A total of 947 students self-reported having taken 
antibiotics for URTIs symptoms: 462 (48.8%) used non-prescription antibiotics and 
the rest obtained a prescription. Non-prescription antibiotics came principally from 
leftover prescriptions (29.0%) and over-the-counter purchases from pharmacies 
(67.3%). One out of every four respondents who sought formal care admitted to 
pressuring their doctors for antibiotics (n=123, 25.4%), with a 100% success rate.  
Knowledge and perceptions about antibiotic use and resistance (Table 1) 
Respondents were assessed on their knowledge about antibiotic use and 
resistance and perceptions on antibiotic efficacy and URTIs as a health threat. The 
overall Cronbach’s alpha, including all items, was 0.81, with subscales of 0.71 (for 
AMR awareness) and 0.81 (for ability to identify antibiotics). Three quarters of 
participants (74.2-88.5%) reported being aware of the dangers posed by overuse of 
antibiotics. A majority of participants (63.0%) had trouble distinguishing cold 
medicine (e.g. Tylenol, Contac NT or Gankang) from antibiotics. 36.5% were 
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unaware antibiotics were not anti-inflammatory drugs; more than 60% had an 
incorrect perception of antibiotic efficacy for URTIs, either being unsure or wrongly 
stating that antibiotics might expedite recovery or alleviate symptoms.  
Factors associated with antibiotic use for URTIs (Table 2) 
Compared with those who did not use antibiotics for treatment of URTIs, 
ability to identify antibiotics (aOR=1.51, 95%CI:1.17-1.94), perceived antibiotics to 
be effective for the common cold (aOR=2.55, 95%CI:1.93-3.38) or as anti-
inflammatory drugs (aOR=1.35, 95%CI:1.12-1.63), not knowing that the common 
cold is self-limiting (aOR=1.35, 95%CI:1.12-1.62), presence of fever (aOR=2.05, 
95%CI:1.62-2.60), multiple symptoms experienced (aOR=1.86, 95%CI:1.41-2.45)], 
keeping antibiotics at home (aOR=2.27, 95%CI:1.83-2.81), and access to over-the-
counter antibiotics (aOR=2.00, 95%CI:1.63-2.45) were associated with a higher 
likelihood of antibiotic use for URTIs. 
Factors associated with the treatment decisions for URTIs and antibiotic use 
(Table 3) 
Relative to those who did nothing or self-treated without antibiotics for 
URTIs (reference group), participants who self-medicated with antibiotics were 
more likely to have perceived antibiotic efficacy for URTIs (aRRR=3.03, 
95%CI:2.10-4.38), mistake antibiotics as anti-inflammatory drugs (aRRR=1.40, 
95%CI:1.10-1.77), not know that the common cold is self-limiting (aRRR=1.34, 
95%CI:1.05-1.71)), experience multiple cold symptoms (aRRR=1.96, 95%CI:1.36-
2.84), kept antibiotics at home (aRRR=4.68, 95%CI:3.24-6.74), and purchased over-
the-counter antibiotics (aRRR=3.21, 95%CI:2.34-4.41). Those who sought formal 
care were more likely to have a high level of AMR awareness (aRRR=0.61, 
95%CI:0.42-0.89), have not known that URTIs are self-limiting (aRRR=1.66, 
95%CI:1.36-2.02), experienced multiple cold symptoms (aRRR=1.64, 95%CI:1.21-
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2.21), and had presence of fever (aRRR=2.98, 95%CI:2.32-3.83)]. Participants who 
had perceived antibiotics to be effective for the common cold (aRRR=1.89, 
95%CI:1.38-2.57), kept antibiotics at home (aRRR=1.24, 95%CI:1.00-1.54), and 
purchased over-the-counter antibiotics (aRRR=1.22, 95%CI:0.99-1.51) were also 
more likely to seek formal care.  
Factors associated with the antibiotic prescriptions for the treatment of URTIs 
(Table 4) 
Participants who sought care and had high levels of AMR awareness had 
lower risks of demanding antibiotics. Relative to those who sought formal care but 
did not get an antibiotics prescription (reference group), participants who had high 
ability to identify antibiotics (aRRR=6.35, 95%CI:2.85-14.13), perceived antibiotics 
to be effective for the common cold (aRRR=3.67, 95%CI:1.61-8.39) or as anti-
inflammatory drugs (aRRR=1.92, 95%CI:1.11-3.33), presence of fever (aRRR=3.24, 
95%CI:1.70-6.18), kept antibiotics at home (aRRR=2.46, 95%CI:1.33-4.56), and 
made over-the-counter purchase (aRRR=3.69, 95%CI:1.97-6.91) had a higher 
likelihood of demanding antibiotic prescriptions. Evidence of structural differences 
was observed in antibiotic prescribing outcomes in point of care. 54.3% of patients 
who sought care at tertiary hospitals and 52.7% at township hospitals were 
prescribed antibiotics for URTIs, whereas 43.2% of county hospitals and 43.1% of 
local clinics gave antibiotic prescriptions for URTIs. All patients who demanded 
antibiotic prescriptions from a doctor received them. 
DISCUSSION  
We found that 33.4% of young Chinese educated in top universities (n=947) 
with URTIs used antibiotics; among them, 462 (48.8%) used non-prescription 
antibiotics and additionally, a quarter of prescriptions originated from patients’ 
demands (n=123, 25.4%). We therefore estimated that the demand side is 
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responsible for 61.8% of antibiotic use for URTIs [(462+123)/947]. Surprisingly, 
high ability to identify antibiotics was linked to higher likelihoods of antibiotic use, 
especially antibiotic prescriptions.  Mistaking antibiotics as anti-inflammatory drugs, 
perceiving antibiotics as efficacious for treating URTIs, and access to non-
prescription antibiotics were strongly associated with antibiotic misuse, including 
self-medication with antibiotics and demands for antibiotic prescriptions. We found 
non-prescription antibiotics are easily accessible in China: 68.2% of participants kept 
antibiotics at home at the time of the survey and 64.2% made over-the-counter 
purchases at least once within the past year. At health facilities, roughly 70% of 
clinicians prescribed antibiotics – most deemed as inappropriate and unnecessary – 
for URTI symptoms, and there was practically no barrier to accessing antibiotic 
prescriptions from a doctor.  
Strengths and limitations: This study is guided by the adapted Health Belief 
Model for analysis in explaining and predicting patients’ treatment decisions and 
antibiotic use for URTIs. We found perceived infection severity, efficacy of 
antibiotic use for URTIs, barriers/access to antibiotics, and cues to action are 
determinants of higher likelihoods of antibiotic use for URTIs, with or without 
prescriptions. In the Chinese context, our data further identified the demands of the 
health system – rather than supply – as the driving force for outpatient antibiotic use 
for URTIs, with a 1.6:1 ratio [62% vs 38%], and that access to antibiotics, with or 
without a prescription, was extremely easy. This model can guide the design and 
development of behavioural change interventions which aim to reduce antibiotic 
misuse in the community, with a focus on the complex interplay between 
individual/interpersonal/societal factors and individuals’ decisions on treatment and 
antibiotic use for URTIs.  
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Though the cross-sectional study design limited us from drawing causal 
relationships between knowledge and practice of antibiotic misuse, it helped to 
generate causal hypotheses and offered several points for intervention. Experiments, 
longitudinal studies, or behavioural data are needed in the near future to avoid recall 
bias, an inherent limitation of self-reported survey data. Considering people may 
have multiple infections during the year and because our target population consisted 
of university students, who are generally younger and healthier than the general 
population, we anticipate antibiotic misuse among the Chinese general population to 
be more prevalent and severe than what has been presented here. Lastly, because the 
samples were clustered therefore the estimated standard errors used in significance 
tests may be biased. In our case, samples were drawn from six universities across 
China, from provinces of different development levels; the differences among these 
provinces might be greater than those among individuals drawn from a random 
sample across the country. We have accounted for such variation at the 
province/university level in the analyses. 
Interpretation of Findings: First, we found that, at the individual level, 
awareness of the danger of AMR was high among students, yet such awareness did 
not translate into prudent antibiotic use. This might imply the existence of an 
externality associated with antibiotic use for treating infections; despite a high 
awareness of AMR, the risks AMR imposes on others are unlikely to be felt directly 
or immediately by either the consumer or the supplier of treatment. Findings from 
this study identified a significant positive correlation between ability to identify 
antibiotics and self-medication, prescriptions, and demand for antibiotics. Some 
scholars have suggested many Chinese users make decisions on antibiotics without 
fully understanding the package insert, and that an inability to identify antibiotics 
may be a barrier to appropriate antibiotic use in China; as such, education 
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interventions to improve ability to identify antibiotics seem warranted.62,67,75 
However, studies demonstrated “successful experiences” in the past for “curing” a 
similar illness, and knowledge of the previously prescribed antibiotics could lead to 
improved ability to identify antibiotics and SMA.75,283,305-307 Most KAP studies113,308 
tested antibiotics-related  knowledge, attitudes, and beliefs and sometimes, even 
practice, as one coherent category - for example,  grouping them into scores – but 
according to our findings, these measures might be inappropriate. Specifically, our 
data suggest heterogeneity exists in the “domain” of knowledge about antibiotics and 
its relationship with antibiotic practices for URTIs. Without sufficient knowledge 
about correct antibiotic efficacy, appropriate care for URTIs, and using antibiotics 
only under professional supervision, simply improving the public’s ability to identify 
antibiotics alone could potentially cause greater misuse. Therefore, the common 
current practice of grouping multiple aspects of antibiotics- or AMR-related 
knowledge, attitudes and beliefs, and even practices into one score might not fully 
capture the complexity of their various associations with antibiotic use behaviours. It 
also means that a blanket awareness campaign or a simple intervention on clear 
labelling of antibiotics is likely to fail without adapting to the local context – a 
finding consistent with the recent assessment of WHO awareness campaign.309 We 
found strong evidence showing that demanding antibiotic prescriptions was 
associated with household stockpiling and over-the-counter purchases of antibiotics. 
Interventions which target “demanders” and “heavy misusers” of antibiotics in the 
community and that correct the misperception of antibiotics’ efficacy for URTIs or 
as anti-inflammatory drugs might reduce misuse.  
Interpersonal relationships have a significant influence on individual’s 
decisions regarding antibiotic use. All the participants who asked for antibiotics 
successfully received them. Even with good intentions,35,38,62,257,261  unrealistic 
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patient expectations and pressure from patients or caregivers to prescribe antibiotics 
have been identified as major reasons why physicians prescribe antibiotics for self-
limiting diseases.35,279,310-312 This indicates an urgent need for further training to help 
clinicians improve clinical skills and doctor–patient communication skills. Because 
URTIs are self-resolving, the prescribers who treat them with antibiotics benefit 
from an apparently successful cure, promoting recommendations by patients and 
leading to a cycle of over-treatment.140 In our case, clinicians’ over-prescribing in 
China - incentivised by financial profits for health facilities30 – might have helped 
shape and reinforce common public misperceptions of antibiotics as effective for 
URTIs, which, in turn, leads to patients’ improved (or “learned”) ability to identify 
antibiotics307,313 and demand for antibiotics, further perpetuating misuse.  
At the societal level, our data showed 68.2% of participants stored 
antibiotics, which mainly came from over-the-counter purchases and previous 
prescriptions. We found the effect of keeping antibiotics at home on antibiotic 
(mis)use in the community is as profound as the impact of unnecessary prescriptions 
for URTIs through formal care. Since 2011, China has implemented policies (such as 
banning over-the-counter purchases and capping antibiotic prescriptions at 20% for 
county hospitals and above and 30% for township hospitals) to control antibiotic 
misuse, but the success of such initiatives has been limited due to poor 
enforcement.40,42,269,270,314,315 In our data, about 70% of URTIs patients who sought 
care were prescribed antibiotics; among them, over 50% of the patients received 
antibiotic prescriptions without prompting and close to 20% successfully obtained 
antibiotics through explicit requests. These data pointed to an urgent need for 
effective, context-tailored hospital stewardship programmes that improve adherence 
to clinical practice guidelines for antibiotic prescribing in China and enhance doctor-
patient communication over antibiotic use. Consistent with other studies,61,120,137,257 
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over-the-counter sales of non-prescription antibiotics at community pharmacies were 
found across China. Societal normative influences on individual’s antibiotic use in 
China are implied from the regional differences in antibiotic use, SMA and care 
seeking behaviours. Additionally, we identified a set of shared misconceptions in the 
community – even among the highly educated – such as viewing antibiotics as 
effective for URTIs and as anti-inflammatory drugs, which acted as drivers of 
antibiotic misuse in China. 
Policy Implications 
Customising strategies according to local needs and socio-ecological environments is 
fundamental to effective intervention. To date, most current AMR interventions in 
China focus on the supply side, such as stewardship programmes aiming to curb 
overprescribing. However, our findings point to an urgent need to complement these 
with context-specific and multilevel interventions targeting the demand-side of 
antibiotic misuse in China. To untangle the perpetual problem of over-prescription 
and ill-informed demands for antibiotics, interventions that include prescribing 
guidelines, communication skills, and patient education are necessary. Enforcing 
regulations regarding the sale of antibiotics, pack-based antibiotic dispensing 
systems, and public educational interventions to reduce consumer-driven 
prescriptions and leftover prescriptions could curb the main sources of antibiotics for 
self-medication use. Introducing interventions to reduce household storage of 
antibiotics, such as drugs/antibiotics take-back programmes, is necessary. 
CONCLUSION 
Determinants of medical decisions for antibiotic use and care seeking are complex. It 
is critical to consider the heterogeneity of culture, health systems, and social norms 
in the assessment and intervention of decision-making regarding antibiotic use. This 
study provided urgently needed evidence for future interventional studies to address 
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the challenges posed by the demand-side and to improve the Chinese general 
population’s antibiotic use.  
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Figure 1.  Conceptual Framework  
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Figure 2. Medical decisions about antibiotic use for upper respiratory tract infections among Chinese university students 
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Table 1. Knowledge and perceptions about antibiotic use and resistance score distribution (n=2834) 
 Yes No I don’t know Alpha 
 n (%) n (%) n (%) 0.81 
AMR awareness    0.71 
1.      Antibiotic overuse is a serious problem in China.  2168 (76.5) 51 (1.8) 615 (21.7)  
2.      The more frequently people use antibiotics; the more difficult it will be to treat bacterial infections. 2270 (80.1) 262 (9.2) 302 (10.7)  
3.      Antibiotic overuse may increase antibiotic resistance.  2509 (88.5) 184 (6.5) 141 (5.0)  
4.      Antibiotic resistance will become a serious problem in China. 2102 (74.2) 61 (2.2) 646 (23.7)  
5.      We will have few antibiotics to use in the future if we don’t use antibiotics properly. 2367 (83.5) 222 (7.8) 245 (8.7)  
Ability to identify antibiotics    0.81 
1.    Penicillin (amoxicillin) 2263 (79.9) 275 (9.7) 296 (10.4)  
2.    Cephalosporin (cefaclor, ceftriaxone sodium) 1969 (69.5) 342 (12.1) 523 (18.5)  
3.    Nonsteroidal Anti-inflammatory Drugs (ibuprofen, aspirin) 1129 (39.8) 894 (31.6) 811 (28.6)  
4.    Quinolones (norfloxacin, ofloxacin) 1306 (46.1) 600 (21.2) 928 (32.8)  
5.    Acetaminophen (Tylenol, Contac NT, Gankang) 799 (28.2) 1049 (37.0) 986 (34.8)  
6.    Macrolides (azithromycin, roxithromycin) 1669 (58.9) 331 (11.7) 834 (29.4)  
7.    Steroids (Dexamethasone, Prednisone) 762 (26.9) 820 (28.9) 1253 (44.2)  
Misconception about antibiotics     
1.     Antibiotics are anti-inflammatory drugs. 575 (20.3) 1799 (63.5) 460 (16.2)  
Perceived antibiotic efficacy on URTIs     
1.    Antibiotics can speed up recovery from flu. 1250 (44.1) 1081 (38.1) 503 (17.8)  
2.    Antibiotics can relieve the symptoms of cold. 1384 (48.8) 943 (33.3) 507 (17.9)  
3.    Antibiotics are effective for sore throat. 978 (34.5) 1620 (57.2) 236 (8.3)  
4.    Antibiotics are effective for treating common cold (cough, runny nose). 687 (24.2) 1912 (67.5) 235 (8.3)  
Perceived threat about URTIs     
1.     Common cold is self-limiting and does not require medication as the symptoms will dissipate naturally 1927 (68.0) 725 (25.6) 182 (6.4)  
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Table 2. Logistic regression to assess factors associated with antibiotic use for upper respiratory tract infections among Chinese 
university students (N=2,834) 
 All students 
with URTIs 
(N=2,834) 
Antibiotic use for URTIs 
(n= 947, 33.42%) 
 
 N (%) n (%) OR (95%CI:) aOR (95%CI:) bp-value 
Knowledge about antibiotics      
AMR awareness     0.97 
Low 181 (6.39) 73 (7.71) Reference Reference  
Medium 571 (20.16) 210 (22.18) 0.86 (0.61-1.21) 1.02 (0.70-1.50)  
High 2082 (73.47) 664 (70.12) 0.69 (0.51-0.95) 0.99 (0.70-1.42)  
Ability to identify antibiotics     0.002 
Low 806 (28.44) 226 (23.86) Reference Reference  
Medium 1267 (44.71) 470 (49.63) 1.51 (1.25-1.83) 1.37 (1.11-1.70)  
High 761 (26.85) 251 (26.50) 1.26 (1.02-1.57) 1.51 (1.17-1.94)  
Perceived severity of the infection      
Common cold is self-limiting      0.002 
Yes 1927 (68.00) 581 (61.35) Reference Reference  
No/I don’t know  907 (32.00) 366 (38.65) 1.57 (1.33-1.85) 1.35 (1.12-1.62)  
Perceived antibiotic efficacy      
Perceived antibiotic efficacy for URTIs      <0.0001 
No/Low 938 (33.10)  200 (21.12) Reference Reference  
Medium 1476 (52.08) 542 (57.23) 2.14 (1.77-2.59) 1.71 (1.39-2.10)  
High 420 (14.82) 205 (21.65) 3.52 (2.75-4.50) 2.55 (1.93-3.38)  
Antibiotics are anti-inflammatory drugs     0.001 
No 1799 (63.48) 524 (55.33) Reference Reference  
Yes/I don’t know  1035 (36.52) 423 (44.67) 1.68 (1.43-1.97) 1.35 (1.12-1.63)  
Cues to action      
Self-diagnosed Symptoms Experienced     <0.0001 
Low 1488 (52.51) 395 (41.71) Reference Reference  
Medium  893 (31.51) 317 (33.47) 1.52 (1.27-1.82) 1.37 (1.13-1.67)  
High 453 (15.98) 235 (24.82) 2.98 (2.40-3.71) 1.86 (1.41-2.45)  
Fever     <0.0001 
No 2235 (78.86) 638 (67.37) Reference Reference  
Yes 599 (21.14) 309 (32.63) 2.67 (2.22-3.21) 2.05 (1.62-2.60)  
Barriers/Access to Antibiotics      
Keeping antibiotics at home     <0.0001 
     No 900 (31.76) 179 (18.90) Reference Reference  
     Yes  1934 (68.24) 768 (81.10) 2.65 (2.20-3.20) 2.27 (1.83-2.81)  
Over-the-counter purchase of non-prescription 
antibiotics in the past year 
    <0.0001 
     No 1015 (35.82) 202 (21.33) Reference Reference  
     Yes  1819 (64.18) 745 (78.67) 2.79 (2.33-3.34) 2.00 (1.63-2.45)  
Socio-demographic characteristics     0.79 
Age 21.13c (2.67)  1.02 (0.99-1.05) 1.00 (0.96-1.03)  
Sex     0.44 
Male  1476 (52.08) 496 (52.38) Reference Reference  
Female  1358 (47.92) 451 (47.62) 0.98 (0.84-1.15) 1.07 (0.90-1.28)  
Urbanicity of Hometown     0.07 
Rural 1644 (58.01) 505 (53.33) Reference Reference  
Urban 1190 (41.99) 442 (46.67) 1.33 (1.14-1.56) 1.20 (0.98-1.47)  
Average household income (RMB, monthly)     0.05 
>10,000 (>$1538) 496 (17.50) 147 (15.52) Reference Reference  
3,001-10,000 ($462-$1538) 1503 (53.03) 470 (49.63) 1.08 (0.87-1.35) 0.92 (0.72-1.17)  
<=3,000 ($461) 835 (29.46) 330 (34.85) 1.55 (1.22-1.97) 1.21 (0.90-1.62)  
Major in Medicine     0.02 
No 2396 (84.54) 835 (88.17) Reference Reference  
Yes 438 (15.46) 112 (11.83) 0.64 (0.51-0.81) 0.73 (0.56-0.95)  
Having at least one parent with medical 
background 
    0.47 
No 2524 (89.06) 836 (88.28) Reference Reference  
Yes 310 (10.94) 111 (11.72) 1.13 (0.88-1.44) 1.11 (0.84-1.46)  
Region (University, Province)     0.001 
North (NKU, Tianjin) 417 (14.71) 121 (12.78) Reference Reference  
East (ZJU, Zhejiang) 459 (16.20) 104 (10.98) 0.72 (0.53-0.97) 0.81 (0.58-1.14)  
Southwest (GZU, Guizhou) 493 (17.40) 223 (23.55) 2.02 (1.53-2.66) 1.56 (1.15-2.13)  
Northwest (LZU, Gansu) 528 (18.63) 203 (21.44) 1.53 (1.16-2.01) 1.29 (0.95-1.74)  
South (WHU, Hubei) 480 (16.94) 121 (12.78) 0.82 (0.61-1.11) 0.93 (0.67-1.28)  
Northeast (JLU, Jilin) 457 (16.13) 175 (18.48) 1.52 (1.14-2.02) 1.09 (0.79-1.49)  
aAdjusted for age, sex, household income, urbanicity, major in medicine, having at least one parent with medical background, and region/province. 
bLikelihood ratio tests for antibiotic use for URTIs 
cmean (SD) 
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Table 3. Multinomial regression model to assess factors associated with treatment decisions for upper respiratory tract 
infections with respect to antibiotic use among Chinese university students (N=2,834) 
 Did not treat 
or self-
treated 
without  
antibiotics 
(n=1,662, 
58.65%) 
Self-
medicated 
with 
antibiotics 
(n=462, 
16.30%) 
  Sought 
formal care 
(n=710, 
25.05%) 
   
 n (%) n (%) RRR (95%CI:) aRRR (95%CI:) n (%) RRR (95%CI:) aRRR (95%CI:) bp-value 
Knowledge about 
antibiotics 
        
AMR awareness        0.006 
Low 84 (5.05) 23 (4.98) Reference Reference 74 (10.42) Reference Reference  
Medium 302 (18.17) 94 (20.35) 1.14 (0.68-1.90) 1.34 (0.77-2.34) 175 (24.65) 0.66 (0.46-0.95) 0.80 (0.54-1.18)  
High 1276 (76.77) 345 (74.68) 0.99 (0.61-1.59) 1.38 (0.82-2.33) 461 (64.93) 0.41 (0.29-0.57) 0.61 (0.42-0.89)  
Ability to identify 
antibiotics 
       0.49 
Low 488 (29.36) 108 (23.38) Reference Reference 210 (29.58) Reference Reference  
Medium 718 (43.20) 224 (48.48) 1.41 (1.09-1.82) 1.08 (0.82-1.43) 325 (45.77) 1.05 (0.85-1.30) 1.08 (0.86-1.36)  
High 456 (27.44) 130 (28.14) 1.29 (0.97-1.71) 1.20 (0.87-1.67) 175 (24.65) 0.89 (0.70-1.13) 1.27 (0.97-1.66)  
Perceived severity of the 
infection 
        
Common cold is self-
limiting  
       <0.0001 
Yes 1216 (73.16) 297 (64.29) Reference Reference 414 (58.31) Reference Reference  
No/I don’t know  446 (26.84) 165 (35.71) 1.51 (1.22-1.89) 1.34 (1.05-1.71) 296 (41.69) 1.95 (1.62-2.34) 1.66 (1.36-2.02)  
Perceived antibiotic 
efficacy 
        
Perceived antibiotic efficacy 
for URTIs  
       <0.0001 
No/Low 664 (39.95) 90 (19.48) Reference Reference 184 (25.92) Reference Reference  
Medium 813 (48.92) 267 (57.79) 2.42 (1.87-3.14) 1.99 (1.50-2.64) 396 (55.77) 1.76 (1.44-2.15) 1.46 (1.17-1.82)  
High 185 (11.13) 105 (22.73) 4.19 (3.02-5.80) 3.03 (2.10-4.38) 130 (18.31) 2.54 (1.92-3.35) 1.89 (1.38-2.57)  
Antibiotics are anti-
inflammatory drugs 
       0.02 
No 1123 (67.57) 249 (53.90) Reference Reference 427 (60.14) Reference Reference  
Yes/I don’t know  539 (32.43) 213 (46.10) 1.78 (1.44-2.20) 1.40 (1.10-1.77) 283 (39.86) 1.38 (1.15-1.66) 1.12 (0.91-1.38)  
Cues to action         
Self-diagnosed Symptoms 
Experienced 
       <0.001 
Low 974 (58.60) 217 (46.97) Reference Reference 297 (41.83) Reference Reference  
Medium  507 (30.51) 152 (32.90) 1.35 (1.07-1.70) 1.30 (1.01-1.68) 234 (32.96) 1.51 (1.24-1.85) 1.29 (1.04-1.61)  
High 181 (10.89) 93 (20.13) 2.31 (1.73-3.08) 1.96 (1.36-2.84) 179 (25.21) 3.24 (2.54-4.14) 1.64 (1.21-2.21)  
Fever        <0.0001 
No 1432 (86.16) 359 (77.71) Reference Reference 444 (62.54) Reference Reference  
Yes 230 (13.84) 103 (22.29) 1.79 (1.38-2.32) 1.23 (0.89-1.72) 266 (37.46) 3.73 (3.04-4.58) 2.98 (2.32-3.83)  
Barriers/Access to 
Antibiotics 
        
Keeping antibiotics at home        <0.0001 
     No 628 (37.79) 38 (8,23) Reference Reference 234 (32.96) Reference Reference  
     Yes  1034 (62.21) 424 (91.77) 6.78 (4.79-9.58) 4.68 (3.24-6.74) 476 (67.04) 1.24 (1.03-1.49) 1.24 (1.00-1.54)  
Over-the-counter purchase of 
non-prescription antibiotics 
in the past year 
       <0.0001 
     No 709 (42.66) 55 (11.90) Reference Reference 251 (35.35) Reference Reference  
     Yes  953 (57.34) 407 (88.10) 5.51 (4.09-7.42) 3.21 (2.34-4.41) 459 (64.65) 1.36 (1.13-1.63) 1.22 (0.99-1.51)  
Socio-demographic 
characteristics 
       0.78 
Age   1.03 (0.99-1.07) 1.01 (0.97-1.05)  0.99 (0.96-1.02) 0.99 (0.95-1.03)  
Sex        0.19 
Male  876 (52.71) 243 (52.60) Reference Reference 357 (50.28) Reference Reference  
Female  786 (47.29) 219 (47.40) 1.00 (0.82-1.23) 1.22 (0.97-1.52) 353 (49.72) 1.10 (0.92-1.31) 1.12 (0.92-1.35)  
Urbanicity of Hometown        0.64 
Rural 1000 (60.17) 273 (59.09) Reference Reference 371 (52.25) Reference Reference  
Urban 662 (39.83) 189 (40.91) 1.05 (0.85-1.29) 1.07 (0.83-1.39) 339 (47.75) 1.38 (1.16-1.65) 1.11 (0.89-1.38)  
Average household income 
(RMB, monthly) 
       0.14 
>10,000 (>$1538) 307 (18.47) 83 (17.97) Reference Reference 106 (14.93) Reference Reference  
3,001-10,000 ($462-$1538) 907 (54.57) 239 (51.73) 0.97 (0.74-1.29) 0.82 (0.60-1.12) 357 (50.28) 1.14 (0.89-1.47) 1.07 (0.82-1.41)  
<=3,000 ($461) 448 (26.96) 140 (30.30) 1.16 (0.85-1.57) 0.97 (0.67-1.41) 247 (34.79) 1.60 (1.22-2.09) 1.37 (0.99-1.89)  
Self-efficacy for healthcare 
decisions 
        
Major in Medicine        0.03 
No 1365 (82.13) 397 (85.93) Reference Reference 634 (89.30) Reference Reference  
Yes 297 (17.87) 65 (14.07) 0.75 (0.56-1.01) 0.89 (0.64-1.25) 76 (10.70) 0.55 (0.42-0.72) 0.68 (0.50-0.91)  
Having at least one parent 
with medical background 
       0.34 
No 1488 (89.53) 395 (85.50) Reference Reference 641 (90.28) Reference Reference  
Yes 174 (10.47) 67 (14.50) 1.45 (1.07-1.96) 1.27 (0.91-1.78) 69 (9.72) 0.92 (0.69-1.23) 1.00 (0.72-1.37)  
Region (University, 
Province) 
       <0.0001 
North (NKU, Tianjin) 276 (16.61) 81 (17.53) Reference Reference 60 (8.45) Reference Reference  
East (ZJU, Zhejiang) 310 (18.65) 38 (8.23) 0.42 (0.27-0.63) 0.50 (0.32-0.79) 111 (15.63) 1.65 (1.16-2.35) 1.86 (1.27-2.73)  
Southwest (GZU, 
Guizhou) 
240 (14.44) 84 (18.18) 1.19 (0.84-1.69) 0.98 (0.66-1.44) 169 (23.80) 3.24 (2.30-4.56) 2.49 (1.72-3.60)  
Northwest (LZU, Gansu) 287 (17.27) 103 (22.29) 1.22 (0.88-1.71) 1.08 (0.75-1.56) 138 (19.44) 2.21 (1.57-3.12) 1.92 (1.33-2.77)  
South (WHU, Hubei) 297 (17.87) 50 (10.82) 0.57 (0.39-0.85) 0.66 (0.43-1.00) 133 (18.73) 2.06 (1.46-2.91) 2.39 (1.66-3.45)  
Northeast (JLU, Jilin) 252 (15.16) 106 (22.94) 1.43 (1.02-2.01) 1.10 (0.76-1.60) 99 (13.94) 1.81 (1.26-2.60) 1.37 (0.93-2.03)  
aAdjusted for age, sex, household income, urbanicity, major in medicine, having at least one parent with medical background, and region/province. 
bLikelihood ratio tests for treatment decisions for URTIs 
cmean (SD) 
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Table 4. Multinomial regression model to assess factors associated with diagnostic outcomes with respect to antibiotic 
prescriptions for upper respiratory tract infections among Chinese university students who sought care (N=710) 
 All students 
who sought 
care 
(N=710) 
No antibiotic 
prescription 
(n=225, 
31.69%) 
Prescribed with 
antibiotics 
(n=362, 50.99%) 
  Asked for 
antibiotics 
(n=123, 
17.32%) 
   
 N (%) n (%) n (%) RRR (95%CI:) aRRR (95%CI:) n (%) RRR (95%CI:) aRRR (95%CI:) bp-value 
Knowledge about antibiotics          
AMR awareness         0.004 
Low 74 (10.42) 24 (10.67) 27 (7.46) Reference Reference 23 (18.70) Reference Reference  
Medium 175 (24.65) 59 (26.22) 84 (23.20) 1.27 (0.67-2.41) 1.18 (0.59-2.38) 32 (26.02) 0.57 (0.28-1.16) 0.37 (0.16-0.87)  
High 461 (64.93) 142 (63.11) 251 (69.34) 1.57 (0.87-2.83) 1.62 (0.82-3.19) 68 (55.28) 0.50 (0.26-0.95) 0.40 (0.17-0.91)  
Ability to identify 
antibiotics 
        <0.0001 
Low 210 (29.58) 92 (40.89) 100 (27.62) Reference Reference 18 (14.63) Reference Reference  
Medium 325 (45.77) 79 (35.11) 180 (49.72) 2.10 (1.42-3.09) 1.85 (1.20-2.84) 66 (53.66) 4.27 (2.34-7.79) 4.03 (2.01-8.11)  
High 175 (24.65) 54 (24.00) 82 (22.65) 1.40 (0.90-2.18) 1.48 (0.88-2.46) 39 (31.71) 3.69 (1.92-7.08) 6.35 (2.85-14.13)  
Perceived Severity of 
the infection 
         
Common cold is self-
limiting  
        0.25 
Yes 414 (58.31) 130 (57.78) 209 (57.73) Reference Reference 75 (60.98) Reference Reference  
No/I don’t know  296 (41.69) 95 (42.22) 153 (42.27) 1.00 (0.72-1.40) 0.89 (0.61-1.29) 48 (39.02) 0.88 (0.56-1.37) 0.64 (0.38-1.09)  
Perceived antibiotic 
efficacy 
         
Antibiotic efficacy         0.04 
Low 184 (25.92) 74 (32.89) 91 (25.14) Reference Reference 19 (15.45) Reference Reference  
Medium 396 (55.77) 121 (53.78) 207 (57.18) 1.39 (0.95-2.03) 1.23 (0.80-1.87) 68 (55.28) 2.19 (1.22-3.93) 2.17 (1.12-4.24)  
High 130 (18.31) 30 (13.33) 64 (17.68) 1.73 (1.02-2.95) 1.56 (0.86-2.84) 36 (29.27) 4.67 (2.32-9.40) 3.67 (1.61-8.39)  
Antibiotics are anti-
inflammatory drugs 
        0.07 
No 427 (60.14) 152 (67.56) 219 (60.50) Reference Reference 56 (45.53) Reference Reference  
Yes/I don’t know  283 (39.86) 73 (32.44) 143 (39.50) 1.36 (0.96-1.93) 1.26 (0.85-1.89) 67 (54.47) 2.49 (1.59-3.91) 1.92 (1.11-3.33)  
Cues to action          
Self-diagnosed 
Symptoms Experienced 
        0.18 
Low 297 (41.83) 119 (52.89) 138 (38.12) Reference Reference 40 (32.52) Reference Reference  
Medium  234 (32.96) 69 (30.67) 122 (33.70) 1.52 (1.04-2.24) 1.48 (0.97-2.25) 43 (34.96) 1.85 (1.10-3.13) 1.65 (0.89-3.06)  
High 179 (25.21) 37 (16.44) 102 (28.18) 2.38 (1.52-3.72) 1.77 (1.00-3.13) 40 (32.52) 3.22 (1.81-5.70) 1.48 (0.67-3.28)  
Fever         0.001 
No 444 (62.54) 165 (73.33) 224 (61.88) Reference Reference 55 (44.72) Reference Reference  
Yes  266 (37.46) 60 (26.67) 138 (38.12) 1.69 (1.18-2.44) 1.40 (0.87-2.25) 68 (55.28) 3.40 (2.14-5.40) 3.24 (1.70-6.18)  
Barriers/Access to 
Antibiotics 
         
Keeping antibiotics at 
home 
        0.01 
     No 234 (32.96) 93 (41.33) 116 (32.04) Reference Reference 25 (20.33) Reference Reference  
     Yes  476 (67.04) 132 (58.67) 246 (67.96) 1.49 (1.06-2.11) 1.39 (0.93-2.07) 98 (79.67) 2.76 (1.65-4.61) 2.46 (1.33-4.56)  
Over-the-counter 
purchase of non-
prescription antibiotics 
        0.0001 
     No 251 (35.35) 104 (46.22) 125 (34.53) Reference Reference 22 (17.89) Reference Reference  
     Yes  459 (64.65) 121 (53.78) 237 (65.47) 1.63 (1.16-2.29) 1.68 (1.14-2.48) 101 (82.11) 3.95 (2.32-6.71) 3.69 (1.97-6.91)  
Point of care         <0.01 
Tertiary hospital 116 (16.34) 28 (12.44) 63 (17.40)/54.3 Reference Reference 25 (20.33)/21.6 
Reference Reference  
Secondary/County 
hospital  
81 (11.41) 23 (10.22) 35 (9.67)/43.2 0.68 (0.34-1.35) 0.56 (0.26-1.21) 23 
(18.70)/28.4 
1.12 (0.51-2.47) 0.83 (0.32-2.14)  
Community Health 
Centres/Township 
hospital  
448 (63.10) 159 (70.67) 236 (65.19)/52.7 0.66 (0.40-1.08) 0.56 (0.32-0.98) 53 
(43.09)/11.8 
0.37 (0.20-0.70) 0.35 (0.17-0.74)  
Private Clinics/ 
Village clinics 
65 (9.15) 15 (6.67) 28 (7.73)/43.1 0.83 (0.38-1.79) 0.61 (0.26-1.43) 22 
(17.89)/33.8 
1.64 (0.70-3.84) 1.03 (0.37-2.89)  
Socio-demographic characteristics        0.49 
Age    1.02 (0.95-1.09) 0.96 (0.89-1.04)  1.04 (0.96-1.13) 0.95 (0.85-1.04)  
Sex         0.36 
Male  357 (50.28) 104 (46.22) 193 (53.31) Reference Reference 60 (48.78) Reference Reference  
Female  353 (49.72) 121 (53.78) 169 (46.69) 0.75 (0.54-1.05) 0.78 (0.54-1.13) 63 (51.22) 0.90 (0.58-1.40) 0.96 (0.57-1.61)  
Urbanicity of 
Hometown 
        0.10 
Rural 371 (52.25) 139 (61.78) 173 (47.79) Reference Reference 59 (47.97) Reference Reference  
Urban 339 (47.75) 86 (38.22) 189 (52.21) 1.77 (1.26-2.48) 1.52 (1.00-2.31) 64 (52.03) 1.75 (1.12-2.73) 1.69 (0.93-3.06)  
Average household 
income (RMB, monthly) 
        0.49 
>10,000 (>$1538) 106 (14.93) 42 (18.67) 49 (13.54) Reference Reference 15 (12.20) Reference Reference  
3,001-10,000 ($462-
$1538) 
357 ((50.28) 126 (56.00) 173 (47.79) 1.18 (0.73-1.89) 1.09 (0.65-1.82) 58 (47.15) 1.29 (0.66-2.51) 1.10 (0.50-2.39)  
<=3,000 ($461) 247 (34.79) 57 (25.33) 140 (38.67) 2.11 (1.26-3.52) 1.59 (0.86-2.93) 50 (40.65) 2.46 (1.22-4.95) 1.67 (0.67-4.05)  
Major in Medicine         0.33 
    No 634 (89.30) 196 (87.11) 325 (89.78) Reference Reference 113 (91.87) Reference Reference  
Yes 76 (10.70) 29 (12.89) 37 (10.22) 0.77 (0.46-1.29) 0.65 (0.36-1.16) 10 (8.13) 0.60 (0.28-1.27) 0.62 (0.26-1.52)  
Having at least one 
parent with medical 
background 
        0.02 
No 641 (90.28) 200 (88.89) 333 (91.99) Reference Reference 108 (87.80) Reference Reference  
Yes 69 (9.72) 25 (11.11) 29 (8.01) 0.70 (0.40-1.22) 0.87 (0.46-1.64) 15 (12.20) 1.11 (0.56-2.20) 1.02 (0.43-2.41)  
Region (University, 
Province) 
        0.07 
North (NKU, Tianjin) 60 (8.45) 20 (8.89) 29 (8.01) Reference Reference 11 (8.94) Reference Reference  
East (ZJU, Zhejiang) 111 (15.63) 45 (20.00) 56 (15.47) 0.86 (0.43-1.71) 0.95 (0.45-2.01) 10 (8.13) 0.40 (0.15-1.10) 0.41 (0.13-1.27)  
Southwest (GZU, 
Guizhou) 
169 (23.80) 30 (13.33) 101 (27.90) 2.32 (1.15-4.68) 1.87 (0.87-4.05) 38 (30.89) 2.30 (0.96-5.54) 1.31 (0.46-3.68)  
Northwest (LZU, 
Gansu) 
138 (19.44) 38 (16.89) 72 (19.89) 1.31 (0.65-2.61) 1.23 (0.57-2.62) 28 (22.76) 1.34 (0.55-3.24) 0.68 (0.24-1.92)  
South (WHU, Hubei) 133 (18.73) 62 (27.56) 60 (16.57) 0.67 (0.34-1.31) 0.80 (0.39-1.67) 11 (8.94) 0.32 (0.12-0.86) 0.33 (0.11-1.01)  
Northeast (JLU, Jilin) 99 (13.94) 30 (13.33) 44 (12.15) 1.01 (0.49-2.11) 0.76 (0.34-1.72) 25 (20.33) 1.52 (0.61-3.75) 0.44 (0.15-1.32)  
aAdjusted for age, sex, household income, urbanicity, major in medicine, having at least one parent with medical background, and region/province. 
bLikelihood ratio tests for prescribing outcomes for URTIs 
cmean (SD) 
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CHAPTER SEVEN 
Development of an antibiotic take-back programme to reduce non-prescription 
use and unsafe disposal in rural China: a mixed-methods approach 
This thesis has reported on a series of research activities conducted between 2017 
and 2019, with the aim of developing a behavioural change intervention to reduce 
antibiotic misuse through a focus on reducing unnecessary demand and increasing 
safe disposal beyond clinical settings. I investigated and identified the components 
of a new take-back programme for disposing of household’s expired, unwanted, or 
unused (EUU) antibiotics in rural China. 
I conducted the literature search, created the figures and the conceptual framework, 
developed study design and instruments, conducted data analysis and interpretation, 
and drafted and revised the manuscript. The development process and feasibility 
assessment of a novel evidence-based, theory-driven, community-based intervention 
has been prepared as a draft of the manuscript, with comments on drafts from Weiyi 
Wang, Professors James Hargreaves, Mark Petticrew, and Xudong Zhou. This 
manuscript has been submitted to BMC Medical Research Methodology for 
publication consideration. 
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An extended introduction of the development of the intervention. 
In this chapter, I described the process of developing a community-based take-back 
programme for disposing of household’s expired, unwanted, or unused (EUU) 
antibiotics in rural China. Below I present the respective evidence generated in each 
step prior to this chapter (presented in chapters two to six) that was used to inform 
intervention design: 
Thesis structure Key findings to inform 
intervention design 
Implications for intervention 
design 
Chapter two identifies 
non-clinical factors 
influencing the 
general public's and 
healthcare providers’ 
antibiotic use in the 
Chinese community 
a) Identification of factors and 
their potential pathways 
influencing public’s 
antibiotic use and 
informing a conceptual 
framework for antibiotic 
use, which served as 
Theory of Change (See 
Figure 1) for the 
intervention development. 
 Intervention design to address 
some of these 
factors/pathways.  
 The theory of change was later 
used to inform a logic model 
(Figure 2) 
Chapter three 
identifies behavioural 
change techniques 
(BCTs) that may 
effectively reduce 
inappropriate use of 
medicines and medical 
procedures 
b) Interventions consisting of 
health education messages 
(BCTs 4.1, 4.2, 5.1, 5.2), 
incentives (BCTs 10.1, 
10.2), and a supporting 
environment (BCT 12.1, 
12.5) that encourages the 
adoption of a new 
behaviour (BCT 8.2)  are 
more likely to be 
successful. 
 Intervention design to include 
health education messages, 
recommended alternative 
behaviour, incentives, and a 
supporting environment. 
Chapter four assesses 
the prevalence of 
antibiotic misuse in 
children in the 
Chinese context 
c) Almost half of the 
surveyed parents kept 
antibiotics at home for 
children  
d) Many Chinese parents self-
medicated children with 
antibiotics (prophylactic or 
treatment) and before 
seeking formal care. 
e) Household antibiotics 
primarily came from 
leftover prescriptions and 
over-the-counter purchases 
(OTC). 
 Household storage of 
antibiotics is a critical gap in 
current efforts to contain AMR 
in China (and most LMIC). 
 Health education messages to 
include awareness of the 
danger of AMR and non-
prescription use of antibiotics. 
Note: Issues around OTC were 
going to be addressed by other 
intervention components of the 
JGHT bid. 
Chapter five assesses 
the factors influencing 
Chinese parents’ 
treatment decisions 
for paediatric URTIs. 
f) Perceived antibiotic 
efficacy for URTIs 
symptoms is associated 
with an increased odds of 
self-medication with 
antibiotics and demand of 
antibiotic prescriptions. 
g) Parents who kept 
antibiotics at home for 
children were associated 
 Health education message 
content selection (BCTs 4.1, 
4.2, 5.1, 5.2) 
 Intervention design to reduce 
household storage of 
antibiotics. (BCTs 10.1, 10.2, 
8.2, 12.1, 12.5) 
Note: Issues around OTC were 
going to be addressed by other 
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with increased odds of self-
medication with antibiotics 
for URTIs in children and 
over-the-counter purchases.  
h) Household antibiotics 
primarily came from 
leftover prescriptions and 
over-the-counter purchases 
(OTC). 
intervention components of the 
JGHT bid. 
Chapter six assesses 
the factors influencing 
Chinese young adults’ 
treatment decisions 
for URTIs. 
i) Not knowing URTIs are 
self-limiting and perceived 
antibiotic efficacy for 
URTIs symptoms are 
associated with increased 
odds of self-medication 
with antibiotics and 
demand of antibiotic 
prescriptions. 
j) Participants who kept 
antibiotics at home were 
associated with increased 
odds of self-medication 
with antibiotics.  
k) Household antibiotics 
primarily came from 
leftover prescriptions and 
over-the-counter purchases 
(OTC). 
 
Briefly, in chapter two, I identified factors and their potential pathways influencing 
public’s antibiotic use, which informed a conceptual framework which served as 
Theory of Change (See Figure 1) for the intervention development. In chapter three, 
I found there had not been interventions that addressed inappropriate or unnecessary 
use of antibiotics in the community in LMIC including China. In chapters four to six, 
I found in China, household unsupervised use of antibiotics on adults and children 
alike has been a pervasive practice especially in the rural community. Many came 
from household storage, obtained from community pharmacies or leftover 
prescriptions. Keeping antibiotics at home led to a higher likelihood of self-
medication. The demand-side of the health care system in China accounted for 40% 
of antibiotic use for childhood self-limiting illnesses and 60% for young adults in the 
country. I found that perception of antibiotics as effective for treating viral upper 
respiratory tract infections (URTIs) and access to non-prescription antibiotics were 
associated with inappropriate antibiotic use in the Children community. 
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Following Theory of Change, I aimed to develop a context-tailored, behavioural 
change intervention to improve antibiotic use in rural China that would 1) address 
the social-contextual factor of inappropriate community antibiotic use by removing 
access to non-prescription antibiotics storage at home to reduce the likelihood of 
unsupervised use of antibiotics in adults or children, and 2) implement a health 
education intervention (as a cue to action) to improve antibiotic literacy especially its 
(in-)efficacy for the common cold in target community. Specifically, the proposed 
intervention had two major components: a community-based bartering programme 
where residents were encouraged to bring household EUU antibiotics in for 
household items, and a health education campaign with messages on (a) prudent 
antibiotic use and antibiotic literacy, (b) care management for acute upper 
respiratory tract infection (URTI) symptoms, and (c) antibiotic take-back 
programme.  
To recruit a pilot site for the development and adaptation of the intervention, I 
worked closely with local partners at Zhejiang University and identified/approached 
a rural village in Zhejiang Province. We followed a theory-based work stream plan 
(Table 1) in the adaptation, implementation and evaluation of this intervention, and 
developed a logic model (Figure 2) according to local characteristics and Theory of 
Change. A community advisory board consisting of researchers and community 
representatives was formed to guide the process. A mixed-methods formative 
evaluation was conducted, consisting of (1) quantitative surveying of a 
representative sample of 50 households in the target community and (2) qualitative 
semi-structured stakeholders’ interviews to explore the design, development and 
adaptation, and implementation of the proposed intervention. Quantitative and 
qualitative data from a similar village – serving as a control - were also collected. 
The chosen communities had high social capital where everyone knows everyone 
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(Table 2). I reflected the collaborative knowledge translation process for evidence-
based practice in the concept of implementation capital (Figure 3). 
Working with local partners, I chose health education messages based on findings 
from chapters four to six, as presented in Figure 4, and adopted the manual on 
prudent antibiotic use, developed by China’s National Health Commission 
(Appendix I), to train the community implementer of the take-back programme. 
Before implementing the pilot intervention, I made several key assumptions based 
on findings from the literature review and secondary data analyses about antibiotic 
use in rural China. As presented in Table 3, after the mixed-methods, baseline 
formative evaluation of 50 sampled households in the pilot village, some of these 
assumptions held unchanged, but some were adjusted as part of the local adaptation 
process. Qualitative data collected from the 50 households further informed the 
development of health education strategy (Table 4). Table 5 reported the intervention 
materials design and descriptions, developed for the pilot study.  
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Development of a take-back programme that reduces household antibiotic 
storage for unsupervised use in rural China: a mixed-methods approach 
SYNOPSIS 
BACKGROUND: Non-prescription use of antibiotics and unsafe disposal in 
communities may harm human and environmental health and contribute to the global 
threat of antimicrobial resistance. Currently, there is a lack of public-targeted 
behaviour change interventions to address this threat.  
OBJECTIVE: This study describes the process of developing an evidence-based, 
theory-driven, community-based take-back programme for disposing of household’s 
expired, unwanted, or unused (EUU) antibiotics in rural China.  
METHODS: We incorporated and operationalised the RE-AIM framework, the 
community-based participatory research principles, 6SQuID model, and intervention 
mapping procedures in a theory-based work stream plan in the adaptation, 
implementation and evaluation of this intervention. A community advisory board 
consisting of researchers and community representatives was formed to guide the 
process. A mixed-methods formative evaluation was conducted, consisting of (1) 
quantitative surveying of a representative sample of 50 households in the target 
community and (2) qualitative semi-structured stakeholders’ interviews to explore 
the design, development and adaptation, and implementation of the proposed 
intervention. Quantitative and qualitative data from a similar village – serving as a 
control - were also collected. 
RESULTS: After knowledge syntheses of existing literature and primary research, 
the adaptation process underwent three steps: 1) model development; 2): 
collaboration and partnership for evidence-based intervention development; and 3) 
realist assessment (mixed-methods), which included forming a theory of change and 
logic model.  
272 | P a g e  
 
CONCLUSIONS: This study illustrates the potential efficacy of community-based 
antibiotic take-back programmes in China encouraging safe disposal and decreasing 
availability of EUU antibiotics in households for unsupervised use.  
KEYWORDS: drug take-back; environment; community health, social marketing; 
drug abuse, prescription drugs, antimicrobial resistance (AMR), RE-AIM, 
community-based participatory research (CBPR), intervention mapping 
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BACKGROUND 
Antimicrobial resistance (AMR) claims 700,000 lives annually, and AMR-
related mortality is rising.43 A majority of human antibiotic consumption occurs in 
community settings, especially in low-and-middle income countries (LMICs) where 
40% of the population commonly self-medicate with antibiotics; half of such 
antibiotics come from household storage.305 China is one of the world's largest 
producers and consumers of antibiotics and faces severe challenges from this crisis, 
with levels of per-capita antibiotic use and AMR-related health burden that are 
among the world’s highest.32  In the past decade, the Chinese government has 
enacted a series of measures to control the rate of antibiotic prescriptions, including 
the recent essential medicines scheme and zero-mark up policy,51 which separates 
drug sales from medical treatment at public hospitals. Such policies may effectively 
remove inappropriate financial incentives from hospitals but, as presented in the 
2019 BMJ review of China’s 10-year progress on health system reform, largely 
ignores primary care and rural settings where the majority of people reside and 
outpatient dispensing takes place.44 Few interventions aim to regulate communities’ 
easy access to antibiotics.269 Lord Jim O’Neill warned that, given the current trend, 
the associated global economic burden could reach US $100 trillion and cause 4.73 
million deaths in the Asia-Pacific region alone by 2050. 
Nationwide surveys demonstrate that over 70% of Chinese households store 
antibiotics, which are eventually self-administered without professional 
supervision.41,68,305,316 Depending on the region, 40-50% report SMA without seeing 
a doctor,61,64,75 and 20-30% had used antibiotics to prevent the common cold in the 
past year.45 Sources of SMA come from leftover prescriptions and over-the-counter 
purchases in local pharmacies.45,64 The practice of storing antibiotics at home for 
future self-medication persists even when Chinese migrate abroad.119,317-319 
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Furthermore, little attention has been paid to the danger of SMA and unsafe disposal 
in communities. Because there is no safe disposal programme for household medical 
waste, household antibiotics are disposed of as common trash and deposited in 
landfills, potentially becoming a hazard to environment, wildlife, and human health, 
especially in countries, like China, with poor waste management systems.320  
 
Interventions, like drug take-back programs, for reducing household access to 
expired, unwanted, or unused (EUU) medications have been implemented in 
developed countries, including the United States and many European countries, e.g. 
Sweden and Germany, for over a decade and have had positive impacts on raising 
public awareness about and reducing misuse and abuse of drugs.218,321-323 However, 
such practices are seldom seen in LMIC. In China, awareness and practices 
regarding safe disposal of antibiotics are non-existent. To date, no interventions have 
addressed non-prescription household antibiotic use or convenient and 
environmentally-responsible disposal methods for systemically removing or 
reducing household antibiotic stockpiles in China. The need for evidence-based, 
public-targeted interventions is pressing. In this study, we report on the 
implementation of science procedures translating available evidence into the 
development of an antibiotic take-back and disposal programme in rural China, 
where community antibiotic misuse is the most severe.261,324  
METHODS 
This paper details a series of research activities conducted between 2017 and 2019, 
with the overall aim of developing a behavioural change intervention to reduce 
antibiotic misuse beyond clinical settings in rural China.  
Hypothesis and theory of change  
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The Health Belief Model92,93 was developed in the early 1950s based on 
psychological and behavioural theory to understand people’s responses to symptoms 
and adoption of disease prevention strategies and medical treatments. It suggests that 
an individual's course of action often depends on the person's perceptions of the 
benefits (i.e. the perceived efficacy of antibiotics) and barriers (i.e. access to 
antibiotics) related to health behaviour that can protect the person from a health 
threat. By examining these constructs, HBM will predict the likelihood the person 
will adopt the behaviour. Social Ecological Model100, on the other hand, was 
developed to understand of the dynamic interrelations among various personal and 
environmental factors. Both models have been used to explain antibiotic use.92,93,100 
Accordingly, we developed a Theory of Change (ToC, see Figure 1) with a 
hypothesis that behaviour is influenced by context, personal knowledge and 
perceptions of benefits, barriers, and efficacy of actions. Specifically, the Theory of 
Change developed suggested that behavioural change would most likely occur in a 
social context with dynamic and reciprocal interactions between the person, 
community, and environment - both spatially and temporally - as an individual’s 
behaviour is influenced by their past experiences through expectations and 
reinforcements. Whenever possible, the Theory of Change was applied to guide 
quantitative and qualitative data analyses to understand health behaviours in the 
target context, which led to the development of a simplified logic model (Figure 2) 
informing behavioural interventions.  
Work stream plan of this project (presented in Table 1) integrates the community-
based participatory research (CBPR) principles,325,326 the RE-AIM (Reach, 
Effectiveness, Adoption, Implementation, and Maintenance) model,327 and 
intervention mapping procedures89,328 in the development, implementation and 
evaluation of an antibiotic take-back programme in rural China. CBPR is a 
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collaborative research approach that emphasises the importance of creating 
partnerships between researchers and knowledge users of the research. We followed 
the CBPR principles with a strong commitment to build on community strengths and 
resources and to facilitate collaborative partnerships in all phases of the research. A 
community advisory board (CAB) was formed as a coalition of researchers, 
government officials, and local partners to lead the adaptation, implementation and 
evaluation process. By integrating the RE-AIM model in the work stream plan for 
intervention development and feasibility assessment, we ensure each key element of 
RE-AIM is considered at the beginning of the intervention design and throughout the 
entire process. Finally, we adopted the Intervention Mapping (IM) procedures - from 
program objective-setting to generating evaluation plans - as a roadmap and 
guideline for knowledge translation for the development of theory- and evidence-
based behavioural change interventions. As shown in the work stream plan, steps 
taken in the development of behavioural change interventions were iterative and 
cumulative, as we fluctuated between tasks, while each step built on previous steps. 
These steps have been closely aligned with the Six Essential Steps for Quality 
Intervention Development (6SQuID) model,91a  pragmatic evidence-based guide to 
maximise likely effectiveness. 
Setting and sample  
Formative data (pre-intervention) for the intervention came from a 
representative community panel of 50 households from each of the two selected rural 
villages – one intervention and one control - in Zhejiang, China, conducted prior to 
the implementation of an antibiotic take-back programme in June 2019. All 
households in the two villages were eligible for inclusion and those agreeing to 
participate gave informed consent. Due to the intervention design and local context, 
we targeted self-identified female heads of household. If identified female heads of 
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household were unavailable after the second attempt, their spouse/partner was 
invited to participate. The 21 stakeholders from the intervention village were 
purposively selected, prior to the intervention or immediately after implementation, 
for interviews via the snowballing technique and included a representative sample of 
characteristics relevant to the study setting in terms of age, gender, socio-economic 
status, and community roles.  
Data collection and management 
Face-to-face household surveys with the community panel consisted of 
quantitative and qualitative items assessing antibiotic use and disposal behaviours, 
exposure to and participation in the programme, and cognitive measures of 
programme effects (risk appraisal, self-efficacy, normative influence, and public 
knowledge and perceptions). Inspections of household medical cabinets were 
conducted following each survey. Stakeholders, including residents, local 
government officials, community partners, potential implementers of the 
intervention, community pharmacies and clinicians, and others, were recruited for 
semi-structured interviews. An interview guide was developed with three main 
goals: (1) to assess the target population’s beliefs, perceptions and behaviours in 
order to develop culturally appropriate interventions; (2) to describe the context in 
which these behaviours take place and understand the reasoning underlying such 
behaviours; and (3) to develop and test health education messaging regarding 
prudent antibiotic use in the community. The guide was piloted prior to full-scale 
interviews. Formative data - both quantitative and qualitative - were also collected 
from the control village with a similar sample. Qualitative interviews were audio-
recorded, transcribed by an independent transcription company, checked for 
accuracy, anonymised and imported into Nvivo11 software to facilitate analysis. 
Quantitative Measures 
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The primary objective was to describe antibiotic use and disposal behaviours. 
All respondents were asked whether, in the past month, they have: (a) kept 
antibiotics at home and (b) participated in the take-back programme. Relevant 
antibiotic use knowledge, attitudes, and behaviour outcomes were also measured.  
Data analysis 
Descriptive statistics (frequencies, means and standard deviations) were 
calculated for all quantitative variables to assess baseline antibiotic use behaviour 
patterns. Qualitative data were analysed using framework analysis. Priori codes were 
drawn from the interview topic guide, study objectives, and feasibility evaluation 
framework. LL conducted quantitative analysis and was the primary coder for 
qualitative data, along with ZXD and WWY. Consensus on themes and key findings 
were reached through discussion. 
RESULTS  
Intervention development, implementation, and feasibility testing   
Through discussion and consensus with the community advisory board, we 
defined the desired intervention outcomes of interest as reductions in expired, 
unwanted, or unused (EUU) antibiotics in households in rural China. The immediate 
outcome for the pilot intervention was to reduce household storage of antibiotics and 
inappropriate disposal. The long-term outcome was to reduce self-medication with 
antibiotics and improve awareness and norms around antibiotic use and safe 
disposal. From literature review and our pre-intervention assessment, we found most 
household antibiotics came from leftover prescriptions unintentionally stored at 
home; we therefore chose “the use of bartering market for antibiotic-take back” as 
our target behaviour, and the reduction of household antibiotic storage as our 
primary outcome.  
Intervention adaptation methods: antibiotic take-back programme 
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The intervention presented herein is adapted from U.S. National Take-Back 
Days events,20 which aim to increase public awareness of prescription drug abuse 
and promote safe disposal of expired, unwanted, or unused (EUU) prescription 
medicine by collecting leftover prescription drugs or unused controlled substances in 
the community.218,320,323,329 Supported by the Drug Enforcement Administration 
(DEA), since 2010, take-back events have been implemented across the United 
States, with more than 2,000 official collection sites biannually,329 and consist of two 
main components: drug collection and an awareness campaign. Unfortunately, few 
details have been reported on the development of the events and the rationale and 
design behind each intervention component, and their respective evaluations tend to 
be weak in design and effectiveness.323,329,330 Following the work stream plan, the 
community advisory board adapted the take-back event based on available 
evidence218,320,323,329 and the Theory of Change. The adapted intervention was mainly 
composed of two constituents: antibiotic take-back programme and health education 
messages, presented below. The main objective of the programme is to reduce 
household antibiotic storage for unsupervised use of antibiotics in the community. A 
feasibility study (reported in another manuscript) established the acceptability and 
usability of our intervention. 
Development of intervention adaptation Table 2 presents the socio-
demographic characteristics of the samples for formative study. Fifty (50) 
households were randomly sampled for pre-intervention evaluation in June 2019. 29 
out of 50 households (59.0%) self-reported to have antibiotics stored at home during 
baseline investigation. Of those who used antibiotics in the past month (n=20), 5 
(25.0%) self-reported having self-medicated with antibiotics without a prescription. 
82.4% reported being aware of the potential danger of self-medication with 
antibiotics; 78.4% were aware of the danger of unsafe disposal of antibiotics on 
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human and environmental health. 62.7% knew that antibiotics should not be 
discarded in the bin with other regular garbage. However, when asked about disposal 
practices, a majority of respondents (54.9%) had disposed of antibiotics as regular 
waste, followed by household storage (23.5%) - either unintentionally or 
purposefully for future use, and other methods (15.7%) including flushing down the 
toilet, burying in fields or feeding chickens. A total of 393 minutes of qualitative 
data were collected; each interview lasted approximately 10-34 minutes. Evidence 
generated in systematic reviews of existing evidence and primary research (aims 1-2) 
was used to inform key assumptions for developing intervention elements, which 
were further verified by the quantitative data and modified during the adaptation 
process (Table 3).  
Antibiotic take-back programme: Formative data identified platforms and 
partners to removing household antibiotics leftover in the community. A solution 
readily identified by the community advisory board was for the garbage sorting and 
recycling programme (implemented in all rural villages in Zhejiang province since 
2016) to utilise for providing the infrastructure for antibiotic take-back/removal. This 
programme includes a bartering market in which community members are 
compensated for recycled goods (e.g., through provision of common household 
items customised with health education messages). Additionally, we identified 
several common, popular household items for provision through the bartering 
market.  
Health messages: A community-based health education campaign, as well as 
the appropriate materials and dissemination strategy, were required to promote high 
levels of engagement with this programme. A panel consisting of experts in 
behavioural science, psychology, communication, health promotion, public health 
and community partners was created to inform the development of health education 
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strategies. Informed by findings from Aims 1-2 and formative data, content of the 
communication messages focused on: (a) risks of inappropriate antibiotic use and 
antibiotic disposal, (b) awareness of AMR, and (c) promotion of the antibiotic take-
back programme. The channels of dissemination included: (1) posters and pamphlets 
in public gathering areas: community centres, bartering markets, health clinics and 
township hospital outpatient departments, bus stops, community pharmacies; and (2) 
WeChat education campaigns. The design of health education materials came from a 
crowdsourcing campaign conducted by the Zhejiang University Centre of Health 
Communication in 2016, and was then tailored to improve the local community’s 
antibiotic literacy around prudent use. Figure 4 presented selected sample health 
education materials and design covering (1) how to identify antibiotics, (2) how to 
safely dispose antibiotics, (3) how to safely use antibiotics, especially when 
individuals and/or family members have a common cold, and (4) information of the 
antibiotic take-back programme. Cognitive testing was conducted with 30 residents 
prior to implementation (See Table 4). 
Formative data also identified a training need for the Women’s Federation in 
the intervention village, with a focus on identification of antibiotics and risks of 
inappropriate use or disposal of antibiotics. To meet this need, we adopted the 
training materials on prudent antibiotic use developed by China’s National Health 
Commission (Appendix I. Training materials and design) In the standard of care 
village (control), the Women’s Federation and its bartering market would continue 
their usual practices. 
Design of feasibility study  
Guided by the work stream plan, formative data were used to guide the 
design of a pilot study conducted in two villages in Zhejiang testing the acceptability 
and feasibility of an antibiotics take-back programme with respect to:  
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Reach - the community engagement approach: CAB and Women’s 
Federation will lead the outreach effort. Channels of dissemination will include 
traditional media, such as posters and pamphlets, and WeChat groups and other 
social networks. 
Effectiveness: Measures of feasibility and process evaluation data were 
adapted from evaluation studies on take-back programmes322,323,329-332 and their 
validity and reliability were retested in the target population during the pre-
intervention assessment. 
Adoption: Our formative data suggested that, although prescription drug 
diversion in the U.S. might be viewed as a type of behavioural disorder carrying 
potential social stigma,333 in China keeping antibiotics at home for future use is a 
socially acceptable common practice.60,334 While awareness of the danger of 
prescription drug abuse for non-medical purposes is high in the U.S., awareness of 
the risks of self-medication with antibiotics is relatively low in China.60,334 However, 
Zhejiang recently implemented a series of environmental protection programmes at 
the community level; therefore, awareness and social norms around environmental 
protection are high in the area. The pilot intervention therefore included messages 
about the dangers of non-prescription antibiotic use and inappropriate antibiotic 
disposal to human, community, and environmental health. The pilot will also test the 
appropriate/effective incentives for rural residents to turn in leftover antibiotics. 
Implementation: The local Women’s Federation, which runs a WeChat 
(social media) group, includes female members of all households for health 
promotion and communication purposes and is responsible for the recycling 
programme, bartering markets for recyclables. As such, they were well-positioned to 
be the implementer of the intervention. 
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Maintenance (Sustainability): Studies indicate that inconvenience, a dearth of 
readily available programmes, reduced motivation from perceived future need, and 
lack of economic incentives were major reasons for non-participation in drug take-
back events.323,329,335  CAB therefore designed the intervention to be embedded into 
existing infrastructure, allowing the antibiotic take-back programme to potentially be 
a permanent, on-going public health initiative. The existing town-run bartering 
market for recyclables was deemed the most appropriate site, allowing participating 
residents to give antibiotics directly to bartering market personnel in exchange for 
small household items. This was intended to incentivise users to bring in antibiotics, 
generate awareness, enhance a sense of local ownership of the programme, and, in 
the long run, create a new norm around antibiotic take-back for safe disposal.329   
Programme implementation and process evaluation.  Within the first month 
of pilot testing, a total of 50 households participated in the antibiotic take-back 
programme at the town centre.   We found a much greater proportion of antibiotics 
returned belonging to narrow-spectrum antibiotic groups (penicillin, amoxicillin, 
erythromycin), and a lower proportion of antibiotics belonging to more expensive, 
second-generation macrolides (azithromycin, clarithromycin). The total budget to 
conduct the household intervention and evaluation was 10,000.00 RMB for 800 
households, $1.78 per household in 2019 dollars. The cost of materials for health 
education intervention was approximately 1200.00 RMB ($172.00) per campaign. 
Details of the intervention design and materials were reported in Table 5. Figures 4 
and 5 presented sample training and health education materials demonstrating 
wording, colour, and font size.   
DISCUSSION 
This study addresses drivers of antibiotic misuse that are currently unexplored and 
unaddressed in both the literature and existing stewardship programmes across China 
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and most low-and-middle-income countries (LMIC): access to expired, unwanted, or 
unused (EUU) antibiotics in the household and unawareness of the associated danger 
on human and environmental health if not safely disposed. It contributes to the 
growing body of evidence in implementation research that seeks to understand what 
interventions do and do not work, how and why implementation succeeds or fails, 
and how improvements can be made. We described the process of developing and 
adapting an intervention from one context to another (U.S. to China) to address a 
relevant but different health concern (prescription drugs abuse to antibiotic misuse 
and antibiotic resistance) and factors affecting implementation, including the process 
of implementation. Findings from aim 1 identified a critical knowledge gap of 
rigorous studies on the development of public-targeted behavioural change 
interventions that recognise the complex, interactive social and behavioural 
influences on antibiotic use in the community. Intervention content, design, 
development and implementation strategies are rarely presented in sufficient detail, 
with limited evidence on the rationale and theory behind intervention components.  
Strengths of this study include utilisation of a mixed-methods approach to 
achieve the study aims. Employing both quantitative and qualitative methods 
allowed identification of key components of the intervention and evaluation. Both 
qualitative and quantitative data and their integration were drawn on throughout 
various research activities. The quantitative results helped to 1) investigate social 
determinants of inappropriate antibiotics use in the context of China, 2) identify the 
specifications for the development of a behavioural intervention, e.g. target 
inappropriate antibiotic practices among the target population (e.g. urban/rural, 
high/low socioeconomic status, or various age groups), and 3) test hypotheses. 
Qualitative results informed hypotheses and explored the acceptability and feasibility 
of proposed interventions.  
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Our study sites embodied the characteristics of “small worlds” 336 – where 
“everyone knows everyone else,” as described by Watts and Strogatz. The small 
worlds networks in these tight-knit communities allowed us to capitalise on two 
distinct forms of social capital - bonding and bridging – which coexist at the setting 
level and concurrently influence individual behaviours.336 In both the intervention 
and control villages, over 90% of the residents knew the chairwomen of the 
Women’s Federation, as well as at least half of the village officials, and agreed that 
their communities were tight-knit, where the residents maintained good relationships 
and were helpful to one another. Through the lens of the implementation framework, 
Neal and Neal viewed these two types of social capital as resources, namely 
“implementation capital.”337 In practice, we identified five key dimensions of 
implementation capital that determined the success of the knowledge translation 
process, which were bonding social capital, bridging social capital, human capital, 
financial capital and contextual capital. [Figure 3] The “bonding social capital” 
facilitates a sense of community and reinforces community norms. The “bridging 
social capital” connects researchers and villagers who are otherwise unfamiliar with 
each other. The former two constructs relate to whether evidence-based interventions 
can be successfully introduced to a community. We additionally identified “financial 
capital” (e.g. monetary or in-kind goods and services to run the bartering market and 
push out health messages), “human capital” (e.g. education, training or tools that 
could improve Women Federation’s capacity and capability), and “contextual 
capital,” which we defined as existing opportunity structures that make the chosen 
community a suitable location for certain activities. These latter three types of capital 
are necessary conditions in actualising the implementation of the proposed evidence-
based practice.  
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In our case, the local Chinese Women’s Federation - the most influential non-
governmental organisation (NGO) in rural China – served as a gatekeeper and 
information broker for the community. By engaging them as the implementer of the 
intervention, we harnessed their bonding and bridging capital and gained entrance to 
introduce a new idea into the community. As implementers, the Women’s Federation 
not only improved the implementation of EBP by influencing individual perceptions 
and behaviours (bonding social capital),337,338 it guided us as researchers in 
navigating local social networks (bridging social capital). Equally important, recent 
health policy reforms and the existing environmental policies set a solid foundation, 
the contextual capital, for the proposed intervention. Zhejiang province has adopted 
a national environment policy since 2010 and instituted a series of province-wide 
environmental protection programmes, including a comprehensive water governance 
policy -“Five Water Treatment (五水共治 Wǔ shuǐ gòng zhì) – and a recycling 
programme. Our formative data indicated participation in household waste sorting 
programme for environmental protection is around 65% and the bartering market for 
recyclables is 25%. The selected study sites had historical legacies of community 
infrastructure (physically and societally) for an action-oriented health education 
strategy to recycle left-over antibiotics as an environmental pollutant and biohazard.  
The aims of the proposed intervention were well-aligned with the national 
and local policies and the mission of Women’s Federation, which is to advocate for 
the rights, protection, and health of women, children and the environment. In fact, 
the antibiotic take-back programme initially proposed placing containers alongside 
other recycling bins across the community following an awareness campaign, similar 
to an approach for prescription drugs take-back tested in New Jersey.339 However, 
local Women’s Federation, who ran the local recycling programme, bartering 
markets, and the WeChat groups for female villagers, advised adapting the 
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intervention design to better utilise existing platforms and fit local context and 
networks, which allowed us to reduce the required “financial capital” and “human 
capital” for implementing the project. This way, the Women’s Federation helped 
develop solutions to tackle cross-context implementation barriers and determined the 
best way to introduce innovations into the local system. This adaptation overcame 
implementation barriers within the specific local context and improved the 
sustainability and scalability of the proposed intervention, given that most towns in 
Zhejiang province have a bartering market run by their respective local chapter of 
Women’s Federation. Therefore, within the five dimensions, one aspect of 
implementation capital might facilitate or offset the other. For example, without 
project funding to support the bartering market, even with bridging social capital, the 
intervention idea may remain in the discussion phase between researchers and 
potential implementers but never make it to implementation. Conversely, leadership 
commitment (contextual capital) may lead to more financial support from the 
government or community in the form of subsidies or donations. In this particular 
intervention, with high implementation capital, we anticipate high intervention 
feasibility and acceptability. Furthermore, interactions exist among the five domains 
of implementation capital. For example, contextual capital, such as leadership 
commitment, could be leveraged to mobilise social capital along with other 
resources to support the implementation of evidence-based practices. Though we 
mainly kept the proposed project grassroots and locally run, in practice, commitment 
from the township government helped open the door to potential study sites where 
local community leaders welcomed researchers.   
Our formative data demonstrated residents’ concerns over antibiotics as 
pollutants to the environment (78.4%). Future studies should explore how public 
concerns can be leveraged as contextual capital and engage communities in a “One 
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Health” intervention aiming to increase prudent antibiotic use and disposal. Future 
research on social networks may expand on the “small worlds” theory and generate 
additional insight regarding the diffusion of innovations for reducing antibiotic 
misuse.  
CONCLUSION 
This study fills the knowledge gap by describing systematic steps taken to 
adapt a theory-driven, community-based intervention for a new context and a new 
health risk. There is a lack of environmentally safe disposal guidelines and take-back 
services for the proper disposal of antibiotics in China. In this study, we described 
the steps we took to employ the theory-based work stream plan to guide the 
development and assessment of community-based interventions. Evidence 
established that exposure to the educational messages is insufficient to overcome the 
influence of past behaviours of antibiotic use.207 This proposed intervention served a 
dual-purpose: (a) to reduce access to unnecessary antibiotics in the household, and 
(b) to promote safe disposal. The intervention addresses a critical need of a public-
targeted behavioural change intervention to decrease inappropriate antibiotic use in 
the community. This study also illustrated the critical role five-dimensional 
implementation capital plays in facilitating the knowledge translation process from 
evidence to an intervention that aims to tackle antibiotic misuse in the community 
setting in the local context.  
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Table 1. Work stream plan 
 
Aims Alignment with  
6SQuID91 
Methods/Ta
sks 
Activities Products 
Aim 1: Synthesise 
existing evidence 
about the problem 
and explore 
possible solutions 
 
 
 
 
Step 1. defining and 
understanding the problem 
and its causes;  
 
Step 2. identifying which 
causal or contextual factors 
are modifiable: which have 
the greatest scope for 
change and who would 
benefit most;  
Systematic 
Reviews 
1) Systematic review (SR1) on determinants of 
antibiotic misuse in the community, including 
primary care and hospital outpatient clinics in 
the Chinese context.  
2) Systematic review (SR2) on public-targeted 
behavioural change interventions to reduce 
inappropriate, unnecessary, and non-essential 
use of medicines or medical procedures. 
3) SR1 and thematic synthesis of qualitative 
studies of views, attitudes and experiences of 
health care providers and users (i.e. health 
professionals, patients, and caregivers) about 
treatment choices and antibiotic use for self-
limiting illnesses in the Chinese context. 
4) Synthesis of SR1 and SR2 to identify 
knowledge gaps where determinants of 
antibiotic misuse in the community are 
insufficiently addressed.  
Key 
assumptions 
about the 
problem 
Aim 2:Assess  
problems in the 
context and form 
assumptions 
Step 2. identifying which 
causal or contextual factors 
are modifiable: which have 
the greatest scope for 
change and who would 
benefit most; 
 
Step 3. deciding on the 
mechanisms of change; 
 
Quantitativ
e Research 
1) Large-scale surveys on knowledge, attitudes 
and practice of treatment choice and antibiotic 
use among young adults (university students) 
regarding self-limiting illnesses in the Chinese 
context. 
2) Large-scale surveys on knowledge, attitudes 
and practice of treatment choices and antibiotic 
use among young parents (with children under 
13) with respect to self-limiting illnesses in the 
Chinese context. 
Key 
assumptions 
about the 
problem 
Aim 3: Develop 
and adapt 
intervention 
 
 
Step 4. clarifying how these 
will be delivered;   
 
Mixed-
methods 
3a. Theoretical Model Development 
1) Development of a Theory of Change (ToC). 
2) Formation of key assumptions for intervention 
development. 
Theory of 
Change 
(Figure 1-5) 
3b: Preparation for Knowledge Translation  
1) Scoping and stage-setting  Identify pilot sites  Introduce proposed project aims and 
explain rationale for an intervention  Confirm presence of problems identified 
and needs  Introduce intervention adaptation process  Establish partnership and collaboration 
2) Preparation for adaptation of knowledge to 
local context  Define desired aim and the behavioural 
target of this intervention  Explore and identify intervention 
components  Discuss how the intervention may or may 
not address the problems and needs  Discuss how the intervention may or may 
not address key planning and evaluation 
issues: reach, effectiveness, adoption, 
implementation, maintenance (RE-AIM).  Identify areas for intervention adaption  Map resources needed to implement a pilot 
intervention and assess available 
Implementation Capital for evidence-
based practice    Form logic model 
Logic model 
 
Step 5. testing and adapting 
the intervention 
Implementation (pilot) 
3c: Realist assessment of problems and needs of 
local context and appropriateness of proposed 
intervention 
1) Conduct pre-intervention (baseline) evaluation, 
which consists of face-to-face surveys with 
quantitative and qualitative components, to 
assess problems and needs in local context. 
2) Interview stakeholders to assess 
appropriateness, acceptability and feasibility of 
the proposed intervention.  
3) Evidence synthesis of findings from Aims 1-2 
and realist assessments with target population 
and stakeholders:  Identify the objectives, content, and 
channels for delivery of key health 
messages for the proposed intervention.   Pilot-test health messages. 
4) Critically synthesise mixed-methods findings 
revising the logic model and finalising the 
adapted intervention 
Finalised 
logic model 
 
Finalised  
intervention 
design for 
feasibility 
study  
Aim 4: Evaluation: 
Assess feasibility 
and acceptability of 
the intervention 
 
Step 5. testing and adapting 
the intervention  
 
(Note: for this project, I 
only conducted feasibility 
evaluation) 
Mixed-
methods 
1) Develop feasibility study design 
2) Conduct endpoint and follow-up evaluations 
3) Conduct process evaluation 
4) Analyse evaluation outcomes 
5) Address 14 methodological issues of feasibility 
research for full-scale intervention 
development  
6) Identify strengths, limitations and next steps  
Finalised 
intervention 
design for 
pilot study 
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Table 2. Sample characteristics 
 
 INTERVENTION CONTROL 
Number of Household 916 447 
Population size 3015 1624 
Data collection methods Household Survey 
n (%) 
Stakeholders 
Interviews, n (%) 
Household Survey 
n (%) 
Sample size n=50 n=21 n=50 
Sex    
Woman 42 (84.0) 19 (90.5) 36 (72.0) 
Man  8 (16.0) 2 (9.5) 14 (28.0) 
Age    
Minimum  23 24 22 
Mean (sd) 45.5 (10.0) 40.6 (9.1) 49.3 (15.1) 
Maximum  65 54 72 
Highest Attainment Education    
College or above (> 12 years) 3 (6.0) 3 (14.3) 7 (14.0) 
High school (10-12 years) 11 (22.0) 5 (23.8) 10 (20.0) 
Middle school (6-9 years) 24 (48.0) 10 (47.6) 17 (34.0) 
Primary school or less (=<6 years) 12 (24.0) 3 (14.3) 16 (32.0) 
Income    
>10000 3 (6.0) 0 8 (16.0) 
5001-10000 16 (32.0) 6 (28.6) 9 (18.0) 
3001-5000 17 (34.0) 12 (57.1) 16 (32.0) 
<3000 14 (28.0) 3 (14.3) 17 (34.0) 
Employment    
Yes 21 (42.0) 9 (42.3) 11 (22.0) 
No 29 (58.0) 12 (57.1) 39 (78.0) 
Children in the household    
Yes 47 (94.0) 19 (90.5) 33 (66.0) 
No 3 (6.0) 2 (9.5) 17 (34.0) 
Social Capital    
I think my village is a tight-knit 
community; people are very helpful    
Agree 40 (80.0)  43 (86.0) 
Neutral 10 (20.0)  7 (14.0) 
Disagree 0 (0.0)  0 (0.0) 
Do you know the chairwoman of Women’s 
Federation 
   
Yes 48 (96.0)  46 (92.0) 
No 2 (4.0)  4 (8.0) 
People is my village keep frequent contact 
with each other     
Agree 29 (58.0)  31 (62.0) 
Neutral 16 (32.0)  9 (18.0) 
Disagree 5 (10.0)  10 (20.0) 
If I have to make be away for a couple of 
days with short notice, I can ask 
neighbours to look after my family  
   
Agree 34 (68.0)  20 (40.0) 
Neutral 10 (20.0)  13 (26.0) 
Disagree 6 (12.0)  17 (34.0) 
Knowledge and attitudes    
Excessive use of antibiotics will lead to 
antibiotic resistance rendering antibiotics 
to be ineffective in the future 
 
 
  
 
Agree 38 (76.0)  36 (72.0) 
Neutral 6 (12.0)  11 (22.0) 
Disagree 6 (12.0)  3 (6.0) 
One should always obtain a medical 
prescription when using antibiotics  
 
 
  
 
Agree 41 (82.0)  40 (80.0) 
Neutral 5 (10.0)  4 (8.0) 
Disagree 4 (8.0)  6 (12.0) 
Unsafe disposal of antibiotics might cause 
environmental hazard 
 
 
  
 
Agree 39 (78.0)  35 (70.0) 
Neutral 5 (10.0)  10 (20.0) 
Disagree 6 (12.0)  5 (10.0) 
I know when and how to use antibiotics 
when I am/my family is sick 
 
 
  
 
Agree 9 (18.0)  10 (20.0) 
Neutral 13 (26.0)  4 (80.0) 
Disagree 28 (56.0)  36 (72.0) 
Antibiotic use and disposal behaviours    
Household antibiotic storage in the past 
year 
   
Yes 29 (58.0)  23 (46.0) 
No 21 (42.0)  27 (54.0) 
Taken antibiotics in the past month    
Yes 20 (40.0)  14 (28.0) 
No 30 (60.0)  36 (72.0) 
Self-medication with antibiotics in the past 
month 
 
(N=20) 
  
(N=14) 
Yes 5 (25.0)  2 (14.3) 
No 15 (75.0)  12 (85.7) 
Methods to dispose expired, unwanted, 
unused (EUU) antibiotics 
 
 
  
 
Stored in the house 5 (10.0)  1 (2.0) 
Thrown into garbage bin 28 (56.0)  44 (88.0) 
Flushed in the toilet 4 (8.0)  1 (2.0) 
Buried in the field 3 (6.0)  1 (2.0) 
Fed chicken 2 (4.0)  0 (0.0) 
Ingestion 2 (4.0)  1 (2.0) 
Others 6 (12.0)  2 (4.0) 
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Table 3. Key assumptions and adaptation of intervention strategy 
Key assumptions about the pilot community Initial Assumption Formative data to 
verify the assumptions 
Adaptation 
1. Prevalence of household storage of 
antibiotics 
High Unchanged In additional to the current AMR awareness 
messages, intervention strategy should focus 
on:  
(1) defining appropriateness of antibiotic 
disposal 
(2) discouraging household storage of 
antibiotics 
(3) promoting the antibiotic take-back 
programme at the bartering market as 
a preferred platform for EUU 
antibiotics 
(4) appealing to the public concern over 
environmental health  
 
 
2. Prevalence of self-medication with 
antibiotics 
High Unchanged 
3. Awareness of the danger of unsafe antibiotic 
disposal to the environment 
Low High 
4. Awareness of the danger of AMR on human 
health  
Low High 
5. Likelihood to use a drug take-back service  Residents would be more 
likely to use a drug take-back 
service if offered 
compensation and/or if the 
collection site was in a 
frequently visited location 
Unchanged 
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Table 4. Development of health education strategy  
 Qualitative data to inform the development of health education 
strategy (selected quotations) 
Key decisions for the health 
education strategy 
Content Note: content for health education was informed by findings from Aims 1 
and 2 (existing literature and primary research data) where we focused on 
improving awareness of the danger of self-medication with antibiotics and 
unsafe disposal.  
Expert panel evaluated the content 
validity 
Cognitive testing with residents of a 
village of similar characteristics 
Format/Dissemination 
Channels 
 “If you send us a WeChat message, I will read it very diligently.” 
 “The broadcast can actually be heard. Everyone heard it when they 
were buying something on this street.” 
 “News passes quickly from mouth to mouth: everyone will know it”. 
 “WeChat is very good. If it is sent during breakfast, lunch and dinner, 
definitely someone will see it.” 
 “WeChat is fine. I’ve just been too busy recently looking after the 
store, so I didn’t have time to look at it. Nevertheless, if I know there 
is such a thing, I will pay attention to it. ” 
WeChat, posters, pamphlets, radio 
(public announcements), social 
networks 
Frequency/Timing  “If we are sent a message, it is best to send it after 7 or 8 in the 
evening or during our break at noon. Otherwise, we will miss and not 
be able to read it, and even when we are not busy, we will forget 
about it.” 
 “WeChat is very good. If it is sent during breakfast, lunch and dinner, 
definitely someone will see it.” 
Lunch time (12-1pm) 
Dinner time or right after (6-9 pm) 
 
Target audience  I received the WeChat message and read it seriously, but I still need 
to use the medicine myself. 
 I think the acceptance rate of the youth should still be good. 
Young adults 
Residents with an active WeChat 
account 
Messengers CAB meetings: Women’s Federation is connected with all female adults in 
the households and runs the bartering market for recyclables. Our baseline 
data showed 96% (n=48/50) of the residents know the chairwoman of the 
Women’s Federation.  
Women’s Federation 
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Table 5. Intervention materials design and descriptions 
 Target Sessions When Where Materials Description 
Health education 
Programme 
implementer 
Women’s 
Federation 
(n=1) 
45-minute 
briefing and 
training 
May 2019 Village health centre 20-page training guide  Manual including project description and study aims, 
pre-tested health education messages, and guidelines 
(See Figure 4 & Appendices I) 
Target 
population 
Village women 
(n= est. 600 
households) 
Four health 
education 
messages 
June 2019 mobile pre-tested health 
education messages 
Pre-tested health education campaign emphasizes four 
primary messages (antibiotics do not help colds and flu, 
colds and flu are not caused by viruses, antibiotics do 
not kill viruses, do not take antibiotics for colds and 
flu) 
Recycling programme 
Programme 
implementer 
Women’s 
Federation 
(n=1) 
45-minute 
briefing and 
training 
May 2019 Village health centre Feedback form and a 
worksheet for  
antibiotic recycling 
programme 
A monitoring and evaluation form to record antibiotic 
returned to the programme and items in exchange. 
Target 
population 
Villager 
residents 
Entire 
project 
period 
June 2019 Village clinics: (n=1) 
Recycling 
programme (n=1) 
Mail: n=800 
 
Pamphlet  Pamphlet: 21 x 29.7 cm (A4), colour-print, triple fold 
with Zhejiang University logo; emphasizes four 
primary messages (antibiotics do not help colds and flu, 
colds and flu are not caused by viruses, antibiotics do 
not kill viruses, do not take antibiotics for colds and 
flu) (See Figure 4) 
Target 
population 
Villager 
residents 
Entire 
project 
period 
June 2019 Bus stop: (n=8) 
Village clinics: (n=1) 
Recycling 
programme (n=1) 
 
Poster Poster: 60.96 x 91.44 cm; colour; photos of parents not 
to take antibiotics for colds and flu (See Figure 4) 
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Figure 1. Theory of Change 
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Figure 2. Logic Model: antibiotic take-back programme in rural China 
Inputs 
  
Outputs 
  Outcomes – Impact   
 Activities Participation  Short-term Intermediate term Long-term 
Impact 
 
Implementation capital 
of the community 
advisory board and 
Women’s Federation 
 
Funding 
 
State-run environmental 
initiatives: 
 “Five Water Treatment”   
 “Waste Sorting and 
Recycling” programme 
 
Health education materials 
from the Zhejiang 
University crowdsourcing 
campaign 
 
Women’s Federation’s 
WeChat platform 
connecting female 
villagers 
 
Town-run bartering 
market for recyclables  
 
 
 
  
Number of health 
education materials 
distributed 
 
Number of health 
education messages 
disseminated  
 
Number of 
households reached 
 
Number of work 
hours by Women’s 
Federation which 
runs the bartering 
market 
 
Number of 
household items 
exchanged at the 
bartering market 
 
Number and type of 
dispose expired, 
unused, unwanted 
(EUU) antibiotics 
returned  
 
 
Residents  
 
Women’s 
Federation 
 
Community 
advisory board 
 
  
Increase in 
awareness of the 
danger of self-
medication with 
antibiotics without 
professional advice 
 
Increase in  
awareness of the 
danger of unsafe 
disposal of 
antibiotics  
 
Increase in number 
of residents using 
the bartering market 
to dispose expired, 
unused, unwanted 
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reporting greater 
satisfaction using 
the bartering market 
 
 
Reduction in 
number of residents 
storing antibiotics at 
home  
 
Reduction in 
number of residents 
engaging in unsafe 
disposal of 
antibiotics  
 
Reduction in 
number of residents 
engaging in self-
medication of 
antibiotics without 
professional advice 
 
 
Improving in norm 
discouraging self-
medication with 
antibiotics  
 
Improving in norm 
encouraging safe 
disposal of 
antibiotics  
 
Improving in 
prudent use of 
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community 
 
Reduction in 
prevalence of 
antibiotic resistance 
in the community 
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Figure 3. Implementation Capital for Evidence-Based Practice 
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Figure 4. Sample health education materials and design 
 
(a) poster (I) – antibiotic literacy:
 
Attention!!! 
The drugs above are all antibiotics. You should not use them without professional 
guidance nor store them at home. Keeping antibiotics at home is associated with an 
increased risk of self-medication with antibiotics; irresponsible disposal of antibiotics 
leads to environmental pollution.  
Please bring your household antibiotic stock to the antibiotic take-back site in the 
village. In exchange, you will receive a small household item provided by Zhejiang 
University for your participation and support.  
[Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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(b) poster II: care management for children with the common cold or flu 
 
      
Do not give antibiotics to children for the common cold or flu. 
Please consult your doctor regarding how to alleviate the cold symptoms experienced 
by your children. 
Please do not ask doctors for antibiotics (oral antibiotics or IV) 
Antibiotics are not effective to treat the common cold, to alleviate cold symptoms, or to 
expedite cold recovery, caused by a virus. Rather, antibiotics might have an adverse 
impact on children’s health. The best tips for getting over the common cold are to drink 
plenty of fluids and get plenty of rest. 
[Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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(c) pamphlet: prudent use of antibiotics  
 
 
 Antibiotics can save lives, but 
not a cure all 
 If you don’t use antibiotics 
responsibly, not only does it not 
benefit your children, but might 
have an adverse impact 
 Antibiotics can be effective for 
bacterial infections, but not for 
viral infections 
 Antibiotics can eliminate 
bacteria, but not virus. 
 When children are sick, 
antibiotics are not the only 
option. If it is necessary to use 
antibiotics, IV is saved for more 
severe cases. 
Please let 
doctors 
determine 
children’s 
antibiotic 
use. Please 
do not ask 
doctors for 
antibiotics 
(oral 
antibiotics or 
IV) 
 
Please use antibiotics 
responsibly. You should 
learn antibiotic literacy. 
Please do not give 
antibiotics to children for 
the common cold or 
stuffy/runny nose. 
 
[Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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Appendix I. Training materials and design 
 
 
 
Manual on prudent antibiotic use  
 
Protect your own health. Please use 
antibiotics responsibly. 
 
Edited by the National Health 
Commission  
 
Peking University Medical Press 
Table of Contents 
1. What are antibiotics? 
2. How to recognise antibiotics? 
3. What is inappropriate use of 
antibiotics? 
4. Why do antibiotics lose their efficacy? 
5. The damage of antibiotic abuse 
6. What to do? 
7. What not to do?  
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CHAPTER EIGHT 
Cleaning up China’s medicine cabinet – an antibiotic take-back 
programme to reduce unsafe use and disposal of household antibiotics 
in rural China: a mixed-methods feasibility study 
This chapter presents the results of a pilot study conducted in two villages in rural 
Zhejiang – one intervention and one control - in June 2019 testing the acceptability and 
feasibility of an antibiotic take-back programme with respect to:  the community 
engagement approach; the appropriate/effective incentives for rural residents to turn in 
household antibiotics; the appropriateness and literacy level of health education 
messages. 
My local partners at Zhejiang University funded and implemented the pilot study on the 
proposed behavioural change intervention. I designed and led the feasibility evaluation 
for the proposed intervention that aimed to remove household storage of antibiotics in 
the community. Assisted by in Zhejiang University, fifty (50) households from the 
intervention village were randomly sampled for pre- and post-assessment; fifty (50) 
households with similar characteristics from different village served as control group. 
The intervention components were found to be feasible, appropriate, and acceptable, 
with high scalability. The findings and results have been prepared as a draft of the 
manuscript, with comments on drafts from Weiyi Wang, Professors James Hargreaves, 
Mark Petticrew, and Xudong Zhou. This manuscript has been accepted by Antibiotics.  
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ABSTRACT 
BACKGROUND: Antibiotic misuse and unsafe disposal harm the environment and 
human health and contribute to the global threat of antimicrobial resistance. 
Unsupervised use and careless disposal of medications is a common practice in China 
and most low- and middle-income countries (LMICs). This study assesses the feasibility 
of an evidence-based, theory-informed, community-based take-back programme for 
disposing household’s expired, unwanted, or unused antibiotics in rural China.  
METHODS: Guided by the Medical Research Council’s (MRC) framework for the 
evaluation of complex interventions and the RE-AIM (Reach, Effectiveness, Adoption, 
Implementation, and Maintenance) framework, this mixed-methods research design 
comprised a controlled pre–post quantitative component and embedded qualitative 
component. The study methodology’s feasibility was examined using following data : 
1) quantitative surveying of a representative community panel of 50 households, and 2) 
qualitative semi-structured stakeholders’ interviews. Specifically, quantitative data from 
three implementation phases (i.e. pre-intervention, intervention, and post-intervention) 
were used to assess recruitment, retention, follow-up measure response rates, missing 
follow-up measure data, and usage data. Qualitative data were gathered to assess 
acceptability. Data from a similar village – serving as a control – were also collected.  
RESULTS: All a priori feasibility objectives were met: conversion to consent was 
100.0% (100 screened, approached, recruited and consented). All participants 
completed the pre-intervention assessment, and 44/50 households in the intervention 
village completed the post-intervention assessment. The programme, embedded in 
existing social and physical infrastructure for dissemination, directly reached over 
68.2% (30/44) of its target audience. Fourteen implementation research methodological 
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issues for future full-scale trials (e.g. sample size calculation, eligibility, recruitment, 
etc.) were critically examined and summarised. 
CONCLUSION: This feasibility study presents an overall favourable public response 
toward a theory-driven, community-based bartering market for antibiotic-take-back as a 
feasible, acceptable, and appropriate intervention, warranting the expansion of the pilot 
programme. It filled the knowledge gap by describing systematic steps taken to adapt 
community-based interventions for a new context and a new health risk, and to conduct 
feasibility studies. This study illustrates the feasibility, acceptability, and potential 
efficacy of community-based antibiotic take-back programmes to encourage safe 
antibiotic use and disposal in the rural community.  
KEYWORDS: drug take-back; environment; community health; drug abuse; 
prescription drugs; antimicrobial resistance (AMR) 
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BACKGROUND 
The effectiveness of antibiotics has been undermined by decades of antibiotic misuse 
constituting a global health threat - antimicrobial resistance (AMR) - that might threaten 
human survival.43,340 A majority of human antibiotic consumption occurs in community 
settings outside of clinical facilities, especially in low-and-middle income countries 
(LMICs) where antibiotic self-medication is close to 40%; half of these antibiotics come 
from household storage.305 China, one of the world's largest producers and consumers of 
antibiotics, faces among the most severe challenges of this crisis, with antibiotic 
residues and resistance genes detectable in surface water, waste water treatment plants, 
soil, vegetable produce, and animals.32,42,341,342 Since 2011, the Chinese government has 
implemented a series of measures to contain this problem; however, most of these 
stewardship programmes focus on regulating prescriptions in hospitals and few address 
the easy access to antibiotics available in communities.269 Nationwide surveys 
demonstrated that over 70% of Chinese households stored antibiotics that were 
eventually self-administered without professional supervision.41,68,305,316  
Recent reviews showed expired, unwanted, or unused (EUU) medicines were either 
stored unintentionally as leftovers or kept purposefully to treat similar conditions in the 
future (33%); among those who disposed of unused medicines, 50% used a take-back 
programme and 42% disposed the medicines in the trash or toilet.320,329,343,344 The 
improper disposal of unused antibiotics can harm the health of the environment, 
wildlife, and humans, especially in countries, like China, with poor waste management 
systems.320 The awareness and concern over the presence of pharmaceuticals in 
drinking water and the threat of misuse posed by EUU medications has led to 
interventions like drug take-back programs for the removal of household access in 
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developed countries (e.g. the United States, Sweden, and Germany) in the past 
decade.330,344 Evaluations of take-back events demonstrated their positive effect on 
raising awareness about and reducing misuse or abuse of drugs.218,321-323 The attention 
on ecopharmacovigilance (EPV) in China is recent, which focuses on minimization 
of environmental risks posed by pharmaceutical residues and the needs to guard 
against and control the pharmaceutical pollution source.345-348 However, despite being 
one of the largest producers and consumers of antibiotics, discussions about safely 
disposing of antibiotics are practically non-existent in China. No interventions to date 
have attempted to address non-prescription household antibiotics use. There are few 
convenient and environmentally responsible disposal methods for systemically 
removing or reducing household antibiotic stockpiles in China, and public-targeted 
interventions are a pressing need.  
In this study, we employed a mixed-methods approach to assess the feasibility and 
acceptance of an antibiotic take-back and disposal programme in rural China where 
antibiotic misuse in the community is the most severe.65,324  
METHODS 
This study aims to determine the feasibility and acceptability of the proposed 
intervention, an antibiotic take-back programme in rural China. The proposed 
intervention consists of two components: a community-based antibiotic take-back 
programme and health education. We first pre-tested intervention materials and 
implementation methods with experts and potential users for validity and 
appropriateness. Second, we explored stakeholders’ views on potential facilitators and 
barriers to the intervention. Last, utilising a mixed-methods design, we assessed the 
feasibility, acceptability, and scalability of a pilot intervention and explored its 
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effectiveness. The study design and process of adapting existing interventions to new 
populations and settings are reported in detail elsewhere. 
Feasibility study design 
Guided by the Medical Research Council’s (MRC) framework for the evaluation of 
complex interventions349 and the RE-AIM (Reach, Effectiveness, Adoption, 
Implementation, and Maintenance) framework,327 this mixed-methods research design 
comprised a controlled pre–post quantitative component and embedded qualitative 
component. The study methodology’s feasibility was first examined using the following 
quantitative data: recruitment, retention, follow-up measure response rates, missing 
follow-up measure data, and usage data. The study design and intervention’s feasibility 
and acceptability were then explored using qualitative semi-structured interviews with 
stakeholders. We noted that this pilot study was designed to test the feasibility of one 
intervention component of a large trial on complex intervention, not the efficacy or 
effectiveness of the new intervention, which is the aim of a full scale randomized 
controlled trial (RCT).350 Lastly, we systematically explored and addressed the 14 
potential methodological issues of feasibility studies identified by Bugge et al and 
Shanyinde et al.351,352 
Setting and sample  
Feasibility data for the intervention came from a representative community panel of 50 
households in two rural villages – one intervention and one control - in Zhejiang, China, 
conducted over the first 30 days of implementation of an antibiotic take-back 
programme in June 2019. All households in the villages were eligible for inclusion and 
those agreeing to participate gave informed consent. Due to the intervention design and 
the local context, we targeted the self-identified female heads of household. Qualitative 
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data came from 21 purposively-selected stakeholders of the community, who 
represented the characteristics relevant to the study setting in terms of age, gender, 
socio-economic status, and community roles.  
Data collection and management 
For baseline, intervention, and post-intervention evaluations with the community panel, 
face-to-face household surveys consisted of quantitative and qualitative items assessing 
antibiotic use and disposal behaviours, exposure to and participation in the programme, 
and public knowledge and perceptions about antibiotic use. Inspections of household 
medical cabinets were conducted at the end of each survey. Stakeholders, including 
residents, local government officials, community partners, potential implementers of the 
intervention, community pharmacies and clinicians, and local residents, were recruited 
for semi-structured interviews and to access process evaluation data in the pilot village. 
Baseline and final evaluation data - both quantitative and qualitative - were also 
collected from the control village with a similar sample. Stakeholders’ interviews were 
audio-recorded, transcribed by an independent transcription company, checked for 
accuracy, anonymised and imported into Nvivo11 software to facilitate analysis. 
Sample size 
While a sample size was not calculated (outcomes of interest were intervention and 
study design feasibility and acceptability), previous studies have identified a minimum 
of 20 participants is required to identify 95% of usability problems.353 Although there is 
current no published guidance as to the sample size required for a pilot or feasibility 
trial and that this pilot study employed a controlled pre-and-post design (not a trial), we 
set the sample size to be 50 household per arm, which was higher than the median 
among the published UK pilot trials.354 This intervention was delivered at the village, 
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rather than the individual, level. In a full-scale study, village- or township-level 
randomisation as part of a cluster trial would be appropriate. For this study, the 
feasibility of randomisation was not tested.  
Measures  
The intervention aimed to reduce household antibiotic storage and improve safe 
antibiotic disposal; this informed measure selection. The feasibility and acceptability of 
the selected study measures were assessed to determine those most appropriate for a 
future cluster trial.  
Primary measures: The primary objective was to describe antibiotic storage and 
disposal behaviours. All respondents were asked whether, in the past month, they have: 
(a) kept antibiotics at home and (b) participated in the take-back programme.  
Secondary measures included awareness and perceptions of the potential danger of 
“unsafe disposal” and “non-prescription antibiotic use” on human and environmental 
health. 
Process evaluation: Routine data on programme utilisation, costs, and in-kind expenses 
were calculated. Returned antibiotics were stored in a pre-prepared bag with a pre-
designed information sheet including details of each collection, e.g. types and amount 
of the drugs received and source of antibiotics, and user’s satisfaction.  
Data on participants’ socio-demographic characteristics were also collected. 
Data analysis 
Descriptive statistics (frequencies, means and standard deviations) were calculated for 
all variables. Qualitative data were analysed using framework analysis. A priori codes 
were drawn from the interview topic guide, study objectives, and feasibility evaluation 
framework. LL was the primary coder and interpreted the data, along with two other 
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coders, ZXD and WWY. Consensus on themes and key findings were reached through 
discussion. 
RESULTS  
Table 1 reports the demographic and background characteristics of the study 
participants. A total of 412 minutes of qualitative stakeholders interview data were 
collected (n=21); each interview lasted approximately 10-34 minutes. 19 out of 21 
respondents were female; all but three did not go to college. The mean age was 40.6 
(±9.1) years. In the intervention village, 29 of the 50 households who completed the 
questionnaire in the baseline surveys self-reported having antibiotics stored at home 
prior to intervention; among them, seven (7) returned the antibiotics during the 30-day 
intervention period. 20 out of 50 reported having taken antibiotics within the month 
before the baseline survey; among them, five (5) took antibiotics without a prescription. 
44 households in the intervention village and 39 households in the control village 
completed the post-intervention questionnaires with no missing data. Additionally, a 
month after the intervention, a follow-up assessment was conducted in pilot village to 
understand the change in awareness and perceptions of the potential danger of “non-
prescription antibiotic use” and “unsafe disposal” on human and environmental health. 
Table 2 presented that 40 households in the intervention village completed the 
assessment with one household skipped several items (missing data). Due to the nature 
of the data and small sample size, these analyses are only useful for descriptive 
purposes.  
Recruitment and retention: Fifty households in each study site were approached; all 
were eligible and recruited. The proportion of households approached who consented 
(conversion to consent) was 100% - well above the target set of 60.0%. Among them, 
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44 in the intervention village and 39 in the control village retained and completed the 
pre- and post-intervention questionnaires.  
Reach is measured by the percentage of residents who were informed about the 
programme and were potential users. 30 out of 44 households in the community panel 
had heard of the antibiotic take-back programme. 13.3% had heard about it from 
WeChat and Women’s Federation, over 90% from print materials.  
Effectiveness is measured by project participation and increases in awareness of the 
danger of unsafe use or disposal of antibiotics. A total of 48 households used the 
bartering market (7 households from the community panel) and 34 said they would 
recommend other villages to adopt the antibiotic take-back programme in their bartering 
markets. 
Adoption: No barriers to adoption were identified by implementers. Not knowing about 
the take-back programme, no household storage, and no time to bring antibiotics in 
were listed as the top three reasons for non-participation. Nevertheless, 38 households 
intended to participate in the future and 8 already recommended using the bartering 
market for antibiotic take-back to at least one other person in the past month. 
Implementation of the programme, measured by fidelity, was delivered as intended. All 
eligible Women’s Federation members were actively involved in intervention delivery. 
A total of 48 households used the bartering market for antibiotic take-back and disposal; 
all returned antibiotics were properly sorted and documented according to study 
protocol, reported in Table 2. Intervention adherence and participant compliance was 
achieved. 
Maintenance concerns the long-term maintenance of behaviour change at the individual 
level, which is not assessed in this study. At the village level, the potential for the 
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antibiotic take-back programme to become a routine part of the culture is high. Among 
the 44 households who completed the post-intervention assessment, 40 interviewees 
thought the take-back programme should stay a part of the bartering market and be 
promoted to other villages, 4 stayed neutral, and none disagreed.  
Acceptability and appropriateness: The acceptability and appropriateness of the 
intervention is high. Awareness around the environmental protection is high. The 
intervention was appropriate, acceptable and sustainable to the implementers, the 
Women’s Federation. Data from the control group showed high acceptability for 
participating in an antibiotic take-back programme (31/36), which will indicate 
scalability. 
Process evaluation outcomes are reported in Table 2.  Respondents listed reasons to 
continue or expand the bartering market for antibiotic-take back: 34 said to protect the 
environment, 18 to prevent inappropriate use at home, and 12 because there is no other 
platform to safely dispose antibiotics, and 10 respondents felt incentivized by the 
household items at the bartering market.  
Data that address 14 implementation research methodological issues for future full-scale 
trials are presented in Table 3.  
DISCUSSION 
This is one of the first feasibility studies in China and in low-and-middle income 
countries (LMIC) for a community-based behavioural change intervention to reduce 
antibiotic misuse and resistance. This study presents the high feasibility and 
acceptability of a community-based antibiotic take-back service offered at a local 
bartering market for recyclables. The overall positive feedback supports the need and 
warrants the continuation and expansion of the programme. There is a lack of 
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environmentally safe disposal guidelines and take-back services for the proper disposal 
of antibiotics in China. This proposed intervention served a dual-purpose: (a) to reduce 
access to unnecessary antibiotics in the household and the likelihood of self-medication 
with antibiotics without supervision, and (b) to promote safe disposal and protect the 
environment. Villagers confirmed the local town-run bartering market as a convenient 
site for an antibiotic disposal programme. Health education and removal of household 
antibiotic storage can reduce the likelihood of self-medication with antibiotics.  
Strengths of this study include utilisation of a mixed-methods approach and adoption of 
the RE-AIM and MRC evaluation frameworks to achieve the study aims. With RE-AIM 
constructs embedded in the study design since project inception, we were equipped to 
identify ‘what works for whom, in what contexts, and how.’ The findings from this 
study should be interpreted with several limitations. The small sample and use of one 
site may seem to limit the results’ generalisability. Because data were collected from a 
representative sample of rural Chinese residents in the participating site, representing 
5.5% (50/916) of the households, and from a control site (11.2%, 50/447) at three 
different time points, the general pattern of findings observed in this study is 
sufficiently robust for a feasibility study to alleviate concerns about potential 
spuriousness. This investigation offers needed empirical feasibility data on the 
antibiotic take-back programme for a large trial. 
Interpretation of findings 
This study identified a critical gap of current AMR strategy in the Chinese 
infrastructure where EUU antibiotics in the community are left unattended. There is a 
lack of knowledge of and platform for proper disposal and a strong interest in 
participating in take-back programmes. Formative data found that the local awareness 
316 | P a g e  
 
and concern over the presence of pharmaceuticals in drinking water and the threat of 
misuse were high in both intervention and control villages, yet self-medication with 
antibiotics were common among local residents who seemed to be unsure of what 
constitutes proper disposal and showed reluctance in giving up habits of household 
storage of antibiotics. We found individual’s health decisions about antibiotic use to be 
complex and not entirely driven by their cognitive and rational characteristics - 
contextual factors, including access to antibiotics and interpersonal connections, are 
equally or more critical to healthcare decision-making processes. Evidence showed 
when information or time is limited and complexity of the situation is overwhelming, 
individuals often combine rationality with other sources of so-called tacit or experiential 
knowledge and utilise strategies such as trust, intuition and emotion to assist decision 
making.238  Antibiotic misuse in China is driven by a complex set of factors embedded 
in its culture and beliefs, health system, and society.30,41,44 Data from this project 
highlighted that increasing knowledge and raising awareness about the consequences of 
the inappropriate use and disposal alone is unlikely to enable the desired behaviour 
change. A complex intervention that also support prudent prescriptions, reduce over-
the-counter purchases, improve dispensing system to reduce leftover prescriptions in 
addition to the proposed community-based intervention for an extended period of time 
will be necessary. Further clarifications about what constitutes “appropriate practices” 
in the given context should be included in the education intervention. In our sampled 
villages, respondents who engaged in misuse  behaviours such as feeding children with 
antibiotics, burying them in the field, taking them before expiration, or not thinking 
antibiotics can “go bad” might consider their behaviour as “being completely 
appropriate.” Changing the local social and infrastructure environments for appropriate 
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antibiotic use and disposal while providing actionable information about how and 
when/where to use and dispose antibiotics are key to cue people to action. Educating 
about how to care for common self-limiting illnesses and non-antibiotic alternatives for 
symptom relief will improve the likelihood for better use of antibiotics. Health 
education messages for the project should address these concerns during full scale 
implementation. This study also informed data collection strategy during full scale 
implementation. We found that many younger adults of a working age stayed away 
during the week for work, leaving only grandparents and children in the village; it was 
therefore best to reach them over weekends. This scenario has important implications 
on the planning of data collection when large sample size is involved as it restricts the 
number of days allowed for data collection. Furthermore, it is concerning that within 30 
days, we saw a sharp decrease in the household antibiotic storage in the pilot village 
from 34.0% to 27.8% in the absence of an intervention. There might be several possible 
explanations for this phenomenon: first, a Hawthorne effect (also referred to as the 
observer effect) in which individuals modify their habits of storing antibiotic at home in 
response to their awareness of being observed. However, we ruled out this possibility 
because this effect was not seen in the intervention village which was also being 
observed. Also, formative data suggested that unlike prescription drug diversion in the 
U.S. which might be viewed as a type of behavioural disorder carrying a potential social 
stigma,34 in China keeping antibiotics at home for future use is a socially acceptable 
common practice.35,36 The concern over under-reporting of household storage of 
antibiotics is low. Furthermore, the quantity of household storage of antibiotics was 
verified by an inspection of the household medical cabinet onsite, leaving little room for 
error in reporting. A small sample size, a short study duration, or the timing of data 
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collection (e.g. flu season or not) may all also be variables in play. However, this 
speculation could not fully explain the sudden drop in the storage observed in the 
control village, which calls for further qualitative investigation. On the other hand, since 
there is currently no mechanism in place to remove the excess antibiotics from these 
households, the reduction in the storage can only be assumed to either have been 
consumed without a prescription or discarded inappropriately. This discovery was 
worrisome, especially considering the timing of the feasibility study (June) was not 
peak season for upper respiratory tract infections (URTI) and was low season for 
antibiotic consumption. Given this timing, compounded with easy access to antibiotics 
and the population size of 577 million rural residents, it is clear that the severity of 
misuse and mishandling of antibiotics in the community requires an urgent need for 
interventions. Nevertheless, during the 30-day period, this programme was able to reach 
a sizable portion (68.2%, 30/44) of the intended target audience with messages 
promoting the safe disposal of antibiotics, and among them, 26.7% (8/30) further spread 
this message, including people outside of the intervention villages. The frequent 
exchange of information between villages reported in this study also indicated that in a 
full-scale study, township-level randomisation - rather than village-level – would be 
appropriate as part of a cluster trial. Future research on social networks may be able to 
generate additional insight regarding the diffusion of innovations for reducing antibiotic 
misuse. Moreover, given the high levels of antibiotic residues in fresh water and soil in 
China, future studies should explore whether those more conscious about environmental 
protection are more likely to engage in prudent antibiotic use and disposal, which may 
inform a “One Health” approach. Finally, we recognise that although the proposed 
intervention will remove household antibiotic stockpiling, it will not address all the 
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challenges associated with antibiotic misuse in the community. A multifaceted 
intervention that also enforces regulations regarding the sale of antibiotics and pack-
based antibiotic dispensing systems to reduce leftover antibiotic prescriptions is 
necessary to curb the main sources of non-prescription antibiotics for self-medication 
use. 
To date, research reporting has mainly focused on effectiveness of interventions rather 
than the process of identifying and evaluating key components and the parameters 
within which they operate. Such lack of detail in the “contexts” and “mechanisms” that 
determine the effectiveness of interventions make replication and adaptation difficult, as 
it is hard to judge “what works for whom, in what contexts”, and why and how. This 
study filled the knowledge gap by describing systematic steps taken to adapt 
community-based interventions for a new context and a new health risk, and to conduct 
feasibility studies. From a global health perspective, the results of this study 
demonstrate that a take-back programme can be a potentially effective instrument for 
decreasing the availability of unnecessary antibiotics and potential misuse in 
communities across China and around the world, especially in LMIC. As many rural 
Chinese towns have bartering markets, the proposed intervention has great potential for 
significance and scalability.  
CONCLUSION 
This feasibility study presents an overall favourable public response toward an 
antibiotic-take-back programme as a feasible, acceptable, and appropriate intervention, 
warranting the expansion of the pilot programme. The intervention can be an important 
component of a multifaceted AMR strategy to decrease inappropriate antibiotic use in 
the community, especially those in low-and-middle income countries including China.  
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Table 1. Sample characteristics 
 INTERVENTION CONTROL 
Population Size 3015 1624 
No. of Household  916 447 
 Baseline Survey Stakeholders 
Interview 
Baseline Survey 
Sample size 50 21 50 
Sex    
Woman 42 (84.0) 19 (90.5) 36 (72.0) 
Man 8 (16.0) 2 (9.5) 14 (28.0) 
Age    
Minimum 23 24 22 
Mean (sd) 45.8 (10.0) 40.6 (9.1) 49.1 (15.2) 
Maximum 65 54 72 
Highest Attainment Education    
College or above  3 (6.0) 3 (14.3) 7 (14.0) 
High school 11 (22.0) 5 (23.8) 10 (20.0) 
Middle school 24 (48.0) 10 (47.6) 17 (34.0) 
Primary school or less  12 (24.0) 3 (14.3) 16 (32.0) 
Income    
>10000 3 (6.0) 0 8 (16.0) 
5001-10000 16 (32.0) 6 (28.6) 9 (18.0) 
3001-5000 17 (34.0) 12 (57.1) 16 (32.0) 
<3000 14 (28.0) 3 (14.3) 17 (34.0) 
Employment    
Yes 21 (42.0) 9 (42.3) 11 (22.0) 
No 29 (58.0) 12 (57.1) 39 (78.0) 
Children in the household    
Yes 47 (94.0) 19 (90.5) 33 (66.0) 
No 3 (6.0) 2 (9.5) 17 (34.0) 
Having an active WeChat account    
Yes 40 (80.0)  32 (64.0) 
No 10 (20.0)  18 (36.0) 
How often do you use WeChat?    
All the time  27 (67.50)  27 (87.38) 
Frequent 9 (22.50)  2 (6.25) 
Sometimes 2 (5.0)  1 (3.13) 
Not frequent 1 (2.50)  2 (6.25) 
Never 1 (2.50)  0 (0.0) 
Do you participate in the waste sort and 
recycle initiatives? 
   
Yes 41 (82.0)  39 (78.0) 
No 9 (18.0)  11 (22.0) 
Have you ever used the bartering market for 
recyclables? 
   
Yes  11 (22.0)  4 (8.0) 
No 39 (78.0)  46 (92.0) 
Methods to dispose expired, unwanted, 
unused (EUU) antibiotics 
 
 
  
 
Stored in the house 5 (10.0)  1 (2.0) 
Thrown into garbage bin 28 (56.0)  44 (88.0) 
Flushed in the toilet 4 (8.0)  1 (2.0) 
Buried in the field 3 (6.0)  1 (2.0) 
Fed chicken 2 (4.0)  0 (0.0) 
Ingestion 2 (4.0)  1 (2.0) 
Others 6 (12.0)  2 (4.0) 
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Table 2. Awareness of the danger of antibiotic resistance and unsafe disposal and associated practices among community panels 
 INTERVENTION VILLAGE 
n (%) 
CONTROL VILLAGE 
n (%) 
INTERVENTION 
COMPONENTS 
PRE- POST- FOLLO
W UP* 
PRE- POST-* 
 N=50 N=44 N=40 N=50 N=39 
Health education strategy 
Knowledge and attitudes toward 
self-medication with and disposal 
of antibiotics 
     
Antibiotic overuse may increase 
antibiotic resistance      
Agree 33 (66.0) 35 (79.5) 30 (75.0) 37 (74.0) 27 (71.1) 
Neutral 11 (22.0) 6 (13.6) 9 (22.5) 12 (24.0) 8 (21.1) 
Disagree 6 (12.0) 3 (6.8) 1 (2.5) 1 (2.0) 3 (7.9) 
Inappropriate disposal of antibiotics 
can harm the environment       
Agree 45 (90.0) 42 (95.4) 37 (92.5) 40 (80.0) 31 (81.6) 
Neutral 4 (8.0) 2 (4.6) 2 (5.0) 5 (10.0) 6 (15.8) 
Disagree 1 (2.0) 0 1 (2.5) 5 (10.0) 1 (2.63) 
Inappropriate disposal of antibiotics 
can harm the environment, I will 
dispose it appropriately 
     
Agree 44 (88.0) 40 (90.9) 37 (92.5) 35 (70.0) 35 (89.8) 
Neutral 10 (5.0) 4 (9.1) 2 (5.0) 10 (20.0) 2 (5.1) 
Disagree 1 (2.0) 0 1 (2.5) 5 (10.0) 2 (5.1) 
Inappropriate disposal of antibiotics 
can harm the environment, I know 
how to dispose it appropriately  
     
Agree 29 (58.0) 28 (63.6) 27 (67.5) 21 (42.0) 20 (51.3) 
Neutral 13 (26.0) 6 (13.6) 5 (12.5) 13 (26.0) 6 (15.4) 
Disagree 8 (16.0) 10 (22.7) 8 (20.0) 16 (32.0) 13 (33.3) 
Self-medication with antibiotics 
might have an adverse impact on our 
health 
     
Agree 41 (82.0) 44 (100.0) 34 (85.0) 44 (88.0) 32 (84.2) 
Neutral 7 (14.0) 0 5 (12.5) 3 (6.0) 4 (10.5) 
Disagree 2 (4.0) 0 1 (2.5) 3 (6.0) 2 (5.3) 
Self-medication with antibiotics 
might have an adverse impact on 
health, one should not take 
antibiotics without professional 
supervision 
     
Agree 42 (84.0) 42 (95.6) 31 (79.5) 38 (76.0) 29 (74.4) 
Neutral 4 (8.0) 0 4 (10.3) 8 (16.0) 5 (12.8) 
Disagree 4 (8.0) 2 (4.6) 4 (10.3) 4 (8.0) 5 (12.8) 
Self-medication with antibiotics 
might have an adverse impact on our 
health, one should not store 
antibiotics at home 
     
Agree 24 (48.0) 30 (68.18) 18 (46.1) 26 (52.0) 24 (63.2) 
Neutral 12 (24.0) 6 (13.6) 7 (18.0) 12 (24.0) 10 (26.3) 
Disagree 14 (28.0) 8 (18.2) 14 (35.9) 12 (24.0) 4 (10.5) 
Participation in the antibiotic take-
back programme 
     
Household antibiotic storage at the 
time of survey  
     
Yes 25 (50.0) 22 (50.0) 18 (45.0) 17 (34.0) 8 (21.1) 
No 25 (50.0) 22 (50.0) 22 (55.0) 33 (66.0) 30 (78.9) 
Participation in the take-back 
programme      
Yes - 7 (31.8) 6 (33.3) - - 
No - 15 (68.2) 12 (66.7) - - 
*Some items had missing data from one household 
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Table 3. Process evaluation on the antibiotic take-back programme 
Quantitative data 
Health education strategy 
No. of households in the 
intervention village completed post-
evaluation 
44 households 
No. of households received the 
health education messages 
30/44 households (68.2%) 
No. of households further spread this 
message 
8/30 households ( 26.7%) 
Bartering market for household expired, unwanted, or unused (EUU) antibiotics 
No. of households participated in the 
bartering market (including those 
who are not in the community panel) 
48 households 
Antibiotics take-back via the 
bartering market No. of box 
Cephalosporin (cefaclor, 
ceftriaxone sodium) 
Penicillin (amoxicillin)  
Quinolones (norfloxacin, 
ofloxacin) 
Macrolides (Azithromycin) 
Nitroimidazoles (Tixiaozuo) 
Others (non-
antimicrobials/non-antibiotics)  
10 
11 
2 
7 
1 
19 
Total no. of returned antibiotics 
(boxes)/total costs 50 boxes/RMB 592 
Qualitative data: users' opinions on the feasibility of the bartering market 
 Participants Non-participants 
Acceptability of 
the bartering 
market 
1.          I have seen health education materials and realized that 
overuse of antibiotics can cause harm to the human body.  “It is written on the leaflet that it is not good to take too much of it, so 
I brought it here.” (Male, 65 years old, primary school)  “In the past, I would put some medicine at home, and I would take it 
when I subsequently got sick. I think the doctors actually prescribe 
more or less the same medication, but after reading the leaflet, I felt 
these materials are very useful. It is bad to take too much of it, and 
you can't do this either. It has to be placed at the recycling point.” 
(Female, 42 years old, high school graduate) 
 
2. Throwing antibiotics anywhere can pollute the environment. 
They are better handled by the bartering market.  “The medicine is left at home, and it will be thrown away after a long 
period time. [I learned that] It will pollute the environment, so I 
brought it to the bartering market after seeing the ad.” (Male, 65 
years old, primary school graduate)  “It is not good to throw medicine as one pleases. You can't throw 
them away randomly. After reading the text messages carefully, I felt 
there was something to gain.” (Male, 62 years old, middle school 
graduate)  “I saw a notice saying that throwing medicine along with other 
garbage would pollute the environment. The bartering market is very 
good and can be taken advantage of.” (Female, 40 years old, middle 
school graduate) 
 
 
3. There is no use keeping it at home. There are even gifts 
redeemable at the bartering market.  “It is useless for me to keep medicine at home. The bartering market 
is quite good, and there are even redeemable gifts there, so they can 
be taken advantage of.” (Female, 40 years old, middle school 
graduate) 
 
 
 
4. I don't know how to handle it correctly myself.  “I seemed to have set it up for a period of time before, but no one put 
it there. We usually just keep it at home, and I am worried that the 
children will take it randomly. If there is a recycling point, it will be 
more convenient because one can just put it directly there. Directly 
throwing antibiotics into an ordinary trash can doesn't seem too good 
either, but we don't know how to deal with it.” (Female, 33, high 
school graduate) 
1. I saw the relevant materials but was too 
late to take them to the bartering market.  “Recently, it was really busy at home. I didn't 
have time to take it there. In the future, if I 
have time here, I will take it there. It [the 
bartering market] is just a stone’s throw 
away, so it is very convenient.” (Male, 48 
years old, high school graduate) 
 
 
 
 
2. There is no reserve of antibiotics at 
home.  “We are usually in Wenzhou; there are no 
antibiotics at home. I don't really like keeping 
too much medicine at home.” (Female, 29 
years old, high school graduate)  “We have no medicine at home, but after 
reading this material, I will be willing to take 
it there in the future.” (Male, 43 years old, 
high school graduate) 
 
 
 
 
 
 
 
3. No relevant health education materials 
were received.  “I didn't receive the text messages. It may be 
that there was something wrong with the 
mobile phone. We are already old, so we don't 
always check our mobile phones. I don’t know 
where the leaflet was placed; it could no 
longer be found.” (Female, 49 years old, 
middle school graduate) 
 
4. If something remains, I can use it next 
time. I am not very willing to take it there.  “I also know that if it is just a small illness, 
one just needs to rest a few days even without 
taking medication to get well. But when one 
goes to work, they cannot rest for several 
days. I have to keep the medicine for use in 
the future. I don’t want to buy medicine again. 
The symptoms are similar every time. And the 
medicine prescribed by the doctor is more or 
less the same. Just taking the same medicine 
as last time is enough; taking medicine makes 
one recover faster. And some medicines have 
one or two left, and I would be embarrassed 
to take them there in exchange for a gift.” 
(Male, 31 years old, college graduate) 
Acceptability of 
the Incentives 
 “I think that ordinary soap, scented soap, toothpaste and other 
similar things can be used, it would be very good, I personally like 
it.” (Female, 42 years old, high school graduate)  “As regards gifts, it’s hard to say. Personal needs are different, and 
more choices are better.” (Female, 40 years old, middle school 
graduate) 
 “Some medicines have one or two pieces left, 
and I would be embarrassed to take them 
there in exchange for a gift.” (Male, 31 years 
old, college graduate) 
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Table 4. Summary of the findings against 14 methodological issues for feasibility 
research 
METHODOLOGICAL 
ISSUES 
FINDINGS EVIDENCE 
1. Did the feasibility study allow a 
sample size calculation for the 
main trial? 
Yes 50 household approached 
50 households eligible 
50 households consent to participate 
in the study 
48 households used the bartering 
market; 7 households were from the 
panel  
2. What factors influenced 
eligibility and what proportion of 
those approached were eligible? 
All households were 
eligible  
All households were eligible 
3. Was recruitment successful?  Yes 50/50 (100%) households agreed to 
participate in the panel 
4. Did eligible participants 
consent?  
Good conversion to 
consent 
Fifty recruited out of 50 eligible, 
consent rate of 100.0% 
5. Were participants successfully 
randomised and did 
randomisation yield equality in 
groups? 
Not applicable in this 
study 
Not applicable in this study 
6. Were blinding procedures 
adequate? 
Not applicable in this 
study 
Not applicable in this study 
7. Did participants adhere to the 
intervention? 
Good adherence to the 
protocol 
All take-back antibiotics were 
returned and documented according 
to the protocol. 
8. Was the intervention acceptable 
to the participants?  
acceptability explored in 
qualitative interviews 
Residents from the intervention and 
control sites and the implementers 
found the intervention acceptable 
9. Was it possible to calculate 
intervention costs and duration?  
Yes Costs for resource utilisation were 
assessed for participant use of 
antibiotic take-back programme and 
in-kind wage of implementors  
10. Were outcome assessments 
completed? 
There was no missing 
data from the take-back 
bartering market or from 
the household surveys. 
There was no missing data as 
outcome data were collected in 
person. 
11. Were outcomes measured 
those that were the  most 
appropriate outcomes? 
Outcome measures used 
did assess main outcomes 
of interest 
Bartering market use data, 
household antibiotic stocks, and 
returned antibiotic were 
documented and analysed. 
12. Was retention to the study 
good?  
Good (88.0) Response rates: 
Pre-intervention assessment (50/50) 
Post-intervention assessment 
(44/50) 
13. Were the logistics of running a 
cluster randomised controlled trial 
addressed? 
The buy-in from the 
Women's Federation on 
site positively influenced 
the logistical running of 
study  
There were no difficulties identified 
in the various processes and the 
researcher’s ability to implement 
them. Residents once recruited were 
readily identified. 
14. Did all components of the 
protocol work together? 
There were no 
difficulties identified in 
the various processes and 
the researcher’s ability to 
implement them.  
Residents and the implementer (i.e. 
the Women’s Federation) found the 
intervention acceptable, feasible, 
and easy to implement. 
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CHAPTER NINE: DISCUSSION 
9.1 Introduction 
The aim of this PhD project was to develop a behaviour change intervention to 
reduce antibiotic misuse beyond clinical settings in China. I used a theory-based 
work stream plan to structure a synthesis of the findings from a workstream of 
research activities to inform the design of a complex intervention.  
9.2 Research contributions 
This PhD project has contributed to the generation of new evidence that addresses 
the pressing global health issue of antimicrobial resistance (AMR) and employs 
implementation research methods for the development, application, and feasibility 
assessment of a new behavioural change intervention in new contexts. These 
contributions are detailed in chapter nine and are summarised briefly here: 
1) Identification of non-clinical determinants that influence antibiotic (mis)use in 
China. (Chapter two) 
2) Identification of factors and their potential pathways influencing public’s 
antibiotic use. (Chapter two)  
3) Identification of behaviour change techniques (BCTs) that may be effective in 
reducing inappropriate or non-essential demand/use of medications or medical 
services. (Chapter three) This new knowledge has contributed to the 
development and selection of the community-based intervention components that 
aim not only to provide helpful information about the danger of AMR and unsafe 
disposal of antibiotic (BCTs 4.1, 4.2, 5.1, 5.2) but also to offer behaviour 
substitutes (8.2), incentives (10.1, 10.2), and improved environments (12.1, 12.5) 
that would reduce access to non-prescription antibiotics in rural Chinese 
households. 
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4) Prevalence of antibiotic misuse for self-limiting illnesses among Chinese 
children in the community, within and beyond clinical settings. (Chapter four) 
5) Identification of risk factors influencing antibiotic use for URTIs in the Chinese 
community. (Chapters five and six) This new knowledge has contributed to the 
development and selection of the community-based intervention that aims to 
reduce access to non-prescription antibiotics in rural Chinese households.  
6) Identification of the heterogeneity in the association between antibiotic use and 
various types of antibiotics-related knowledge, where the ability to identify 
antibiotics, perceived antibiotic efficacy for URTIs, and misconceptions about 
antibiotics as anti-inflammatory drugs were associated with increased odds of 
antibiotic use for URTIs. The findings suggested that raising public awareness 
about antibiotic resistance without tailoring the messages to local context may 
have unintended consequences. This new knowledge has contributed to the 
selection of the content of the health messages for AMR education interventions 
in the context of China and will be useful to future interventions of its kind. 
(Chapters five and six) 
7) Development of a community-based intervention that reduces household 
antibiotic storage – the first one of its kind in China and low and middle-income 
countries (LMIC) which share the same challenges. There has not yet been an 
intervention that aims to reduce household storage of antibiotics. (Chapter seven) 
8) Development of an intervention development and adaptation process, the theory-
based work stream plan, which integrated the principles of RE-AIM, intervention 
mapping, and community-based participatory research (CBPR) to address 
methodological questions set out by the MRC guidelines and for the future 
implementation of the full trial. The work stream plans offers a theory-driven 
structure for the acquisition of feasibility-related evidence and for the translation 
328 | P a g e  
 
of research evidence into evidence-based practice into a new context. (Chapter 
seven) 
9) Development of a public-targeted behaviour change intervention that recognises 
the social and behavioural influences on individual antibiotic use in the 
community. This is the first community-based AMR behavioural change 
intervention in China and low and middle-income countries (LMIC). (Chapters 
seven) 
10) Development of the conceptual framework, implementation capital for evidence-
based practice, for knowledge translation process. (Chapter seven) 
11) Implementation of a feasibility study (first of its kind in China) for a community-
based behavioural change intervention with an aim to reduce safe-medication 
and unsafe disposal of antibiotics in rural China. (Chapter eight) 
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9.3 Summary of main findings 
I developed and showed that a theory-based work stream plan was effective 
in guiding the adaptation and development of an evidence-based practice (EBP) – an 
operationalising blend of the RE-AIM (Reach, Effectiveness, Adoption, 
Implementation, and Maintenance) framework,327 community-based participatory 
research (CBPR) partnership principles,325 and course of action of intervention 
mapping (IM)89 and 6SQuID model, to guide and test the process of adapting 
existing interventions to new populations and settings. The review on non-clinical 
factors of antibiotic use in China (Chapter two, Aim 1) showed the majority of 
antibiotics for human use in China are consumed in the outpatient setting, often 
unnecessarily for viral URTIs - untreatable by antibiotics – especially in lower-level 
hospitals and health clinics.33,36,37,57 Poor policy enforcement as well as loopholes in 
the current health system, permit inappropriate prescribing behaviours and access to 
antibiotics at retail pharmacies to continue in China, especially in primary care 
settings and in rural areas.32,355 The review also identified limited data on the drivers 
of doctors’ inappropriate prescribing behaviours and that current stewardship 
programmes may not address the root causes of the issue. I found there is an urgent 
need for behaviour change interventions directed at health system users in China to 
improve prudent antibiotic use. Findings from Chapter three (Aim 1) identified a 
critical knowledge gap of rigorous studies on the development of public-targeted 
behaviour change interventions that recognise the complex, interactive social and 
behavioural influences on antibiotic use in the community. Intervention content, 
design, development process, and implementation strategies are rarely presented in 
sufficient detail, with limited evidence offered on the rationale and theory behind the 
intervention components, making replicability difficult. The review showed that 
interventions consisting of both health education messages and a supporting 
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environment that encourages and incentivises the adoption of a new behaviour are 
more likely to be successful.  
Figure 9.1 Intravenous infusion site at community health stations  
(photo credit: Leesa Lin) 
In Chapters four to six (Aim 2), I presented an urgent need for an effective 
behavioural intervention to reduce demand for antibiotics for URTIs in the 
community beyond clinical settings, as lay people have formed a self-diagnostic 
process and response to URTIs that they often carry out prior to or in lieu of seeking 
clinical care. The quantitative data analyses showed the demand-side of the health 
system is driving roughly 70% of antibiotic use for URTIs in young adults and 40% 
in children under the age of 13 in China. Self-medication with antibiotics for URTI 
symptoms is highly prevalent, with a majority of patients or caregivers (55%) 
deciding to self-treat when self-diagnosed with URTIs; among them, about 35% 
used antibiotics. The success rates of patients or caregivers in requesting antibiotics 
from doctors for URTIs was extremely high: 100% for young adults and 70% for 
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caregivers - the majority received antibiotics via infusion. [See Figure 9.1] Non-
prescription antibiotics are easily accessible in China; a majority of patients and 
caregivers reported having kept antibiotics at home for future use, with roughly 60% 
being leftover antibiotics from previous prescriptions and 40% from over-the-
counter purchases in local retail pharmacies. Cephalosporine, Amoxicillin, and 
Azithromycin were the most commonly used antibiotics to treat URTIs, both with 
and without a prescription.  
People’s medical decisions and care-seeking behaviours for treating URTIs 
are shaped equally or more by individual and contextual factors than by clinical 
diagnoses. There is heterogeneity in the association between antibiotic use and 
various types of antibiotics-related knowledge, where the ability to identify 
antibiotics, perceived antibiotic efficacy for URTIs, and misconceptions about 
antibiotics as anti-inflammatory drugs were associated with increased odds of 
antibiotic use for URTIs. Interventions enhancing patients’ or caregivers’ self-
efficacy for healthcare decision-making, especially regarding care management for 
URTIs, and correcting (mis-)perceptions around antibiotic efficacy for URTI 
symptoms, might reduce misuse. Context-appropriate multifaceted interventions are 
vital to untangling the perpetual problem of over-prescription and ill-informed 
demands for antibiotics. Simultaneously enhancing both prescribing guidelines and 
patient education targeting the family as a unit is critical. Education interventions 
should be disseminated via medical professionals or media in order to effectively cue 
people to a proper response. Enforcing regulations regarding the sale of antibiotics 
and pack-based antibiotic dispensing systems to reduce household antibiotic 
stockpiling could curb the main sources of non-prescription antibiotics for self-
medication use in the community.  
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The formative data presented in Chapter seven (Aim 3) found that antibiotics 
are currently dispensed in packs, not by doses, which leads to leftover antibiotics in 
households which, in turn, become the main source of antibiotics for self-
medication. Public awareness of the dangers that inappropriate use and disposal of 
antibiotics pose on the health of humans, the community or the environment is high, 
yet such high awareness does not translate into responsible antibiotic use and 
disposal. There is practically no safe disposal programme for household medical 
waste in the community, and as such, household antibiotics are disposed of as 
common trash bound for a landfill, potentially becoming an environmental hazard. 
Nevertheless, recent health policy reforms and existing environmental policies have 
set a solid foundation for the proposed intervention. An existing recycling 
programme and social network platform provided an opportunity in infrastructure 
(physically and societally) for an action-oriented health education strategy to take 
back left-over antibiotics as an environmental pollutant and biohazard. I described 
the process of development and adaptation of an intervention from one context to 
another (U.S. to China), to address a relevant but different global health concern 
(prescription drugs abuse to antibiotic misuse and antibiotic resistance) and factors 
affecting implementation and the process of implementation itself. Finally, in 
Chapter eight (Aim 4), a feasibility study established the acceptability and usability 
of the proposed intervention in which 14 implementation research methodological 
issues for future trials were carefully assessed. 
9.4 Strengths and limitations of the study  
The strengths of this study include 1) use of two sets of large-scale 
population survey data, with harmonised questions on antibiotic use-related 
knowledge and practice, among a new population for whom an existing drug take-
back programme was adapted to reduce inappropriate or unnecessary antibiotic 
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consumption, 2) integration of practical reality and the inclusion of existing 
evidence, as well as both qualitative and quantitative data from primary research, 
and 3) adoption of participatory approach with commitment from the knowledge 
users. The work stream plan effectively allowed me to incorporate existing evidence 
into a theory-informed logic model developed within a given context. I integrated 
quantitative and qualitative findings to develop an evidence-based intervention that 
aligned with the needs and experiences of local partners and community members. 
Additionally, conducting interactive formative research in a community intervention 
helped foster a sense of ownership among participants towards the proposed 
intervention and positive attitudes towards researchers who demonstrated respect for 
local opinions. The collaborative aspect of the work stream plan, informed by a 
community-based participatory approach and intervention mapping procedures, is 
particularly important in the context of China, where interpersonal relationships are 
fundamental to collaborative activities and community leaders, including local 
officials, are viewed as gatekeepers of the community. The high feasibility, 
acceptability and sustainability were possible because of the high implementation 
capital the local partners in Zhejiang University and I were able to mobilise within a 
relatively short period of time, which allowed me and my colleagues to put together 
a grant application of a 30-town trial on a community-based complex intervention 
based on this project for the joint global health trial (call 9), which made it to the 
final stage. 
The systematic review in chapter two found that there have not been 
consistent measures of antibiotic misuse behaviours in China and around the world, 
making comparisons of prevalence across studies and regions challenging. We did 
not find any national representative surveys on antibiotic use. In fact, the samples 
included in the secondary data analyses chapters four to six represented one of the 
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largest surveys conducted on this topic in the country. The participants represented 
healthcare decision-makers (for self or for children) of a population – young adults 
(university students) and young parents (with children under 13) – that are younger 
than the general public, which put constraints on the generalisability of the findings 
drawn from these data. These population are not only younger and better educated 
but also have had more exposure and presence on new media and technology (e.g. 
Weibo and WeChat) that emerged in the past decade, coincident with the Chinese 
government’s efforts on tackling AMR and health reforms.  
Although at least half of the sample in both datasets came from rural settings 
and/or with lower socio-economic positions, I expected them to have accessed and 
processed medical information differently than previous generations. As such, and 
considering people may have multiple infections during the year, I anticipate 
antibiotic misuse among the Chinese general population to be more prevalent and 
severe than what has been presented here. Longitudinal studies, behavioural data, or 
medical records such as prescriptions or clinical visits are needed in the near future 
to avoid recall bias, an inherent limitation of self-reported survey data.  
Both surveys yielded high response rates above 85%. The high prevalence of 
antibiotic misuse recorded made (under-)responding bias less likely to be of a 
concern. However, when conducting the formal feasibility pilot study in rural 
Zhejiang (Aims 3 and 4), Zhejiang University and I decided to collect all data face-
to-face due to low ability to recognise antibiotics levels of the targeted population. 
This operation highlighted the importance of an adequate translation and adaptation 
process from evidence generated from large scale surveys to practice in local 
context, especially in a country like China which has a large population that is 
diverse in culture and ethnicity, health systems, and development stages. In practice, 
it was critical to assess whether these knowledge, attitudes, practice (KAP) surveys 
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were valid or sufficient in capturing the local realities, especially among 
subpopulations that require further investigation. Furthermore, this conclusion 
echoes with the findings of systematic reviews (Aims 1) and the primary data 
collected for this study which indicated a need to investigate the effectiveness of 
current nation-wide AMR awareness campaigns in improving public’s antibiotic use. 
The limitations of this PhD project lie mainly in the secondary data from 
population-based surveys, generalisability of findings from each step laid out in the 
work stream plan, and translation from evidence to the development of the bartering 
market and health education materials to reduce antibiotic misuse, as there is 
currently no direct evidence regarding the mechanisms through which interventions 
work. First, because the samples were clustered the estimated standard errors used in 
significance tests may be biased. Specifically, the estimated standard errors might be 
under-estimated because the similarities between individuals within clusters are 
greater than those between individuals in a random sample drawn from the 
population. As such, significance levels reported might have been over-reported or 
underreported. However, in our case, samples of parents with young children 
(chapters four and five) were drawn from three provinces of different development 
levels (and from six provinces for university student data in chapter six) and then 
from the rural and urban areas within each province; the differences between these 
provinces and/or between rural and urban areas might be greater than those between 
individuals drawn from a random sample across the country. Variations at the 
province and/or urbanicity levels were accounted for in the analyses. Second, 
additionally, the models in chapter five (including adjusted models) did not include 
more than one of the key variables of interest because we were only interested in 
identifying factors for future interventions so the estimated effects would not be 
independent and could be confounded. Further, because I conducted multiple tests on 
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various factors of different URTI care and antibiotic use outcomes, there might be a 
possibility that the analysis gave a significant value when there in fact was none, 
which can be understood as the “role of chance”. I, therefore, examined the full 
models with key factors adjusted for each other, controlling for sociodemographic 
factors, and found the conclusions remained unchanged.  
Third, results from this study found that Chinese consumers often confused 
antibiotics for anti-inflammatory drugs, and were confused by their various types 
and efficacy, and by their chemical components, brand names and/or drug labels. 
Without adequate knowledge about care for illnesses and antibiotic efficacy, our data 
indicated that those with high ability to identify antibiotics might be more likely to 
seek out and misuse antibiotics. However, reverse causality is also likely, where high 
usage of antibiotics led to higher levels of knowledge about the drugs. Studies have 
shown previous recommendations from a physician for similar symptoms and prior 
successful experiences with antibiotics could lead to higher use, including 
SMA.160,283,284 To effectively reduce antibiotic misuse in China, interventions should 
not only educate the public about antibiotics, but correct local misconceptions about 
care for childhood illnesses; otherwise, antibiotic resistance awareness campaigns 
about antibiotics might be counterproductive and may actually increase public 
demand for antibiotics.  
Fourth, behavioural data that were gathered via survey instruments (chapters 
four to six) were by nature self-reported from health care consumers who may have 
been reluctant to report practices that could be considered inappropriate or may have 
been subject to recall bias, an inherent limitation of self-reported survey data. 
Experiments, longitudinal studies, or behavioural data are needed in the near future 
to avoid recall bias. Considering people may have multiple infections during the year 
and because our target population consisted of university students and parents of 
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young children, who are generally younger and have more knowledge about 
antibiotics and URTI care management than the general population, we anticipate 
antibiotic misuse among the Chinese general population to be more prevalent and 
severe than what has been presented in this thesis.  
As for knowledge translation for the development of the intervention, the 
effectiveness of community-based interventions to reduce inappropriate use of 
medicines and medical interventions varies greatly. Furthermore, limited systematic 
research has been conducted to identify the design features (or the process to identify 
the design features) of health education materials and delivery strategies on prudent 
antibiotic use that are most likely to result in behavioural change. The evidence used 
to inform the two components of the intervention - the bartering market and health 
education – was clear and valid; in fact, my studies were the first to highlight 
heterogeneity within the knowledge domain of antibiotic use, resistance, and their 
association with antibiotic use behaviours. Working with local partners, we tailored 
the health education messages and strategy accordingly. However, relating to actual 
design and implementation, I struggled to find evidence from the literature that could 
guide the intervention design elements, such as layout, font and colour for print 
materials. Instead, I relied on elements identified in the previous crowdsourcing 
campaign on a similar topic, the community advisory board, expert opinions, and 
traditional testing with end-users to inform practical decisions involved in designing 
the intervention. Also, other than potential Hawthorne effects (observer bias) - a 
phenomenon in which individuals alter their behaviour in response to being 
observed, which usually refers to positive changes - there are a few obvious 
limitations to the available data. First, this study population reflected a narrow and 
generally less educated population sample in rural China, and thus our results may 
not be generalizable to other communities across China. Second, this was a single-
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centre pilot study with a controlled before and after study design, and therefore I 
recognize that practices of antibiotic use and disposal, as well as practices for 
running the bartering markets, may differ amongst centres. That being said, the 
baseline rates of household storage of antibiotics between the two sites supported the 
notion that the proposed intervention has a high likelihood to be feasible, acceptable 
and appropriate to other rural villages. Third, its cross-sectional nature and the fact 
that estimates of health education message exposure and behavioural outcomes were 
limited to the past 30 days greatly complicated the task of estimating the true effect 
of the interventions on audiences. Community panels were approached at three 
different time points for feasibility assessments in a period of 6 weeks, which may 
have influenced their behaviours and/or induced a potential for a response bias in 
their reporting of results, as it became apparent to the interviewees what were the 
outcomes of interest. Fourth, as with any survey-based research, there exists the 
possibility of social desirability bias. Although the interviewers reassured all 
participants of their anonymity, face-to-face interviews relied on self-reporting, 
which may not accurately reflect patients’ actual antibiotic use and disposal 
practices. Nevertheless, because important confounders were controlled for and a 
control village was included for the feasibility assessments, the general pattern of 
findings observed in this study is sufficiently robust to alleviate concerns about their 
potential spuriousness. Fifth, there might be a seasonal effect that was not observed. 
The prevalence of flu infections and cold is heavily affected by seasonality and the 
pilot was conducted in the summertime in China, during which the prevalence of the 
common cold was expected to be lower, which might have led to a lower rate of 
household antibiotic storage and unsupervised use. However, the aim of the 
feasibility study was to assess the likelihood of the proposed intervention to be 
feasible, acceptable and appropriate to Chinese rural villages;  therefore, seasonality 
339 | P a g e  
 
was not a relevant consideration when implementing the pilot.  Sixth, we found a 
high proportion of residents in the rural villages had employment outside their 
village and were only home during the weekends. As such, most of the assessment 
activities had to take place on the weekends, which might have had critical 
implications to budgeting of evaluation time and resources for the full trial. Seventh, 
validated tools for the take-back programmes are rarely available. As such, question 
items included in this project were identified from available publications on similar 
activities, such as the American Medicine Chest Challenge (AMCC) and other 
prescription drugs disposal programmes to address key variables, including disposal, 
storage, and awareness. Nonetheless, feasibility assessment results regarding the 
quantity of antibiotics returned, prevalence of self-medication with and household 
storage of antibiotics, awareness of the risks of unsupervised use of antibiotics and 
unsafe disposal, and the willingness of residents to respond to surveys regarding 
antibiotic use were informative for the design of a larger study. Eighth, it should be 
mentioned that the bartering market was a free service and the costs incurred for the 
pilot project were low - on average RMB10-12 per box of antibiotics and a very 
small incremental increase for the labour and time involved by the implementors. 
For a larger trial of multiple centres with a longer duration, honorariums might be 
appropriate for the implementors and survey respondents to recognise their 
commitment and contribution to the project. Ninth, as shown in our data, China is a 
vast country with great regional disparity. The site for the pilot study was located in 
Zhejiang province, a well-developed province whose residents generally share a 
higher awareness of the issues of environmental protection compared to other 
Chinese provinces with lower provincial GDP ranking; as such, the design, 
implementation, and feasibility evaluation findings from this pilot study (i.e. health 
education messages combined with antibiotic take-back programme) might not be 
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generalisable to rural areas in provinces with fewer resources or human capital. 
Tenth, the small sample and use of one site for the feasibility study may seem to 
limit the generalisability of the results. Because data were collected from a 
representative sample of rural Chinese residents in the participating site, representing 
5.5% (50/916) of the households, and from a control site (11.2%, 50/447) at three 
different time points, the general pattern of findings observed in this study is 
sufficiently robust for a feasibility study to alleviate concerns about potential 
spuriousness. Lastly, the rural setting in which the pilot study was conducted was a 
“small world” where nearly everybody knows the chairwomen of the Women’s 
Federation personally. In the anonymous setting of an urbanized area, people might 
be less willing to cooperate and to allow an evaluator to enter their homes for 
interviews and to investigate their medicine cabinet. As such, a formal acceptability 
assessment may be needed in other settings; even so, I do not anticipate significant 
differences in the household storage practices of people living in a big city.  
From a public health perspective, the aim of this intervention is well-aligned 
with a newly emerging focus on ecopharmacovigilance (EPC), which aims to 
minimise the environmental risks posed by pharmaceutical residues and the need to 
guard against and control pharmaceutical pollution sources.345-348 The results of this 
study confirm findings of previous studies in high income countries that drug take-
back events have a strong potential to be an effective vehicle for decreasing the 
availability of prescription drugs (including antibiotics) for potential misuse in 
communities nationwide. Further research into this type of intervention seems 
warranted and should provide insight into its effectiveness in reducing unsafe 
medication use, intoxications, and waste.  
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9.5 Implications 
Antibiotic use in community accounts for a significant part of the overall 
human use. In China, about half of antibiotic prescriptions take place at outpatient 
settings.356 In Chapters four to six, we found that the health care consumers might be 
responsible for as high as 60% or 40% of community use (with or without 
prescription) for acute upper respiratory tract infections (URTIs) in adults and 
children, respectively. Compared with the estimate regarding university students,45 
parents appeared to be more cautious, but still drove 40% of antibiotic misuse in 
children. 7.7% of Chinese parents admitted to having asked doctors for antibiotics 
for paediatric URTIs, which is similar to what has been reported in some European 
countries.357 Previous studies have shown that as high as 50% of the antibiotic 
prescriptions for URTIs were unnecessary.356,358,359 Overuse of medical care for self-
limiting illnesses combined with a high prescription rate and the population size of 
the country drove the high overall antibiotic consumption in China. Chinese children 
are particularly vulnerable. In our data, about 77.3% of children with common cold 
symptoms in the past month sought care, which was more than twice as many as 
those in UK (34-40%),272 while the possibility of receiving an antibacterial 
prescription for such symptoms was around 33% in UK,273,274 compared to 53% in 
our survey. As such, we estimated that an average Chinese child consumes more 
than three times the amount of antibiotics than is taken by their peers in UK or other 
European countries.273,275-277 The gap is even wider for Chinese children in infancy 
and early childhood, as they have higher usage of medical care than older children. 
This estimate is alarming considering non-prescription use antibiotics in Chinese 
children was not included in this estimation. Our data indicates one in four Chinese 
children (n= 2,464, 25.9%) has self-medicated with antibiotics at least once in the 
past year - either for prevention use or treating minor ailments - which is 8-10 times 
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higher than that of the United States and some European countries.153,275-277 The true 
magnitude of this problem is underestimated because repeated use was not included 
in the calculation. This estimate is consistent with a survey conducted in 1995 and 
demonstrates that Chinese parental antibiotic misuse for their children has not 
improved over the past two decades.278 However, as shown in chapter three, as of 
2019 there was not a public-target intervention addressing unsupervised use of 
antibiotics in the community in China or other low- and middle-income countries 
(LMIC), apart from a policy ban on over-the-counter purchases, which has had very 
limited impact in China. Even in high income countries, I have found very few 
interventions that addressed factors that drove antibiotic demand in community 
settings. 
Therefore, the proposed pilot intervention to remove expired, unwanted, or 
unused (EUU) antibiotics from households was not only one of the first in China, but 
also in the LMIC. Evidently, the review findings in chapter two and survey data 
reported in chapters four to six have demonstrated that unnecessary and 
inappropriate use of antibiotics in China has been driven by a complex set of factors 
on both sides of the health care system for decades and has been embedded in the 
local culture of health care; as such, this PhD project aimed to develop and 
feasibility-test an evidence-based, context-tailored, community-based behavioural 
change intervention that can be integrated as a component in a complex intervention 
simultaneously targeting all factors of unnecessary and inappropriate use. The 
concept of such a complex intervention has been presented as a proposal of a 30-
township community-based cluster-randomised trial in chapter one (1.8. Joint Global 
Health Trial (JGHT)). According to the review in chapter three, there were only a 
limited number of community-based intervention trials targeting the demand-side - 
the patients or the public in the United States,103,360 and none in LMIC. 
343 | P a g e  
 
9.5.1 Implications for implementation research 
To date, research reporting has mainly focused on effectiveness of 
interventions rather than the process of identifying and developing key components 
and the parameters within which they operate. Such lack of detail in the “contexts” 
and “mechanisms” that determine the effectiveness of interventions make replication 
and adaptation difficult, as it is hard to judge “what works for whom, in what 
contexts”, and why and how.  
This thesis explains study methodologies and explicit steps I undertook in 
intervention design, development and adaptation, and evaluation prior to piloting, 
and enables examination of any modifications and improvements I might make to 
the intervention design between feasibility and effectiveness studies. It contributes to 
the growing body of evidence in implementation research, which seeks to understand 
not only what is and isn’t working, but how and why implementation does or does 
not work, and how to improve it. The iterative synthesis process defined in the work 
stream plan provides a method for the development of future complex interventions 
in the community using a theoretical framework and implementation research 
procedures combined with empirical findings from existing evidence and primary 
research. The model of implementation capital mapped out resources required to 
activate and operationalise the knowledge translation process. This study contributes 
to implementation science, an emerging field that has a great demand to address a 
critical knowledge gap. The INDEX study (‘IdentifyiNg and assessing different 
approaches to DEveloping compleX interventions) has been funded by MRC to 
produce guidance on intervention development. In mid-2019, INDEX reported a 
systematic review of approaches to intervention development, which had identified 
the range of approaches available, and instructed how to synthesise the actions 
within these approaches. These efforts will help researchers to unpack effective 
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interventions that have been assessed and validated, develop complex interventions, 
and inform future guidance on intervention development.361 
9.5.2 Implications for AMR research 
Individual’s health decisions are not entirely driven by their cognitive and 
rational characteristics.  Contextual factors – including access to antibiotics and 
interpersonal connections – are equally or more critical to healthcare decision-
making processes. Across China, among the educated (chapter 7 – survey data on 
university students) and less educated (chapters 2 and 8 – formative data on rural 
residents) alike, there exists a high level of awareness of the danger of AMR, which 
might have been the fruitful result of the Chinese government’s recent AMR 
awareness campaign. Yet, alarmingly, evidence showed that such awareness did not 
translate into prudent antibiotic use. Such a phenomenon might be explained by two 
possible reasons. First, there exists an externality associated with antibiotic use for 
treating infections: despite a high awareness of AMR, the risks AMR imposes on 
others are unlikely to be felt directly or immediately by either the consumer or the 
supplier of treatment. Second, individuals use non-rational strategies to manage risk 
and uncertainty: in particular, when information or time is limited and the 
complexity of the situation is overwhelming, individuals often combine rationality 
with other sources of so-called tacit or experiential knowledge and utilise strategies 
such as trust, intuition, and emotion to assist decision-making.238 As such, a blanket 
awareness campaign on prudent antibiotic use is insufficient to enable the desired 
behavioural change; an intervention has to include actionable knowledge that cues 
people to act. My findings are supported by a recent assessment of the public-funded 
antibiotic awareness campaigns (AAC) conducted since 2010.309 The authors came 
to a similar conclusion that there has been limited evidence demonstrating the 
effectiveness of antibiotic awareness campaigns and that the adaptation of these 
345 | P a g e  
 
campaigns to local context was not systematic.309 Key messages of future antibiotic 
awareness campaigns should be based rigorously on “scientific evidence, context 
specificities and behavioural change theory."309 
 Considering evidence from both rational and irrational strategies for health 
decision-making, the behavioural theories can be used to explain and predict 
antibiotic use and to inform behavioural change strategies that aim to reduce 
inappropriate use. Finally, heterogeneity exists in the “domain” of knowledge about 
antibiotics and its relationship with antibiotic practices for URTIs. Therefore, the 
common current practice of grouping multiple aspects of antibiotics- or AMR-
related knowledge, attitudes and beliefs, and even practices into one score might not 
fully capture the complexity of their various associations with antibiotic use 
behaviours. Future research should explore various aspects of antibiotics- or AMR-
related knowledge separately with respect to associated antibiotic use behaviours 
within the given context so as to inform AMR strategy. 
The proposed intervention tackles antibiotic use behaviours that are un-
explored or underexplored in both the literature and existing antibiotic stewardship 
programmes, specifically antibiotic use in the community which includes household 
storage of antibiotics and self-medication. It aimed to create an environment where 
household storage of antibiotics for self-medication and unsafe disposal are viewed 
negatively as irresponsible behaviours and are associated with adverse impacts on 
the health of humans, the community and the environment. By removing easy access 
to antibiotics from a household, we reduce the likelihood of self-medication with 
antibiotics without professional advice. However, similar to prescription drug take-
back programmes in Europe and the United States, the intervention itself will not 
address all the fundamental root causes of overuse and misuse. I recognise that the 
intervention leaves the sources of household antibiotics –leftover antibiotic 
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prescriptions and over-the-counter purchases – largely unaddressed. To fully tackle 
the issue of inappropriate use of antibiotics at community level in China and other 
LMICs that face similar challenges, other avenues to unnecessary antibiotics must be 
addressed.  The proposed intervention can inform a critical component of a 
multifaceted intervention that addresses all drivers of antibiotic misuse in the 
community, including at the population, regulatory, and policy levels. 
9.5.3 Implications for AMR strategy in China 
We conclude that prior successful experiences with antibiotics, including 
request of antibiotic prescription or self-medication with antibiotics, have largely 
contributed to antibiotic demand in China. After decades of excessive prescription of 
antibiotics - driven by financial incentives for the hospitals and prescribers362 - the 
general public in China have “learned” to use antibiotics for self-limiting illnesses 
despite the fact that clinical conditions do not require them. This phenomenon 
further compounded - through easy access to antibiotics (with or without 
prescription) - the current tense doctor-patient relationship environment in China 
where workplace violence against healthcare professionals is frequently 
reported.363,364 It also highlighted the inadequate diagnostic capacity of the 
prescribers and demonstrated that China’s stewardship programmes, which mainly 
aim to change prescribing behaviours, have limited impact. The newly released BMJ 
review44 on China’s 10-year effort towards health reform highlighted the urgency of 
tackling the inappropriate use of antibiotics in primary care or rural settings, where 
most antibiotic use takes place. In 2015, Public Health England released a 
comprehensive literature review assessing the available evidence to support 
behavioural-science-based interventions that have the potential to drive more 
effective and sustained behaviour changes for reducing the risk of antibiotic 
resistance.365 Lord Jim O’Neill suggested that tackling unnecessary antibiotic use 
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requires interventions that reach the general public. Interventions addressing the 
supply and demand sides of the health system are most likely to be effective in 
reducing antibiotic misuse and resistance in the community. In the context of China, 
this implies community-level complex interventions that simultaneously: (1) 
enhance clinical diagnostic and dispensing capacities, (2) improve clinician/parent 
communication, (3) dispense antibiotics by doses to reduce leftover antibiotics, (4) 
provide clinicians/pharmacists with alternate treatment actions that have the best 
chance of reducing antibiotic prescriptions in primary care for URTIs, (5) enforce 
regulations on over-the-counter purchases, (6) increase public awareness of the 
associated danger on human and environmental health, (7) improve the norms 
around self-medication and unsafe disposal of antibiotics, and (8) provide platforms 
to remove expired, unwanted, or unused (EUU) antibiotics from households. As a 
next step, research should focus on further optimising and testing feasibility of 
interventions that address unnecessary or inappropriate demand. It should prioritise 
the assessment of the design and development of each intervention component that 
contributes to an evidence-based, context-tailored complex intervention. 
Specifically, one should examine the (1) appropriateness and effectiveness of public 
education messages on safe use and disposal of antibiotics, (2) engagement and 
dissemination strategies that are tailored to different sub-communities in the Chinese 
context including the elderly, parents, migrants, and young adults, etc., and (3) 
adaption of the antibiotic take-back programme to the local context leveraging 
implementation capital. Interventions that foster effective communication between 
prescribers and consumers about prudent antibiotic use will help reduce unnecessary 
prescriptions, as well as requests of antibiotics from patients. Such interventions will 
also empower prescribers to adhere to clinical guidelines and make a prescribing 
decision based on their professional assessment. Each component of the complex 
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intervention should be tested for feasibility and acceptability, ideally before a full-
scale randomised controlled trial of the complex intervention takes place. A pilot 
trial of a smaller scale should also be implemented to test effectiveness.  
On a longer term basis, there is little evidence regarding the impact of 
optimised antibiotic use on rates of AMR in the community to date – a critical 
evidence gap in the field. Guillemot et al (2001, Pediatrics) and Belongia et al (2005, 
Clin Infect Dis) showed behavioural change interventions that last only several 
months might not be sufficient to show an impact on resistance rates. A multifaceted 
intervention that addresses both supply- and demand-side factors of antibiotic misuse 
in China is urgently needed. Findings from this thesis informed the design of a multi-
year, community-based, multi-level behaviour change intervention, where each 
component of the trial is tailored to the social,33 healthcare,37 and political355 context 
and has robust theoretical foundations for its mechanism of action. The proposed 
complex intervention has four components – (1) reduce pharmacy non-prescription 
sales, (2) improve hospital dispensing, (3) institute community recycling and health 
education, and (4) enforce doctor training and stewardship policies – which aim to 
remove the barriers at the structural, community, and individual levels that result in 
inappropriate antibiotic use in the community.  
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CONCLUSIONS 
Following a theory-based work stream plan, I successfully integrated 
multiple studies into a critical synthesis of evidence to inform the development of a 
community-based behaviour change intervention. The formative procedures 
conducted for the development of the intervention consist of a combination of 
qualitative and quantitative data collection and analysis methods laid out from Aim 1 
to Aim 4. Each aim allowed me to specify what the components should be as well as 
how they should be adapted to target population, suitable context, and potential 
pathways which they would be expected to work through for behavioural change. 
The review of assessed community-based behavioural interventions under Aim 1 
allowed me to identify key programme parameters for cross-cultural adaptation, 
whereas the secondary data analyses of population surveys under Aim 2 aided in the 
identification of modifiable risk factors and helped pinpoint and prioritise key 
features relating to local perceptions and behaviours about antibiotics and treatment 
of self-limiting illnesses especially URTIs. Behavioural models including the Health 
Belief Model and Social Ecological Model were used to inform the conceptual 
framework to guide this study, especially the review findings and quantitative data 
analyses to identify risk factors for antibiotic use, which contributed to informing the 
elements in the feasibility study and process evaluation. Aim 3 developed theoretical 
models for evidence-based knowledge translation and established a collaborative 
partnership with local stakeholders of the potential pilot site. The qualitative 
approach supported theory generation, interpretation of quantitative findings, and 
allowed solutions to arise out of the data, therefore suggesting strategies that might 
be particularly effective with the target audience. The mixed-methods approach of 
the feasibility study in Aim 4 aided in better adapting the interventions to local 
conditions, which will lead to effectiveness in changing health behaviours for better 
outcomes. A showcase of the preliminary findings was awarded the best presentation 
at the Medical Research Foundation (MRF) National PhD Training Programme in 
Antimicrobial Resistance Research in August 2018. Findings from this study have 
successfully informed the design and development of a proposal for a multi-level, 
community-wide complex intervention to reduce inappropriate antibiotic use and 
antimicrobial resistance in Zhejiang province in China.  
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October 22, 2018 
 
Department of Public Health, Environments and Society 
Faculty of Public Health and Policy 
London School of Hygiene & Tropical Medicine 
 
Re: Confirmation of Collaboration with Leesa Lin and Permission of Data Use 
We are pleased to provide this letter for Leesa Lin. We are writing to confirm our support of her 
proposed doctoral project as stated in her upgrading report.  Ms. Lin has shared a preliminary copy 
of the report with us as an instrument of communication while we discuss the collaboration. 
 
Zhejiang University has a strong track record of working with UK and US institutes such as 
University College London, Wellcome Trust, Harvard University and Yale University. Ms. Lin and 
our team have worked closely on two large-scale population surveys investigating antibiotic use 
behaviours of: 
 university students (status: complete, sample size: 11,192), 
 parents of children aged 0-13 (status: complete, sample size: 10,256.) 
 
We have agreed to offer the said data to Ms. Lin to achieve Aim 2 where Ms. Lin will assess 
surveyed populations’ medical decisions in relation to antibiotic use and treatments for the common 
cold. Findings from Aim 2 will be used to inform the development of an evidence-based, context-
appropriate behavioural intervention to reduce inappropriate use in the community in China. We 
agree that Ms. Lin will be the first author of the manuscripts generated from the proposed analyses – 
one per dataset focused on medical decisions - and Zhejiang University will provide feedback on 
manuscripts when they are drafted and have co-authorship. The final author list will be agreed upon 
prior to publication according to contributions. In principle the following author list has been agreed 
as a starting point: Lin, xxx, xxx, Fearon, Zhou*, Hargreaves. 
 
For the proposed field work under Aim 3, Zhejiang University would obtain an Institutional Review 
Board approval in compliance with local ethics guidelines and support the proposed activities, 
including facilitating the recruitment of project participants and collection of data according to the 
design. 
 
We are interested in testing the effectiveness of Ms. Lin’s proposed intervention and piloting the 
protocol developed under Aim 4 in addressing the challenge of antibiotic misuse in the Chinese 
communities. However, there is currently no plan and no timeline for doing so. 
 
Should you have any questions, please do not hesitate to contact me at: zhouxudong@zju.edu.cn 
Sincerely, 
 
 
Xudong Zhou, Ph.D., Associate professor 
Zhejiang University Institute of Social Medicine and Family Medicine 
866 Yuhangtang Road, Hangzhou 310058, China 
Email: zhouxudong@zju.edu.cn 
Tel: +86 571 88208221 
351 | P a g e  
 
APPENDIX II. SAMPLE HEALTH EDUCATION 
MATERIALS 
poster (I) – antibiotic literacy: 
 
Attention!!! 
The drugs above are all antibiotics. You should not use them without professional 
guidance nor store them at home. Keeping antibiotics at home is associated with an 
increased risk of self-medication with antibiotics; irresponsible disposal of antibiotics 
leads to environmental pollution.  
Please bring your household antibiotic stock to the antibiotic take-back site in the 
village. In exchange, you will receive a small household item provided by Zhejiang 
University for your participation and support.  
[*Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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(b) poster II: care management for children with the common cold or flu 
 
      
Do not give antibiotics to children for the common cold or flu. 
Please consult your doctor regarding how to alleviate the cold symptoms experienced 
by your children. 
Please do not ask doctors for antibiotics (oral antibiotics or IV) 
Antibiotics are not effective to treat the common cold, to alleviate cold symptoms, or to 
expedite cold recovery, caused by a virus. Rather, antibiotics might have an adverse 
impact on children’s health. The best tips for getting over the common cold are to drink 
plenty of fluids and get plenty of rest. 
[*Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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(c) pamphlet: prudent use of antibiotics  
 
 
 Antibiotics can save lives, but 
not a cure all 
 If you don’t use antibiotics 
responsibly, not only does it not 
benefit your children, but might 
have an adverse impact 
 Antibiotics can be effective for 
bacterial infections, but not for 
viral infections 
 Antibiotics can eliminate 
bacteria, but not virus. 
 When children are sick, 
antibiotics are not the only 
option. If it is necessary to use 
antibiotics, IV is saved for more 
severe cases. 
Please let 
doctors 
determine 
children’s 
antibiotic 
use. Please 
do not ask 
doctors for 
antibiotics 
(oral 
antibiotics or 
IV) 
 
Please use antibiotics 
responsibly. You should 
learn antibiotic literacy. 
Please do not give 
antibiotics to children for 
the common cold or 
stuffy/runny nose. 
 
[*Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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APPENDIX III. SAMPLE TRAINING MATERIAL*  
 
 
 
Manual on prudent antibiotic use  
 
Protect your own health. Please use 
antibiotics responsibly. 
 
Edited by the National Health 
Commission  
 
Peking University Medical Press 
Table of Contents 
 
1. What are antibiotics? 
2. How to recognise antibiotics? 
3. What is inappropriate use of 
antibiotics? 
4. Why do antibiotics lose their efficacy? 
5. The damage of antibiotic abuse 
6. What to do? 
7. What not to do?  
 
[*Developed by Zhejiang University Research Team on Prudent Antibiotic Use] 
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APPENDIX IV. ETHICS APPROVAL 
The primary objective of this PhD study was to develop a behavioural intervention to 
reduce inappropriate antibiotic use in the community, and the purpose of the 
stakeholder interviews is to test its feasibility, appropriateness and acceptability in 
the local context. Therefore, no sensitive, private data were collected. 
Ethical approval for various research activities was granted by Zhejiang University 
and then by the London School of Hygiene and Tropical Medicine: 
Aim 2:  
 Local approval for primary data collection by the School of Public Health 
Zhejiang University: 
‐ on university students:  Reference number ZGL20160922 on 15th 
September 2015.  
‐ on parents of young children: Reference number ZGL201706-2 on 
23rd June 2017. 
 UK approval for secondary data analysis by London School of Hygiene and 
Tropical Medicine: 
‐ LSHTM Ethics Ref: 14678 on 12th March 2018. 
Aims 3 and 4: 
 Local approval for primary data collection by the School of Public Health 
Zhejiang University:  
‐ Qualitative study on factors influencing antibiotic use in China:  
Reference number ZGL201812-2 on 3rd January 2019 
‐ Pilot feasibility study on improving antibiotic use and disposal of 
rural residents in China through take-back of unused antibiotics:  
Reference number ZGL201901-1 on 29th January 2019 
 UK approval for primary data collection by London School of Hygiene and 
Tropical Medicine 
‐ LSHTM Ethics Ref: 16261 on 17th May 2019. 
  
Zhejiang University School of Public Health – Medical Ethics Committee 
Scientific Research Project Ethics Review Application Form 
ZUSPH Ethics Review No. [ZGL201706-2] 
Name of 
Project 
Knowledge, behaviours and their determinants of antibiotic use among parents of young children 
Applying 
Department 
Department of Social Medicine Project leader: ZHOU Xudong 
Participating researchers: PENG Dandan 
Submitted 
Materials 
Scientific Research Project Ethics Review Application Form      Problem Notification Form      Research Plan and Project Summary      
Informed Consent Form      Accompanying instructions  
Review 
Assessment 
Investigator eligibility: Meets national criteria      Does not meet criteria        Resources: 
 
                             Self-funded Means of obtaining Informed Consent Form: Appropriate      Inappropriate 
  
Experimentation plan: Appropriate      Inappropriate  
Ethics 
Committee 
Member 
Names 
And 
Signatures 
Name Signature Name Signature Name Signature 
SHI Weixing  JIN Yongtang [signature] ZHU Shankuang  
SHEN Yi [signature] XIA DAjing  WANG Wei  
YE Huaizhuang  Song Yongxin    
      
      
Results: 
Of the _2_ people who attended, _2_ people voted as follows: 
 _2_ votes to approve; _0_ votes to approve after corrections(s); _0_ votes to reconvene and reassess after correction(s); _0_ votes to reject. 
Review 
Decision 
Approve Approve with minor changes Reconvene and reassess after changes Reject 
    
Reviewer(s) comments: 
 
 
 
                          Agree to implement. 
 
 
 
 
 
Committee Chair (signature): 
 
Zhejiang University School of Public Health – Medical Ethics Committee (seal): 
 
June 23, 2017 
   
[signature and 
red-ink stamp] 
 List of Medical Ethics Committee Members, Zhejiang University School of Public Health 
Ethics Committee 
position Name Sex Specialty Position Work unit 
Chair SHI Weixing Male Medical ethics Professor Zhejiang University School of Public Health 
Vice-chair JIN Yongtang Male Occupational health and environmental hygiene Professor 
Zhejiang University School of Public 
Health 
Committee member ZHU Shankuan Male Nutrition and food hygiene Professor Zhejiang University School of Public Health 
Committee member XIA Dajing Female Health toxicology Professor Zhejiang University School of Public Health 
Committee member WANG Wei Male Mental illness and mental health Professor Zhejiang University School of Public Health 
Committee member SHEN Yi Male Medical statistics Professor Zhejiang University School of Public Health 
Committee member YE Huaizhuang Male Health inspection Professor Zhejiang University School of Public Health 
Committee member Song Yongxin Male Jurisprudence Professor Hangzhou Zijin Community 
 
 
 
 
 
Secretary:  MENG Fei 
Address:  Zhejiang University School of Medicine, Multifunctional Building 807 (866 Yuhang Tang Road, Hangzhou City, Zhejiang 
Province 310058) 
Phone: 0571-88981319 
Fax: 0571-88208099 
[red-ink stamp] 
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Zhejiang University School of Public Health – Medical Ethics Committee 
Scientific Research Project Ethics Review Application Form 
ZUSPH Ethics Review No. ZGL20160922 
Name of 
Project 
New media as interventions to improve prudent antibiotic use among university students nationwide 
Applying 
Department 
Department of Social Medicine Project leader: ZHOU Xudong 
Participating researchers: WANG Xiaomin, PENG Dandan, WANG Weiyi 
Submitted 
Materials 
Scientific Research Project Ethics Review Application Form      Problem Notification Form      Research Plan and Project Summary      
Informed Consent Form      Accompanying instructions  
Review 
Assessment 
Investigator eligibility: Meets national criteria      Does not meet criteria        Resources: 
 
                             Self-funded Means of obtaining Informed Consent Form: Appropriate      Inappropriate 
  
Experimentation plan: Appropriate      Inappropriate  
Ethics 
Committee 
Member 
Names 
And 
Signatures 
Name Signature Name Signature Name Signature 
SHI Weixing  JIN Yongtang [signature] ZHU Shankuang  
SHEN Yi [signature] XIA DAjing  WANG Wei  
YE Huaizhuang  Song Yongxin    
      
      
Results: 
Of the _2_ people who attended, _2_ people voted as follows: 
 _2_ votes to approve; _0_ votes to approve after corrections(s); _0_ votes to reconvene and reassess after correction(s); _0_ votes to reject. 
Review 
Decision 
Approve Approve with minor changes Reconvene and reassess after changes Reject 
    
Reviewer(s) comments: 
 
 
 
                          Approve. 
 
 
 
 
 
Committee Chair (signature): 
 
Zhejiang University School of Public Health – Medical Ethics Committee (seal): 
 
September 15, 2015 
   
[signature and 
red-ink stamp] 
 List of Medical Ethics Committee Members, Zhejiang University School of Public Health 
Ethics Committee 
position Name Sex Specialty Position Work unit 
Chair SHI Weixing Male Medical ethics Professor Zhejiang University School of Public Health 
Vice-chair JIN Yongtang Male Occupational health and environmental hygiene Professor 
Zhejiang University School of Public 
Health 
Committee member ZHU Shankuan Male Nutrition and food hygiene Professor Zhejiang University School of Public Health 
Committee member XIA Dajing Female Health toxicology Professor Zhejiang University School of Public Health 
Committee member WANG Wei Male Mental illness and mental health Professor Zhejiang University School of Public Health 
Committee member SHEN Yi Male Medical statistics Professor Zhejiang University School of Public Health 
Committee member YE Huaizhuang Male Health inspection Professor Zhejiang University School of Public Health 
Committee member Song Yongxin Male Jurisprudence Professor Hangzhou Zijin Community 
 
 
 
 
 
Secretary:  MENG Fei 
Address:  Zhejiang University School of Medicine, Multifunctional Building 807 (866 Yuhang Tang Road, Hangzhou City, Zhejiang 
Province 310058) 
Phone: 0571-88981319 
Fax: 0571-88208099 
[red-ink stamp] 
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Observational / Interventions Research Ethics Committee
 
 
 
Leesa Lin 
LSHTM
12 March 2018 
Dear Leesa
Study Title: Antibiotic misuse in China: a secondary analysis of cross‑sectional survey data 
LSHTM Ethics Ref: 14678 
Thank you for responding to the Observational Committee’s request for further information on the above research and submitting revised documentation.
The further information has been considered on behalf of the Committee by the Chair. 
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on the basis described in the application form, protocol and supporting documentation
as revised, subject to the conditions specified below.
Conditions of the favourable opinion
Approval is dependent on local ethical approval having been received, where relevant. 
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
Document
Type
File Name Date Version
Protocol /
Proposal
Survey_Interventions to improve antibiotic use among university students 15/09/2015 1
Protocol /
Proposal
Study Protocol_Interventions to improve antibiotic use among university students
??????????????????? - ??
15/09/2015 1
Consent
form
Informed Consent_University Students ??????????_EN CH 15/09/2015 1
Local
Approval
IRB Approval Letter_University Students ???????????_EN CH 15/09/2015 1
Protocol /
Proposal
Study Protocol_Understanding factors influencing parents knowledge and practice of
antibiotic use ??????????????????????-??
23/06/2017 1
Protocol /
Proposal
Survey_Understanding factors influencing parents knowledge and practice of antibiotic
use
23/06/2017 1
Consent
form
Informed Consent_Parents ?????????_EN CH 23/06/2017 1
Local
Approval
IRB Approval Letter_Parents ?????????? EN CH 23/06/2017 1
Investigator
CV
CV_LEESA K LIN_201801 01/01/2018 1
Covering
Letter
Clarification Request_20180301 01/03/2018 1
 
After ethical review
Page 1 of 2
The Chief Investigator (CI) or delegate is responsible for informing the ethics committee of any subsequent changes to the application.  These must be submitted to the Committee for review
using an Amendment form.  Amendments must not be initiated before receipt of written favourable opinion from the committee.  
The CI or delegate is also required to notify the ethics committee of any protocol violations and/or Suspected Unexpected Serious Adverse Reactions (SUSARs) which occur during the project
by submitting a Serious Adverse Event form. 
An annual report should be submitted to the committee using an Annual Report form on the anniversary of the approval of the study during the lifetime of the study. 
At the end of the study, the CI or delegate must notify the committee using an End of Study form. 
All aforementioned forms are available on the ethics online applications website and can only be submitted to the committee via the website at: http://leo.lshtm.ac.uk
Additional information is available at: www.lshtm.ac.uk/ethics
   
Chair
ethics@lshtm.ac.uk
http://www.lshtm.ac.uk/ethics/ 
Page 2 of 2
Medical Ethics Committee, Zhejiang University School of Public Health 
 
Ethics Approval for Research Project 
 
(Zhe-Da-Gong-Wei) Lun-Yan-Pi No. (ZGL201812-2) 
Project 
Name Qualitative Study on Factors Influencing Antibiotic Use in China 
Department of 
Applicant 
 
The Institute of Social 
Medicine and Family Medicine 
of Zhejiang University 
Person Responsible for Project: Zhou Xudong 
Participants: Leesa Lin (Harvard University), Wang 
Xiaomin, Lu Jingjing, Xu Yannan 
Submitted 
Materials 
Application form for ethics review  Project notification form  Research program and 
project summary  Informed consent form  Related explanations  
Review 
Qualifications of researchers:  
Meets requirements      
Does not meet requirements  
Funding source: Self-funded 
Method for obtaining informed consent:  
Appropriate   
Not appropriate   
Testing method:  
Appropriate   
Not appropriate   
Signatures of 
Ethics 
Committee 
Members 
 
 
 
 
Name of Committee 
Member Signature 
Name of 
Committee 
Member 
Signature 
Name of 
Committee 
Member 
Signature 
Shi Weixing  Jin Yongtang [signed] Zhu Shankuan  
Shen Yi  Xia Dajing  Wang Wei  
Ye Huaizhuang [signed] Song Yongxin    
      
Result 
In Attendance: 2; Votes: 2 
Approved 2 votes; Approved after making necessary revisions 0 votes; Revise and resubmit 0 
votes; Not approved 0 votes 
Outcome 
Approved 
Approved 
after minor 
revisions 
Revise and resubmit Not approved 
    
Review comments: 
 
 
 
Application Approved 
 
Committee Director (Signature): [Signed] 
 
Medical Ethics Committee, Zhejiang University School of Public Health (Stamp):  
 
January 3, 2019 
   
Medical Ethics 
Committee, Zhejiang 
University School of 
Public Health 
List of Members of Medical Ethics Committee, Zhejiang University School of Public Health 
 
Committee 
Position Name Sex Expertise Job title Employer 
Director Shi Weixing Male Medical ethics Professor School of Public Health, Zhejiang University 
Deputy 
Director Jin Yongtang Male 
Occupational and 
Environmental 
Health 
Professor School of Public Health, Zhejiang University 
Member Zhu Shankuan Male Nutrition and Food Hygiene Professor 
School of Public Health, 
Zhejiang University 
Member Xia Dajing Female Health Toxicology Professor School of Public Health, Zhejiang University 
Member Wang Wei Male Psychiatry and Mental Health Professor 
School of Public Health, 
Zhejiang University 
Member Shen Yi Male Medical Statistics Professor School of Public Health, Zhejiang University 
Member Ye Huaizhuang Male Sanitary Inspection Professor School of Public Health, Zhejiang University 
Member Song Yongxin Male Law Professor Zijin Community, Hangzhou 
 
Secretary: Meng Fei  
Address: Room 807, Zonghe Building. Zhejiang University School of Medicine (310058  No. 866, Yuhangtang 
Road, Hangzhou City, Zhejiang Province) 
Telephone: 0571-88981319 
Fax: 0571-88208099 
 
Medical Ethics 
Committee, Zhejiang 
University School of 
Public Health 
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Medical Ethics Committee, Zhejiang University School of Public Health 
Ethics Approval for Research Project 
(Zhe-Da-Gong-Wei) Lun-Yan-Pi No. (ZGL201901-1) 
Project 
Name 
Feasibility Study on Improving Antibiotic Use and Disposal of Rural Residents in China 
through Take-back of Unused Antibiotics 
Department of 
Applicant 
The Institute of Social Medicine 
and Family Medicine of 
Zhejiang University 
Person Responsible for Project: Zhou Xudong 
Participants: Zhou Xudong, Wang Xiaomin, Wang Weiyi, 
Lu Jingjing, Yao Tingting, Cai Jingjing 
Submitted 
Materials 
Application form for ethics review  Project notification form  Research program and 
project summary  Informed consent form  Related explanations  
Review 
Qualifications of researchers: 
Meets requirements      
Does not meet requirements  
Funding source: Self-funded 
Method for obtaining informed consent:  
Appropriate   
Not appropriate   
Testing method:  
Appropriate   
Not appropriate   
Signatures of 
Ethics 
Committee 
Members 
Name of Committee 
Member Signature 
Name of 
Committee 
Member 
Signature 
Name of 
Committee 
Member 
Signature 
Shi Weixing Jin Yongtang [signed] Zhu Shankuan 
Shen Yi Xia Dajing Wang Wei 
Ye Huaizhuang [signed] Song Yongxin 
Result 
In Attendance: 2; Votes: 2 
Approved 2 votes; Approved after making necessary revisions 0 votes; Revise and resubmit 0 
votes; Not approved 0 votes 
Outcome 
Approved 
Approved 
after minor 
revisions 
Revise and resubmit Not approved 
 
Review comments: 
Application Approved 
Committee Director (Signature): [Signed] 
Medical Ethics Committee, Zhejiang University School of Public Health (Stamp):  
January 29, 2019 
Medical Ethics 
Committee, Zhejiang 
University School of 
Public Health 
Pilot
 
 List of Members of Medical Ethics Committee, Zhejiang University School of Public Health 
 
Committee 
Position Name Sex Expertise Job title Employer 
Director Shi Weixing Male Medical ethics Professor School of Public Health, Zhejiang University 
Deputy 
Director Jin Yongtang Male 
Occupational and 
Environmental 
Health 
Professor School of Public Health, Zhejiang University 
Member Zhu Shankuan Male Nutrition and Food Hygiene Professor 
School of Public Health, 
Zhejiang University 
Member Xia Dajing Female Health Toxicology Professor School of Public Health, Zhejiang University 
Member Wang Wei Male Psychiatry and Mental Health Professor 
School of Public Health, 
Zhejiang University 
Member Shen Yi Male Medical Statistics Professor School of Public Health, Zhejiang University 
Member Ye Huaizhuang Male Sanitary Inspection Professor School of Public Health, Zhejiang University 
Member Song Yongxin Male Law Professor Zijin Community, Hangzhou 
 
Secretary: SiJia Wu  
Address: Room 906, Zonghe Building. Zhejiang University School of Medicine (310058  No. 866, Yuhangtang 
Road, Hangzhou City, Zhejiang Province) 
Telephone: 0571-88208098 
Fax: 0571-88208099 
 
Medical Ethics 
Committee, Zhejiang 
University School of 
Public Health 
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Observational / Interventions Research Ethics Committee
 
 
 
Ms Leesa Lin 
LSHTM
17 May 2019 
Dear Ms Leesa Lin
Study Title:  Antibiotic misuse in China - Development of evidence-based behavioural interventions to reduce inappropriate use of antibiotics beyond clinical settings  
LSHTM Ethics Ref: 16261 
Thank you for responding to the Observational Committee’s request for further information on the above research and submitting revised documentation.
The further information has been considered on behalf of the Committee by the Chair. 
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on the basis described in the application form, protocol and supporting documentation
as revised, subject to the conditions specified below.
Conditions of the favourable opinion
Approval is dependent on local ethical approval having been received, where relevant. 
Approved documents
The final list of documents reviewed and approved by the Committee is as follows:
The committee Suggest to the PI that they do some back translation of their information and consent forms
Document Type File Name Date Version
Local Approval Ethics Approval_Antibiotic use in the community_Zhejiang University_CH 03/01/2019 1
Local Approval Ethics Approval_Antibiotic use in the community_Zhejiang University_EN
translated
03/01/2019 1
Local Approval Ethics Approval_Zhejiang University_Feasibility Study_CH 29/01/2019 1
Information Sheet Interview Guide_CH_022019 29/01/2019 1
Information Sheet Interview Guide_EN_022019 29/01/2019 1
Protocol /
Proposal
Study Protocol_EN_201902 29/01/2019 1
Advertisements Recruitment emails_CH 29/01/2019 1
Advertisements Recruitment emails_EN 29/01/2019 1
Local Approval Ethics approval_Zhejiang University Feasibility Study_EN 29/01/2019 1
Investigator CV CV_Leesa Lin_2019 28/02/2019 1
Information Sheet Antibiotic use in the community_China_Zhejiang University Consent_CH.pdf 01/04/2019 2
Information Sheet Antibiotic use in the community_China_Zhejiang University Consent_EN.pdf 01/04/2019 2
Information Sheet Revised Consent_042019_EN_highlighted changes 01/04/2019 2
Information Sheet Revised Consent_042019_CH_highlighted changes 01/04/2019 2
Covering Letter Response to ethics committee_30042019 30/04/2019 1
 
After ethical review
The Chief Investigator (CI) or delegate is responsible for informing the ethics committee of any subsequent changes to the application.  These must be submitted to the Committee for review
using an Amendment form.  Amendments must not be initiated before receipt of written favourable opinion from the committee.  
Page 1 of 2
The CI or delegate is also required to notify the ethics committee of any protocol violations and/or Suspected Unexpected Serious Adverse Reactions (SUSARs) which occur during the project
by submitting a Serious Adverse Event form. 
An annual report should be submitted to the committee using an Annual Report form on the anniversary of the approval of the study during the lifetime of the study. 
At the end of the study, the CI or delegate must notify the committee using an End of Study form. 
All aforementioned forms are available on the ethics online applications website and can only be submitted to the committee via the website at: http://leo.lshtm.ac.uk
Additional information is available at: www.lshtm.ac.uk/ethics
Professor John DH Porter
Chair
ethics@lshtm.ac.uk
http://www.lshtm.ac.uk/ethics/ 
Page 2 of 2
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APPENDIX V. TIMETABLE 
 
 
Research aims and tasks Pre-PhD 2017 2018    2019   Viva 
  Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 
Aim 1 – systematic reviews  
Chapter 2  
Search strategy           
Data extraction           
Data analysis           
Draft manuscript             
Submission for publication             
Chapter 3  
Search strategy           
Data extraction           
Data analysis           
Draft manuscript             
Submission for publication             
Aim 2 – Social epidemiological methods  
Local ethics (by ZHU)           
Data collection (by ZHU)             
Chapter 4  
Ethics approval (LSHTM)             
Data analysis           
Draft manuscript           
Submission for publication             
Chapter 5  
Ethics approval (LSHTM)             
Data analysis           
Draft manuscript             
Submission for publication             
Chapter 6  
Ethics approval (LSHTM)             
Data analysis           
Draft manuscript             
Submission for publication             
Aim 3 – Intervention Development & Adaptation  
JGHT bid (led by ZHU)             
Local ethics (by ZHU)             
JGHT feasibility and pilot studies for 
intervention components #1-3 and 
some elements for #4 (by ZHU) 
            
Chapter 7  
Ethics approval (LSHTM)             
Data collection               
Data analysis               
Draft manuscript               
Submission for publication             
Aim 4 – Feasibility assessment  
JGHT bid (led by ZHU)             
Local ethics (by ZHU)             
Formal pilot project to assess the 
JGHT bid intervention component #4 
(by ZHU) 
            
Chapter 8  
Ethics approval (LSHTM)             
Data collection               
Data analysis               
Draft manuscript             
Submission for publication             
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APPENDIX VI. DATA MANAGEMENT PLAN 
All data files from this study have been de-identified. These files are managed, processed, and stored in a secure environment (i.e. 
lockable computer systems with passwords, firewall system in place, and virus/malicious intruder protection) and by controlling access 
to digital files with encryption and/or password protection.  
Data Type Study Description of data acquisition Format Software 
Literature 
reviews 
Review of published non-clinical factors 
influencing antibiotic use in the community in 
China 
 
Research Aim  1 – systematic 
literature review 
Text and numerical data 
(.xls) 
Microsoft 
Excel & 
STATA-15 
Review of quantitatively-assessed evidence-
based behavioural change interventions to reduce 
inappropriate or unnecessary medical use 
Research Aim  1 – systematic 
literature review 
Text and numerical data 
(.xls) 
Microsoft 
Excel & 
STATA-15 
Quantitative Large-scale cross-sectional population survey 
data on (a) university students and (b) parents of 
young children (<13-year-old) 
Research Aim 2 – social 
epidemiological 
methods/secondary data analysis 
Analysis (.dta) STATA-15 
 Quantitative data from the household panels and 
process evaluation data 
Research Aims 3 & 4 – Face-to-
face interviews, the bartering 
market usage records 
Analysis (.dta) STATA-15 
Qualitative In-depth interviews on antibiotic use in the 
community in the context of China 
Interview notes  Form (.docx) 
Analysis (.nvp) 
Microsoft 
Word 
Nvivo-11 
Semi-structured interviews on the feasibility and 
acceptability of a proposed behavioural 
intervention that is designed to reduce antibiotic 
misuse and unsafe disposal in the community 
Research Aims 3 & 4 – interview 
notes or transcription of audio 
recording of stakeholders’ 
interviews 
Audio (.mp3) 
Form (.docx) 
Analysis (.nvp) 
 
 
Microsoft 
Word 
Nvivo-11 
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APPENDIX VII. STUDY TOOLS INTERVIEW GUIDES 
 
普通感冒用抗生素因素 
[一般民众] 
 
目的: 了解民众之于普通感冒和抗生素使用的相关医疗决策。 
目标参与者: 干预小区居民. 访谈指南将根据受访者在家庭人口组成和其在家庭
的角色进行调整 (例如:年幼子女的父母,多代同堂家庭).  
 
社会人口特征 
 年龄_______ 
 性别_______ 
 教育水平_______ 
 医疗背景_______ 
 职业_______ 
 每月家庭平均收入_______ 
 家庭人口组成_______ 
 您有孩子吗？年龄和性别 _ _ _ _ _ _ _ ？ 
 
第一部分– 自我健康管理和观点, 日常自我健康诊断和药物使用习惯 
1. [自我健康认知]您如何描述您的健康状况？ 您每天做些什么来维护健康 (包
括保养与调理)? 
2. [药物的一般使用] 您是否定期服药或保健食品 (包括中医和维他命)？大多
听谁的建议？ 
3. [信任] 当您觉得不舒服的时候, 您会怎么做？您去哪一家诊所？您相信医生
建议吗？ 
4. [中医] 您对中医有什么看法？相信中医？怎么决定看西医或中医？ 
5. [健康咨询]如果您对您的健康有疑问, 您会去哪？[请排名反应按序列您是否
信任医生、政府或家人和朋友提供的医疗保健建议？ 
6. [健康信息] 您通常从哪里获得健康信息？为什么？ 
 提示：您相信这些信息来源吗？微信呢？ 
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 提示：您是否曾分享、发送健康信息？那是什么健康信息？为什么, 如
何分享、发送的?  
7. [对于在家中有孩子的人] 孩子主要是谁在照顾？生病时，是谁决定怎么处
里? 祖父母或其他人是否会参与孩子的医疗决定? 这和其他重要决定(例如教
育) 类似吗, 还是不一样？关于孩子的健康问题，您的信息来源主要是哪里？
您会和其他人谈论孩子的健康或医疗问题吗? (伴侣？朋友？家庭？教师？
您最常听谁的意见？您最相信谁的意见？ 
 
社区 
8. 谁是社区中有影响力或值得信赖的意见领袖？ 
9. 您周末还是下班后去哪里？社区成员都去哪里，聚集在哪里？ 
10. 您能告诉我现有的回收计划吗？您参加了吗？为什么？您认为这是什么目
的？经验如何？ 
 提示：可持续回收计划的基础设施. 谁在您家里处理回收？ 
 
第二部分– 抗生素使用和常见感冒等医疗决策的社会规范  
[普通感冒的自我诊断]  
11. 您是否能正确诊断普通感冒的症状？如果是, 请大致描述？(注意关于”发炎”
的用词) 
 提示： 
o "我有信心, 我可以正确诊断自己的普通感冒的症状" [李克特量
表, 1-7] 
o (如适用)"我有信心, 我可以正确诊断我的孩子的普通感冒的症状" 
[李克特量表, 1-7] 
 提示: 如果是, 您是如何学会诊断他们？ 
 提示: 如果是, 普通感冒的症状是什么？ 一般您会怎么应对? 
o 让它自己好起来 – 为什么？会放任不管多久？ 
o 寻求治疗 - 为什么？在哪里寻求治疗, 为什么？ 
o 自我治疗 - 为什么？如何自我治疗, 为什么？ 
 提示: 如果没有, 如果您经历 [喉咙痛、咳嗽、鼻塞、流鼻涕、腹泻、发
烧等], 您该怎么办？ 
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 提示: 据您所知，人们如何得到普通感冒？ 
 提示: 家里其他人(如老年人或儿童)得了感冒后，怎么应对？ 
 提示: 平均来说, 一年中您得几次普通感冒？ 
 
[最近一次普通感冒的经验]  
12. 您最近一次感冒是什么时候？ 
 提示: 谁决定怎么应对？ 
 提示: 您做了什么？ 
o 让它自己好起来 – 为什么？前后病了多久？ 
o 寻求治疗-为什么？在哪里寻求治疗, 为什么？ 
 提示: 如果看了医生, 您去了哪里？医生做了什么？给您开
了抗生素吗？您跟医生要过抗生素吗？ 
o 自我治疗-为什么？如何自我治疗, 为什么？ 
 提示: 如果使用药物, 是什么药物？ 
 提示: 如果使用抗生素, 为什么？抗生素从哪来的？ 
 (如适用)您的孩子最近一次感冒是什么时候？ 
 
[普通感冒的管理]  
13. 您会考虑其他选择吗？(例如中医？咳嗽药？观望几天？ 
 提示: 如果医生告诉您, 普通感冒是一种自限性的疾病, 它自然会痊愈, 您
会怎么应对？ 
 提示: 如果医生建议您观察几天, 您会怎么应对？ 
 提示: 如果医生没有为普通感冒开抗生素, 您会怎么应对？ 
 提示: 您是否在当地药房购买了抗生素？ 
o 如果是, 那是为了什么？ 
o 您购买了抗生素用了处方了吗？如果是这样,处方是哪里来的？ 
o 如果您不能在没有医生处方的情况下购买当地药房, 您会怎么应
对？ 
 提示: 在不使用 [抗生素] 的情况下, 您有没有信心自我管理普通感冒的
症状？为什么？ 
o "我相信我能自我处理普通感冒的症状"[李克特量表, 1-7] 
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o (如适用)"我相信我能自我处理我的孩子的普通感冒症状 "[李克特
量表, 1-7] 
 
[对抗生素的认知]  
14. 您听说过 "抗生素" 吗？ 
 提示: 如果是, 抗生素是什么？您什么时候需要抗生素？ 
 提示: 如果是, 在哪里可以得到抗生素？抗生素的价格一般是多少？负担
得起吗？ 
15. 这句话有什么看法: "抗生素是消炎药"? 
16. 以下哪一项是抗生素？ 
 青霉素类药物, 如阿莫西林 
 头孢类药物, 如头孢克洛/头孢曲松钠等 
 非甾体药物, 如布洛芬/默林/阿司匹林等 
 甾体类药物如地塞米松/泼尼松等 
 喹诺酮类药物, 如氧氟沙星/诺氟沙星等 
 大环内酯类药物, 如阿奇霉素/罗红霉素等 
17. 您认为下面的语句怎么样？ 
 如果需要使用抗生素，应优先选用输液方式。 
 病情一旦好转，应该立即停止使用抗生素。  
 抗生素越贵越有效。 
 新抗生素比老抗生素更有效。 
 进口的抗生素比国产的有效。 
18. 结构性因素–政策和访问: 
 关于抗生素的销售和使用的现行政策是什么？ 
 您知道在哪里可以得到抗生素？ 
 
[使用抗生素进行自我治疗] 
19. 在过去的一年里, 您有没有使用过抗生素而不先找医生？何时何地？ 
 (如适用) 使用抗生素的方式与您平常服用的其他药物有不同吗？   
 提示: 您用了哪种抗生素？为什么？ 
 提示: 您从哪儿弄来的抗生素？为什么？ 
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 提示: 您听从指示服用抗生素了吗？您按指示吃了整个疗程了吗？为什
么？ 
 提示: 您是否担心您可能服用了错误的药物？为什么？ 
 (如适用)在过去的一年里, 您有没有让您的孩子使用抗生素而不先找医
生？为什么？您拿了什么抗生素？效果如何？ 
 提示: 您 (或您的孩子) 是否经历过任何抗生素副作用不良影响？ 
 
[家中储备抗生素] 
20. 您家目前是否有储备抗生素吗？ 
 提示: 如果是, 请问有什么抗生素 [药物名称]? 
 提示: 如果是, 为什么？ 
 提示: 如果是, 您在哪里买的？为什么？ 
 提示: 如果是, 如何储备抗生素？ 
 提示: 如果是, 您曾经给过别人抗生素吗？是什么抗生素? 和谁？为什
么？结果如何？ 
 提示: 如果是, 您是否在某个时候处理[丢弃]掉抗生素？如果是, 怎么处
理的？为什么？ 
 提示: 如果是, 并且使用过, 您怎么使用家中储备的抗生素？您怎么知道
该怎么做？经验如何？ 
 提示: [干预] 如果是, 如果政府鼓励 "回收"储备抗生素, 您会参加吗？您
觉得怎么样？为什么？您认为政府为什么要 "回收" 抗生素？ 
 
[最近使用抗生素的经验] 
21. 您最后一次服用抗生素是什么时候？ 
 提示: 您用了什么抗生素？ 
 提示: 为了什么目的？ 
 提示: 您从哪儿弄来的抗生素？为什么？  
 提示: 如果您不能从当地药房得到它, 您会怎么应对？为什么？ 
 提示: 您听从指示服用抗生素了吗？您完成整个疗程了吗？为什么？ 
 提示: 您是否经历过任何副作用？ 
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[抗生素耐药细菌认知] 
22. 您听说过 "抗生素耐药性细菌" 这个词吗？如果是, 那是什么？听说了什么？ 
23. 您同意下列任何一项声明吗？ 
 过度使用抗生素是中国的一个严重问题。 
 抗生素有效治疗病毒感染。 
 抗生素是有效的治疗细菌感染。 
 人们使用的抗生素越多, 以后治疗的难度就越大。 
 过量使用抗生素会导致细菌对抗生素产生抗药性。 
 中国的抗生素耐药性将是一个严重的问题。 
 
[风险感知-感知严重性和感知敏感性] 
24. 风险感知– 
 您认为您或您的家人会有多大可能感染上耐药性细菌感染？[李克特量
表, 1-7] 
 您认为您社区里的人有多有可能感染上耐药性细菌感染？[李克特量表, 
1-7] 
 如果您或您的家庭成员感染上耐药性细菌, 您认为会有多严重？？[李克
特量表, 1-7] 
 如果您社区里的人感染上耐药性细菌, 您认为会有多严重？[李克特量表, 
1-7] 
 如果自我使用抗生素, 您认为您或您的家人有多大可能会有不良反应？
[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您社区里的人有多大可能会有不良反应？
[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您或您的家人有不良反应的话，会有多严
重？[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您社区里的人有不良反应的话，会有多严
重？[李克特量表, 1-7] 
 
 
[普通感冒和抗生素使用的社会规范] 
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25. 描述性规范– 
 如果您的朋友或邻居有普通感冒的症状, 您会给他们什么建议？您希望
他们怎么应对？为什么？ 
 您认为用上次使用剩下的抗生素可以吗？如果您发现您的朋友或邻居使
用了剩余的抗生素, 您会怎么应对？为什么？ 
 您认为向医生要求抗生素可以吗？如果您发现您的朋友或邻居问医生要
抗生素, 您会怎么应对？为什么？ 
 您认为用抗生素治疗常见的感冒症状可以吗？如果您的朋友或邻居用抗
生素治疗感冒症状, 您会怎么应对？为什么？ 
 当您感觉好些的时候, 您认为停止服用抗生素可以吗？如果您的朋友或
邻居在感觉好些的时候停止服用抗生素, 您会怎么应对？为什么？ 
 
26. 限制性规范- 
 当您遇到感冒的症状时, 您的朋友或邻居会怎么反应？ 
 当您有剩余的抗生素时, 您认为其他人希望您怎么处理？如果您使用剩
余的抗生素, 您的朋友或邻居会如何反应？ 
 如果您的朋友或邻居得知您向医生索取抗生素, 您会如何反应？ 
 如果您的朋友或邻居得知您使用抗生素自我治疗感冒症状, 您会如何反
应？ 
 如果您在感觉好些的时候停止服用抗生素, 您的朋友或邻居会如何反应？ 
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抗生素用于普通感冒-抗生素回收 
 
利益相关者采访 
 
目标： 
 理解可能干预措施的背景 
 评估可能干预措施的可接受性和可行性 
 
目标参与者: 可能的干预站点中的利益干系人 
1. 政策执行者 (如当地政府官员) 
2. 干预执行者 (如妇女联合会) 
3. 其他利益相关者 (如社区药房) 
4. 目标人群 (如一般公众)  
注意: 该指南可能根据利益干系人类型和相关性进行修改调整 
. 
社会人口特征 
 年龄_______ 
 性别_______ 
 教育水平_______ 
 医疗背景_______ 
 每月家庭平均收入_______ 
 您有孩子吗？年龄和性别 _ _ _ _ _ _ _ ？ 
 单位_______ 
 职位_______ 
 服务年限_______ 
 
单位 
1. 请问您的单位主要负责什么业务、主要的工作内容、和优先事项是什么？ 
2. 您在这个单位中的角色是什么, 您主要的工作内容、和优先事项是什么？ 
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抗生素的认知 
1. 关于抗生素的销售和使用的现行政策是什么？ 
2. 您听说过 "抗生素耐药性" 吗？如果是, 那是什么？ 
3. [风险感知]- 
 您认为您或您的家人会有多大可能感染上耐药性细菌感染？[李克特量
表, 1-7] 
 您认为您社区里的人有多有可能感染上耐药性细菌感染？[李克特量表, 
1-7] 
 如果您或您的家庭成员感染上耐药性细菌, 您认为会有多严重？？[李克
特量表, 1-7] 
 如果您社区里的人感染上耐药性细菌, 您认为会有多严重？[李克特量表, 
1-7] 
 如果自我使用抗生素, 您认为您或您的家人有多大可能会有不良反应？
[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您社区里的人有多大可能会有不良反应？
[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您或您的家人有不良反应的话，会有多严
重？[李克特量表, 1-7] 
 如果自我使用抗生素, 您认为您社区里的人有不良反应的话，会有多严
重？[李克特量表, 1-7] 
4. 您认为下面的语句怎么样？为什么？ 
 抗生素过度使用在中国是个严重的问题。               
 抗生素耐药在中国将会成为一个严重的问题。           
 人们使用抗生素越频繁，以后细菌感染就越难治好。     
 过度使用抗生素会使细菌会对抗生素产生耐药性。       
 如果不合理使用抗生素，将来有效的抗生素将越来越少。 
 
健康教育信息评估 
[提交健康教育信息] 
5. 您觉得这文章/海报主要在说什么? 
 提示： 您有什么反馈？ 
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 您最喜欢哪种格式？文章、海报、微信？ 
 提示：您会分享这个 [健康信息] 吗？怎么分享和为什么？  
 提示：您会和谁分享这个 [健康信息]？怎么分享和为什么？ 
 提示：如果您的医生和您分享这个[健康信息], 您会怎么应对？如果是
当地的 CDC/亲戚/邻居/直系亲属呢？ 
 
可能行为干预的内容: 
6. 谁是社区中有影响力或值得信赖的意见领袖？ 
7. 您通常从哪里获得健康信息？为什么？您相信这些信息来源吗？微信？ 
8. 您能告诉我关于现有的回收程序？ 
 您自己家里参与了吗？为什么？您认为这是什么目的？经验如何？ 
 目前社区内回收项目的基础设施程序 
 您/您的机构是否参与抗生素 "收回"程序如果有的话？为什么？ 
 如果该现有回收程序要包括抗生素, 您认为原因是什么？您会参加吗？
为什么？ 
 预期可能成本? 
 
可行性 
9. [可行性和可接受性] 想问问您的意见, 将现有回收计划纳入抗生素, 您觉得
如何? 能与现行计划良好结合吗？可持续性？有这个需求吗?  
10. [可实施性和实用性] 如果我们要实施一项健康教育运动, 鼓励抗生素 "回收"
您觉得可行吗?可以被小区接受吗？为什么？您个人会参加吗？为什么？ 
 提示: 谁应该实现它？谁应该参加这项活动？ 
 提示：您的单位是否可能参与其中？为什么？它是否符合您单位的业务
目标？会给您的单位带来什么影响吗, 正面或负面的？ 
 提示: 需要哪些资源？会增加实施成本吗？ 
 提示: 您能想到任何风险吗？我们能降低抗生素滥用的风险吗？ 
 提示: 潜在的障碍或阻力？如何和为什么？有可能的解决方案？ 
11. 项目设计 
 提示: 社区民众一般聚集在哪里？ 
 提示：周末还是下班后都去哪里？ 
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 提示: 传播和传播的渠道和格式呢? (例如社交媒体、广播和电视广
告、海报、小册子和儿童保育演示文稿)中心/学校, 报纸, 新闻发布
会, 传单和邮件, 社区领袖或学校教师, 和其他教育材料)？ 
 提示: 什么是有效的或适当的实施渠道 (例如基于社区的组织、学
校、社区中心, 加入政府赞助的活动)？ 
12. 评价 
 提示:  关于实施时间，有没有建议 (如与学校日历年度重合, 避免农
历新年等主要节假日)? 
 提示:  关于干预的评估，可能使用什么样的行为数据，哪个单位会
有的？  
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抗生素用于普通感冒-健康教育信息的测试 
[一般民众] 
 
 
目的: 测试和完善健康教育信息 
 
健康教育信息测试 
第一步: 干预前: 抗生素耐药细菌相关的知识评估和风险感知项目 
 
第二步: [提供与 抗生素耐药细菌相关的健康教育信息–小册子、新闻文章、或
WHO/当地疾控中心/医生/学校教师的官方声明]: 
‐ 在中国的环境中, 抗生素耐药细菌和抗生素滥用的危险因素。 
‐ 如何管理常见的感冒症状。 
‐ 如何负责任地使用抗生素。 
‐ 如何正确处置抗生素。 
‐ 抗生素可能改变肠道环境, 影响人的健康 
第三步: 干预后: 抗生素耐药细菌相关的知识评估和风险感知项目 
 
健康教育干预内容评价 
1. 您觉得这文章/海报主要在说什么? 
 提示： 您有什么反馈？ 
2. 创新传播 
 提示：在您同意他说的吗？ 
 提示：您认为人们收到这条信息后会怎么应对？ 
 提示：如果您认识的人使用剩余的抗生素治疗感冒, 您会怎么应对, 为什
么？ 
 提示：如果您认识的人自我使用抗生素治疗感冒, 您会怎么应对, 为什
么？ 
3. 社交网络 
 提示：您会分享这个 [健康信息] 吗？怎么分享和为什么？  
 提示：您会和谁分享这个 [健康信息]？怎么分享和为什么？ 
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 提示：如果您的医生和您分享这个[健康信息], 您会怎么应对？如果是
当地的 CDC/亲戚/邻居/直系亲属呢？ 
4. 健康教育成效 
 这个 [健康信息] 是否会改变您如何应对常见感冒症状？如果是, 会有什
么样的改变和为什么？如果不是, 为什么？ 
 您觉得这个 [健康信息] 会改变其他人应对常见感冒的症状吗？如果是, 
会有什么样的改变和为什么？如果不是没有, 为什么？ 
 这个 [健康信息] 会改变您使用抗生素的方式 (例如, 自我治疗或向医生索
要抗生素) 吗？如果是, 如何和为什么？如果不是, 为什么？ 
 这个 [健康信息] 是否会改变其他人使用抗生素的方式 (例如, 自我治疗或
向医生索要抗生素)？如果是, 会有什么样的改变和为什么？如果不是, 
为什么？ 
 
健康教育干预的实施 
5. 您最喜欢哪种格式？文章、海报、微信？ 
6. 谁是社区中有影响力或值得信赖的意见领袖？ 
 提示：周末还是下班后都去哪里？ 
 提示：社区成员聚集在哪里？ 
7. 您能告诉我关于现有的回收程序？ 
 您自己家里参与了吗？为什么？您认为这是什么目的？经验如何？ 
 目前小区内回收项目的基础设施程序 
 提示：如果该现有回收程序要包括抗生素, 您认为原因是什么？您会参
加吗？为什么？ 
27. 您通常从哪里获得健康信息？为什么？ 
 提示：您相信这些信息来源吗？微信呢？ 
 提示：您是否曾分享、发送健康信息？ 
 提示：如果是, 那是什么健康信息？为什么, 如何分享、发送的?  
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ANTIBIOTIC USE FOR THE COMMON COLD 
 
[general community members] 
 
Aim: to understand local norms around medical decision-making for the 
common cold and antibiotic use.  
 
Socio-demographic characteristics 
 Age _______  
 Gender _______ 
 Education Level _______ 
 Medical background_______ 
 Monthly household income_______ 
 Do you have children? _______ If so, age and sex_______? 
 
Part I – Understand norms around medical decisions for antibiotic use and the 
common colds 
[Health maintenance & TCM] 
 Do you do anything in particular to stay healthy? [e.g. eating habits, vitamins, 
exercise, etc.] 
 Have you ever seen a traditional Chinese medical doctor? [If yes, how often and 
why? If no, why?] 
 Have you tried Chinese treatments, e.g. acupuncture, gua-sha, tui-na? [Why? How 
often?] 
 Do you include Chinese herbs in your diet, e.g. ginseng, goji, siwu, etc.? [Why? 
How often?] 
 What do you think of Chinese herb medicine, e.g. banlangen? Have you tried it? 
[Why? How often?] 
 What do you think of infusion? How about the needle? 
 What’s inflammation? 
 How often do you see a doctor?  
 
[Self-diagnosis of the Common cold]  
28. Can you recognise the symptoms of the common cold? 
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 Prompt:  
o “I am confident that I can diagnose correctly the symptoms of the 
common cold for myself” [a 7-point likert scale, 1-7] 
o (If applicable) “I am confident that I can diagnose correctly the 
symptoms of the common cold for my children” [a 7-point likert 
scale, 1-7] 
 Prompt: If yes, how did you learn to recognise them? 
 Prompt: If yes, what are they? What to do and why?  
o let it run its course – why? for how long and why? 
o seek treatment – why? Where to seek treatment and why? 
o self-treat – Why? How to self-treat and why?  
 Prompt: If no, what do you do if you experience [sore throat, cough, stuffy 
nose, runny nose, diarrhea, fever, etc.]? 
 Prompt: How do people get the common cold? 
 Prompt: How about treatment options for family (e.g. the elderly or 
children?)?  
 Prompt: On average, how often do you experience the common cold in a 
year? 
 
[Recent experience with the Common Cold]  
29. When was the last time that you had the common cold? 
 Prompt: who was involved in the treatment decision? 
 Prompt: what did you do?  
o let it run its course – why? for how long and why? 
o seek treatment – why? Where to seek treatment and why? 
 Prompt: If health services were used, where did you go? What 
did the doctor do? Were you prescribed antibiotics? Did you 
ask for antibiotics?  
o self-treat – Why? How to self-treat and why?  
 Prompt: If medicine was used, what was it?  
 Prompt: If antibiotics are used, why? Where did you get it? 
 (If applicable) When was the last time that your child had the common cold? 
 
[Management of the Common Cold]  
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30. Would you consider alternative options? (e.g. traditional Chinese medicine? 
Cough medicine? advice to watch and wait?) 
 Prompt: What would you do if doctors tell you that the common cold is a 
self-limiting illness and it would go away naturally? 
 Prompt: What would you do if doctors advise you to watch and wait? 
 Prompt: What would you do if doctors do not prescribe antibiotics for the 
common cold. 
 Prompt: Have you purchased antibiotics in a local pharmacy?  
o If so, what was it for? 
o Did you present a prescription? If so, where did you get the 
prescription? 
o What would you do if you cannot purchase a local pharmacy without 
a doctor’s prescription. 
 Prompt: How confident are you to manage the symptoms of the common 
cold without using [antibiotics]? Why?  
o “I am confident that I can manage the symptoms of the common cold 
for myself” [a 7-point likert scale, 1-7] 
o (If applicable) “I am confident that I can manage the symptoms of the 
common cold for my children” [a 7-point likert scale, 1-7] 
 
[What do people know about antibiotics?]  
31. Have you heard of the medicine “antibiotics”?  
 Prompt: If yes, what are they? When would you need them?  
 Prompt: If yes, where can you get them? How much (price) do they cost? Are 
they affordable? 
32. What do you think of the statement: “antibiotics are anti-inflammatory drugs”?  
33. Which one(s) of the following are antibiotics?  
 Penicillin drugs such as amoxicillin 
 Cephalosporins such as cefaclor/ceftus sodium 
 Non-steroidal drugs such as ibuprofen/merlin/aspirin 
 Dexamethasone/prednisone and other steroids 
 Quinolones such as ofloxacin/norfloxacin 
 Macrolides such as azithromycin/roxithromycin 
34. What do you think of the following statements? 
394 | P a g e  
 
 Infusion is more effective than oral antibiotics. 
 Antibiotics should be stopped immediately when one’s condition improves.
  
 The more expensive the antibiotics, the more Effective.  
 New antibiotics are more effective than old Antibiotics.  
 The imported antibiotics are more effective than domestic.  
35. Structural factors – policy and access: 
 What are the existing policies regarding antibiotic access and use? 
 Where can you get the antibiotics? 
 
[Self-medication with antibiotics]  
36. Have you ever used antibiotics without seeking a doctor first in the past year? 
When and why? 
 Prompt: What did you take? Why? 
 Prompt: For what purpose?  
 Prompt: Where did you get them? Why? 
 Prompt: Did you follow the instructions? Did you complete the course? Why 
or why not? 
 Prompt: Were you concerned that you might have taken wrong medicine? 
Why or why not?* 
 (If applicable) Have you ever let you kid(s) use antibiotics without seeking a 
doctor first in the past year? When? Why? What did you take? How? 
 Prompt: Did you (or your children) experience any adverse effect? 
 
[Keeping antibiotics at home] 
37. Do you currently have antibiotics at home? 
 Prompt: if yes, please specify the name of the specific antibiotics                                       
 Prompt: if yes, why? What do you do with them? 
 Prompt: if yes, where did you get them? Why? 
 Prompt: if yes, how do you store them? 
 Prompt: if yes, did you ever share them with others? What? Whom? Why? 
How? 
 Prompt: if yes, do you dispose them at some point? If so, when and why? 
 Prompt: if yes and used them, what did you use them for? How did you know 
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what to do? How was the experience? 
 Prompt: [Intervention] if yes, if the government encourages “take-back”, 
would you participate in it? What do you think? Why? Why do you think the 
government wants to “take back” antibiotics? 
 
[Recent experience with antibiotics]  
38. When was the last time you took antibiotics? 
 Prompt: What did you take? 
 Prompt: For what purpose? 
 Prompt: Where did you get them? Why?  
 Prompt: What would you do if you cannot get it from a local pharmacy? 
Why? 
 Prompt: Did you follow the instructions? Did you complete the course? 
Why? 
 Prompt: Did you experience any adverse effect? 
 
[AMR Awareness] 
39. Have you heard of the term “antibiotic resistance”? If so, what is it? Where did 
you last hear about it? 
40. Do you agree with any of the following statement? 
 Excessive use of antibiotics is a serious problem in China.            
 Antibiotics are effective in treating viral infections.  
 Antibiotics are effective in the treatment of bacterial infections.  
 The more antibiotics people use, the more difficult it is to cure them later.  
 Overuse of antibiotics can cause bacteria to become resistant to antibiotics.  
 Antibiotic resistance in China will be a serious problem.      
 
[Risk perception - Perceived Severity and Perceived Susceptibility] 
41. Risk Perception –  
 How likely do you think you or your family would be to contract drug-
resistant bacterial infections？[a 7-point likert scale, 1-7]  
 How likely do you think someone in your community would be to contract 
drug-resistant bacterial infections？[a 7-point likert scale, 1-7] 
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 How serious would it be if you or your family member contracted a drug-
resistant bacterial infection？[a 7-point likert scale, 1-7] 
 How serious would it be if someone in your community contracted a drug-
resistant bacterial infection？[a 7-point likert scale, 1-7] 
 How likely do you think you or your family would be to experience adverse 
effect when self-medicating with antibiotics？[a 7-point likert scale, 1-7] 
 How likely do you think someone in your community would be to experience 
adverse effect when self-medicating with antibiotics？[a 7-point likert scale, 
1-7] 
 How serious would it be if you or your family experienced an adverse effect 
when self-medicating with antibiotics？[a 7-point likert scale, 1-7] 
 How serious would it be if someone in your community experienced an 
adverse effect when self-medicating with antibiotics？[a 7-point likert scale, 
1-7] 
 
[Social Norms around treating the common cold and antibiotic use] 
42. Descriptive norm –  
 If your friend or neighbor experienced the symptoms of the common cold, 
what would you say to them? What do you expect them to do? Why? 
 Do you think it is okay to use leftover antibiotics? What would you say if you 
find out your friend or neighbor used leftover antibiotics? Why? 
 Do you think it is okay to ask doctors for antibiotics? What would you say if 
you find out your friend or neighbor asked doctors for antibiotics? Why? 
 Do you think it is okay to self-medicate with antibiotics for the common cold 
symptoms? What would you do if your friend or neighbor self-medicated with 
antibiotics for common cold symptoms? Why? 
 Do you think it is okay to stop taking antibiotics when you feel better? What 
would you do if your friend or neighbor stopped taking antibiotics when they 
feel better? Why? 
43. Injunctive norms -  
 How would your friend or neighbor react when you experience the symptoms 
of the common cold? 
 What do you think others expect you to do when you have leftover antibiotics? 
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How would your friend or neighbor react if you used leftover antibiotics? 
 How would your friend or neighbor react if they learned that you asked doctors 
for antibiotics? 
 How would your friend or neighbor react if they learned that you self-
medicated with antibiotics for the common cold symptoms? 
 How would your friend or neighbor react if you stopped taking antibiotics 
when you felt better? 
 
Part II – Explore local channels for communication 
[Health Communication Channels] 
44. Who are the influencers or trusted messengers in the community? 
45. From where do you usually get health information? Why?  
 Prompt: Do you trust these information sources? How about WeChat? 
 Prompt: Do you share health information? 
 Prompt: If so, what was it? why, and how?  
46. Where do you go on the weekend or after work? Where do community members 
gather? 
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STAKEHOLDERS’ INTERVIEWS 
 
Aims: 
 To understand the context of the proposed intervention 
 To assess the acceptability and feasibility of the proposed intervention 
 
Socio-demographic characteristics 
 Age _______  
 Gender _______ 
 Education Level _______ 
 Medical background_______ 
 Do you have children? _______ If so, age and sex_______? 
 Organisation _______ 
 Position _______ 
 
General 
13. What are the existing policies regarding antibiotic access and use? 
14. Have you heard about “antibiotic resistance”? If so, what is it? 
15. [Risk perception] - 
 How likely do you think you or your family would be to contract drug-
resistant bacterial infections？[a 7-point likert scale, 1-7]  
 How likely do you think someone in your community would be to contract 
drug-resistant bacterial infections？[a 7-point likert scale, 1-7] 
 How serious would it be if you or your family member contracted a drug-
resistant bacterial infection？[a 7-point likert scale, 1-7] 
 How serious would it be if someone in your community contracted a drug-
resistant bacterial infection？[a 7-point likert scale, 1-7] 
 How likely do you think you or your family would be to experience adverse 
effect when self-medicating with antibiotics？[a 7-point likert scale, 1-7] 
 How likely do you think someone in your community would be to experience 
adverse effect when self-medicating with antibiotics？[a 7-point likert scale, 
1-7] 
 How serious would it be if you or your family experienced an adverse effect 
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when self-medicating with antibiotics？[a 7-point likert scale, 1-7] 
 How serious would it be if someone in your community experienced an 
adverse effect when self-medicating with antibiotics？[a 7-point likert scale, 
1-7] 
16. What do you think of the following statements? Why? 
a) The more frequently people use antibiotics, the more difficult it will be to 
treat bacterial infections. 
b) Antibiotic overuse may increase antibiotic resistance. 
c) We will have few antibiotics to use in the future if we don’t use antibiotics 
properly. 
d) Antibiotic overuse is a serious problem in China. 
e) Antibiotic resistance will become a serious problem in China. 
 
Health Education Message Appraisal 
[presenting health education messages] 
17. What are the key messages here?  
 Prompt: What do you think about them? 
 Prompt: Which format do you like the best? 
 Prompt: Would you share this [health information]? Why or why not?  
 Prompt: If so, who would you share this [health information] with? 
How and why? 
 
Content and contextual factors of the intervention:  
18. Who are the influencers or trusted messengers in the community? 
19. From where do you usually get health information? Why? Do you trust these 
information sources? How about WeChat? 
20. Can you tell me about the existing recycling programme(s)? 
 Are you participating in it? Why or why not? What do you think is the purpose 
of this? How is the experience? 
 The infrastructure for a sustainable recycling programme 
 Would you/your agency participate in the antibiotics “take back” programme 
if there is one? Why or why not? 
 If the existing recycling programme to include antibiotics, what do you think 
the reasons are? Would you participate in it? Why or why not? 
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Implementation and evaluation 
21. If we are to implement an education campaign which leads up to an antibiotic “take 
back” programme, what do you think? [feasibility and acceptability] 
 Prompt: Effectiveness: would it work? Why or why not? 
 Prompt: Can you think of any risks? Can we mitigate the risk? 
 Prompt: Potential barriers or resistance? How and why? Possible 
solutions? 
22. Implementation 
 Prompt: Who should implement it? Who should participate in this? 
 Prompt: What would be the resources needed? 
 Prompt: Where do community members gather? 
 Prompt: Where do you go on the weekend or after work?  
 Prompt: What channels and formats for communication and 
dissemination (e.g. social media, radio and television advertisements, 
posters, pamphlets, and presentations at childcare centres/schools, 
newspaper, press conferences, flyers and mailings, community leaders or 
school teachers, and other educational materials)? 
 Prompt: What would be the effective or appropriate channels of 
implementation (e.g. community-based organisations, schools, 
community centres, joining government-sponsored events)?  
23. Evaluation 
 Prompt: Timeline (e.g. coinciding with school calendar year, avoiding the 
major holidays such as the Chinese New Year) 
 Prompt: Behavioural data availability 
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ANTIBIOTIC USE FOR THE COMMON COLD – PILOT TESTING 
OF HEALTH EDUCATION MESSAGES 
[general community members] 
 
Aim: to test and refine health education messaging 
 
Message comprehension  
Step 1: Pre-intervention: AMR-related knowledge assessment (23 items, tested by 
Aim 2 large-scale surveys) and Risk Perception items 
 
Step 2: [To Present AMR-related education information – a pamphlet, a news article, 
or an official statement from local CDC/doctors/school teachers]: 
‐ The danger of AMR and antibiotic misuse in the context of China. 
‐ How to manage the common cold symptoms. 
‐ How to use antibiotics responsibly. 
‐ How to dispose antibiotics properly. 
‐ Antibiotics might change gut environment and affect one’s health 
Step 3: Post-intervention: AMR-related knowledge assessment (23 items, tested by 
Aim 2 large-scale surveys) and Risk Perception items 
 
Appraisal 
8. What are the key messages here?  
 Prompt: What do you think about them? 
9. Diffusion of Innovation 
 Prompt: What do you think of this [health information]? Do you agree, why 
or why not? 
 Prompt: What do you think people would do after receiving this message? 
 Prompt: If someone you know use leftover antibiotics to treat the common 
cold, what would you do and why? 
 Prompt: If someone you know use self-medicate with antibiotics to treat the 
common cold, what would you do and why? 
10. Social Network 
 Prompt: Would you share this [health information]? How and why?  
 Prompt: Who would you share this [health information]? How and why? 
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 Prompt: If your doctor share this [health information] with you, what would 
you do? How about local CDC/relatives/neighbors/immediate family 
members? 
11. Perceived effectiveness 
 Would this [health information] change how you handle the symptoms of the 
common cold for your family? If so, how and why? If not, why? 
 Would this [health information] change how others handle the symptoms of 
the common cold for your family? If so, how and why? If not, why? 
 Would this [health information] change how you use antibiotics (e.g. self-
medication or asking doctors for antibiotics)? If so, how and why? If not, why? 
 Would this [health information] change how others use antibiotics (e.g. self-
medication or asking doctors for antibiotics)? If so, how and why? If not, why? 
 
Delivery of the education intervention 
12. Which format do you like the best? 
13. Who are the influencers or trusted messengers in the community? 
14. Where do you go on the weekend or after work? 
 Prompt: Where do community members gather? 
15. Can you tell me about the existing recycling programme(s)? 
 Prompt: Are you participating in it? Why or why not? What do you think is the 
purpose of this? How is the experience? 
 Prompt: The infrastructure for a sustainable recycling programme 
 Prompt: Would you participate in the antibiotics “take back” programme if 
there is one? Why or why not? 
 Prompt: If the existing recycling programme to include antibiotics, what do 
you think the reasons are? Would you participate in it? Why or why not? 
47. From where do you usually get health information? Why?  
 Prompt: Do you trust these information sources? How about WeChat? 
 Prompt: Do you share health information? 
 Prompt: If so, what was it? why, and how?  
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